| atc_code,atc_name,ddd,uom,adm_r,note | |
| A,ALIMENTARY TRACT AND METABOLISM,NA,NA,NA,NA | |
| A01,STOMATOLOGICAL PREPARATIONS,NA,NA,NA,NA | |
| A01A,STOMATOLOGICAL PREPARATIONS,NA,NA,NA,NA | |
| A01AA,Caries prophylactic agents,NA,NA,NA,NA | |
| A01AA01,sodium fluoride,1.1,mg,O,0.5 mg fluoride | |
| A01AA02,sodium monofluorophosphate,NA,NA,NA,NA | |
| A01AA03,olaflur,1.1,mg,O,NA | |
| A01AA04,stannous fluoride,NA,NA,NA,NA | |
| A01AA30,combinations,NA,NA,NA,NA | |
| A01AA51,"sodium fluoride, combinations",NA,NA,NA,NA | |
| A01AB,Antiinfectives and antiseptics for local oral treatment,NA,NA,NA,NA | |
| A01AB02,hydrogen peroxide,60,mg,O,NA | |
| A01AB03,chlorhexidine,30,mg,O,NA | |
| A01AB04,amphotericin B,40,mg,O,NA | |
| A01AB05,polynoxylin,0.18,g,O,NA | |
| A01AB06,domiphen,3,mg,O,NA | |
| A01AB07,oxyquinoline,80,mg,O,NA | |
| A01AB08,neomycin,NA,NA,NA,NA | |
| A01AB09,miconazole,0.2,g,O,NA | |
| A01AB10,natamycin,20,mg,O,NA | |
| A01AB11,various,NA,NA,NA,NA | |
| A01AB12,hexetidine,NA,NA,NA,NA | |
| A01AB13,tetracycline,NA,NA,NA,NA | |
| A01AB14,benzoxonium chloride,NA,NA,NA,NA | |
| A01AB15,tibezonium iodide,NA,NA,NA,NA | |
| A01AB16,mepartricin,NA,NA,NA,NA | |
| A01AB17,metronidazole,NA,NA,NA,NA | |
| A01AB18,clotrimazole,NA,NA,NA,NA | |
| A01AB19,sodium perborate,NA,NA,NA,NA | |
| A01AB21,chlortetracycline,NA,NA,NA,NA | |
| A01AB22,doxycycline,NA,NA,NA,NA | |
| A01AB23,minocycline,1,mg,O,NA | |
| A01AC,Corticosteroids for local oral treatment,NA,NA,NA,NA | |
| A01AC01,triamcinolone,NA,NA,NA,NA | |
| A01AC02,dexamethasone,NA,NA,NA,NA | |
| A01AC03,hydrocortisone,NA,NA,NA,NA | |
| A01AC54,"prednisolone, combinations",NA,NA,NA,NA | |
| A01AD,Other agents for local oral treatment,NA,NA,NA,NA | |
| A01AD01,epinephrine,NA,NA,NA,NA | |
| A01AD02,benzydamine,NA,NA,NA,NA | |
| A01AD05,acetylsalicylic acid,NA,NA,NA,NA | |
| A01AD06,adrenalone,NA,NA,NA,NA | |
| A01AD07,amlexanox,NA,NA,NA,NA | |
| A01AD08,becaplermin,NA,NA,NA,NA | |
| A01AD11,various,NA,NA,NA,NA | |
| A02,DRUGS FOR ACID RELATED DISORDERS,NA,NA,NA,NA | |
| A02A,ANTACIDS,NA,NA,NA,NA | |
| A02AA,Magnesium compounds,NA,NA,NA,NA | |
| A02AA01,magnesium carbonate,NA,NA,NA,NA | |
| A02AA02,magnesium oxide,NA,NA,NA,NA | |
| A02AA03,magnesium peroxide,NA,NA,NA,NA | |
| A02AA04,magnesium hydroxide,3,g,O,NA | |
| A02AA05,magnesium silicate,NA,NA,NA,NA | |
| A02AA10,combinations,NA,NA,NA,NA | |
| A02AB,Aluminium compounds,NA,NA,NA,NA | |
| A02AB01,aluminium hydroxide,NA,NA,NA,NA | |
| A02AB02,algeldrate,5,g,O,NA | |
| A02AB03,aluminium phosphate,NA,NA,NA,NA | |
| A02AB04,dihydroxialumini sodium carbonate,4,g,O,NA | |
| A02AB05,aluminium acetoacetate,NA,NA,NA,NA | |
| A02AB06,aloglutamol,NA,NA,NA,NA | |
| A02AB07,aluminium glycinate,NA,NA,NA,NA | |
| A02AB10,combinations,NA,NA,NA,NA | |
| A02AC,Calcium compounds,NA,NA,NA,NA | |
| A02AC01,calcium carbonate,NA,NA,NA,NA | |
| A02AC02,calcium silicate,6,g,O,NA | |
| A02AC10,combinations,NA,NA,NA,NA | |
| A02AD,"Combinations and complexes of aluminium, calcium and magnesium compounds",NA,NA,NA,NA | |
| A02AD01,ordinary salt combinations,NA,NA,NA,Standard dose: 10 tablets or 50 ml mixt | |
| A02AD02,magaldrate,NA,NA,NA,NA | |
| A02AD03,almagate,NA,NA,NA,NA | |
| A02AD04,hydrotalcite,NA,NA,NA,NA | |
| A02AD05,almasilate,NA,NA,NA,NA | |
| A02AF,Antacids with antiflatulents,NA,NA,NA,NA | |
| A02AF01,magaldrate and antiflatulents,NA,NA,NA,NA | |
| A02AF02,ordinary salt combinations and antiflatulents,NA,NA,NA,NA | |
| A02AG,Antacids with antispasmodics,NA,NA,NA,NA | |
| A02AH,Antacids with sodium bicarbonate,NA,NA,NA,NA | |
| A02AX,"Antacids, other combinations",NA,NA,NA,NA | |
| A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),NA,NA,NA,NA | |
| A02BA,H2-receptor antagonists,NA,NA,NA,NA | |
| A02BA01,cimetidine,0.8,g,O,NA | |
| A02BA01,cimetidine,0.8,g,P,NA | |
| A02BA02,ranitidine,0.3,g,O,NA | |
| A02BA02,ranitidine,0.3,g,P,NA | |
| A02BA03,famotidine,40,mg,O,NA | |
| A02BA03,famotidine,40,mg,P,NA | |
| A02BA04,nizatidine,0.3,g,O,NA | |
| A02BA04,nizatidine,0.3,g,P,NA | |
| A02BA05,niperotidine,NA,NA,NA,NA | |
| A02BA06,roxatidine,0.15,g,O,NA | |
| A02BA07,ranitidine bismuth citrate,0.8,g,O,NA | |
| A02BA08,lafutidine,20,mg,O,NA | |
| A02BA51,"cimetidine, combinations",NA,NA,NA,NA | |
| A02BA53,"famotidine, combinations",NA,NA,NA,NA | |
| A02BB,Prostaglandins,NA,NA,NA,NA | |
| A02BB01,misoprostol,0.8,mg,O,NA | |
| A02BB02,enprostil,70,mcg,O,NA | |
| A02BC,Proton pump inhibitors,NA,NA,NA,NA | |
| A02BC01,omeprazole,20,mg,O,NA | |
| A02BC01,omeprazole,20,mg,P,NA | |
| A02BC02,pantoprazole,40,mg,O,NA | |
| A02BC02,pantoprazole,40,mg,P,NA | |
| A02BC03,lansoprazole,30,mg,O,NA | |
| A02BC04,rabeprazole,20,mg,O,NA | |
| A02BC05,esomeprazole,30,mg,O,NA | |
| A02BC05,esomeprazole,30,mg,P,NA | |
| A02BC06,dexlansoprazole,30,mg,O,NA | |
| A02BC07,dexrabeprazole,NA,NA,NA,NA | |
| A02BC08,vonoprazan,NA,NA,NA,NA | |
| A02BC53,"lansoprazole, combinations",NA,NA,NA,NA | |
| A02BC54,"rabeprazole, combinations",NA,NA,NA,NA | |
| A02BD,Combinations for eradication of Helicobacter pylori,NA,NA,NA,NA | |
| A02BD01,"omeprazole, amoxicillin and metronidazole",NA,NA,NA,NA | |
| A02BD02,"lansoprazole, tetracycline and metronidazole",NA,NA,NA,NA | |
| A02BD03,"lansoprazole, amoxicillin and metronidazole",NA,NA,NA,NA | |
| A02BD04,"pantoprazole, amoxicillin and clarithromycin",NA,NA,NA,NA | |
| A02BD05,"omeprazole, amoxicillin and clarithromycin",NA,NA,NA,NA | |
| A02BD06,"esomeprazole, amoxicillin and clarithromycin",NA,NA,NA,NA | |
| A02BD07,"lansoprazole, amoxicillin and clarithromycin",NA,NA,NA,NA | |
| A02BD08,"bismuth subcitrate, tetracycline and metronidazole",NA,NA,NA,NA | |
| A02BD09,"lansoprazole, clarithromycin and tinidazole",NA,NA,NA,NA | |
| A02BD10,"lansoprazole, amoxicillin and levofloxacin",NA,NA,NA,NA | |
| A02BD11,"pantoprazole, amoxicillin, clarithromycin and metronidazole",NA,NA,NA,NA | |
| A02BD12,"rabeprazole, amoxicillin and clarithromycin",NA,NA,NA,NA | |
| A02BD13,"rabeprazole, amoxicillin and metronidazole",NA,NA,NA,NA | |
| A02BD14,"vonoprazan, amoxicillin and clarithromycin",NA,NA,NA,NA | |
| A02BD15,"vonoprazan, amoxicillin and metronidazole",NA,NA,NA,NA | |
| A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),NA,NA,NA,NA | |
| A02BX01,carbenoxolone,0.15,g,O,NA | |
| A02BX02,sucralfate,4,g,O,NA | |
| A02BX03,pirenzepine,0.1,g,O,NA | |
| A02BX03,pirenzepine,20,mg,P,NA | |
| A02BX04,methiosulfonium chloride,NA,NA,NA,NA | |
| A02BX05,bismuth subcitrate,0.48,g,O,NA | |
| A02BX06,proglumide,1.2,g,O,NA | |
| A02BX07,gefarnate,NA,NA,NA,NA | |
| A02BX08,sulglicotide,NA,NA,NA,NA | |
| A02BX09,acetoxolone,NA,NA,NA,NA | |
| A02BX10,zolimidine,NA,NA,NA,NA | |
| A02BX11,troxipide,NA,NA,NA,NA | |
| A02BX12,bismuth subnitrate,NA,NA,NA,NA | |
| A02BX13,alginic acid,NA,NA,NA,NA | |
| A02BX14,rebamipide,0.3,g,O,NA | |
| A02BX51,"carbenoxolone, combinations excl. psycholeptics",NA,NA,NA,NA | |
| A02BX71,"carbenoxolone, combinations with psycholeptics",NA,NA,NA,NA | |
| A02BX77,"gefarnate, combinations with psycholeptics",NA,NA,NA,NA | |
| A02X,OTHER DRUGS FOR ACID RELATED DISORDERS,NA,NA,NA,NA | |
| A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,NA,NA,NA,NA | |
| A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,NA,NA,NA,NA | |
| A03AA,"Synthetic anticholinergics, esters with tertiary amino group",NA,NA,NA,NA | |
| A03AA01,oxyphencyclimine,20,mg,O,NA | |
| A03AA03,camylofin,0.2,g,O,NA | |
| A03AA03,camylofin,0.2,g,R,NA | |
| A03AA04,mebeverine,0.3,g,O,NA | |
| A03AA05,trimebutine,0.6,g,O,NA | |
| A03AA06,rociverine,NA,NA,NA,NA | |
| A03AA07,dicycloverine,80,mg,O,NA | |
| A03AA07,dicycloverine,80,mg,P,NA | |
| A03AA08,dihexyverine,NA,NA,NA,NA | |
| A03AA09,difemerine,NA,NA,NA,NA | |
| A03AA30,piperidolate,NA,NA,NA,NA | |
| A03AB,"Synthetic anticholinergics, quaternary ammonium compounds",NA,NA,NA,NA | |
| A03AB01,benzilone,70,mg,O,NA | |
| A03AB02,glycopyrronium bromide,3,mg,O,NA | |
| A03AB02,glycopyrronium bromide,0.3,mg,P,NA | |
| A03AB02,glycopyrronium bromide,3,mg,R,NA | |
| A03AB03,oxyphenonium,25,mg,O,NA | |
| A03AB04,penthienate,15,mg,O,NA | |
| A03AB05,propantheline,60,mg,O,NA | |
| A03AB05,propantheline,60,mg,P,NA | |
| A03AB06,otilonium bromide,NA,NA,NA,NA | |
| A03AB07,methantheline,0.15,g,O,NA | |
| A03AB08,tridihexethyl,0.125,g,O,NA | |
| A03AB09,isopropamide,10,mg,O,NA | |
| A03AB10,hexocyclium,0.15,g,O,NA | |
| A03AB11,poldine,12,mg,O,NA | |
| A03AB12,mepenzolate,0.1,g,O,NA | |
| A03AB13,bevonium,0.2,g,O,NA | |
| A03AB14,pipenzolate,20,mg,O,NA | |
| A03AB15,diphemanil,NA,NA,NA,NA | |
| A03AB16,(2-benzhydryloxyethyl)diethyl-methylammonium iodide,0.3,g,O,NA | |
| A03AB17,tiemonium iodide,NA,NA,NA,NA | |
| A03AB18,prifinium bromide,NA,NA,NA,NA | |
| A03AB19,timepidium bromide,NA,NA,NA,NA | |
| A03AB21,fenpiverinium,NA,NA,NA,NA | |
| A03AB53,"oxyphenonium, combinations",NA,NA,NA,NA | |
| A03AC,"Synthetic antispasmodics, amides with tertiary amines",NA,NA,NA,NA | |
| A03AC02,dimethylaminopropionylphenothiazine,NA,NA,NA,NA | |
| A03AC04,nicofetamide,NA,NA,NA,NA | |
| A03AC05,tiropramide,NA,NA,NA,NA | |
| A03AD,Papaverine and derivatives,NA,NA,NA,NA | |
| A03AD01,papaverine,0.1,g,O,NA | |
| A03AD01,papaverine,0.1,g,P,NA | |
| A03AD02,drotaverine,0.1,g,O,NA | |
| A03AD02,drotaverine,0.1,g,P,NA | |
| A03AD30,moxaverine,50,mg,O,NA | |
| A03AE,Serotonin receptor antagonists,NA,NA,NA,NA | |
| A03AE01,alosetron,1,mg,O,NA | |
| A03AE03,cilansetron,NA,NA,NA,NA | |
| A03AX,Other drugs for functional gastrointestinal disorders,NA,NA,NA,NA | |
| A03AX01,fenpiprane,NA,NA,NA,NA | |
| A03AX02,diisopromine,NA,NA,NA,NA | |
| A03AX03,chlorbenzoxamine,0.15,g,O,NA | |
| A03AX04,pinaverium,0.15,g,O,NA | |
| A03AX05,fenoverine,NA,NA,NA,NA | |
| A03AX06,idanpramine,NA,NA,NA,NA | |
| A03AX07,proxazole,NA,NA,NA,NA | |
| A03AX08,alverine,NA,NA,NA,NA | |
| A03AX09,trepibutone,NA,NA,NA,NA | |
| A03AX10,isometheptene,NA,NA,NA,NA | |
| A03AX11,caroverine,NA,NA,NA,NA | |
| A03AX12,phloroglucinol,NA,NA,NA,NA | |
| A03AX13,silicones,0.5,g,O,NA | |
| A03AX14,valethamate,NA,NA,NA,NA | |
| A03AX15,menthae piperitae aetheroleum,NA,NA,NA,NA | |
| A03AX30,trimethyldiphenylpropylamine,50,mg,O,NA | |
| A03AX30,trimethyldiphenylpropylamine,50,mg,P,NA | |
| A03AX58,"alverine, combinations",NA,NA,NA,NA | |
| A03B,"BELLADONNA AND DERIVATIVES, PLAIN",NA,NA,NA,NA | |
| A03BA,"Belladonna alkaloids, tertiary amines",NA,NA,NA,NA | |
| A03BA01,atropine,1.5,mg,O,NA | |
| A03BA01,atropine,1.5,mg,P,NA | |
| A03BA03,hyoscyamine,1.2,mg,O,NA | |
| A03BA04,belladonna total alkaloids,1,mg,O,NA | |
| A03BB,"Belladonna alkaloids, semisynthetic, quaternary ammonium compounds",NA,NA,NA,NA | |
| A03BB01,butylscopolamine,60,mg,O,NA | |
| A03BB01,butylscopolamine,60,mg,P,NA | |
| A03BB01,butylscopolamine,60,mg,R,NA | |
| A03BB02,methylatropine,3,mg,O,NA | |
| A03BB03,methylscopolamine,12,mg,O,NA | |
| A03BB03,methylscopolamine,12,mg,P,NA | |
| A03BB04,fentonium,60,mg,O,NA | |
| A03BB05,cimetropium bromide,NA,NA,NA,NA | |
| A03BB06,homatropine methylbromide,NA,NA,NA,NA | |
| A03C,ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS,NA,NA,NA,NA | |
| A03CA,Synthetic anticholinergic agents in combination with psycholeptics,NA,NA,NA,NA | |
| A03CA01,isopropamide and psycholeptics,NA,NA,NA,NA | |
| A03CA02,clidinium and psycholeptics,NA,NA,NA,NA | |
| A03CA03,oxyphencyclimine and psycholeptics,NA,NA,NA,NA | |
| A03CA04,otilonium bromide and psycholeptics,NA,NA,NA,NA | |
| A03CA05,glycopyrronium bromide and psycholeptics,NA,NA,NA,NA | |
| A03CA06,bevonium and psycholeptics,NA,NA,NA,NA | |
| A03CA07,ambutonium and psycholeptics,NA,NA,NA,NA | |
| A03CA08,diphemanil and psycholeptics,NA,NA,NA,NA | |
| A03CA09,pipenzolate and psycholeptics,NA,NA,NA,NA | |
| A03CA30,emepronium and psycholeptics,NA,NA,NA,NA | |
| A03CA34,propantheline and psycholeptics,NA,NA,NA,NA | |
| A03CB,Belladonna and derivatives in combination with psycholeptics,NA,NA,NA,NA | |
| A03CB01,methylscopolamine and psycholeptics,NA,NA,NA,NA | |
| A03CB02,belladonna total alkaloids and psycholeptics,NA,NA,NA,NA | |
| A03CB03,atropine and psycholeptics,NA,NA,NA,NA | |
| A03CB04,homatropine methylbromide and psycholeptics,NA,NA,NA,NA | |
| A03CB31,hyoscyamine and psycholeptics,NA,NA,NA,NA | |
| A03CC,Other antispasmodics in combination with psycholeptics,NA,NA,NA,NA | |
| A03D,ANTISPASMODICS IN COMBINATION WITH ANALGESICS,NA,NA,NA,NA | |
| A03DA,Synthetic anticholinergic agents in combination with analgesics,NA,NA,NA,NA | |
| A03DA01,tropenzilone and analgesics,NA,NA,NA,NA | |
| A03DA02,pitofenone and analgesics,NA,NA,NA,NA | |
| A03DA03,bevonium and analgesics,NA,NA,NA,NA | |
| A03DA04,ciclonium and analgesics,NA,NA,NA,NA | |
| A03DA05,camylofin and analgesics,NA,NA,NA,NA | |
| A03DA06,trospium and analgesics,NA,NA,NA,NA | |
| A03DA07,tiemonium iodide and analgesics,NA,NA,NA,NA | |
| A03DB,Belladonna and derivatives in combination with analgesics,NA,NA,NA,NA | |
| A03DB04,butylscopolamine and analgesics,NA,NA,NA,NA | |
| A03DC,Other antispasmodics in combination with analgesics,NA,NA,NA,NA | |
| A03E,ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS,NA,NA,NA,NA | |
| A03EA,"Antispasmodics, psycholeptics and analgesics in combination",NA,NA,NA,NA | |
| A03ED,Antispasmodics in combination with other drugs,NA,NA,NA,NA | |
| A03F,PROPULSIVES,NA,NA,NA,NA | |
| A03FA,Propulsives,NA,NA,NA,NA | |
| A03FA01,metoclopramide,30,mg,O,NA | |
| A03FA01,metoclopramide,30,mg,P,NA | |
| A03FA01,metoclopramide,30,mg,R,NA | |
| A03FA02,cisapride,30,mg,O,NA | |
| A03FA02,cisapride,30,mg,R,NA | |
| A03FA03,domperidone,30,mg,O,NA | |
| A03FA03,domperidone,30,mg,P,NA | |
| A03FA03,domperidone,0.12,g,R,NA | |
| A03FA04,bromopride,20,mg,O,NA | |
| A03FA04,bromopride,20,mg,P,NA | |
| A03FA05,alizapride,0.15,g,O,NA | |
| A03FA05,alizapride,0.15,g,P,NA | |
| A03FA06,clebopride,NA,NA,NA,NA | |
| A03FA07,itopride,NA,NA,NA,NA | |
| A03FA08,cinitapride,NA,NA,NA,NA | |
| A03FA09,mosapride,NA,NA,NA,NA | |
| A04,ANTIEMETICS AND ANTINAUSEANTS,NA,NA,NA,NA | |
| A04A,ANTIEMETICS AND ANTINAUSEANTS,NA,NA,NA,NA | |
| A04AA,Serotonin (5HT3) antagonists,NA,NA,NA,NA | |
| A04AA01,ondansetron,16,mg,O,NA | |
| A04AA01,ondansetron,16,mg,P,NA | |
| A04AA01,ondansetron,16,mg,R,NA | |
| A04AA02,granisetron,2,mg,O,NA | |
| A04AA02,granisetron,3,mg,P,NA | |
| A04AA02,granisetron,3.1,mg,TD,NA | |
| A04AA03,tropisetron,5,mg,O,NA | |
| A04AA03,tropisetron,5,mg,P,NA | |
| A04AA04,dolasetron,0.2,g,O,NA | |
| A04AA04,dolasetron,0.1,g,P,NA | |
| A04AA05,palonosetron,0.5,mg,O,NA | |
| A04AA05,palonosetron,0.25,mg,P,NA | |
| A04AA55,"palonosetron, combinations",NA,NA,NA,NA | |
| A04AD,Other antiemetics,NA,NA,NA,NA | |
| A04AD01,scopolamine,NA,NA,NA,NA | |
| A04AD02,cerium oxalate,NA,NA,NA,NA | |
| A04AD04,chlorobutanol,NA,NA,NA,NA | |
| A04AD05,metopimazine,15,mg,O,NA | |
| A04AD05,metopimazine,15,mg,P,NA | |
| A04AD10,dronabinol,NA,NA,NA,NA | |
| A04AD11,nabilone,3,mg,O,NA | |
| A04AD12,aprepitant,165,mg,O,NA | |
| A04AD12,aprepitant,150,mg,P,Refers to fosaprepitant | |
| A04AD13,casopitant,NA,NA,NA,NA | |
| A04AD14,rolapitant,0.18,g,O,NA | |
| A04AD51,"scopolamine, combinations",NA,NA,NA,NA | |
| A04AD54,"chlorobutanol, combinations",NA,NA,NA,NA | |
| A05,BILE AND LIVER THERAPY,NA,NA,NA,NA | |
| A05A,BILE THERAPY,NA,NA,NA,NA | |
| A05AA,Bile acids and derivatives,NA,NA,NA,NA | |
| A05AA01,chenodeoxycholic acid,1,g,O,NA | |
| A05AA02,ursodeoxycholic acid,0.75,g,O,NA | |
| A05AA03,cholic acid,NA,NA,NA,NA | |
| A05AA04,obeticholic acid,10,mg,O,NA | |
| A05AB,Preparations for biliary tract therapy,NA,NA,NA,NA | |
| A05AB01,nicotinyl methylamide,NA,NA,NA,NA | |
| A05AX,Other drugs for bile therapy,NA,NA,NA,NA | |
| A05AX01,piprozolin,NA,NA,NA,NA | |
| A05AX02,hymecromone,NA,NA,NA,NA | |
| A05AX03,cyclobutyrol,NA,NA,NA,NA | |
| A05B,"LIVER THERAPY, LIPOTROPICS",NA,NA,NA,NA | |
| A05BA,Liver therapy,NA,NA,NA,NA | |
| A05BA01,arginine glutamate,NA,NA,NA,NA | |
| A05BA03,silymarin,NA,NA,NA,NA | |
| A05BA04,citiolone,NA,NA,NA,NA | |
| A05BA05,epomediol,NA,NA,NA,NA | |
| A05BA06,ornithine oxoglurate,NA,NA,NA,NA | |
| A05BA07,tidiacic arginine,NA,NA,NA,NA | |
| A05BA08,glycyrrhizic acid,NA,NA,NA,NA | |
| A05BA09,metadoxine,NA,NA,NA,NA | |
| A05C,DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION,NA,NA,NA,NA | |
| A06,DRUGS FOR CONSTIPATION,NA,NA,NA,NA | |
| A06A,DRUGS FOR CONSTIPATION,NA,NA,NA,NA | |
| A06AA,"Softeners, emollients",NA,NA,NA,NA | |
| A06AA01,liquid paraffin,15,g,O,NA | |
| A06AA02,docusate sodium,0.15,g,O,NA | |
| A06AA51,"liquid paraffin, combinations",NA,NA,NA,NA | |
| A06AB,Contact laxatives,NA,NA,NA,NA | |
| A06AB01,oxyphenisatine,10,mg,O,NA | |
| A06AB02,bisacodyl,10,mg,O,NA | |
| A06AB02,bisacodyl,10,mg,R,NA | |
| A06AB03,dantron,50,mg,O,NA | |
| A06AB04,phenolphthalein,0.2,g,O,NA | |
| A06AB05,castor oil,20,g,O,NA | |
| A06AB06,senna glycosides,NA,NA,NA,NA | |
| A06AB07,cascara,NA,NA,NA,NA | |
| A06AB08,sodium picosulfate,5,mg,O,NA | |
| A06AB09,bisoxatin,0.12,g,O,NA | |
| A06AB20,contact laxatives in combination,NA,NA,NA,NA | |
| A06AB30,contact laxatives in combination with belladonna alkaloids,NA,NA,NA,NA | |
| A06AB52,"bisacodyl, combinations",NA,NA,NA,NA | |
| A06AB53,"dantron, combinations",NA,NA,NA,NA | |
| A06AB56,"senna glycosides, combinations",NA,NA,NA,NA | |
| A06AB57,"cascara, combinations",NA,NA,NA,NA | |
| A06AB58,"sodium picosulfate, combinations",NA,NA,NA,NA | |
| A06AC,Bulk-forming laxatives,NA,NA,NA,NA | |
| A06AC01,ispaghula (psylla seeds),7,g,O,NA | |
| A06AC02,ethulose,3,g,O,NA | |
| A06AC03,sterculia,8,g,O,NA | |
| A06AC05,linseed,NA,NA,NA,NA | |
| A06AC06,methylcellulose,2,g,O,NA | |
| A06AC07,triticum (wheat fibre),10,g,O,NA | |
| A06AC08,polycarbophil calcium,2.5,g,O,NA | |
| A06AC51,"ispaghula, combinations",NA,NA,NA,NA | |
| A06AC53,"sterculia, combinations",NA,NA,NA,NA | |
| A06AC55,"linseed, combinations",NA,NA,NA,NA | |
| A06AD,Osmotically acting laxatives,NA,NA,NA,NA | |
| A06AD01,magnesium carbonate,7,g,O,NA | |
| A06AD02,magnesium oxide,7,g,O,NA | |
| A06AD03,magnesium peroxide,NA,NA,NA,NA | |
| A06AD04,magnesium sulfate,7,g,O,NA | |
| A06AD10,mineral salts in combination,NA,NA,NA,NA | |
| A06AD11,lactulose,6.7,g,O,NA | |
| A06AD12,lactitol,10,g,O,NA | |
| A06AD13,sodium sulfate,NA,NA,NA,NA | |
| A06AD14,pentaerithrityl,NA,NA,NA,NA | |
| A06AD15,macrogol,10,g,O,NA | |
| A06AD16,mannitol,NA,NA,NA,NA | |
| A06AD17,sodium phosphate,50,g,O,NA | |
| A06AD18,sorbitol,10,g,O,NA | |
| A06AD19,magnesium citrate,NA,NA,NA,NA | |
| A06AD21,sodium tartrate,NA,NA,NA,NA | |
| A06AD61,"lactulose, combinations",NA,NA,NA,NA | |
| A06AD65,"macrogol, combinations",NA,NA,NA,NA | |
| A06AG,Enemas,NA,NA,NA,NA | |
| A06AG01,sodium phosphate,NA,NA,NA,NA | |
| A06AG02,bisacodyl,NA,NA,NA,NA | |
| A06AG03,"dantron, incl. combinations",NA,NA,NA,NA | |
| A06AG04,glycerol,NA,NA,NA,NA | |
| A06AG06,oil,NA,NA,NA,NA | |
| A06AG07,sorbitol,NA,NA,NA,NA | |
| A06AG10,"docusate sodium, incl. combinations",NA,NA,NA,NA | |
| A06AG11,"sodium lauryl sulfoacetate, incl. combinations",NA,NA,NA,NA | |
| A06AG20,combinations,NA,NA,NA,NA | |
| A06AH,Peripheral opioid receptor antagonists,NA,NA,NA,NA | |
| A06AH01,methylnaltrexone bromide,6,mg,P,NA | |
| A06AH02,alvimopan,NA,NA,NA,NA | |
| A06AH03,naloxegol,25,mg,O,NA | |
| A06AH04,naloxone,NA,NA,NA,NA | |
| A06AH05,naldemedine,0.2,mg,O,NA | |
| A06AX,Other drugs for constipation,NA,NA,NA,NA | |
| A06AX01,glycerol,NA,NA,NA,NA | |
| A06AX02,carbon dioxide producing drugs,NA,NA,NA,NA | |
| A06AX03,lubiprostone,NA,NA,NA,NA | |
| A06AX04,linaclotide,0.29,mg,O,NA | |
| A06AX05,prucalopride,2,mg,O,NA | |
| A06AX06,tegaserod,12,mg,O,NA | |
| A06AX07,plecanatide,3,mg,O,NA | |
| A06AX08,tenapanor,NA,NA,NA,NA | |
| A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",NA,NA,NA,NA | |
| A07A,INTESTINAL ANTIINFECTIVES,NA,NA,NA,NA | |
| A07AA,Antibiotics,NA,NA,NA,NA | |
| A07AA01,neomycin,5,g,O,NA | |
| A07AA02,nystatin,1.5,MU,O,NA | |
| A07AA03,natamycin,0.3,g,O,NA | |
| A07AA04,streptomycin,NA,NA,NA,NA | |
| A07AA05,polymyxin B,3,MU,O,NA | |
| A07AA06,paromomycin,3,g,O,NA | |
| A07AA07,amphotericin B,0.4,g,O,NA | |
| A07AA08,kanamycin,3,g,O,NA | |
| A07AA09,vancomycin,2,g,O,NA | |
| A07AA10,colistin,9,MU,O,NA | |
| A07AA11,rifaximin,0.6,g,O,NA | |
| A07AA12,fidaxomicin,0.4,g,O,NA | |
| A07AA13,rifamycin,NA,NA,NA,NA | |
| A07AA51,"neomycin, combinations",NA,NA,NA,NA | |
| A07AA54,"streptomycin, combinations",NA,NA,NA,NA | |
| A07AB,Sulfonamides,NA,NA,NA,NA | |
| A07AB02,phthalylsulfathiazole,9,g,O,NA | |
| A07AB03,sulfaguanidine,4,g,O,NA | |
| A07AB04,succinylsulfathiazole,NA,NA,NA,NA | |
| A07AC,Imidazole derivatives,NA,NA,NA,NA | |
| A07AC01,miconazole,1,g,O,NA | |
| A07AX,Other intestinal antiinfectives,NA,NA,NA,NA | |
| A07AX01,broxyquinoline,NA,NA,NA,NA | |
| A07AX02,acetarsol,NA,NA,NA,NA | |
| A07AX03,nifuroxazide,0.6,g,O,NA | |
| A07AX04,nifurzide,NA,NA,NA,NA | |
| A07B,INTESTINAL ADSORBENTS,NA,NA,NA,NA | |
| A07BA,Charcoal preparations,NA,NA,NA,NA | |
| A07BA01,medicinal charcoal,5,g,O,NA | |
| A07BA51,"medicinal charcoal, combinations",NA,NA,NA,NA | |
| A07BB,Bismuth preparations,NA,NA,NA,NA | |
| A07BC,Other intestinal adsorbents,NA,NA,NA,NA | |
| A07BC01,pectin,NA,NA,NA,NA | |
| A07BC02,kaolin,NA,NA,NA,NA | |
| A07BC03,crospovidone,NA,NA,NA,NA | |
| A07BC04,attapulgite,NA,NA,NA,NA | |
| A07BC05,diosmectite,9,g,O,NA | |
| A07BC30,combinations,NA,NA,NA,NA | |
| A07BC54,"attapulgite, combinations",NA,NA,NA,NA | |
| A07C,ELECTROLYTES WITH CARBOHYDRATES,NA,NA,NA,NA | |
| A07CA,Oral rehydration salt formulations,NA,NA,NA,NA | |
| A07D,ANTIPROPULSIVES,NA,NA,NA,NA | |
| A07DA,Antipropulsives,NA,NA,NA,NA | |
| A07DA01,diphenoxylate,15,mg,O,NA | |
| A07DA02,opium,0.1,g,O,NA | |
| A07DA03,loperamide,10,mg,O,NA | |
| A07DA04,difenoxin,NA,NA,NA,NA | |
| A07DA05,loperamide oxide,5,mg,O,NA | |
| A07DA06,eluxadoline,0.2,g,O,NA | |
| A07DA52,"morphine, combinations",NA,NA,NA,NA | |
| A07DA53,"loperamide, combinations",NA,NA,NA,NA | |
| A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,NA,NA,NA,NA | |
| A07EA,Corticosteroids acting locally,NA,NA,NA,NA | |
| A07EA01,prednisolone,NA,NA,NA,NA | |
| A07EA02,hydrocortisone,NA,NA,NA,NA | |
| A07EA03,prednisone,NA,NA,NA,NA | |
| A07EA04,betamethasone,NA,NA,NA,NA | |
| A07EA05,tixocortol,NA,NA,NA,NA | |
| A07EA06,budesonide,9,mg,O,NA | |
| A07EA06,budesonide,2,mg,SL,NA | |
| A07EA07,beclometasone,NA,NA,NA,NA | |
| A07EB,"Antiallergic agents, excl. corticosteroids",NA,NA,NA,NA | |
| A07EB01,cromoglicic acid,0.8,g,O,NA | |
| A07EC,Aminosalicylic acid and similar agents,NA,NA,NA,NA | |
| A07EC01,sulfasalazine,2,g,O,NA | |
| A07EC01,sulfasalazine,2,g,R,NA | |
| A07EC02,mesalazine,1.5,g,O,NA | |
| A07EC02,mesalazine,1.5,g,R,NA | |
| A07EC03,olsalazine,1,g,O,NA | |
| A07EC04,balsalazide,6.75,g,O,NA | |
| A07F,ANTIDIARRHEAL MICROORGANISMS,NA,NA,NA,NA | |
| A07FA,Antidiarrheal microorganisms,NA,NA,NA,NA | |
| A07FA01,lactic acid producing organisms,NA,NA,NA,NA | |
| A07FA02,saccharomyces boulardii,1,g,O,NA | |
| A07FA51,"lactic acid producing organisms, combinations",NA,NA,NA,NA | |
| A07X,OTHER ANTIDIARRHEALS,NA,NA,NA,NA | |
| A07XA,Other antidiarrheals,NA,NA,NA,NA | |
| A07XA01,albumin tannate,3,g,O,NA | |
| A07XA02,ceratonia,NA,NA,NA,NA | |
| A07XA03,calcium compounds,NA,NA,NA,NA | |
| A07XA04,racecadotril,NA,NA,NA,NA | |
| A07XA06,crofelemer,NA,NA,NA,NA | |
| A07XA51,"albumin tannate, combinations",NA,NA,NA,NA | |
| A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",NA,NA,NA,NA | |
| A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",NA,NA,NA,NA | |
| A08AA,Centrally acting antiobesity products,NA,NA,NA,NA | |
| A08AA01,phentermine,15,mg,O,NA | |
| A08AA02,fenfluramine,0.12,g,O,NA | |
| A08AA03,amfepramone,75,mg,O,NA | |
| A08AA04,dexfenfluramine,30,mg,O,NA | |
| A08AA05,mazindol,1,mg,O,NA | |
| A08AA06,etilamfetamine,NA,NA,NA,NA | |
| A08AA07,cathine,NA,NA,NA,NA | |
| A08AA08,clobenzorex,NA,NA,NA,NA | |
| A08AA09,mefenorex,NA,NA,NA,NA | |
| A08AA10,sibutramine,10,mg,O,NA | |
| A08AA11,lorcaserin,NA,NA,NA,NA | |
| A08AA56,"ephedrine, combinations",NA,NA,NA,NA | |
| A08AA62,bupropion and naltrexone,NA,NA,NA,NA | |
| A08AB,Peripherally acting antiobesity products,NA,NA,NA,NA | |
| A08AB01,orlistat,0.36,g,O,NA | |
| A08AX,Other antiobesity drugs,NA,NA,NA,NA | |
| A08AX01,rimonabant,20,mg,O,NA | |
| A09,"DIGESTIVES, INCL. ENZYMES",NA,NA,NA,NA | |
| A09A,"DIGESTIVES, INCL. ENZYMES",NA,NA,NA,NA | |
| A09AA,Enzyme preparations,NA,NA,NA,NA | |
| A09AA01,diastase,NA,NA,NA,NA | |
| A09AA02,"multienzymes (lipase, protease etc.)",NA,NA,NA,NA | |
| A09AA03,pepsin,NA,NA,NA,NA | |
| A09AA04,tilactase,NA,NA,NA,NA | |
| A09AB,Acid preparations,NA,NA,NA,NA | |
| A09AB01,glutamic acid hydrochloride,1.5,g,O,NA | |
| A09AB02,betaine hydrochloride,1,g,O,NA | |
| A09AB03,hydrochloric acid,NA,NA,NA,NA | |
| A09AB04,citric acid,2,g,O,NA | |
| A09AC,"Enzyme and acid preparations, combinations",NA,NA,NA,NA | |
| A09AC01,pepsin and acid preparations,NA,NA,NA,NA | |
| A09AC02,multienzymes and acid preparations,NA,NA,NA,NA | |
| A10,DRUGS USED IN DIABETES,NA,NA,NA,NA | |
| A10A,INSULINS AND ANALOGUES,NA,NA,NA,NA | |
| A10AB,"Insulins and analogues for injection, fast-acting",NA,NA,NA,NA | |
| A10AB01,insulin (human),40,U,P,NA | |
| A10AB02,insulin (beef),40,U,P,NA | |
| A10AB03,insulin (pork),40,U,P,NA | |
| A10AB04,insulin lispro,40,U,P,NA | |
| A10AB05,insulin aspart,40,U,P,NA | |
| A10AB06,insulin glulisine,40,U,P,NA | |
| A10AB30,combinations,40,U,P,NA | |
| A10AC,"Insulins and analogues for injection, intermediate-acting",NA,NA,NA,NA | |
| A10AC01,insulin (human),40,U,P,NA | |
| A10AC02,insulin (beef),40,U,P,NA | |
| A10AC03,insulin (pork),40,U,P,NA | |
| A10AC04,insulin lispro,40,U,P,NA | |
| A10AC30,combinations,40,U,P,NA | |
| A10AD,"Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",NA,NA,NA,NA | |
| A10AD01,insulin (human),40,U,P,NA | |
| A10AD02,insulin (beef),40,U,P,NA | |
| A10AD03,insulin (pork),40,U,P,NA | |
| A10AD04,insulin lispro,40,U,P,NA | |
| A10AD05,insulin aspart,40,U,P,NA | |
| A10AD06,insulin degludec and insulin aspart,40,U,P,NA | |
| A10AD30,combinations,40,U,P,NA | |
| A10AE,"Insulins and analogues for injection, long-acting",NA,NA,NA,NA | |
| A10AE01,insulin (human),40,U,P,NA | |
| A10AE02,insulin (beef),40,U,P,NA | |
| A10AE03,insulin (pork),40,U,P,NA | |
| A10AE04,insulin glargine,40,U,P,NA | |
| A10AE05,insulin detemir,40,U,P,NA | |
| A10AE06,insulin degludec,40,U,P,NA | |
| A10AE30,combinations,40,U,P,NA | |
| A10AE54,insulin glargine and lixisenatide,40,U,P,Refers to insulin glargine | |
| A10AE56,insulin degludec and liraglutide,40,U,P,Refers to insulin degludec | |
| A10AF,Insulins and analogues for inhalation,NA,NA,NA,NA | |
| A10AF01,insulin (human),15,mg,Inhal.powder,NA | |
| A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",NA,NA,NA,NA | |
| A10BA,Biguanides,NA,NA,NA,NA | |
| A10BA01,phenformin,0.1,g,O,NA | |
| A10BA02,metformin,2,g,O,NA | |
| A10BA03,buformin,0.2,g,O,NA | |
| A10BB,Sulfonylureas,NA,NA,NA,NA | |
| A10BB01,glibenclamide,7,mg,O,microcryst.substance | |
| A10BB01,glibenclamide,10,mg,O,NA | |
| A10BB02,chlorpropamide,0.375,g,O,NA | |
| A10BB03,tolbutamide,1.5,g,O,NA | |
| A10BB04,glibornuride,38,mg,O,NA | |
| A10BB05,tolazamide,0.5,g,O,NA | |
| A10BB06,carbutamide,0.75,g,O,NA | |
| A10BB07,glipizide,10,mg,O,NA | |
| A10BB08,gliquidone,60,mg,O,NA | |
| A10BB09,gliclazide,60,mg,O,NA | |
| A10BB10,metahexamide,NA,NA,NA,NA | |
| A10BB11,glisoxepide,NA,NA,NA,NA | |
| A10BB12,glimepiride,2,mg,O,NA | |
| A10BB31,acetohexamide,0.5,g,O,NA | |
| A10BC,Sulfonamides (heterocyclic),NA,NA,NA,NA | |
| A10BC01,glymidine,1,g,O,NA | |
| A10BD,Combinations of oral blood glucose lowering drugs,NA,NA,NA,NA | |
| A10BD01,phenformin and sulfonylureas,NA,NA,NA,NA | |
| A10BD02,metformin and sulfonylureas,NA,NA,NA,NA | |
| A10BD03,metformin and rosiglitazone,NA,NA,NA,NA | |
| A10BD04,glimepiride and rosiglitazone,NA,NA,NA,NA | |
| A10BD05,metformin and pioglitazone,NA,NA,NA,NA | |
| A10BD06,glimepiride and pioglitazone,NA,NA,NA,NA | |
| A10BD07,metformin and sitagliptin,NA,NA,NA,NA | |
| A10BD08,metformin and vildagliptin,NA,NA,NA,NA | |
| A10BD09,pioglitazone and alogliptin,NA,NA,NA,NA | |
| A10BD10,metformin and saxagliptin,NA,NA,NA,NA | |
| A10BD11,metformin and linagliptin,NA,NA,NA,NA | |
| A10BD12,pioglitazone and sitagliptin,NA,NA,NA,NA | |
| A10BD13,metformin and alogliptin,NA,NA,NA,NA | |
| A10BD14,metformin and repaglinide,NA,NA,NA,NA | |
| A10BD15,metformin and dapagliflozin,NA,NA,NA,NA | |
| A10BD16,metformin and canagliflozin,NA,NA,NA,NA | |
| A10BD17,metformin and acarbose,NA,NA,NA,NA | |
| A10BD18,metformin and gemigliptin,NA,NA,NA,NA | |
| A10BD19,linagliptin and empagliflozin,NA,NA,NA,NA | |
| A10BD20,metformin and empagliflozin,NA,NA,NA,NA | |
| A10BD21,saxagliptin and dapagliflozin,NA,NA,NA,NA | |
| A10BD22,metformin and evogliptin,NA,NA,NA,NA | |
| A10BD23,metformin and ertugliflozin,NA,NA,NA,NA | |
| A10BD24,sitagliptin and ertugliflozin,NA,NA,NA,NA | |
| A10BD25,"metformin, saxagliptin and dapagliflozin",NA,NA,NA,NA | |
| A10BD26,metformin and lobeglitazone,NA,NA,NA,NA | |
| A10BF,Alpha glucosidase inhibitors,NA,NA,NA,NA | |
| A10BF01,acarbose,0.3,g,O,NA | |
| A10BF02,miglitol,0.3,g,O,NA | |
| A10BF03,voglibose,0.6,mg,O,NA | |
| A10BG,Thiazolidinediones,NA,NA,NA,NA | |
| A10BG01,troglitazone,0.4,g,O,NA | |
| A10BG02,rosiglitazone,6,mg,O,NA | |
| A10BG03,pioglitazone,30,mg,O,NA | |
| A10BG04,lobeglitazone,0.5,mg,O,NA | |
| A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors,NA,NA,NA,NA | |
| A10BH01,sitagliptin,0.1,g,O,NA | |
| A10BH02,vildagliptin,0.1,g,O,NA | |
| A10BH03,saxagliptin,5,mg,O,NA | |
| A10BH04,alogliptin,25,mg,O,NA | |
| A10BH05,linagliptin,5,mg,O,NA | |
| A10BH06,gemigliptin,50,mg,O,NA | |
| A10BH07,evogliptin,5,mg,O,NA | |
| A10BH08,teneligliptin,NA,NA,NA,NA | |
| A10BH51,sitagliptin and simvastatin,NA,NA,NA,NA | |
| A10BH52,gemigliptin and rosuvastatin,NA,NA,NA,NA | |
| A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,NA,NA,NA,NA | |
| A10BJ01,exenatide,0.286,mg,P,depot inj | |
| A10BJ01,exenatide,15,mcg,P,NA | |
| A10BJ02,liraglutide,1.5,mg,P,NA | |
| A10BJ03,lixisenatide,20,mcg,P,NA | |
| A10BJ04,albiglutide,5.7,mg,P,NA | |
| A10BJ05,dulaglutide,0.16,mg,P,NA | |
| A10BJ06,semaglutide,0.11,mg,P,NA | |
| A10BJ07,beinaglutide,NA,NA,NA,NA | |
| A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,NA,NA,NA,NA | |
| A10BK01,dapagliflozin,10,mg,O,NA | |
| A10BK02,canagliflozin,0.2,g,O,NA | |
| A10BK03,empagliflozin,17.5,mg,O,NA | |
| A10BK04,ertugliflozin,10,mg,O,NA | |
| A10BK05,ipragliflozin,NA,NA,NA,NA | |
| A10BK06,sotagliflozin,NA,NA,NA,NA | |
| A10BK07,luseogliflozin,NA,NA,NA,NA | |
| A10BX,"Other blood glucose lowering drugs, excl. insulins",NA,NA,NA,NA | |
| A10BX01,guar gum,NA,NA,NA,NA | |
| A10BX02,repaglinide,4,mg,O,NA | |
| A10BX03,nateglinide,0.36,g,O,NA | |
| A10BX05,pramlintide,NA,NA,NA,NA | |
| A10BX06,benfluorex,0.45,g,O,NA | |
| A10BX08,mitiglinide,30,mg,O,NA | |
| A10X,OTHER DRUGS USED IN DIABETES,NA,NA,NA,NA | |
| A10XA,Aldose reductase inhibitors,NA,NA,NA,NA | |
| A10XA01,tolrestat,NA,NA,NA,NA | |
| A11,VITAMINS,NA,NA,NA,NA | |
| A11A,"MULTIVITAMINS, COMBINATIONS",NA,NA,NA,NA | |
| A11AA,Multivitamins with minerals,NA,NA,NA,NA | |
| A11AA01,multivitamins and iron,NA,NA,NA,NA | |
| A11AA02,multivitamins and calcium,NA,NA,NA,NA | |
| A11AA03,"multivitamins and other minerals, incl. combinations",NA,NA,NA,NA | |
| A11AA04,multivitamins and trace elements,NA,NA,NA,NA | |
| A11AB,"Multivitamins, other combinations",NA,NA,NA,NA | |
| A11B,"MULTIVITAMINS, PLAIN",NA,NA,NA,NA | |
| A11BA,"Multivitamins, plain",NA,NA,NA,NA | |
| A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",NA,NA,NA,NA | |
| A11CA,"Vitamin A, plain",NA,NA,NA,NA | |
| A11CA01,retinol (vit A),50,TU,O,NA | |
| A11CA01,retinol (vit A),50,TU,P,NA | |
| A11CA02,betacarotene,NA,NA,NA,NA | |
| A11CB,Vitamin A and D in combination,NA,NA,NA,NA | |
| A11CC,Vitamin D and analogues,NA,NA,NA,NA | |
| A11CC01,ergocalciferol,NA,NA,NA,NA | |
| A11CC02,dihydrotachysterol,1,mg,O,NA | |
| A11CC03,alfacalcidol,1,mcg,O,NA | |
| A11CC03,alfacalcidol,1,mcg,P,NA | |
| A11CC04,calcitriol,1,mcg,O,NA | |
| A11CC04,calcitriol,1,mcg,P,NA | |
| A11CC05,colecalciferol,20,mcg,O,NA | |
| A11CC06,calcifediol,NA,NA,NA,NA | |
| A11CC20,combinations,NA,NA,NA,NA | |
| A11CC55,"colecalciferol, combinations",NA,NA,NA,NA | |
| A11D,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12",NA,NA,NA,NA | |
| A11DA,"Vitamin B1, plain",NA,NA,NA,NA | |
| A11DA01,thiamine (vit B1),50,mg,O,NA | |
| A11DA01,thiamine (vit B1),50,mg,P,NA | |
| A11DA02,sulbutiamine,NA,NA,NA,NA | |
| A11DA03,benfotiamine,NA,NA,NA,NA | |
| A11DB,Vitamin B1 in combination with vitamin B6 and/or vitamin B12,NA,NA,NA,NA | |
| A11E,"VITAMIN B-COMPLEX, INCL. COMBINATIONS",NA,NA,NA,NA | |
| A11EA,"Vitamin B-complex, plain",NA,NA,NA,NA | |
| A11EB,Vitamin B-complex with vitamin C,NA,NA,NA,NA | |
| A11EC,Vitamin B-complex with minerals,NA,NA,NA,NA | |
| A11ED,Vitamin B-complex with anabolic steroids,NA,NA,NA,NA | |
| A11EX,"Vitamin B-complex, other combinations",NA,NA,NA,NA | |
| A11G,"ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS",NA,NA,NA,NA | |
| A11GA,"Ascorbic acid (vitamin C), plain",NA,NA,NA,NA | |
| A11GA01,ascorbic acid (vit C),0.2,g,O,NA | |
| A11GA01,ascorbic acid (vit C),0.2,g,P,NA | |
| A11GB,"Ascorbic acid (vitamin C), combinations",NA,NA,NA,NA | |
| A11GB01,ascorbic acid (vit C) and calcium,NA,NA,NA,NA | |
| A11H,OTHER PLAIN VITAMIN PREPARATIONS,NA,NA,NA,NA | |
| A11HA,Other plain vitamin preparations,NA,NA,NA,NA | |
| A11HA01,nicotinamide,0.15,g,O,NA | |
| A11HA02,pyridoxine (vit B6),0.16,g,O,NA | |
| A11HA02,pyridoxine (vit B6),0.16,g,P,NA | |
| A11HA03,tocopherol (vit E),0.2,g,O,NA | |
| A11HA03,tocopherol (vit E),0.2,g,P,NA | |
| A11HA04,riboflavin (vit B2),NA,NA,NA,NA | |
| A11HA05,biotin,NA,NA,NA,NA | |
| A11HA06,pyridoxal phosphate,NA,NA,NA,NA | |
| A11HA07,inositol,NA,NA,NA,NA | |
| A11HA08,tocofersolan,0.2,g,O,Expressed as tocopherol | |
| A11HA30,dexpanthenol,NA,NA,NA,NA | |
| A11HA31,calcium pantothenate,NA,NA,NA,NA | |
| A11HA32,pantethine,NA,NA,NA,NA | |
| A11J,"OTHER VITAMIN PRODUCTS, COMBINATIONS",NA,NA,NA,NA | |
| A11JA,Combinations of vitamins,NA,NA,NA,NA | |
| A11JB,Vitamins with minerals,NA,NA,NA,NA | |
| A11JC,"Vitamins, other combinations",NA,NA,NA,NA | |
| A12,MINERAL SUPPLEMENTS,NA,NA,NA,NA | |
| A12A,CALCIUM,NA,NA,NA,NA | |
| A12AA,Calcium,NA,NA,NA,NA | |
| A12AA01,calcium phosphate,2,g,O,NA | |
| A12AA02,calcium glubionate,2.75,g,P,NA | |
| A12AA03,calcium gluconate,3,g,O,NA | |
| A12AA03,calcium gluconate,3,g,P,NA | |
| A12AA04,calcium carbonate,3,g,O,NA | |
| A12AA05,calcium lactate,2,g,O,NA | |
| A12AA06,calcium lactate gluconate,3,g,O,equivalent to 0.5 g Ca2+ | |
| A12AA07,calcium chloride,0.2,g,P,NA | |
| A12AA08,calcium glycerylphosphate,NA,NA,NA,NA | |
| A12AA09,calcium citrate lysine complex,0.5,g,O,NA | |
| A12AA10,calcium glucoheptonate,3,g,O,NA | |
| A12AA11,calcium pangamate,NA,NA,NA,NA | |
| A12AA13,calcium citrate,NA,NA,NA,NA | |
| A12AA20,calcium (different salts in combination),0.5,g,O,Ca2+ | |
| A12AA30,calcium laevulate,1,g,P,NA | |
| A12AX,"Calcium, combinations with vitamin D and/or other drugs",NA,NA,NA,NA | |
| A12B,POTASSIUM,NA,NA,NA,NA | |
| A12BA,Potassium,NA,NA,NA,NA | |
| A12BA01,potassium chloride,3,g,O,NA | |
| A12BA02,potassium citrate,4,g,O,NA | |
| A12BA03,potassium hydrogentartrate,7.5,g,O,NA | |
| A12BA04,potassium hydrogencarbonate,4,g,O,NA | |
| A12BA05,potassium gluconate,NA,NA,NA,NA | |
| A12BA30,potassium (different salts in combination),NA,NA,NA,NA | |
| A12BA51,"potassium chloride, combinations",NA,NA,NA,NA | |
| A12C,OTHER MINERAL SUPPLEMENTS,NA,NA,NA,NA | |
| A12CA,Sodium,NA,NA,NA,NA | |
| A12CA01,sodium chloride,1,g,O,NA | |
| A12CA02,sodium sulfate,NA,NA,NA,NA | |
| A12CB,Zinc,NA,NA,NA,NA | |
| A12CB01,zinc sulfate,0.6,g,O,NA | |
| A12CB02,zinc gluconate,NA,NA,NA,NA | |
| A12CB03,zinc protein complex,NA,NA,NA,NA | |
| A12CC,Magnesium,NA,NA,NA,NA | |
| A12CC01,magnesium chloride,2.5,g,O,NA | |
| A12CC01,magnesium chloride,0.8,g,P,NA | |
| A12CC02,magnesium sulfate,3,g,O,NA | |
| A12CC02,magnesium sulfate,1,g,P,NA | |
| A12CC03,magnesium gluconate,5,g,O,NA | |
| A12CC04,magnesium citrate,2,g,O,NA | |
| A12CC05,magnesium aspartate,NA,NA,NA,NA | |
| A12CC06,magnesium lactate,NA,NA,NA,NA | |
| A12CC07,magnesium levulinate,NA,NA,NA,NA | |
| A12CC08,magnesium pidolate,NA,NA,NA,NA | |
| A12CC09,magnesium orotate,NA,NA,NA,NA | |
| A12CC10,magnesium oxide,NA,NA,NA,NA | |
| A12CC30,magnesium (different salts in combination),NA,NA,NA,NA | |
| A12CD,Fluoride,NA,NA,NA,NA | |
| A12CD01,sodium fluoride,88,mg,O,40 mg fluoride | |
| A12CD02,sodium monofluorophosphate,0.152,g,O,20 mg fluoride | |
| A12CD51,"fluoride, combinations",NA,NA,NA,NA | |
| A12CE,Selenium,NA,NA,NA,NA | |
| A12CE01,sodium selenate,0.2,mg,O,Se | |
| A12CE02,sodium selenite,0.2,mg,O,Se | |
| A12CE02,sodium selenite,0.2,mg,P,NA | |
| A12CX,Other mineral products,NA,NA,NA,NA | |
| A13,TONICS,NA,NA,NA,NA | |
| A13A,TONICS,NA,NA,NA,NA | |
| A14,ANABOLIC AGENTS FOR SYSTEMIC USE,NA,NA,NA,NA | |
| A14A,ANABOLIC STEROIDS,NA,NA,NA,NA | |
| A14AA,Androstan derivatives,NA,NA,NA,NA | |
| A14AA01,androstanolone,NA,NA,NA,NA | |
| A14AA02,stanozolol,5,mg,O,NA | |
| A14AA02,stanozolol,3.5,mg,P,NA | |
| A14AA03,metandienone,5,mg,O,NA | |
| A14AA04,metenolone,10,mg,O,NA | |
| A14AA04,metenolone,7,mg,P,NA | |
| A14AA05,oxymetholone,0.25,g,O,NA | |
| A14AA06,quinbolone,NA,NA,NA,NA | |
| A14AA07,prasterone,NA,NA,NA,NA | |
| A14AA08,oxandrolone,NA,NA,NA,NA | |
| A14AA09,norethandrolone,NA,NA,NA,NA | |
| A14AB,Estren derivatives,NA,NA,NA,NA | |
| A14AB01,nandrolone,2,mg,P,NA | |
| A14AB02,ethylestrenol,2,mg,O,NA | |
| A14AB03,oxabolone cipionate,NA,NA,NA,NA | |
| A14B,OTHER ANABOLIC AGENTS,NA,NA,NA,NA | |
| A15,APPETITE STIMULANTS,NA,NA,NA,NA | |
| A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,NA,NA,NA,NA | |
| A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,NA,NA,NA,NA | |
| A16AA,Amino acids and derivatives,NA,NA,NA,NA | |
| A16AA01,levocarnitine,2,g,O,NA | |
| A16AA01,levocarnitine,2,g,P,NA | |
| A16AA02,ademetionine,NA,NA,NA,NA | |
| A16AA03,glutamine,NA,NA,NA,NA | |
| A16AA04,mercaptamine,2,g,O,NA | |
| A16AA05,carglumic acid,0.2,g,O,NA | |
| A16AA06,betaine,6,g,O,NA | |
| A16AA07,metreleptin,NA,NA,NA,NA | |
| A16AB,Enzymes,NA,NA,NA,NA | |
| A16AB01,alglucerase,NA,NA,NA,NA | |
| A16AB02,imiglucerase,300,U,P,NA | |
| A16AB03,agalsidase alfa,1,mg,P,NA | |
| A16AB04,agalsidase beta,5,mg,P,NA | |
| A16AB05,laronidase,1,TU,P,NA | |
| A16AB06,sacrosidase,68,TU,O,NA | |
| A16AB07,alglucosidase alfa,0.1,g,P,NA | |
| A16AB08,galsulfase,NA,NA,NA,NA | |
| A16AB09,idursulfase,NA,NA,NA,NA | |
| A16AB10,velaglucerase alfa,300,U,P,NA | |
| A16AB11,taliglucerase alfa,NA,NA,NA,NA | |
| A16AB12,elosulfase alfa,20,mg,P,NA | |
| A16AB13,asfotase alfa,NA,NA,NA,NA | |
| A16AB14,sebelipase alfa,5,mg,P,NA | |
| A16AB15,velmanase alfa,NA,NA,NA,NA | |
| A16AB16,idursulfase beta,NA,NA,NA,NA | |
| A16AB17,cerliponase alfa,21,mg,P,NA | |
| A16AB18,vestronidase alfa,NA,NA,NA,NA | |
| A16AB19,pegvaliase,NA,NA,NA,NA | |
| A16AX,Various alimentary tract and metabolism products,NA,NA,NA,NA | |
| A16AX01,thioctic acid,0.6,g,O,NA | |
| A16AX01,thioctic acid,0.6,g,P,NA | |
| A16AX02,anethole trithione,NA,NA,NA,NA | |
| A16AX03,sodium phenylbutyrate,20,g,O,NA | |
| A16AX04,nitisinone,20,mg,O,NA | |
| A16AX05,zinc acetate,0.15,g,O,NA | |
| A16AX06,miglustat,0.3,g,O,NA | |
| A16AX07,sapropterin,NA,NA,NA,NA | |
| A16AX08,teduglutide,5,mg,P,NA | |
| A16AX09,glycerol phenylbutyrate,15,g,O,NA | |
| A16AX10,eliglustat,0.168,g,O,NA | |
| A16AX11,sodium benzoate,NA,NA,NA,NA | |
| A16AX12,trientine,0.45,g,O,Expressed as trientine | |
| A16AX13,uridine triacetate,NA,NA,NA,NA | |
| A16AX14,migalastat,61.5,mg,O,NA | |
| A16AX15,telotristat,0.75,g,O,NA | |
| A16AX16,givosiran,NA,NA,NA,NA | |
| A16AX17,triheptanoin,NA,NA,NA,NA | |
| A16AX18,lumasiran,NA,NA,NA,NA | |
| A16AX30,sodium benzoate and sodium phenylacetate,NA,NA,NA,NA | |
| B,BLOOD AND BLOOD FORMING ORGANS,NA,NA,NA,NA | |
| B01,ANTITHROMBOTIC AGENTS,NA,NA,NA,NA | |
| B01A,ANTITHROMBOTIC AGENTS,NA,NA,NA,NA | |
| B01AA,Vitamin K antagonists,NA,NA,NA,NA | |
| B01AA01,dicoumarol,0.1,g,O,NA | |
| B01AA02,phenindione,0.1,g,O,NA | |
| B01AA03,warfarin,7.5,mg,O,NA | |
| B01AA03,warfarin,7.5,mg,P,NA | |
| B01AA04,phenprocoumon,3,mg,O,NA | |
| B01AA07,acenocoumarol,5,mg,O,NA | |
| B01AA08,ethyl biscoumacetate,0.6,g,O,NA | |
| B01AA09,clorindione,NA,NA,NA,NA | |
| B01AA10,diphenadione,NA,NA,NA,NA | |
| B01AA11,tioclomarol,NA,NA,NA,NA | |
| B01AA12,fluindione,NA,NA,NA,NA | |
| B01AB,Heparin group,NA,NA,NA,NA | |
| B01AB01,heparin,10,TU,P,NA | |
| B01AB02,antithrombin III,2.1,TU,P,NA | |
| B01AB04,dalteparin,2.5,TU,P,anti Xa | |
| B01AB05,enoxaparin,2,TU,P,anti Xa | |
| B01AB06,nadroparin,2.85,TU,P,anti Xa | |
| B01AB07,parnaparin,3.2,TU,P,anti Xa | |
| B01AB08,reviparin,1.43,TU,P,anti Xa | |
| B01AB09,danaparoid,1.5,TU,P,anti Xa | |
| B01AB10,tinzaparin,3.5,TU,P,anti Xa | |
| B01AB11,sulodexide,500,LSU,O,LSU = lipoprotein lipase releasing units | |
| B01AB11,sulodexide,500,LSU,P,LSU = lipoprotein lipase releasing units | |
| B01AB12,bemiparin,2.5,TU,P,NA | |
| B01AB51,"heparin, combinations",NA,NA,NA,NA | |
| B01AC,Platelet aggregation inhibitors excl. heparin,NA,NA,NA,NA | |
| B01AC01,ditazole,NA,NA,NA,NA | |
| B01AC02,cloricromen,NA,NA,NA,NA | |
| B01AC03,picotamide,NA,NA,NA,NA | |
| B01AC04,clopidogrel,75,mg,O,NA | |
| B01AC05,ticlopidine,0.5,g,O,NA | |
| B01AC06,acetylsalicylic acid,1,tablet,O,Independent of strength | |
| B01AC07,dipyridamole,0.4,g,O,NA | |
| B01AC07,dipyridamole,0.2,g,P,NA | |
| B01AC08,carbasalate calcium,1,tablet,O,NA | |
| B01AC09,epoprostenol,NA,NA,NA,NA | |
| B01AC10,indobufen,NA,NA,NA,NA | |
| B01AC11,iloprost,0.15,mg,Inhal.solution,NA | |
| B01AC11,iloprost,50,mcg,P,NA | |
| B01AC13,abciximab,25,mg,P,NA | |
| B01AC15,aloxiprin,NA,NA,NA,NA | |
| B01AC16,eptifibatide,0.2,g,P,NA | |
| B01AC17,tirofiban,10,mg,P,NA | |
| B01AC18,triflusal,0.6,g,O,NA | |
| B01AC19,beraprost,NA,NA,NA,NA | |
| B01AC21,treprostinil,4.3,mg,P,NA | |
| B01AC22,prasugrel,10,mg,O,NA | |
| B01AC23,cilostazol,0.2,g,O,NA | |
| B01AC24,ticagrelor,0.18,g,O,NA | |
| B01AC25,cangrelor,50,mg,P,NA | |
| B01AC26,vorapaxar,2.08,mg,O,NA | |
| B01AC27,selexipag,1.8,mg,O,NA | |
| B01AC30,combinations,NA,NA,NA,NA | |
| B01AC56,"acetylsalicylic acid, combinations with proton pump inhibitors",NA,NA,NA,NA | |
| B01AD,Enzymes,NA,NA,NA,NA | |
| B01AD01,streptokinase,1.5,MU,P,NA | |
| B01AD02,alteplase,0.1,g,P,NA | |
| B01AD03,anistreplase,30,U,P,NA | |
| B01AD04,urokinase,3,MU,P,NA | |
| B01AD05,fibrinolysin,NA,NA,NA,NA | |
| B01AD06,brinase,NA,NA,NA,NA | |
| B01AD07,reteplase,20,U,P,NA | |
| B01AD08,saruplase,NA,NA,NA,NA | |
| B01AD09,ancrod,NA,NA,NA,NA | |
| B01AD10,drotrecogin alfa (activated),40,mg,P,NA | |
| B01AD11,tenecteplase,40,mg,P,NA | |
| B01AD12,protein C,NA,NA,NA,NA | |
| B01AE,Direct thrombin inhibitors,NA,NA,NA,NA | |
| B01AE01,desirudin,30,mg,P,NA | |
| B01AE02,lepirudin,0.25,g,P,NA | |
| B01AE03,argatroban,0.2,g,P,NA | |
| B01AE04,melagatran,6,mg,P,NA | |
| B01AE05,ximelagatran,48,mg,O,NA | |
| B01AE06,bivalirudin,0.25,g,P,NA | |
| B01AE07,dabigatran etexilate,0.3,g,O,NA | |
| B01AF,Direct factor Xa inhibitors,NA,NA,NA,NA | |
| B01AF01,rivaroxaban,20,mg,O,NA | |
| B01AF02,apixaban,10,mg,O,NA | |
| B01AF03,edoxaban,60,mg,O,NA | |
| B01AF04,betrixaban,NA,NA,NA,NA | |
| B01AX,Other antithrombotic agents,NA,NA,NA,NA | |
| B01AX01,defibrotide,1.75,g,P,NA | |
| B01AX04,dermatan sulfate,NA,NA,NA,NA | |
| B01AX05,fondaparinux,2.5,mg,P,NA | |
| B01AX07,caplacizumab,10,mg,P,NA | |
| B02,ANTIHEMORRHAGICS,NA,NA,NA,NA | |
| B02A,ANTIFIBRINOLYTICS,NA,NA,NA,NA | |
| B02AA,Amino acids,NA,NA,NA,NA | |
| B02AA01,aminocaproic acid,16,g,O,NA | |
| B02AA01,aminocaproic acid,16,g,P,NA | |
| B02AA02,tranexamic acid,2,g,O,NA | |
| B02AA02,tranexamic acid,2,g,P,NA | |
| B02AA03,aminomethylbenzoic acid,0.25,g,O,NA | |
| B02AB,Proteinase inhibitors,NA,NA,NA,NA | |
| B02AB01,aprotinin,500,TU,P,NA | |
| B02AB02,alfa1 antitrypsin,0.6,g,P,NA | |
| B02AB04,camostat,NA,NA,NA,NA | |
| B02AB05,ulinastatin,NA,NA,NA,NA | |
| B02B,VITAMIN K AND OTHER HEMOSTATICS,NA,NA,NA,NA | |
| B02BA,Vitamin K,NA,NA,NA,NA | |
| B02BA01,phytomenadione,20,mg,O,NA | |
| B02BA01,phytomenadione,20,mg,P,NA | |
| B02BA02,menadione,10,mg,O,NA | |
| B02BA02,menadione,2,mg,P,NA | |
| B02BB,Fibrinogen,NA,NA,NA,NA | |
| B02BB01,"fibrinogen, human",5,g,P,NA | |
| B02BC,Local hemostatics,NA,NA,NA,NA | |
| B02BC01,absorbable gelatin sponge,NA,NA,NA,NA | |
| B02BC02,oxidized cellulose,NA,NA,NA,NA | |
| B02BC03,tetragalacturonic acid hydroxymethylester,NA,NA,NA,NA | |
| B02BC05,adrenalone,NA,NA,NA,NA | |
| B02BC06,thrombin,NA,NA,NA,NA | |
| B02BC07,collagen,NA,NA,NA,NA | |
| B02BC08,calcium alginate,NA,NA,NA,NA | |
| B02BC09,epinephrine,NA,NA,NA,NA | |
| B02BC30,combinations,NA,NA,NA,NA | |
| B02BD,Blood coagulation factors,NA,NA,NA,NA | |
| B02BD01,"coagulation factor IX, II, VII and X in combination",NA,NA,NA,NA | |
| B02BD02,coagulation factor VIII,NA,NA,NA,NA | |
| B02BD03,factor VIII inhibitor bypassing activity,NA,NA,NA,NA | |
| B02BD04,coagulation factor IX,NA,NA,NA,NA | |
| B02BD05,coagulation factor VII,NA,NA,NA,NA | |
| B02BD06,von Willebrand factor and coagulation factor VIII in combination,NA,NA,NA,NA | |
| B02BD07,coagulation factor XIII,NA,NA,NA,NA | |
| B02BD08,coagulation factor VIIa,NA,NA,NA,NA | |
| B02BD10,von Willebrand factor,NA,NA,NA,NA | |
| B02BD11,catridecacog,NA,NA,NA,NA | |
| B02BD13,coagulation factor X,NA,NA,NA,NA | |
| B02BD14,susoctocog alfa,NA,NA,NA,NA | |
| B02BD30,thrombin,NA,NA,NA,NA | |
| B02BX,Other systemic hemostatics,NA,NA,NA,NA | |
| B02BX01,etamsylate,NA,NA,NA,NA | |
| B02BX02,carbazochrome,NA,NA,NA,NA | |
| B02BX03,batroxobin,NA,NA,NA,NA | |
| B02BX04,romiplostim,30,mcg,P,NA | |
| B02BX05,eltrombopag,50,mg,O,NA | |
| B02BX06,emicizumab,15,mg,P,NA | |
| B02BX07,lusutrombopag,NA,NA,NA,NA | |
| B02BX08,avatrombopag,NA,NA,NA,NA | |
| B02BX09,fostamatinib,NA,NA,NA,NA | |
| B03,ANTIANEMIC PREPARATIONS,NA,NA,NA,NA | |
| B03A,IRON PREPARATIONS,NA,NA,NA,NA | |
| B03AA,"Iron bivalent, oral preparations",NA,NA,NA,NA | |
| B03AA01,ferrous glycine sulfate,0.2,g,O,Fe2+ | |
| B03AA02,ferrous fumarate,0.2,g,O,Fe2+ | |
| B03AA03,ferrous gluconate,0.2,g,O,Fe2+ | |
| B03AA04,ferrous carbonate,0.2,g,O,Fe2+ | |
| B03AA05,ferrous chloride,0.2,g,O,Fe2+ | |
| B03AA06,ferrous succinate,0.2,g,O,Fe2+ | |
| B03AA07,ferrous sulfate,0.2,g,O,Fe2+ | |
| B03AA08,ferrous tartrate,0.2,g,O,Fe2+ | |
| B03AA09,ferrous aspartate,0.2,g,O,Fe2+ | |
| B03AA10,ferrous ascorbate,0.2,g,O,Fe2+ | |
| B03AA11,ferrous iodine,0.2,g,O,Fe2+ | |
| B03AA12,ferrous sodium citrate,NA,NA,NA,NA | |
| B03AB,"Iron trivalent, oral preparations",NA,NA,NA,NA | |
| B03AB01,ferric sodium citrate,0.75,g,O,Fe3+ | |
| B03AB02,saccharated iron oxide,0.11,g,O,Fe3+ | |
| B03AB03,sodium feredetate,0.17,g,O,Fe3+ | |
| B03AB04,ferric hydroxide,NA,NA,NA,NA | |
| B03AB05,ferric oxide polymaltose complexes,90,mg,O,Fe3+ | |
| B03AB07,chondroitin sulfate-iron complex,NA,NA,NA,NA | |
| B03AB08,ferric acetyl transferrin,NA,NA,NA,NA | |
| B03AB09,ferric proteinsuccinylate,80,mg,O,Fe3+ | |
| B03AB10,ferric maltol,60,mg,O,Fe3+ | |
| B03AC,"Iron, parenteral preparations",NA,NA,NA,NA | |
| B03AD,Iron in combination with folic acid,NA,NA,NA,NA | |
| B03AD01,ferrous amino acid complex,NA,NA,NA,NA | |
| B03AD02,ferrous fumarate,NA,NA,NA,NA | |
| B03AD03,ferrous sulfate,NA,NA,NA,NA | |
| B03AD04,ferric oxide polymaltose complexes,NA,NA,NA,NA | |
| B03AD05,ferrous gluconate,NA,NA,NA,NA | |
| B03AE,Iron in other combinations,NA,NA,NA,NA | |
| B03AE01,"iron, vitamin B12 and folic acid",NA,NA,NA,NA | |
| B03AE02,"iron, multivitamins and folic acid",NA,NA,NA,NA | |
| B03AE03,iron and multivitamins,NA,NA,NA,NA | |
| B03AE04,"iron, multivitamins and minerals",NA,NA,NA,NA | |
| B03AE10,various combinations,NA,NA,NA,NA | |
| B03B,VITAMIN B12 AND FOLIC ACID,NA,NA,NA,NA | |
| B03BA,Vitamin B12 (cyanocobalamin and analogues),NA,NA,NA,NA | |
| B03BA01,cyanocobalamin,70,mcg,N,NA | |
| B03BA01,cyanocobalamin,1,mg,O,NA | |
| B03BA01,cyanocobalamin,20,mcg,P,NA | |
| B03BA02,cyanocobalamin tannin complex,20,mcg,P,NA | |
| B03BA03,hydroxocobalamin,20,mcg,P,NA | |
| B03BA04,cobamamide,NA,NA,NA,NA | |
| B03BA05,mecobalamin,1.5,mg,O,NA | |
| B03BA05,mecobalamin,0.2,mg,P,NA | |
| B03BA51,"cyanocobalamin, combinations",NA,NA,NA,NA | |
| B03BA53,"hydroxocobalamin, combinations",NA,NA,NA,NA | |
| B03BB,Folic acid and derivatives,NA,NA,NA,NA | |
| B03BB01,folic acid,0.4,mg,O,prophylactic dose | |
| B03BB01,folic acid,10,mg,P,therapeutic dose | |
| B03BB51,"folic acid, combinations",NA,NA,NA,NA | |
| B03X,OTHER ANTIANEMIC PREPARATIONS,NA,NA,NA,NA | |
| B03XA,Other antianemic preparations,NA,NA,NA,NA | |
| B03XA01,erythropoietin,1,TU,P,NA | |
| B03XA02,darbepoetin alfa,4.5,mcg,P,NA | |
| B03XA03,methoxy polyethylene glycol-epoetin beta,4,mcg,P,NA | |
| B03XA04,peginesatide,NA,NA,NA,NA | |
| B03XA05,roxadustat,NA,NA,NA,NA | |
| B03XA06,luspatercept,NA,NA,NA,NA | |
| B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,NA,NA,NA,NA | |
| B05A,BLOOD AND RELATED PRODUCTS,NA,NA,NA,NA | |
| B05AA,Blood substitutes and plasma protein fractions,NA,NA,NA,NA | |
| B05AA01,albumin,NA,NA,NA,NA | |
| B05AA02,other plasma protein fractions,NA,NA,NA,NA | |
| B05AA03,fluorocarbon blood substitutes,NA,NA,NA,NA | |
| B05AA05,dextran,NA,NA,NA,NA | |
| B05AA06,gelatin agents,NA,NA,NA,NA | |
| B05AA07,hydroxyethylstarch,NA,NA,NA,NA | |
| B05AA08,hemoglobin crosfumaril,NA,NA,NA,NA | |
| B05AA09,hemoglobin raffimer,NA,NA,NA,NA | |
| B05AA10,hemoglobin glutamer (bovine),NA,NA,NA,NA | |
| B05AX,Other blood products,NA,NA,NA,NA | |
| B05AX01,erythrocytes,NA,NA,NA,NA | |
| B05AX02,thrombocytes,NA,NA,NA,NA | |
| B05AX03,blood plasma,NA,NA,NA,NA | |
| B05AX04,stem cells from umbilical cord blood,NA,NA,NA,NA | |
| B05B,I.V. SOLUTIONS,NA,NA,NA,NA | |
| B05BA,Solutions for parenteral nutrition,NA,NA,NA,NA | |
| B05BA01,amino acids,NA,NA,NA,NA | |
| B05BA02,fat emulsions,NA,NA,NA,NA | |
| B05BA03,carbohydrates,NA,NA,NA,NA | |
| B05BA04,protein hydrolysates,NA,NA,NA,NA | |
| B05BA10,combinations,NA,NA,NA,NA | |
| B05BB,Solutions affecting the electrolyte balance,NA,NA,NA,NA | |
| B05BB01,electrolytes,NA,NA,NA,NA | |
| B05BB02,electrolytes with carbohydrates,NA,NA,NA,NA | |
| B05BB03,trometamol,NA,NA,NA,NA | |
| B05BB04,electrolytes in combination with other drugs,NA,NA,NA,NA | |
| B05BC,Solutions producing osmotic diuresis,NA,NA,NA,NA | |
| B05BC01,mannitol,NA,NA,NA,NA | |
| B05BC02,carbamide,NA,NA,NA,NA | |
| B05C,IRRIGATING SOLUTIONS,NA,NA,NA,NA | |
| B05CA,Antiinfectives,NA,NA,NA,NA | |
| B05CA01,cetylpyridinium,NA,NA,NA,NA | |
| B05CA02,chlorhexidine,NA,NA,NA,NA | |
| B05CA03,nitrofural,NA,NA,NA,NA | |
| B05CA04,sulfamethizole,NA,NA,NA,NA | |
| B05CA05,taurolidine,NA,NA,NA,NA | |
| B05CA06,mandelic acid,NA,NA,NA,NA | |
| B05CA07,noxytiolin,NA,NA,NA,NA | |
| B05CA08,ethacridine lactate,NA,NA,NA,NA | |
| B05CA09,neomycin,NA,NA,NA,NA | |
| B05CA10,combinations,NA,NA,NA,NA | |
| B05CB,Salt solutions,NA,NA,NA,NA | |
| B05CB01,sodium chloride,NA,NA,NA,NA | |
| B05CB02,sodium citrate,NA,NA,NA,NA | |
| B05CB03,magnesium citrate,NA,NA,NA,NA | |
| B05CB04,sodium bicarbonate,NA,NA,NA,NA | |
| B05CB10,combinations,NA,NA,NA,NA | |
| B05CX,Other irrigating solutions,NA,NA,NA,NA | |
| B05CX01,glucose,NA,NA,NA,NA | |
| B05CX02,sorbitol,NA,NA,NA,NA | |
| B05CX03,glycine,NA,NA,NA,NA | |
| B05CX04,mannitol,NA,NA,NA,NA | |
| B05CX10,combinations,NA,NA,NA,NA | |
| B05D,PERITONEAL DIALYTICS,NA,NA,NA,NA | |
| B05DA,Isotonic solutions,NA,NA,NA,NA | |
| B05DB,Hypertonic solutions,NA,NA,NA,NA | |
| B05X,I.V. SOLUTION ADDITIVES,NA,NA,NA,NA | |
| B05XA,Electrolyte solutions,NA,NA,NA,NA | |
| B05XA01,potassium chloride,NA,NA,NA,NA | |
| B05XA02,sodium bicarbonate,NA,NA,NA,NA | |
| B05XA03,sodium chloride,NA,NA,NA,NA | |
| B05XA04,ammonium chloride,NA,NA,NA,NA | |
| B05XA05,magnesium sulfate,NA,NA,NA,NA | |
| B05XA06,"potassium phosphate, incl. combinations with other potassium salts",NA,NA,NA,NA | |
| B05XA07,calcium chloride,NA,NA,NA,NA | |
| B05XA08,sodium acetate,NA,NA,NA,NA | |
| B05XA09,sodium phosphate,NA,NA,NA,NA | |
| B05XA10,magnesium phosphate,NA,NA,NA,NA | |
| B05XA11,magnesium chloride,NA,NA,NA,NA | |
| B05XA12,zinc chloride,NA,NA,NA,NA | |
| B05XA13,hydrochloric acid,NA,NA,NA,NA | |
| B05XA14,sodium glycerophosphate,NA,NA,NA,NA | |
| B05XA15,potassium lactate,NA,NA,NA,NA | |
| B05XA16,cardioplegia solutions,NA,NA,NA,NA | |
| B05XA17,potassium acetate,NA,NA,NA,NA | |
| B05XA18,zinc sulfate,NA,NA,NA,NA | |
| B05XA30,combinations of electrolytes,NA,NA,NA,NA | |
| B05XA31,electrolytes in combination with other drugs,NA,NA,NA,NA | |
| B05XB,Amino acids,NA,NA,NA,NA | |
| B05XB01,arginine hydrochloride,NA,NA,NA,NA | |
| B05XB02,alanyl glutamine,NA,NA,NA,NA | |
| B05XB03,lysine,NA,NA,NA,NA | |
| B05XC,Vitamins,NA,NA,NA,NA | |
| B05XX,Other i.v. solution additives,NA,NA,NA,NA | |
| B05XX02,trometamol,NA,NA,NA,NA | |
| B05Z,HEMODIALYTICS AND HEMOFILTRATES,NA,NA,NA,NA | |
| B05ZA,"Hemodialytics, concentrates",NA,NA,NA,NA | |
| B05ZB,Hemofiltrates,NA,NA,NA,NA | |
| B06,OTHER HEMATOLOGICAL AGENTS,NA,NA,NA,NA | |
| B06A,OTHER HEMATOLOGICAL AGENTS,NA,NA,NA,NA | |
| B06AA,Enzymes,NA,NA,NA,NA | |
| B06AA02,fibrinolysin and desoxyribonuclease,NA,NA,NA,NA | |
| B06AA03,hyaluronidase,NA,NA,NA,NA | |
| B06AA04,chymotrypsin,NA,NA,NA,NA | |
| B06AA07,trypsin,NA,NA,NA,NA | |
| B06AA10,desoxyribonuclease,NA,NA,NA,NA | |
| B06AA55,"streptokinase, combinations",NA,NA,NA,NA | |
| B06AB,Heme products,NA,NA,NA,NA | |
| B06AB01,hemin,NA,NA,NA,NA | |
| B06AC,Drugs used in hereditary angioedema,NA,NA,NA,NA | |
| B06AC01,"c1-inhibitor, plasma derived",1.4,TU,P,NA | |
| B06AC02,icatibant,30,mg,P,NA | |
| B06AC03,ecallantide,NA,NA,NA,NA | |
| B06AC04,conestat alfa,3.5,TU,P,NA | |
| B06AC05,lanadelumab,21.4,mg,P,NA | |
| B06AC05,lanadelumab,NA,NA,NA,NA | |
| B06AX,Other hematological agents,NA,NA,NA,NA | |
| B06AX01,crizanlizumab,NA,NA,NA,NA | |
| B06AX02,betibeglogene autotemcel,NA,NA,NA,NA | |
| C,CARDIOVASCULAR SYSTEM,NA,NA,NA,NA | |
| C01,CARDIAC THERAPY,NA,NA,NA,NA | |
| C01A,CARDIAC GLYCOSIDES,NA,NA,NA,NA | |
| C01AA,Digitalis glycosides,NA,NA,NA,NA | |
| C01AA01,acetyldigitoxin,0.2,mg,O,NA | |
| C01AA02,acetyldigoxin,0.5,mg,O,NA | |
| C01AA03,digitalis leaves,0.1,g,O,NA | |
| C01AA04,digitoxin,0.1,mg,O,NA | |
| C01AA04,digitoxin,0.1,mg,P,NA | |
| C01AA05,digoxin,0.25,mg,O,NA | |
| C01AA05,digoxin,0.25,mg,P,NA | |
| C01AA06,lanatoside C,1,mg,O,NA | |
| C01AA06,lanatoside C,1,mg,R,NA | |
| C01AA07,deslanoside,1,mg,P,Acute treatment | |
| C01AA08,metildigoxin,0.2,mg,O,NA | |
| C01AA08,metildigoxin,0.2,mg,P,NA | |
| C01AA09,gitoformate,NA,NA,NA,NA | |
| C01AA52,"acetyldigoxin, combinations",NA,NA,NA,NA | |
| C01AB,Scilla glycosides,NA,NA,NA,NA | |
| C01AB01,proscillaridin,0.75,mg,O,NA | |
| C01AB51,"proscillaridin, combinations",NA,NA,NA,NA | |
| C01AC,Strophanthus glycosides,NA,NA,NA,NA | |
| C01AC01,g-strophanthin,0.25,mg,P,NA | |
| C01AC03,cymarin,2.5,mg,O,NA | |
| C01AX,Other cardiac glycosides,NA,NA,NA,NA | |
| C01AX02,peruvoside,NA,NA,NA,NA | |
| C01B,"ANTIARRHYTHMICS, CLASS I AND III",NA,NA,NA,NA | |
| C01BA,"Antiarrhythmics, class Ia",NA,NA,NA,NA | |
| C01BA01,quinidine,1.2,g,O,NA | |
| C01BA02,procainamide,3,g,O,NA | |
| C01BA02,procainamide,3,g,P,NA | |
| C01BA03,disopyramide,0.4,g,O,NA | |
| C01BA03,disopyramide,0.4,g,P,NA | |
| C01BA04,sparteine,0.2,g,P,NA | |
| C01BA05,ajmaline,0.3,g,O,NA | |
| C01BA08,prajmaline,30,mg,O,NA | |
| C01BA12,lorajmine,0.3,g,O,NA | |
| C01BA13,hydroquinidine,NA,NA,NA,NA | |
| C01BA51,"quinidine, combinations excl. psycholeptics",NA,NA,NA,NA | |
| C01BA71,"quinidine, combinations with psycholeptics",NA,NA,NA,NA | |
| C01BB,"Antiarrhythmics, class Ib",NA,NA,NA,NA | |
| C01BB01,lidocaine,3,g,P,NA | |
| C01BB02,mexiletine,0.8,g,O,NA | |
| C01BB02,mexiletine,0.8,g,P,NA | |
| C01BB03,tocainide,1.2,g,O,NA | |
| C01BB03,tocainide,1.2,g,P,NA | |
| C01BB04,aprindine,0.1,g,O,NA | |
| C01BB04,aprindine,0.1,g,P,NA | |
| C01BC,"Antiarrhythmics, class Ic",NA,NA,NA,NA | |
| C01BC03,propafenone,0.3,g,O,NA | |
| C01BC03,propafenone,0.3,g,P,NA | |
| C01BC04,flecainide,0.2,g,O,NA | |
| C01BC04,flecainide,0.2,g,P,NA | |
| C01BC07,lorcainide,0.2,g,P,NA | |
| C01BC08,encainide,0.1,g,O,NA | |
| C01BC09,ethacizine,NA,NA,NA,NA | |
| C01BD,"Antiarrhythmics, class III",NA,NA,NA,NA | |
| C01BD01,amiodarone,0.2,g,O,NA | |
| C01BD01,amiodarone,0.2,g,P,NA | |
| C01BD02,bretylium tosilate,NA,NA,NA,NA | |
| C01BD03,bunaftine,NA,NA,NA,NA | |
| C01BD04,dofetilide,NA,NA,NA,NA | |
| C01BD05,ibutilide,1,mg,P,NA | |
| C01BD06,tedisamil,NA,NA,NA,NA | |
| C01BD07,dronedarone,0.8,g,O,NA | |
| C01BG,"Other antiarrhythmics, class I and III",NA,NA,NA,NA | |
| C01BG01,moracizine,0.75,g,O,NA | |
| C01BG07,cibenzoline,NA,NA,NA,NA | |
| C01BG11,vernakalant,0.2,g,P,NA | |
| C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,NA,NA,NA,NA | |
| C01CA,Adrenergic and dopaminergic agents,NA,NA,NA,NA | |
| C01CA01,etilefrine,50,mg,O,NA | |
| C01CA01,etilefrine,50,mg,P,NA | |
| C01CA02,isoprenaline,90,mg,O,NA | |
| C01CA02,isoprenaline,90,mg,P,NA | |
| C01CA03,norepinephrine,6,mg,P,NA | |
| C01CA04,dopamine,0.5,g,P,NA | |
| C01CA05,norfenefrine,25,mg,O,NA | |
| C01CA06,phenylephrine,4,mg,P,NA | |
| C01CA07,dobutamine,0.5,g,P,NA | |
| C01CA08,oxedrine,0.2,g,O,NA | |
| C01CA08,oxedrine,0.2,g,P,NA | |
| C01CA09,metaraminol,50,mg,P,NA | |
| C01CA10,methoxamine,30,mg,P,NA | |
| C01CA11,mephentermine,30,mg,P,NA | |
| C01CA12,dimetofrine,NA,NA,NA,NA | |
| C01CA13,prenalterol,10,mg,P,NA | |
| C01CA14,dopexamine,0.5,g,P,NA | |
| C01CA15,gepefrine,30,mg,O,NA | |
| C01CA16,ibopamine,0.3,g,O,NA | |
| C01CA17,midodrine,30,mg,O,NA | |
| C01CA18,octopamine,NA,NA,NA,NA | |
| C01CA19,fenoldopam,NA,NA,NA,NA | |
| C01CA21,cafedrine,NA,NA,NA,NA | |
| C01CA22,arbutamine,NA,NA,NA,NA | |
| C01CA23,theodrenaline,NA,NA,NA,NA | |
| C01CA24,epinephrine,0.5,mg,P,NA | |
| C01CA25,amezinium metilsulfate,30,mg,O,NA | |
| C01CA26,ephedrine,50,mg,P,NA | |
| C01CA27,droxidopa,1,g,O,NA | |
| C01CA30,combinations,NA,NA,NA,NA | |
| C01CA51,"etilefrine, combinations",NA,NA,NA,NA | |
| C01CE,Phosphodiesterase inhibitors,NA,NA,NA,NA | |
| C01CE01,amrinone,0.5,g,P,NA | |
| C01CE02,milrinone,50,mg,P,NA | |
| C01CE03,enoximone,1,g,P,NA | |
| C01CE04,bucladesine,NA,NA,NA,NA | |
| C01CX,Other cardiac stimulants,NA,NA,NA,NA | |
| C01CX06,angiotensinamide,5,mg,P,NA | |
| C01CX07,xamoterol,0.4,g,O,NA | |
| C01CX08,levosimendan,11,mg,P,NA | |
| C01CX09,angiotensin II,NA,NA,NA,NA | |
| C01D,VASODILATORS USED IN CARDIAC DISEASES,NA,NA,NA,NA | |
| C01DA,Organic nitrates,NA,NA,NA,NA | |
| C01DA02,glyceryl trinitrate,5,mg,O,NA | |
| C01DA02,glyceryl trinitrate,2.5,mg,oral aerosol,NA | |
| C01DA02,glyceryl trinitrate,2.5,mg,SL,NA | |
| C01DA02,glyceryl trinitrate,5,mg,TD,NA | |
| C01DA04,methylpropylpropanediol dinitrate,NA,NA,NA,NA | |
| C01DA05,pentaerithrityl tetranitrate,0.12,g,O,NA | |
| C01DA07,propatylnitrate,30,mg,O,NA | |
| C01DA08,isosorbide dinitrate,60,mg,O,NA | |
| C01DA08,isosorbide dinitrate,20,mg,oral aerosol,NA | |
| C01DA08,isosorbide dinitrate,20,mg,SL,NA | |
| C01DA08,isosorbide dinitrate,0.1,g,TD,NA | |
| C01DA09,trolnitrate,20,mg,O,NA | |
| C01DA13,eritrityl tetranitrate,90,mg,O,NA | |
| C01DA14,isosorbide mononitrate,40,mg,O,NA | |
| C01DA20,organic nitrates in combination,NA,NA,NA,NA | |
| C01DA38,tenitramine,NA,NA,NA,NA | |
| C01DA52,"glyceryl trinitrate, combinations",NA,NA,NA,NA | |
| C01DA54,"methylpropylpropanediol dinitrate, combinations",NA,NA,NA,NA | |
| C01DA55,"pentaerithrityl tetranitrate, combinations",NA,NA,NA,NA | |
| C01DA57,"propatylnitrate, combinations",NA,NA,NA,NA | |
| C01DA58,"isosorbide dinitrate, combinations",NA,NA,NA,NA | |
| C01DA59,"trolnitrate, combinations",NA,NA,NA,NA | |
| C01DA63,"eritrityl tetranitrate, combinations",NA,NA,NA,NA | |
| C01DA70,organic nitrates in combination with psycholeptics,NA,NA,NA,NA | |
| C01DB,Quinolone vasodilators,NA,NA,NA,NA | |
| C01DB01,flosequinan,NA,NA,NA,NA | |
| C01DX,Other vasodilators used in cardiac diseases,NA,NA,NA,NA | |
| C01DX01,itramin tosilate,NA,NA,NA,NA | |
| C01DX02,prenylamine,0.12,g,O,NA | |
| C01DX03,oxyfedrine,40,mg,O,NA | |
| C01DX03,oxyfedrine,40,mg,P,NA | |
| C01DX04,benziodarone,0.25,g,O,NA | |
| C01DX05,carbocromen,NA,NA,NA,NA | |
| C01DX06,hexobendine,NA,NA,NA,NA | |
| C01DX07,etafenone,0.225,g,O,NA | |
| C01DX08,heptaminol,0.45,g,O,NA | |
| C01DX08,heptaminol,0.45,g,P,NA | |
| C01DX09,imolamine,90,mg,O,NA | |
| C01DX10,dilazep,0.1,g,O,NA | |
| C01DX11,trapidil,NA,NA,NA,NA | |
| C01DX12,molsidomine,NA,NA,NA,NA | |
| C01DX13,efloxate,0.2,g,O,NA | |
| C01DX14,cinepazet,0.9,g,O,NA | |
| C01DX15,cloridarol,NA,NA,NA,NA | |
| C01DX16,nicorandil,40,mg,O,NA | |
| C01DX18,linsidomine,NA,NA,NA,NA | |
| C01DX19,nesiritide,1.5,mg,P,NA | |
| C01DX21,serelaxin,NA,NA,NA,NA | |
| C01DX22,vericiguat,NA,NA,NA,NA | |
| C01DX51,"itramin tosilate, combinations",NA,NA,NA,NA | |
| C01DX52,"prenylamine, combinations",NA,NA,NA,NA | |
| C01DX53,"oxyfedrine, combinations",NA,NA,NA,NA | |
| C01DX54,"benziodarone, combinations",NA,NA,NA,NA | |
| C01E,OTHER CARDIAC PREPARATIONS,NA,NA,NA,NA | |
| C01EA,Prostaglandins,NA,NA,NA,NA | |
| C01EA01,alprostadil,0.5,mg,P,NA | |
| C01EB,Other cardiac preparations,NA,NA,NA,NA | |
| C01EB02,camphora,0.15,g,O,NA | |
| C01EB03,indometacin,NA,NA,NA,NA | |
| C01EB04,crataegus glycosides,NA,NA,NA,NA | |
| C01EB05,creatinolfosfate,NA,NA,NA,NA | |
| C01EB06,fosfocreatine,NA,NA,NA,NA | |
| C01EB07,"fructose 1,6-diphosphate",NA,NA,NA,NA | |
| C01EB09,ubidecarenone,NA,NA,NA,NA | |
| C01EB10,adenosine,15,mg,P,NA | |
| C01EB11,tiracizine,NA,NA,NA,NA | |
| C01EB13,acadesine,NA,NA,NA,NA | |
| C01EB15,trimetazidine,40,mg,O,NA | |
| C01EB16,ibuprofen,30,mg,P,NA | |
| C01EB17,ivabradine,10,mg,O,NA | |
| C01EB18,ranolazine,1.5,g,O,NA | |
| C01EB21,regadenoson,0.4,mg,P,NA | |
| C01EB22,meldonium,NA,NA,NA,NA | |
| C01EB23,tiazotic acid,NA,NA,NA,NA | |
| C01EX,Other cardiac combination products,NA,NA,NA,NA | |
| C02,ANTIHYPERTENSIVES,NA,NA,NA,NA | |
| C02A,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",NA,NA,NA,NA | |
| C02AA,Rauwolfia alkaloids,NA,NA,NA,NA | |
| C02AA01,rescinnamine,NA,NA,NA,NA | |
| C02AA02,reserpine,0.5,mg,O,NA | |
| C02AA02,reserpine,0.5,mg,P,NA | |
| C02AA03,combinations of rauwolfia alkaloids,NA,NA,NA,NA | |
| C02AA04,"rauwolfia alkaloids, whole root",NA,NA,NA,NA | |
| C02AA05,deserpidine,NA,NA,NA,NA | |
| C02AA06,methoserpidine,NA,NA,NA,NA | |
| C02AA07,bietaserpine,15,mg,O,NA | |
| C02AA52,"reserpine, combinations",NA,NA,NA,NA | |
| C02AA53,"combinations of rauwolfia alkoloids, combinations",NA,NA,NA,NA | |
| C02AA57,"bietaserpine, combinations",NA,NA,NA,NA | |
| C02AB,Methyldopa,NA,NA,NA,NA | |
| C02AB01,methyldopa (levorotatory),1,g,O,NA | |
| C02AB01,methyldopa (levorotatory),1,g,P,NA | |
| C02AB02,methyldopa (racemic),2,g,O,NA | |
| C02AC,Imidazoline receptor agonists,NA,NA,NA,NA | |
| C02AC01,clonidine,0.45,mg,O,NA | |
| C02AC01,clonidine,0.45,mg,P,NA | |
| C02AC02,guanfacine,3,mg,O,NA | |
| C02AC04,tolonidine,0.75,mg,O,NA | |
| C02AC05,moxonidine,0.3,mg,O,NA | |
| C02AC06,rilmenidine,NA,NA,NA,NA | |
| C02B,"ANTIADRENERGIC AGENTS, GANGLION-BLOCKING",NA,NA,NA,NA | |
| C02BA,Sulfonium derivatives,NA,NA,NA,NA | |
| C02BA01,trimetaphan,0.25,g,P,NA | |
| C02BB,Secondary and tertiary amines,NA,NA,NA,NA | |
| C02BB01,mecamylamine,NA,NA,NA,NA | |
| C02BC,Bisquaternary ammonium compounds,NA,NA,NA,NA | |
| C02C,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",NA,NA,NA,NA | |
| C02CA,Alpha-adrenoreceptor antagonists,NA,NA,NA,NA | |
| C02CA01,prazosin,5,mg,O,NA | |
| C02CA02,indoramin,NA,NA,NA,NA | |
| C02CA03,trimazosin,0.3,g,O,NA | |
| C02CA04,doxazosin,4,mg,O,NA | |
| C02CA06,urapidil,0.12,g,O,NA | |
| C02CA06,urapidil,50,mg,P,NA | |
| C02CC,Guanidine derivatives,NA,NA,NA,NA | |
| C02CC01,betanidine,0.1,g,O,NA | |
| C02CC02,guanethidine,30,mg,O,NA | |
| C02CC03,guanoxan,20,mg,O,NA | |
| C02CC04,debrisoquine,20,mg,O,NA | |
| C02CC05,guanoclor,NA,NA,NA,NA | |
| C02CC06,guanazodine,NA,NA,NA,NA | |
| C02CC07,guanoxabenz,25,mg,O,NA | |
| C02D,"ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",NA,NA,NA,NA | |
| C02DA,Thiazide derivatives,NA,NA,NA,NA | |
| C02DA01,diazoxide,0.3,g,P,NA | |
| C02DB,Hydrazinophthalazine derivatives,NA,NA,NA,NA | |
| C02DB01,dihydralazine,75,mg,O,NA | |
| C02DB01,dihydralazine,25,mg,P,NA | |
| C02DB02,hydralazine,0.1,g,O,NA | |
| C02DB03,endralazine,10,mg,O,NA | |
| C02DB04,cadralazine,15,mg,O,NA | |
| C02DC,Pyrimidine derivatives,NA,NA,NA,NA | |
| C02DC01,minoxidil,20,mg,O,NA | |
| C02DD,Nitroferricyanide derivatives,NA,NA,NA,NA | |
| C02DD01,nitroprusside,50,mg,P,NA | |
| C02DG,Guanidine derivatives,NA,NA,NA,NA | |
| C02DG01,pinacidil,50,mg,O,NA | |
| C02K,OTHER ANTIHYPERTENSIVES,NA,NA,NA,NA | |
| C02KA,"Alkaloids, excl. rauwolfia",NA,NA,NA,NA | |
| C02KA01,veratrum,NA,NA,NA,NA | |
| C02KB,Tyrosine hydroxylase inhibitors,NA,NA,NA,NA | |
| C02KB01,metirosine,NA,NA,NA,NA | |
| C02KC,MAO inhibitors,NA,NA,NA,NA | |
| C02KC01,pargyline,NA,NA,NA,NA | |
| C02KD,Serotonin antagonists,NA,NA,NA,NA | |
| C02KD01,ketanserin,40,mg,O,NA | |
| C02KD01,ketanserin,40,mg,P,NA | |
| C02KX,Antihypertensives for pulmonary arterial hypertension,NA,NA,NA,NA | |
| C02KX01,bosentan,0.25,g,O,NA | |
| C02KX02,ambrisentan,7.5,mg,O,NA | |
| C02KX03,sitaxentan,0.1,g,O,NA | |
| C02KX04,macitentan,10,mg,O,NA | |
| C02KX05,riociguat,4.5,mg,O,NA | |
| C02KX52,ambrisentan and tadalafil,NA,NA,NA,NA | |
| C02L,ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION,NA,NA,NA,NA | |
| C02LA,Rauwolfia alkaloids and diuretics in combination,NA,NA,NA,NA | |
| C02LA01,reserpine and diuretics,NA,NA,NA,NA | |
| C02LA02,rescinnamine and diuretics,NA,NA,NA,NA | |
| C02LA03,deserpidine and diuretics,NA,NA,NA,NA | |
| C02LA04,methoserpidine and diuretics,NA,NA,NA,NA | |
| C02LA07,bietaserpine and diuretics,NA,NA,NA,NA | |
| C02LA08,"rauwolfia alkaloids, whole root and diuretics",NA,NA,NA,NA | |
| C02LA09,syrosingopine and diuretics,NA,NA,NA,NA | |
| C02LA50,combination of rauwolfia alkaloids and diuretics incl. other combinations,NA,NA,NA,NA | |
| C02LA51,"reserpine and diuretics, combinations with other drugs",NA,NA,NA,NA | |
| C02LA52,"rescinnamine and diuretics, combinations with other drugs",NA,NA,NA,NA | |
| C02LA71,"reserpine and diuretics, combinations with psycholeptics",NA,NA,NA,NA | |
| C02LB,Methyldopa and diuretics in combination,NA,NA,NA,NA | |
| C02LB01,methyldopa (levorotatory) and diuretics,NA,NA,NA,NA | |
| C02LC,Imidazoline receptor agonists in combination with diuretics,NA,NA,NA,NA | |
| C02LC01,clonidine and diuretics,NA,NA,NA,NA | |
| C02LC05,moxonidine and diuretics,NA,NA,NA,NA | |
| C02LC51,"clonidine and diuretics, combinations with other drugs",NA,NA,NA,NA | |
| C02LE,Alpha-adrenoreceptor antagonists and diuretics,NA,NA,NA,NA | |
| C02LE01,prazosin and diuretics,NA,NA,NA,NA | |
| C02LF,Guanidine derivatives and diuretics,NA,NA,NA,NA | |
| C02LF01,guanethidine and diuretics,NA,NA,NA,NA | |
| C02LG,Hydrazinophthalazine derivatives and diuretics,NA,NA,NA,NA | |
| C02LG01,dihydralazine and diuretics,NA,NA,NA,NA | |
| C02LG02,hydralazine and diuretics,NA,NA,NA,NA | |
| C02LG03,picodralazine and diuretics,NA,NA,NA,NA | |
| C02LG51,"dihydralazine and diuretics, combinations with other drugs",NA,NA,NA,NA | |
| C02LG73,"picodralazine and diuretics, combinations with psycholeptics",NA,NA,NA,NA | |
| C02LK,"Alkaloids, excl. rauwolfia, in combination with diuretics",NA,NA,NA,NA | |
| C02LK01,veratrum and diuretics,NA,NA,NA,NA | |
| C02LL,MAO inhibitors and diuretics,NA,NA,NA,NA | |
| C02LL01,pargyline and diuretics,NA,NA,NA,NA | |
| C02LN,Serotonin antagonists and diuretics,NA,NA,NA,NA | |
| C02LX,Other antihypertensives and diuretics,NA,NA,NA,NA | |
| C02LX01,pinacidil and diuretics,NA,NA,NA,NA | |
| C02N,COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02,NA,NA,NA,NA | |
| C03,DIURETICS,NA,NA,NA,NA | |
| C03A,"LOW-CEILING DIURETICS, THIAZIDES",NA,NA,NA,NA | |
| C03AA,"Thiazides, plain",NA,NA,NA,NA | |
| C03AA01,bendroflumethiazide,2.5,mg,O,NA | |
| C03AA02,hydroflumethiazide,25,mg,O,NA | |
| C03AA03,hydrochlorothiazide,25,mg,O,NA | |
| C03AA04,chlorothiazide,0.5,g,O,NA | |
| C03AA05,polythiazide,1,mg,O,NA | |
| C03AA06,trichlormethiazide,4,mg,O,NA | |
| C03AA07,cyclopenthiazide,0.5,mg,O,NA | |
| C03AA08,methyclothiazide,5,mg,O,NA | |
| C03AA09,cyclothiazide,5,mg,O,NA | |
| C03AA13,mebutizide,NA,NA,NA,NA | |
| C03AB,Thiazides and potassium in combination,NA,NA,NA,NA | |
| C03AB01,bendroflumethiazide and potassium,2.5,mg,O,Refers to bendroflumethiazide | |
| C03AB02,hydroflumethiazide and potassium,25,mg,O,Refers to hydroflumethiazide | |
| C03AB03,hydrochlorothiazide and potassium,25,mg,O,Refers to hydrochlorothiazide | |
| C03AB04,chlorothiazide and potassium,0.5,g,O,Refers to chlorothiazide | |
| C03AB05,polythiazide and potassium,1,mg,O,Refers to polythiazide | |
| C03AB06,trichlormethiazide and potassium,4,mg,O,Refers to trichlormethiazide | |
| C03AB07,cyclopenthiazide and potassium,0.5,mg,O,Refers to cyclopenthiazide | |
| C03AB08,methyclothiazide and potassium,5,mg,O,Refers to methyclothiazide | |
| C03AB09,cyclothiazide and potassium,5,mg,O,Refers to cyclothiazide | |
| C03AH,"Thiazides, combinations with psycholeptics and/or analgesics",NA,NA,NA,NA | |
| C03AH01,"chlorothiazide, combinations",NA,NA,NA,NA | |
| C03AH02,"hydroflumethiazide, combinations",NA,NA,NA,NA | |
| C03AX,"Thiazides, combinations with other drugs",NA,NA,NA,NA | |
| C03AX01,"hydrochlorothiazide, combinations",NA,NA,NA,NA | |
| C03B,"LOW-CEILING DIURETICS, EXCL. THIAZIDES",NA,NA,NA,NA | |
| C03BA,"Sulfonamides, plain",NA,NA,NA,NA | |
| C03BA02,quinethazone,50,mg,O,NA | |
| C03BA03,clopamide,10,mg,O,NA | |
| C03BA04,chlortalidone,25,mg,O,NA | |
| C03BA05,mefruside,25,mg,O,NA | |
| C03BA07,clofenamide,NA,NA,NA,NA | |
| C03BA08,metolazone,5,mg,O,NA | |
| C03BA09,meticrane,NA,NA,NA,NA | |
| C03BA10,xipamide,20,mg,O,NA | |
| C03BA11,indapamide,2.5,mg,O,NA | |
| C03BA12,clorexolone,NA,NA,NA,NA | |
| C03BA13,fenquizone,NA,NA,NA,NA | |
| C03BA82,"clorexolone, combinations with psycholeptics",NA,NA,NA,NA | |
| C03BB,Sulfonamides and potassium in combination,NA,NA,NA,NA | |
| C03BB02,quinethazone and potassium,50,mg,O,Refers to quinethazone | |
| C03BB03,clopamide and potassium,10,mg,O,Refers to clopamide | |
| C03BB04,chlortalidone and potassium,25,mg,O,Refers to chlortalidone | |
| C03BB05,mefruside and potassium,25,mg,O,Refers to mefruside | |
| C03BB07,clofenamide and potassium,NA,NA,NA,NA | |
| C03BC,Mercurial diuretics,NA,NA,NA,NA | |
| C03BC01,mersalyl,NA,NA,NA,NA | |
| C03BD,Xanthine derivatives,NA,NA,NA,NA | |
| C03BD01,theobromine,4,g,O,NA | |
| C03BK,"Sulfonamides, combinations with other drugs",NA,NA,NA,NA | |
| C03BX,Other low-ceiling diuretics,NA,NA,NA,NA | |
| C03BX03,cicletanine,NA,NA,NA,NA | |
| C03C,HIGH-CEILING DIURETICS,NA,NA,NA,NA | |
| C03CA,"Sulfonamides, plain",NA,NA,NA,NA | |
| C03CA01,furosemide,40,mg,O,NA | |
| C03CA01,furosemide,40,mg,P,NA | |
| C03CA02,bumetanide,1,mg,O,NA | |
| C03CA02,bumetanide,1,mg,P,NA | |
| C03CA03,piretanide,NA,NA,NA,NA | |
| C03CA04,torasemide,15,mg,O,NA | |
| C03CA04,torasemide,15,mg,P,NA | |
| C03CB,Sulfonamides and potassium in combination,NA,NA,NA,NA | |
| C03CB01,furosemide and potassium,40,mg,O,Refers to furosemide | |
| C03CB02,bumetanide and potassium,1,mg,O,Refers to bumetanide | |
| C03CC,Aryloxyacetic acid derivatives,NA,NA,NA,NA | |
| C03CC01,etacrynic acid,50,mg,O,NA | |
| C03CC01,etacrynic acid,50,mg,P,NA | |
| C03CC02,tienilic acid,NA,NA,NA,NA | |
| C03CD,Pyrazolone derivatives,NA,NA,NA,NA | |
| C03CD01,muzolimine,20,mg,O,NA | |
| C03CX,Other high-ceiling diuretics,NA,NA,NA,NA | |
| C03CX01,etozolin,NA,NA,NA,NA | |
| C03D,POTASSIUM-SPARING AGENTS,NA,NA,NA,NA | |
| C03DA,Aldosterone antagonists,NA,NA,NA,NA | |
| C03DA01,spironolactone,75,mg,O,NA | |
| C03DA02,potassium canrenoate,0.4,g,P,NA | |
| C03DA03,canrenone,NA,NA,NA,NA | |
| C03DA04,eplerenone,50,mg,O,NA | |
| C03DB,Other potassium-sparing agents,NA,NA,NA,NA | |
| C03DB01,amiloride,10,mg,O,NA | |
| C03DB02,triamterene,0.1,g,O,NA | |
| C03E,DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION,NA,NA,NA,NA | |
| C03EA,Low-ceiling diuretics and potassium-sparing agents,NA,NA,NA,NA | |
| C03EA01,hydrochlorothiazide and potassium-sparing agents,NA,NA,NA,NA | |
| C03EA02,trichlormethiazide and potassium-sparing agents,NA,NA,NA,NA | |
| C03EA03,epitizide and potassium-sparing agents,NA,NA,NA,NA | |
| C03EA04,altizide and potassium-sparing agents,NA,NA,NA,NA | |
| C03EA05,mebutizide and potassium-sparing agents,NA,NA,NA,NA | |
| C03EA06,chlortalidone and potassium-sparing agents,NA,NA,NA,NA | |
| C03EA07,cyclopenthiazide and potassium-sparing agents,NA,NA,NA,NA | |
| C03EA12,metolazone and potassium-sparing agents,NA,NA,NA,NA | |
| C03EA13,bendroflumethiazide and potassium-sparing agents,NA,NA,NA,NA | |
| C03EA14,butizide and potassium-sparing agents,NA,NA,NA,NA | |
| C03EB,High-ceiling diuretics and potassium-sparing agents,NA,NA,NA,NA | |
| C03EB01,furosemide and potassium-sparing agents,NA,NA,NA,NA | |
| C03EB02,bumetanide and potassium-sparing agents,NA,NA,NA,NA | |
| C03X,OTHER DIURETICS,NA,NA,NA,NA | |
| C03XA,Vasopressin antagonists,NA,NA,NA,NA | |
| C03XA01,tolvaptan,30,mg,O,NA | |
| C03XA02,conivaptan,NA,NA,NA,NA | |
| C04,PERIPHERAL VASODILATORS,NA,NA,NA,NA | |
| C04A,PERIPHERAL VASODILATORS,NA,NA,NA,NA | |
| C04AA,2-amino-1-phenylethanol derivatives,NA,NA,NA,NA | |
| C04AA01,isoxsuprine,60,mg,O,NA | |
| C04AA01,isoxsuprine,60,mg,P,NA | |
| C04AA02,buphenine,30,mg,O,NA | |
| C04AA31,bamethan,75,mg,O,NA | |
| C04AB,Imidazoline derivatives,NA,NA,NA,NA | |
| C04AB01,phentolamine,10,mg,O,NA | |
| C04AB01,phentolamine,10,mg,P,NA | |
| C04AB02,tolazoline,75,mg,O,NA | |
| C04AC,Nicotinic acid and derivatives,NA,NA,NA,NA | |
| C04AC01,nicotinic acid,0.2,g,O,NA | |
| C04AC01,nicotinic acid,0.2,g,P,NA | |
| C04AC02,nicotinyl alcohol (pyridylcarbinol),0.3,g,O,NA | |
| C04AC02,nicotinyl alcohol (pyridylcarbinol),0.3,g,P,NA | |
| C04AC03,inositol nicotinate,1.2,g,O,NA | |
| C04AC07,ciclonicate,NA,NA,NA,NA | |
| C04AD,Purine derivatives,NA,NA,NA,NA | |
| C04AD01,pentifylline,NA,NA,NA,NA | |
| C04AD02,xantinol nicotinate,0.9,g,O,NA | |
| C04AD02,xantinol nicotinate,0.9,g,P,NA | |
| C04AD03,pentoxifylline,1,g,O,NA | |
| C04AD03,pentoxifylline,0.3,g,P,NA | |
| C04AD04,etofylline nicotinate,0.3,g,O,NA | |
| C04AE,Ergot alkaloids,NA,NA,NA,NA | |
| C04AE01,ergoloid mesylates,3,mg,O,NA | |
| C04AE01,ergoloid mesylates,3,mg,P,NA | |
| C04AE02,nicergoline,NA,NA,NA,NA | |
| C04AE04,dihydroergocristine,NA,NA,NA,NA | |
| C04AE51,"ergoloid mesylates, combinations",NA,NA,NA,NA | |
| C04AE54,"dihydroergocristine, combinations",NA,NA,NA,NA | |
| C04AF,Enzymes,NA,NA,NA,NA | |
| C04AF01,kallidinogenase,30,U,O,NA | |
| C04AF01,kallidinogenase,30,U,P,NA | |
| C04AX,Other peripheral vasodilators,NA,NA,NA,NA | |
| C04AX01,cyclandelate,0.6,g,O,NA | |
| C04AX02,phenoxybenzamine,30,mg,O,NA | |
| C04AX07,vincamine,NA,NA,NA,NA | |
| C04AX10,moxisylyte,NA,NA,NA,NA | |
| C04AX11,bencyclane,NA,NA,NA,NA | |
| C04AX17,vinburnine,NA,NA,NA,NA | |
| C04AX19,suloctidil,NA,NA,NA,NA | |
| C04AX20,buflomedil,0.6,g,O,NA | |
| C04AX21,naftidrofuryl,0.6,g,O,NA | |
| C04AX23,butalamine,NA,NA,NA,NA | |
| C04AX24,visnadine,0.6,g,O,NA | |
| C04AX26,cetiedil,NA,NA,NA,NA | |
| C04AX27,cinepazide,NA,NA,NA,NA | |
| C04AX28,ifenprodil,NA,NA,NA,NA | |
| C04AX30,azapetine,0.15,g,O,NA | |
| C04AX32,fasudil,NA,NA,NA,NA | |
| C05,VASOPROTECTIVES,NA,NA,NA,NA | |
| C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,NA,NA,NA,NA | |
| C05AA,Corticosteroids,NA,NA,NA,NA | |
| C05AA01,hydrocortisone,NA,NA,NA,NA | |
| C05AA04,prednisolone,NA,NA,NA,NA | |
| C05AA05,betamethasone,NA,NA,NA,NA | |
| C05AA06,fluorometholone,NA,NA,NA,NA | |
| C05AA08,fluocortolone,NA,NA,NA,NA | |
| C05AA09,dexamethasone,NA,NA,NA,NA | |
| C05AA10,fluocinolone acetonide,NA,NA,NA,NA | |
| C05AA11,fluocinonide,NA,NA,NA,NA | |
| C05AA12,triamcinolone,NA,NA,NA,NA | |
| C05AB,Antibiotics,NA,NA,NA,NA | |
| C05AD,Local anesthetics,NA,NA,NA,NA | |
| C05AD01,lidocaine,NA,NA,NA,NA | |
| C05AD02,tetracaine,NA,NA,NA,NA | |
| C05AD03,benzocaine,NA,NA,NA,NA | |
| C05AD04,cinchocaine,NA,NA,NA,NA | |
| C05AD05,procaine,NA,NA,NA,NA | |
| C05AD06,oxetacaine,NA,NA,NA,NA | |
| C05AD07,pramocaine,NA,NA,NA,NA | |
| C05AE,Muscle relaxants,NA,NA,NA,NA | |
| C05AE01,glyceryl trinitrate,NA,NA,NA,NA | |
| C05AE02,isosorbide dinitrate,NA,NA,NA,NA | |
| C05AE03,diltiazem,NA,NA,NA,NA | |
| C05AX,Other agents for treatment of hemorrhoids and anal fissures for topical use,NA,NA,NA,NA | |
| C05AX01,aluminium preparations,NA,NA,NA,NA | |
| C05AX02,"bismuth preparations, combinations",NA,NA,NA,NA | |
| C05AX03,"other preparations, combinations",NA,NA,NA,NA | |
| C05AX04,zinc preparations,NA,NA,NA,NA | |
| C05AX05,tribenoside,NA,NA,NA,NA | |
| C05B,ANTIVARICOSE THERAPY,NA,NA,NA,NA | |
| C05BA,Heparins or heparinoids for topical use,NA,NA,NA,NA | |
| C05BA01,organo-heparinoid,NA,NA,NA,NA | |
| C05BA02,sodium apolate,NA,NA,NA,NA | |
| C05BA03,heparin,NA,NA,NA,NA | |
| C05BA04,pentosan polysulfate sodium,NA,NA,NA,NA | |
| C05BA51,"heparinoid, combinations",NA,NA,NA,NA | |
| C05BA53,"heparin, combinations",NA,NA,NA,NA | |
| C05BB,Sclerosing agents for local injection,NA,NA,NA,NA | |
| C05BB01,monoethanolamine oleate,NA,NA,NA,NA | |
| C05BB02,polidocanol,NA,NA,NA,NA | |
| C05BB03,invert sugar,NA,NA,NA,NA | |
| C05BB04,sodium tetradecyl sulfate,NA,NA,NA,NA | |
| C05BB05,phenol,NA,NA,NA,NA | |
| C05BB56,"glucose, combinations",NA,NA,NA,NA | |
| C05BX,Other sclerosing agents,NA,NA,NA,NA | |
| C05BX01,calcium dobesilate,NA,NA,NA,NA | |
| C05BX51,"calcium dobesilate, combinations",NA,NA,NA,NA | |
| C05C,CAPILLARY STABILIZING AGENTS,NA,NA,NA,NA | |
| C05CA,Bioflavonoids,NA,NA,NA,NA | |
| C05CA01,rutoside,NA,NA,NA,NA | |
| C05CA02,monoxerutin,NA,NA,NA,NA | |
| C05CA03,diosmin,NA,NA,NA,NA | |
| C05CA04,troxerutin,NA,NA,NA,NA | |
| C05CA05,hidrosmin,NA,NA,NA,NA | |
| C05CA51,"rutoside, combinations",NA,NA,NA,NA | |
| C05CA53,"diosmin, combinations",NA,NA,NA,NA | |
| C05CA54,"troxerutin, combinations",NA,NA,NA,NA | |
| C05CX,Other capillary stabilizing agents,NA,NA,NA,NA | |
| C05CX01,tribenoside,NA,NA,NA,NA | |
| C05CX02,naftazone,NA,NA,NA,NA | |
| C05CX03,Hippocastani semen,NA,NA,NA,NA | |
| C07,BETA BLOCKING AGENTS,NA,NA,NA,NA | |
| C07A,BETA BLOCKING AGENTS,NA,NA,NA,NA | |
| C07AA,"Beta blocking agents, non-selective",NA,NA,NA,NA | |
| C07AA01,alprenolol,0.4,g,O,NA | |
| C07AA01,alprenolol,0.4,g,P,NA | |
| C07AA02,oxprenolol,0.16,g,O,NA | |
| C07AA02,oxprenolol,0.16,g,P,NA | |
| C07AA03,pindolol,15,mg,O,NA | |
| C07AA03,pindolol,15,mg,P,NA | |
| C07AA05,propranolol,0.16,g,O,NA | |
| C07AA05,propranolol,0.16,g,P,NA | |
| C07AA06,timolol,20,mg,O,NA | |
| C07AA06,timolol,20,mg,P,NA | |
| C07AA07,sotalol,0.16,g,O,NA | |
| C07AA07,sotalol,0.16,g,P,NA | |
| C07AA12,nadolol,0.16,g,O,NA | |
| C07AA14,mepindolol,5,mg,O,NA | |
| C07AA15,carteolol,10,mg,O,NA | |
| C07AA16,tertatolol,5,mg,O,NA | |
| C07AA17,bopindolol,NA,NA,NA,NA | |
| C07AA19,bupranolol,NA,NA,NA,NA | |
| C07AA23,penbutolol,40,mg,O,NA | |
| C07AA27,cloranolol,NA,NA,NA,NA | |
| C07AB,"Beta blocking agents, selective",NA,NA,NA,NA | |
| C07AB01,practolol,0.3,g,O,NA | |
| C07AB01,practolol,20,mg,P,NA | |
| C07AB02,metoprolol,0.15,g,O,NA | |
| C07AB02,metoprolol,0.15,g,P,NA | |
| C07AB03,atenolol,75,mg,O,NA | |
| C07AB03,atenolol,75,mg,P,NA | |
| C07AB04,acebutolol,0.4,g,O,NA | |
| C07AB04,acebutolol,0.4,g,P,NA | |
| C07AB05,betaxolol,20,mg,O,NA | |
| C07AB06,bevantolol,0.3,g,O,NA | |
| C07AB07,bisoprolol,10,mg,O,NA | |
| C07AB08,celiprolol,0.2,g,O,NA | |
| C07AB09,esmolol,2.5,g,P,NA | |
| C07AB10,epanolol,0.2,g,O,NA | |
| C07AB11,s-atenolol,50,mg,O,NA | |
| C07AB12,nebivolol,5,mg,O,NA | |
| C07AB13,talinolol,0.1,g,O,NA | |
| C07AB14,landiolol,NA,NA,NA,NA | |
| C07AG,Alpha and beta blocking agents,NA,NA,NA,NA | |
| C07AG01,labetalol,0.6,g,O,NA | |
| C07AG01,labetalol,0.6,g,P,NA | |
| C07AG02,carvedilol,37.5,mg,O,NA | |
| C07B,BETA BLOCKING AGENTS AND THIAZIDES,NA,NA,NA,NA | |
| C07BA,"Beta blocking agents, non-selective, and thiazides",NA,NA,NA,NA | |
| C07BA02,oxprenolol and thiazides,NA,NA,NA,NA | |
| C07BA05,propranolol and thiazides,NA,NA,NA,NA | |
| C07BA06,timolol and thiazides,NA,NA,NA,NA | |
| C07BA07,sotalol and thiazides,NA,NA,NA,NA | |
| C07BA12,nadolol and thiazides,NA,NA,NA,NA | |
| C07BA68,"metipranolol and thiazides, combinations",NA,NA,NA,NA | |
| C07BB,"Beta blocking agents, selective, and thiazides",NA,NA,NA,NA | |
| C07BB02,metoprolol and thiazides,NA,NA,NA,NA | |
| C07BB03,atenolol and thiazides,NA,NA,NA,NA | |
| C07BB04,acebutolol and thiazides,NA,NA,NA,NA | |
| C07BB06,bevantolol and thiazides,NA,NA,NA,NA | |
| C07BB07,bisoprolol and thiazides,NA,NA,NA,NA | |
| C07BB12,nebivolol and thiazides,NA,NA,NA,NA | |
| C07BB52,"metoprolol and thiazides, combinations",NA,NA,NA,NA | |
| C07BG,Alpha and beta blocking agents and thiazides,NA,NA,NA,NA | |
| C07BG01,labetalol and thiazides,NA,NA,NA,NA | |
| C07C,BETA BLOCKING AGENTS AND OTHER DIURETICS,NA,NA,NA,NA | |
| C07CA,"Beta blocking agents, non-selective, and other diuretics",NA,NA,NA,NA | |
| C07CA02,oxprenolol and other diuretics,NA,NA,NA,NA | |
| C07CA03,pindolol and other diuretics,NA,NA,NA,NA | |
| C07CA17,bopindolol and other diuretics,NA,NA,NA,NA | |
| C07CA23,penbutolol and other diuretics,NA,NA,NA,NA | |
| C07CB,"Beta blocking agents, selective, and other diuretics",NA,NA,NA,NA | |
| C07CB02,metoprolol and other diuretics,NA,NA,NA,NA | |
| C07CB03,atenolol and other diuretics,NA,NA,NA,NA | |
| C07CB53,"atenolol and other diuretics, combinations",NA,NA,NA,NA | |
| C07CG,Alpha and beta blocking agents and other diuretics,NA,NA,NA,NA | |
| C07CG01,labetalol and other diuretics,NA,NA,NA,NA | |
| C07D,"BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS",NA,NA,NA,NA | |
| C07DA,"Beta blocking agents, non-selective, thiazides and other diuretics",NA,NA,NA,NA | |
| C07DA06,"timolol, thiazides and other diuretics",NA,NA,NA,NA | |
| C07DB,"Beta blocking agents, selective, thiazides and other diuretics",NA,NA,NA,NA | |
| C07DB01,"atenolol, thiazides and other diuretics",NA,NA,NA,NA | |
| C07E,BETA BLOCKING AGENTS AND VASODILATORS,NA,NA,NA,NA | |
| C07EA,"Beta blocking agents, non-selective, and vasodilators",NA,NA,NA,NA | |
| C07EB,"Beta blocking agents, selective, and vasodilators",NA,NA,NA,NA | |
| C07F,"BETA BLOCKING AGENTS, OTHER COMBINATIONS",NA,NA,NA,NA | |
| C07FB,Beta blocking agents and calcium channel blockers,NA,NA,NA,NA | |
| C07FB02,metoprolol and felodipine,NA,NA,NA,NA | |
| C07FB03,atenolol and nifedipine,NA,NA,NA,NA | |
| C07FB07,bisoprolol and amlodipine,NA,NA,NA,NA | |
| C07FB12,nebivolol and amlodipine,NA,NA,NA,NA | |
| C07FB13,metoprolol and amlodipine,NA,NA,NA,NA | |
| C07FX,"Beta blocking agents, other combinations",NA,NA,NA,NA | |
| C07FX01,propranolol and other combinations,NA,NA,NA,NA | |
| C07FX02,sotalol and acetylsalicylic acid,NA,NA,NA,NA | |
| C07FX03,metoprolol and acetylsalicylic acid,NA,NA,NA,NA | |
| C07FX04,bisoprolol and acetylsalicylic acid,NA,NA,NA,NA | |
| C07FX05,metoprolol and ivabradine,NA,NA,NA,NA | |
| C07FX06,carvedilol and ivabradine,NA,NA,NA,NA | |
| C08,CALCIUM CHANNEL BLOCKERS,NA,NA,NA,NA | |
| C08C,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,NA,NA,NA,NA | |
| C08CA,Dihydropyridine derivatives,NA,NA,NA,NA | |
| C08CA01,amlodipine,5,mg,O,NA | |
| C08CA02,felodipine,5,mg,O,NA | |
| C08CA03,isradipine,5,mg,O,NA | |
| C08CA03,isradipine,5,mg,P,NA | |
| C08CA04,nicardipine,90,mg,O,NA | |
| C08CA04,nicardipine,90,mg,P,NA | |
| C08CA05,nifedipine,30,mg,O,NA | |
| C08CA05,nifedipine,30,mg,P,NA | |
| C08CA06,nimodipine,0.3,g,O,NA | |
| C08CA06,nimodipine,50,mg,P,NA | |
| C08CA07,nisoldipine,20,mg,O,NA | |
| C08CA08,nitrendipine,20,mg,O,NA | |
| C08CA09,lacidipine,4,mg,O,NA | |
| C08CA10,nilvadipine,8,mg,O,NA | |
| C08CA11,manidipine,10,mg,O,NA | |
| C08CA12,barnidipine,10,mg,O,NA | |
| C08CA13,lercanidipine,10,mg,O,NA | |
| C08CA14,cilnidipine,10,mg,O,NA | |
| C08CA15,benidipine,NA,NA,NA,NA | |
| C08CA16,clevidipine,NA,NA,NA,NA | |
| C08CA51,amlodipine and celecoxib,NA,NA,NA,NA | |
| C08CA55,"nifedipine, combinations",NA,NA,NA,NA | |
| C08CX,Other selective calcium channel blockers with mainly vascular effects,NA,NA,NA,NA | |
| C08CX01,mibefradil,75,mg,O,NA | |
| C08D,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,NA,NA,NA,NA | |
| C08DA,Phenylalkylamine derivatives,NA,NA,NA,NA | |
| C08DA01,verapamil,0.24,g,O,NA | |
| C08DA01,verapamil,0.24,g,P,NA | |
| C08DA02,gallopamil,NA,NA,NA,NA | |
| C08DA51,"verapamil, combinations",NA,NA,NA,NA | |
| C08DB,Benzothiazepine derivatives,NA,NA,NA,NA | |
| C08DB01,diltiazem,0.24,g,O,NA | |
| C08E,NON-SELECTIVE CALCIUM CHANNEL BLOCKERS,NA,NA,NA,NA | |
| C08EA,Phenylalkylamine derivatives,NA,NA,NA,NA | |
| C08EA01,fendiline,NA,NA,NA,NA | |
| C08EA02,bepridil,0.3,g,O,NA | |
| C08EX,Other non-selective calcium channel blockers,NA,NA,NA,NA | |
| C08EX01,lidoflazine,0.18,g,O,NA | |
| C08EX02,perhexiline,NA,NA,NA,NA | |
| C08G,CALCIUM CHANNEL BLOCKERS AND DIURETICS,NA,NA,NA,NA | |
| C08GA,Calcium channel blockers and diuretics,NA,NA,NA,NA | |
| C08GA01,nifedipine and diuretics,NA,NA,NA,NA | |
| C08GA02,amlodipine and diuretics,NA,NA,NA,NA | |
| C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,NA,NA,NA,NA | |
| C09A,"ACE INHIBITORS, PLAIN",NA,NA,NA,NA | |
| C09AA,"ACE inhibitors, plain",NA,NA,NA,NA | |
| C09AA01,captopril,50,mg,O,NA | |
| C09AA02,enalapril,10,mg,O,NA | |
| C09AA02,enalapril,10,mg,P,NA | |
| C09AA03,lisinopril,10,mg,O,NA | |
| C09AA04,perindopril,4,mg,O,NA | |
| C09AA05,ramipril,2.5,mg,O,NA | |
| C09AA06,quinapril,15,mg,O,NA | |
| C09AA06,quinapril,15,mg,P,NA | |
| C09AA07,benazepril,7.5,mg,O,NA | |
| C09AA08,cilazapril,2.5,mg,O,NA | |
| C09AA09,fosinopril,15,mg,O,NA | |
| C09AA10,trandolapril,2,mg,O,NA | |
| C09AA11,spirapril,6,mg,O,NA | |
| C09AA12,delapril,30,mg,O,NA | |
| C09AA13,moexipril,15,mg,O,NA | |
| C09AA14,temocapril,10,mg,O,NA | |
| C09AA15,zofenopril,30,mg,O,NA | |
| C09AA16,imidapril,10,mg,O,NA | |
| C09B,"ACE INHIBITORS, COMBINATIONS",NA,NA,NA,NA | |
| C09BA,ACE inhibitors and diuretics,NA,NA,NA,NA | |
| C09BA01,captopril and diuretics,NA,NA,NA,NA | |
| C09BA02,enalapril and diuretics,NA,NA,NA,NA | |
| C09BA03,lisinopril and diuretics,NA,NA,NA,NA | |
| C09BA04,perindopril and diuretics,NA,NA,NA,NA | |
| C09BA05,ramipril and diuretics,NA,NA,NA,NA | |
| C09BA06,quinapril and diuretics,NA,NA,NA,NA | |
| C09BA07,benazepril and diuretics,NA,NA,NA,NA | |
| C09BA08,cilazapril and diuretics,NA,NA,NA,NA | |
| C09BA09,fosinopril and diuretics,NA,NA,NA,NA | |
| C09BA12,delapril and diuretics,NA,NA,NA,NA | |
| C09BA13,moexipril and diuretics,NA,NA,NA,NA | |
| C09BA15,zofenopril and diuretics,NA,NA,NA,NA | |
| C09BB,ACE inhibitors and calcium channel blockers,NA,NA,NA,NA | |
| C09BB02,enalapril and lercanidipine,NA,NA,NA,NA | |
| C09BB03,lisinopril and amlodipine,NA,NA,NA,NA | |
| C09BB04,perindopril and amlodipine,NA,NA,NA,NA | |
| C09BB05,ramipril and felodipine,NA,NA,NA,NA | |
| C09BB06,enalapril and nitrendipine,NA,NA,NA,NA | |
| C09BB07,ramipril and amlodipine,NA,NA,NA,NA | |
| C09BB10,trandolapril and verapamil,NA,NA,NA,NA | |
| C09BB12,delapril and manidipine,NA,NA,NA,NA | |
| C09BX,"ACE inhibitors, other combinations",NA,NA,NA,NA | |
| C09BX01,"perindopril, amlodipine and indapamide",NA,NA,NA,NA | |
| C09BX02,perindopril and bisoprolol,NA,NA,NA,NA | |
| C09BX03,"ramipril, amlodipine and hydrochlorothiazide",NA,NA,NA,NA | |
| C09BX04,"perindopril, bisoprolol and amlodipine",NA,NA,NA,NA | |
| C09BX05,ramipril and bisoprolol,NA,NA,NA,NA | |
| C09C,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",NA,NA,NA,NA | |
| C09CA,"Angiotensin II receptor blockers (ARBs), plain",NA,NA,NA,NA | |
| C09CA01,losartan,50,mg,O,NA | |
| C09CA02,eprosartan,0.6,g,O,NA | |
| C09CA03,valsartan,80,mg,O,NA | |
| C09CA04,irbesartan,0.15,g,O,NA | |
| C09CA05,tasosartan,NA,NA,NA,NA | |
| C09CA06,candesartan,8,mg,O,NA | |
| C09CA07,telmisartan,40,mg,O,NA | |
| C09CA08,olmesartan medoxomil,20,mg,O,NA | |
| C09CA09,azilsartan medoxomil,40,mg,O,NA | |
| C09CA10,fimasartan,60,mg,O,NA | |
| C09D,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",NA,NA,NA,NA | |
| C09DA,Angiotensin II receptor blockers (ARBs) and diuretics,NA,NA,NA,NA | |
| C09DA01,losartan and diuretics,NA,NA,NA,NA | |
| C09DA02,eprosartan and diuretics,NA,NA,NA,NA | |
| C09DA03,valsartan and diuretics,NA,NA,NA,NA | |
| C09DA04,irbesartan and diuretics,NA,NA,NA,NA | |
| C09DA06,candesartan and diuretics,NA,NA,NA,NA | |
| C09DA07,telmisartan and diuretics,NA,NA,NA,NA | |
| C09DA08,olmesartan medoxomil and diuretics,NA,NA,NA,NA | |
| C09DA09,azilsartan medoxomil and diuretics,NA,NA,NA,NA | |
| C09DA10,fimasartan and diuretics,NA,NA,NA,NA | |
| C09DB,Angiotensin II receptor blockers (ARBs) and calcium channel blockers,NA,NA,NA,NA | |
| C09DB01,valsartan and amlodipine,NA,NA,NA,NA | |
| C09DB02,olmesartan medoxomil and amlodipine,NA,NA,NA,NA | |
| C09DB04,telmisartan and amlodipine,NA,NA,NA,NA | |
| C09DB05,irbesartan and amlodipine,NA,NA,NA,NA | |
| C09DB06,losartan and amlodipine,NA,NA,NA,NA | |
| C09DB07,candesartan and amlodipine,NA,NA,NA,NA | |
| C09DB08,valsartan and lercanidipine,NA,NA,NA,NA | |
| C09DB09,fimasartan and amlodipine,NA,NA,NA,NA | |
| C09DX,"Angiotensin II receptor blockers (ARBs), other combinations",NA,NA,NA,NA | |
| C09DX01,"valsartan, amlodipine and hydrochlorothiazide",NA,NA,NA,NA | |
| C09DX02,valsartan and aliskiren,NA,NA,NA,NA | |
| C09DX03,"olmesartan medoxomil, amlodipine and hydrochlorothiazide",NA,NA,NA,NA | |
| C09DX04,valsartan and sacubitril,NA,NA,NA,NA | |
| C09DX05,valsartan and nebivolol,NA,NA,NA,NA | |
| C09DX06,"candesartan, amlodipine and hydrochlorothiazide",NA,NA,NA,NA | |
| C09DX07,"irbesartan, amlodipine and hydrochlorothiazide",NA,NA,NA,NA | |
| C09X,OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,NA,NA,NA,NA | |
| C09XA,Renin-inhibitors,NA,NA,NA,NA | |
| C09XA01,remikiren,NA,NA,NA,NA | |
| C09XA02,aliskiren,0.15,g,O,NA | |
| C09XA52,aliskiren and hydrochlorothiazide,NA,NA,NA,NA | |
| C09XA53,aliskiren and amlodipine,NA,NA,NA,NA | |
| C09XA54,"aliskiren, amlodipine and hydrochlorothiazide",NA,NA,NA,NA | |
| C10,LIPID MODIFYING AGENTS,NA,NA,NA,NA | |
| C10A,"LIPID MODIFYING AGENTS, PLAIN",NA,NA,NA,NA | |
| C10AA,HMG CoA reductase inhibitors,NA,NA,NA,NA | |
| C10AA01,simvastatin,30,mg,O,NA | |
| C10AA02,lovastatin,45,mg,O,NA | |
| C10AA03,pravastatin,30,mg,O,NA | |
| C10AA04,fluvastatin,60,mg,O,NA | |
| C10AA05,atorvastatin,20,mg,O,NA | |
| C10AA06,cerivastatin,0.2,mg,O,NA | |
| C10AA07,rosuvastatin,10,mg,O,NA | |
| C10AA08,pitavastatin,2,mg,O,NA | |
| C10AB,Fibrates,NA,NA,NA,NA | |
| C10AB01,clofibrate,2,g,O,NA | |
| C10AB02,bezafibrate,0.6,g,O,NA | |
| C10AB03,aluminium clofibrate,NA,NA,NA,NA | |
| C10AB04,gemfibrozil,1.2,g,O,NA | |
| C10AB05,fenofibrate,0.2,g,O,micronised | |
| C10AB06,simfibrate,NA,NA,NA,NA | |
| C10AB07,ronifibrate,NA,NA,NA,NA | |
| C10AB08,ciprofibrate,0.1,g,O,NA | |
| C10AB09,etofibrate,NA,NA,NA,NA | |
| C10AB10,clofibride,NA,NA,NA,NA | |
| C10AB11,choline fenofibrate,0.135,g,O,Refers to fenofibric acid | |
| C10AC,Bile acid sequestrants,NA,NA,NA,NA | |
| C10AC01,colestyramine,14,g,O,NA | |
| C10AC02,colestipol,20,g,O,NA | |
| C10AC03,colextran,NA,NA,NA,NA | |
| C10AC04,colesevelam,3.75,g,O,NA | |
| C10AD,Nicotinic acid and derivatives,NA,NA,NA,NA | |
| C10AD01,niceritrol,1.5,g,O,NA | |
| C10AD02,nicotinic acid,2,g,O,NA | |
| C10AD03,nicofuranose,NA,NA,NA,NA | |
| C10AD04,aluminium nicotinate,NA,NA,NA,NA | |
| C10AD05,nicotinyl alcohol (pyridylcarbinol),0.9,g,O,NA | |
| C10AD06,acipimox,0.5,g,O,NA | |
| C10AD52,"nicotinic acid, combinations",NA,NA,NA,NA | |
| C10AX,Other lipid modifying agents,NA,NA,NA,NA | |
| C10AX01,dextrothyroxine,4,mg,O,NA | |
| C10AX02,probucol,NA,NA,NA,NA | |
| C10AX03,tiadenol,NA,NA,NA,NA | |
| C10AX05,meglutol,NA,NA,NA,NA | |
| C10AX06,omega-3-triglycerides incl. other esters and acids,NA,NA,NA,NA | |
| C10AX07,magnesium pyridoxal 5-phosphate glutamate,NA,NA,NA,NA | |
| C10AX08,policosanol,NA,NA,NA,NA | |
| C10AX09,ezetimibe,10,mg,O,NA | |
| C10AX10,alipogene tiparvovec,NA,NA,NA,NA | |
| C10AX11,mipomersen,NA,NA,NA,NA | |
| C10AX12,lomitapide,40,mg,O,NA | |
| C10AX13,evolocumab,10,mg,P,NA | |
| C10AX14,alirocumab,5.4,mg,P,NA | |
| C10AX15,bempedoic acid,NA,NA,NA,NA | |
| C10AX16,inclisiran,NA,NA,NA,NA | |
| C10B,"LIPID MODIFYING AGENTS, COMBINATIONS",NA,NA,NA,NA | |
| C10BA,Combinations of various lipid modifying agents,NA,NA,NA,NA | |
| C10BA01,lovastatin and nicotinic acid,NA,NA,NA,NA | |
| C10BA02,simvastatin and ezetimibe,NA,NA,NA,NA | |
| C10BA03,pravastatin and fenofibrate,NA,NA,NA,NA | |
| C10BA04,simvastatin and fenofibrate,NA,NA,NA,NA | |
| C10BA05,atorvastatin and ezetimibe,NA,NA,NA,NA | |
| C10BA06,rosuvastatin and ezetimibe,NA,NA,NA,NA | |
| C10BA07,rosuvastatin and omega-3 fatty acids,NA,NA,NA,NA | |
| C10BA08,atorvastatin and omega-3 fatty acids,NA,NA,NA,NA | |
| C10BA09,rosuvastatin and fenofibrate,NA,NA,NA,NA | |
| C10BA10,bempedoic acid and ezetimibe,NA,NA,NA,NA | |
| C10BX,Lipid modifying agents in combination with other drugs,NA,NA,NA,NA | |
| C10BX01,simvastatin and acetylsalicylic acid,30,mg,O,Refers to simvastatin | |
| C10BX02,pravastatin and acetylsalicylic acid,NA,NA,NA,NA | |
| C10BX03,atorvastatin and amlodipine,NA,NA,NA,NA | |
| C10BX04,"simvastatin, acetylsalicylic acid and ramipril",NA,NA,NA,NA | |
| C10BX05,rosuvastatin and acetylsalicylic acid,NA,NA,NA,NA | |
| C10BX06,"atorvastatin, acetylsalicylic acid and ramipril",NA,NA,NA,NA | |
| C10BX07,"rosuvastatin, amlodipine and lisinopril",NA,NA,NA,NA | |
| C10BX08,atorvastatin and acetylsalicylic acid,NA,NA,NA,NA | |
| C10BX09,rosuvastatin and amlodipine,NA,NA,NA,NA | |
| C10BX10,rosuvastatin and valsartan,NA,NA,NA,NA | |
| C10BX11,"atorvastatin, amlodipine and perindopril",NA,NA,NA,NA | |
| C10BX12,"atorvastatin, acetylsalicylic acid and perindopril",NA,NA,NA,NA | |
| C10BX13,"rosuvastatin, perindopril and indapamide",NA,NA,NA,NA | |
| C10BX14,"rosuvastatin, amlodipine and perindopril",NA,NA,NA,NA | |
| C10BX15,atorvastatin and perindopril,NA,NA,NA,NA | |
| C10BX16,rosuvastatin and fimasartan,NA,NA,NA,NA | |
| C10BX17,rosuvastatin and ramipril,NA,NA,NA,NA | |
| C10BX18,"atorvastatin, amlodipine and ramipril",NA,NA,NA,NA | |
| D,DERMATOLOGICALS,NA,NA,NA,NA | |
| D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,NA,NA,NA,NA | |
| D01A,ANTIFUNGALS FOR TOPICAL USE,NA,NA,NA,NA | |
| D01AA,Antibiotics,NA,NA,NA,NA | |
| D01AA01,nystatin,NA,NA,NA,NA | |
| D01AA02,natamycin,NA,NA,NA,NA | |
| D01AA03,hachimycin,NA,NA,NA,NA | |
| D01AA04,pecilocin,NA,NA,NA,NA | |
| D01AA06,mepartricin,NA,NA,NA,NA | |
| D01AA07,pyrrolnitrin,NA,NA,NA,NA | |
| D01AA08,griseofulvin,NA,NA,NA,NA | |
| D01AA20,combinations,NA,NA,NA,NA | |
| D01AC,Imidazole and triazole derivatives,NA,NA,NA,NA | |
| D01AC01,clotrimazole,NA,NA,NA,NA | |
| D01AC02,miconazole,NA,NA,NA,NA | |
| D01AC03,econazole,NA,NA,NA,NA | |
| D01AC04,chlormidazole,NA,NA,NA,NA | |
| D01AC05,isoconazole,NA,NA,NA,NA | |
| D01AC06,tiabendazole,NA,NA,NA,NA | |
| D01AC07,tioconazole,NA,NA,NA,NA | |
| D01AC08,ketoconazole,NA,NA,NA,NA | |
| D01AC09,sulconazole,NA,NA,NA,NA | |
| D01AC10,bifonazole,NA,NA,NA,NA | |
| D01AC11,oxiconazole,NA,NA,NA,NA | |
| D01AC12,fenticonazole,NA,NA,NA,NA | |
| D01AC13,omoconazole,NA,NA,NA,NA | |
| D01AC14,sertaconazole,NA,NA,NA,NA | |
| D01AC15,fluconazole,NA,NA,NA,NA | |
| D01AC16,flutrimazole,NA,NA,NA,NA | |
| D01AC17,eberconazole,NA,NA,NA,NA | |
| D01AC18,luliconazole,NA,NA,NA,NA | |
| D01AC19,efinaconazole,NA,NA,NA,NA | |
| D01AC20,imidazoles/triazoles in combination with corticosteroids,NA,NA,NA,NA | |
| D01AC52,"miconazole, combinations",NA,NA,NA,NA | |
| D01AC60,"bifonazole, combinations",NA,NA,NA,NA | |
| D01AE,Other antifungals for topical use,NA,NA,NA,NA | |
| D01AE01,bromochlorosalicylanilide,NA,NA,NA,NA | |
| D01AE02,methylrosaniline,NA,NA,NA,NA | |
| D01AE03,tribromometacresol,NA,NA,NA,NA | |
| D01AE04,undecylenic acid,NA,NA,NA,NA | |
| D01AE05,polynoxylin,NA,NA,NA,NA | |
| D01AE06,2-(4-chlorphenoxy)-ethanol,NA,NA,NA,NA | |
| D01AE07,chlorphenesin,NA,NA,NA,NA | |
| D01AE08,ticlatone,NA,NA,NA,NA | |
| D01AE09,sulbentine,NA,NA,NA,NA | |
| D01AE10,ethyl hydroxybenzoate,NA,NA,NA,NA | |
| D01AE11,haloprogin,NA,NA,NA,NA | |
| D01AE12,salicylic acid,NA,NA,NA,NA | |
| D01AE13,selenium sulfide,NA,NA,NA,NA | |
| D01AE14,ciclopirox,NA,NA,NA,NA | |
| D01AE15,terbinafine,NA,NA,NA,NA | |
| D01AE16,amorolfine,NA,NA,NA,NA | |
| D01AE17,dimazole,NA,NA,NA,NA | |
| D01AE18,tolnaftate,NA,NA,NA,NA | |
| D01AE19,tolciclate,NA,NA,NA,NA | |
| D01AE20,combinations,NA,NA,NA,NA | |
| D01AE21,flucytosine,NA,NA,NA,NA | |
| D01AE22,naftifine,NA,NA,NA,NA | |
| D01AE23,butenafine,NA,NA,NA,NA | |
| D01AE24,tavaborole,NA,NA,NA,NA | |
| D01AE54,"undecylenic acid, combinations",NA,NA,NA,NA | |
| D01B,ANTIFUNGALS FOR SYSTEMIC USE,NA,NA,NA,NA | |
| D01BA,Antifungals for systemic use,NA,NA,NA,NA | |
| D01BA01,griseofulvin,0.5,g,O,NA | |
| D01BA02,terbinafine,0.25,g,O,NA | |
| D01BA03,fosravuconazole,0.1,g,O,expressed as ravuconazole | |
| D02,EMOLLIENTS AND PROTECTIVES,NA,NA,NA,NA | |
| D02A,EMOLLIENTS AND PROTECTIVES,NA,NA,NA,NA | |
| D02AA,Silicone products,NA,NA,NA,NA | |
| D02AB,Zinc products,NA,NA,NA,NA | |
| D02AC,Soft paraffin and fat products,NA,NA,NA,NA | |
| D02AD,Liquid plasters,NA,NA,NA,NA | |
| D02AE,Carbamide products,NA,NA,NA,NA | |
| D02AE01,carbamide,NA,NA,NA,NA | |
| D02AE51,"carbamide, combinations",NA,NA,NA,NA | |
| D02AF,Salicylic acid preparations,NA,NA,NA,NA | |
| D02AX,Other emollients and protectives,NA,NA,NA,NA | |
| D02B,PROTECTIVES AGAINST UV-RADIATION,NA,NA,NA,NA | |
| D02BA,Protectives against UV-radiation for topical use,NA,NA,NA,NA | |
| D02BA01,aminobenzoic acid,NA,NA,NA,NA | |
| D02BA02,octinoxate,NA,NA,NA,NA | |
| D02BB,Protectives against UV-radiation for systemic use,NA,NA,NA,NA | |
| D02BB01,betacarotene,0.1,g,O,NA | |
| D02BB02,afamelanotide,NA,NA,NA,NA | |
| D03,PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS,NA,NA,NA,NA | |
| D03A,CICATRIZANTS,NA,NA,NA,NA | |
| D03AA,Cod-liver oil ointments,NA,NA,NA,NA | |
| D03AX,Other cicatrizants,NA,NA,NA,NA | |
| D03AX01,cadexomer iodine,NA,NA,NA,NA | |
| D03AX02,dextranomer,NA,NA,NA,NA | |
| D03AX03,dexpanthenol,NA,NA,NA,NA | |
| D03AX04,calcium pantothenate,NA,NA,NA,NA | |
| D03AX05,hyaluronic acid,NA,NA,NA,NA | |
| D03AX06,becaplermin,NA,NA,NA,NA | |
| D03AX09,crilanomer,NA,NA,NA,NA | |
| D03AX10,enoxolone,NA,NA,NA,NA | |
| D03AX11,sodium chlorite,NA,NA,NA,NA | |
| D03AX12,trolamine,NA,NA,NA,NA | |
| D03AX13,Betulae cortex,NA,NA,NA,NA | |
| D03AX14,Centella asiatica herba,NA,NA,NA,NA | |
| D03B,ENZYMES,NA,NA,NA,NA | |
| D03BA,Proteolytic enzymes,NA,NA,NA,NA | |
| D03BA01,trypsin,NA,NA,NA,NA | |
| D03BA02,collagenase,NA,NA,NA,NA | |
| D03BA03,bromelains,NA,NA,NA,NA | |
| D03BA52,"collagenase, combinations",NA,NA,NA,NA | |
| D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",NA,NA,NA,NA | |
| D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",NA,NA,NA,NA | |
| D04AA,Antihistamines for topical use,NA,NA,NA,NA | |
| D04AA01,thonzylamine,NA,NA,NA,NA | |
| D04AA02,mepyramine,NA,NA,NA,NA | |
| D04AA03,thenalidine,NA,NA,NA,NA | |
| D04AA04,tripelennamine,NA,NA,NA,NA | |
| D04AA09,chloropyramine,NA,NA,NA,NA | |
| D04AA10,promethazine,NA,NA,NA,NA | |
| D04AA12,tolpropamine,NA,NA,NA,NA | |
| D04AA13,dimetindene,NA,NA,NA,NA | |
| D04AA14,clemastine,NA,NA,NA,NA | |
| D04AA15,bamipine,NA,NA,NA,NA | |
| D04AA16,pheniramine,NA,NA,NA,NA | |
| D04AA22,isothipendyl,NA,NA,NA,NA | |
| D04AA32,diphenhydramine,NA,NA,NA,NA | |
| D04AA33,diphenhydramine methylbromide,NA,NA,NA,NA | |
| D04AA34,chlorphenoxamine,NA,NA,NA,NA | |
| D04AB,Anesthetics for topical use,NA,NA,NA,NA | |
| D04AB01,lidocaine,NA,NA,NA,NA | |
| D04AB02,cinchocaine,NA,NA,NA,NA | |
| D04AB03,oxybuprocaine,NA,NA,NA,NA | |
| D04AB04,benzocaine,NA,NA,NA,NA | |
| D04AB05,quinisocaine,NA,NA,NA,NA | |
| D04AB06,tetracaine,NA,NA,NA,NA | |
| D04AB07,pramocaine,NA,NA,NA,NA | |
| D04AX,Other antipruritics,NA,NA,NA,NA | |
| D04AX01,doxepin,NA,NA,NA,NA | |
| D05,ANTIPSORIATICS,NA,NA,NA,NA | |
| D05A,ANTIPSORIATICS FOR TOPICAL USE,NA,NA,NA,NA | |
| D05AA,Tars,NA,NA,NA,NA | |
| D05AC,Antracen derivatives,NA,NA,NA,NA | |
| D05AC01,dithranol,NA,NA,NA,NA | |
| D05AC51,"dithranol, combinations",NA,NA,NA,NA | |
| D05AD,Psoralens for topical use,NA,NA,NA,NA | |
| D05AD01,trioxysalen,NA,NA,NA,NA | |
| D05AD02,methoxsalen,NA,NA,NA,NA | |
| D05AX,Other antipsoriatics for topical use,NA,NA,NA,NA | |
| D05AX01,fumaric acid,NA,NA,NA,NA | |
| D05AX02,calcipotriol,NA,NA,NA,NA | |
| D05AX03,calcitriol,NA,NA,NA,NA | |
| D05AX04,tacalcitol,NA,NA,NA,NA | |
| D05AX05,tazarotene,NA,NA,NA,NA | |
| D05AX52,"calcipotriol, combinations",NA,NA,NA,NA | |
| D05AX55,tazarotene and ulobetasol,NA,NA,NA,NA | |
| D05B,ANTIPSORIATICS FOR SYSTEMIC USE,NA,NA,NA,NA | |
| D05BA,Psoralens for systemic use,NA,NA,NA,NA | |
| D05BA01,trioxysalen,10,mg,O,NA | |
| D05BA02,methoxsalen,10,mg,O,NA | |
| D05BA03,bergapten,NA,NA,NA,NA | |
| D05BB,Retinoids for treatment of psoriasis,NA,NA,NA,NA | |
| D05BB01,etretinate,35,mg,O,NA | |
| D05BB02,acitretin,35,mg,O,NA | |
| D05BX,Other antipsoriatics for systemic use,NA,NA,NA,NA | |
| D05BX51,"fumaric acid derivatives, combinations",NA,NA,NA,NA | |
| D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,NA,NA,NA,NA | |
| D06A,ANTIBIOTICS FOR TOPICAL USE,NA,NA,NA,NA | |
| D06AA,Tetracycline and derivatives,NA,NA,NA,NA | |
| D06AA01,demeclocycline,NA,NA,NA,NA | |
| D06AA02,chlortetracycline,NA,NA,NA,NA | |
| D06AA03,oxytetracycline,NA,NA,NA,NA | |
| D06AA04,tetracycline,NA,NA,NA,NA | |
| D06AX,Other antibiotics for topical use,NA,NA,NA,NA | |
| D06AX01,fusidic acid,NA,NA,NA,NA | |
| D06AX02,chloramphenicol,NA,NA,NA,NA | |
| D06AX04,neomycin,NA,NA,NA,NA | |
| D06AX05,bacitracin,NA,NA,NA,NA | |
| D06AX07,gentamicin,NA,NA,NA,NA | |
| D06AX08,tyrothricin,NA,NA,NA,NA | |
| D06AX09,mupirocin,NA,NA,NA,NA | |
| D06AX10,virginiamycin,NA,NA,NA,NA | |
| D06AX11,rifaximin,NA,NA,NA,NA | |
| D06AX12,amikacin,NA,NA,NA,NA | |
| D06AX13,retapamulin,NA,NA,NA,NA | |
| D06AX14,ozenoxacin,NA,NA,NA,NA | |
| D06AX15,rifamycin,NA,NA,NA,NA | |
| D06B,CHEMOTHERAPEUTICS FOR TOPICAL USE,NA,NA,NA,NA | |
| D06BA,Sulfonamides,NA,NA,NA,NA | |
| D06BA01,silver sulfadiazine,NA,NA,NA,NA | |
| D06BA02,sulfathiazole,NA,NA,NA,NA | |
| D06BA03,mafenide,NA,NA,NA,NA | |
| D06BA04,sulfamethizole,NA,NA,NA,NA | |
| D06BA05,sulfanilamide,NA,NA,NA,NA | |
| D06BA06,sulfamerazine,NA,NA,NA,NA | |
| D06BA51,"silver sulfadiazine, combinations",NA,NA,NA,NA | |
| D06BB,Antivirals,NA,NA,NA,NA | |
| D06BB01,idoxuridine,NA,NA,NA,NA | |
| D06BB02,tromantadine,NA,NA,NA,NA | |
| D06BB03,aciclovir,NA,NA,NA,NA | |
| D06BB04,podophyllotoxin,NA,NA,NA,NA | |
| D06BB05,inosine,NA,NA,NA,NA | |
| D06BB06,penciclovir,NA,NA,NA,NA | |
| D06BB07,lysozyme,NA,NA,NA,NA | |
| D06BB08,ibacitabine,NA,NA,NA,NA | |
| D06BB09,edoxudine,NA,NA,NA,NA | |
| D06BB10,imiquimod,NA,NA,NA,NA | |
| D06BB11,docosanol,NA,NA,NA,NA | |
| D06BB12,sinecatechins,NA,NA,NA,NA | |
| D06BB53,"aciclovir, combinations",NA,NA,NA,NA | |
| D06BX,Other chemotherapeutics,NA,NA,NA,NA | |
| D06BX01,metronidazole,NA,NA,NA,NA | |
| D06BX02,ingenol mebutate,NA,NA,NA,NA | |
| D06BX03,tirbanibulin,NA,NA,NA,NA | |
| D06C,"ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS",NA,NA,NA,NA | |
| D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",NA,NA,NA,NA | |
| D07A,"CORTICOSTEROIDS, PLAIN",NA,NA,NA,NA | |
| D07AA,"Corticosteroids, weak (group I)",NA,NA,NA,NA | |
| D07AA01,methylprednisolone,NA,NA,NA,NA | |
| D07AA02,hydrocortisone,NA,NA,NA,NA | |
| D07AA03,prednisolone,NA,NA,NA,NA | |
| D07AB,"Corticosteroids, moderately potent (group II)",NA,NA,NA,NA | |
| D07AB01,clobetasone,NA,NA,NA,NA | |
| D07AB02,hydrocortisone butyrate,NA,NA,NA,NA | |
| D07AB03,flumetasone,NA,NA,NA,NA | |
| D07AB04,fluocortin,NA,NA,NA,NA | |
| D07AB05,fluperolone,NA,NA,NA,NA | |
| D07AB06,fluorometholone,NA,NA,NA,NA | |
| D07AB07,fluprednidene,NA,NA,NA,NA | |
| D07AB08,desonide,NA,NA,NA,NA | |
| D07AB09,triamcinolone,NA,NA,NA,NA | |
| D07AB10,alclometasone,NA,NA,NA,NA | |
| D07AB11,hydrocortisone buteprate,NA,NA,NA,NA | |
| D07AB19,dexamethasone,NA,NA,NA,NA | |
| D07AB21,clocortolone,NA,NA,NA,NA | |
| D07AB30,combinations of corticosteroids,NA,NA,NA,NA | |
| D07AC,"Corticosteroids, potent (group III)",NA,NA,NA,NA | |
| D07AC01,betamethasone,NA,NA,NA,NA | |
| D07AC02,fluclorolone,NA,NA,NA,NA | |
| D07AC03,desoximetasone,NA,NA,NA,NA | |
| D07AC04,fluocinolone acetonide,NA,NA,NA,NA | |
| D07AC05,fluocortolone,NA,NA,NA,NA | |
| D07AC06,diflucortolone,NA,NA,NA,NA | |
| D07AC07,fludroxycortide,NA,NA,NA,NA | |
| D07AC08,fluocinonide,NA,NA,NA,NA | |
| D07AC09,budesonide,NA,NA,NA,NA | |
| D07AC10,diflorasone,NA,NA,NA,NA | |
| D07AC11,amcinonide,NA,NA,NA,NA | |
| D07AC12,halometasone,NA,NA,NA,NA | |
| D07AC13,mometasone,NA,NA,NA,NA | |
| D07AC14,methylprednisolone aceponate,NA,NA,NA,NA | |
| D07AC15,beclometasone,NA,NA,NA,NA | |
| D07AC16,hydrocortisone aceponate,NA,NA,NA,NA | |
| D07AC17,fluticasone,NA,NA,NA,NA | |
| D07AC18,prednicarbate,NA,NA,NA,NA | |
| D07AC19,difluprednate,NA,NA,NA,NA | |
| D07AC21,ulobetasol,NA,NA,NA,NA | |
| D07AD,"Corticosteroids, very potent (group IV)",NA,NA,NA,NA | |
| D07AD01,clobetasol,NA,NA,NA,NA | |
| D07AD02,halcinonide,NA,NA,NA,NA | |
| D07B,"CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS",NA,NA,NA,NA | |
| D07BA,"Corticosteroids, weak, combinations with antiseptics",NA,NA,NA,NA | |
| D07BA01,prednisolone and antiseptics,NA,NA,NA,NA | |
| D07BA04,hydrocortisone and antiseptics,NA,NA,NA,NA | |
| D07BB,"Corticosteroids, moderately potent, combinations with antiseptics",NA,NA,NA,NA | |
| D07BB01,flumetasone and antiseptics,NA,NA,NA,NA | |
| D07BB02,desonide and antiseptics,NA,NA,NA,NA | |
| D07BB03,triamcinolone and antiseptics,NA,NA,NA,NA | |
| D07BB04,hydrocortisone butyrate and antiseptics,NA,NA,NA,NA | |
| D07BC,"Corticosteroids, potent, combinations with antiseptics",NA,NA,NA,NA | |
| D07BC01,betamethasone and antiseptics,NA,NA,NA,NA | |
| D07BC02,fluocinolone acetonide and antiseptics,NA,NA,NA,NA | |
| D07BC03,fluocortolone and antiseptics,NA,NA,NA,NA | |
| D07BC04,diflucortolone and antiseptics,NA,NA,NA,NA | |
| D07BD,"Corticosteroids, very potent, combinations with antiseptics",NA,NA,NA,NA | |
| D07C,"CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS",NA,NA,NA,NA | |
| D07CA,"Corticosteroids, weak, combinations with antibiotics",NA,NA,NA,NA | |
| D07CA01,hydrocortisone and antibiotics,NA,NA,NA,NA | |
| D07CA02,methylprednisolone and antibiotics,NA,NA,NA,NA | |
| D07CA03,prednisolone and antibiotics,NA,NA,NA,NA | |
| D07CB,"Corticosteroids, moderately potent, combinations with antibiotics",NA,NA,NA,NA | |
| D07CB01,triamcinolone and antibiotics,NA,NA,NA,NA | |
| D07CB02,fluprednidene and antibiotics,NA,NA,NA,NA | |
| D07CB03,fluorometholone and antibiotics,NA,NA,NA,NA | |
| D07CB04,dexamethasone and antibiotics,NA,NA,NA,NA | |
| D07CB05,flumetasone and antibiotics,NA,NA,NA,NA | |
| D07CC,"Corticosteroids, potent, combinations with antibiotics",NA,NA,NA,NA | |
| D07CC01,betamethasone and antibiotics,NA,NA,NA,NA | |
| D07CC02,fluocinolone acetonide and antibiotics,NA,NA,NA,NA | |
| D07CC03,fludroxycortide and antibiotics,NA,NA,NA,NA | |
| D07CC04,beclometasone and antibiotics,NA,NA,NA,NA | |
| D07CC05,fluocinonide and antibiotics,NA,NA,NA,NA | |
| D07CC06,fluocortolone and antibiotics,NA,NA,NA,NA | |
| D07CD,"Corticosteroids, very potent, combinations with antibiotics",NA,NA,NA,NA | |
| D07CD01,clobetasol and antibiotics,NA,NA,NA,NA | |
| D07X,"CORTICOSTEROIDS, OTHER COMBINATIONS",NA,NA,NA,NA | |
| D07XA,"Corticosteroids, weak, other combinations",NA,NA,NA,NA | |
| D07XA01,hydrocortisone,NA,NA,NA,NA | |
| D07XA02,prednisolone,NA,NA,NA,NA | |
| D07XB,"Corticosteroids, moderately potent, other combinations",NA,NA,NA,NA | |
| D07XB01,flumetasone,NA,NA,NA,NA | |
| D07XB02,triamcinolone,NA,NA,NA,NA | |
| D07XB03,fluprednidene,NA,NA,NA,NA | |
| D07XB04,fluorometholone,NA,NA,NA,NA | |
| D07XB05,dexamethasone,NA,NA,NA,NA | |
| D07XB30,combinations of corticosteroids,NA,NA,NA,NA | |
| D07XC,"Corticosteroids, potent, other combinations",NA,NA,NA,NA | |
| D07XC01,betamethasone,NA,NA,NA,NA | |
| D07XC02,desoximetasone,NA,NA,NA,NA | |
| D07XC03,mometasone,NA,NA,NA,NA | |
| D07XC04,diflucortolone,NA,NA,NA,NA | |
| D07XC05,fluocortolone,NA,NA,NA,NA | |
| D07XD,"Corticosteroids, very potent, other combinations",NA,NA,NA,NA | |
| D08,ANTISEPTICS AND DISINFECTANTS,NA,NA,NA,NA | |
| D08A,ANTISEPTICS AND DISINFECTANTS,NA,NA,NA,NA | |
| D08AA,Acridine derivatives,NA,NA,NA,NA | |
| D08AA01,ethacridine lactate,NA,NA,NA,NA | |
| D08AA02,aminoacridine,NA,NA,NA,NA | |
| D08AA03,euflavine,NA,NA,NA,NA | |
| D08AB,Aluminium agents,NA,NA,NA,NA | |
| D08AC,Biguanides and amidines,NA,NA,NA,NA | |
| D08AC01,dibrompropamidine,NA,NA,NA,NA | |
| D08AC02,chlorhexidine,NA,NA,NA,NA | |
| D08AC03,propamidine,NA,NA,NA,NA | |
| D08AC04,hexamidine,NA,NA,NA,NA | |
| D08AC05,polihexanide,NA,NA,NA,NA | |
| D08AC52,"chlorhexidine, combinations",NA,NA,NA,NA | |
| D08AD,Boric acid products,NA,NA,NA,NA | |
| D08AE,Phenol and derivatives,NA,NA,NA,NA | |
| D08AE01,hexachlorophene,NA,NA,NA,NA | |
| D08AE02,policresulen,NA,NA,NA,NA | |
| D08AE03,phenol,NA,NA,NA,NA | |
| D08AE04,triclosan,NA,NA,NA,NA | |
| D08AE05,chloroxylenol,NA,NA,NA,NA | |
| D08AE06,biphenylol,NA,NA,NA,NA | |
| D08AF,Nitrofuran derivatives,NA,NA,NA,NA | |
| D08AF01,nitrofural,NA,NA,NA,NA | |
| D08AG,Iodine products,NA,NA,NA,NA | |
| D08AG01,iodine/octylphenoxypolyglycolether,NA,NA,NA,NA | |
| D08AG02,povidone-iodine,NA,NA,NA,NA | |
| D08AG03,iodine,NA,NA,NA,NA | |
| D08AG04,diiodohydroxypropane,NA,NA,NA,NA | |
| D08AH,Quinoline derivatives,NA,NA,NA,NA | |
| D08AH01,dequalinium,NA,NA,NA,NA | |
| D08AH02,chlorquinaldol,NA,NA,NA,NA | |
| D08AH03,oxyquinoline,NA,NA,NA,NA | |
| D08AH30,clioquinol,NA,NA,NA,NA | |
| D08AJ,Quaternary ammonium compounds,NA,NA,NA,NA | |
| D08AJ01,benzalkonium,NA,NA,NA,NA | |
| D08AJ02,cetrimonium,NA,NA,NA,NA | |
| D08AJ03,cetylpyridinium,NA,NA,NA,NA | |
| D08AJ04,cetrimide,NA,NA,NA,NA | |
| D08AJ05,benzoxonium chloride,NA,NA,NA,NA | |
| D08AJ06,didecyldimethylammonium chloride,NA,NA,NA,NA | |
| D08AJ08,benzethonium chloride,NA,NA,NA,NA | |
| D08AJ10,decamethoxine,NA,NA,NA,NA | |
| D08AJ57,"octenidine, combinations",NA,NA,NA,NA | |
| D08AJ58,"benzethonium chloride, combinations",NA,NA,NA,NA | |
| D08AJ59,"dodeclonium bromide, combinations",NA,NA,NA,NA | |
| D08AK,Mercurial products,NA,NA,NA,NA | |
| D08AK01,mercuric amidochloride,NA,NA,NA,NA | |
| D08AK02,phenylmercuric borate,NA,NA,NA,NA | |
| D08AK03,mercuric chloride,NA,NA,NA,NA | |
| D08AK04,merbromin,NA,NA,NA,NA | |
| D08AK05,"mercury, metallic",NA,NA,NA,NA | |
| D08AK06,thiomersal,NA,NA,NA,NA | |
| D08AK30,mercuric iodide,NA,NA,NA,NA | |
| D08AL,Silver compounds,NA,NA,NA,NA | |
| D08AL01,silver nitrate,NA,NA,NA,NA | |
| D08AL30,silver,NA,NA,NA,NA | |
| D08AX,Other antiseptics and disinfectants,NA,NA,NA,NA | |
| D08AX01,hydrogen peroxide,NA,NA,NA,NA | |
| D08AX02,eosin,NA,NA,NA,NA | |
| D08AX03,propanol,NA,NA,NA,NA | |
| D08AX04,tosylchloramide sodium,NA,NA,NA,NA | |
| D08AX05,isopropanol,NA,NA,NA,NA | |
| D08AX06,potassium permanganate,NA,NA,NA,NA | |
| D08AX07,sodium hypochlorite,NA,NA,NA,NA | |
| D08AX08,ethanol,NA,NA,NA,NA | |
| D08AX53,"propanol, combinations",NA,NA,NA,NA | |
| D09,MEDICATED DRESSINGS,NA,NA,NA,NA | |
| D09A,MEDICATED DRESSINGS,NA,NA,NA,NA | |
| D09AA,Medicated dressings with antiinfectives,NA,NA,NA,NA | |
| D09AA01,framycetin,NA,NA,NA,NA | |
| D09AA02,fusidic acid,NA,NA,NA,NA | |
| D09AA03,nitrofural,NA,NA,NA,NA | |
| D09AA04,phenylmercuric nitrate,NA,NA,NA,NA | |
| D09AA05,benzododecinium,NA,NA,NA,NA | |
| D09AA06,triclosan,NA,NA,NA,NA | |
| D09AA07,cetylpyridinium,NA,NA,NA,NA | |
| D09AA08,aluminium chlorohydrate,NA,NA,NA,NA | |
| D09AA09,povidone-iodine,NA,NA,NA,NA | |
| D09AA10,clioquinol,NA,NA,NA,NA | |
| D09AA11,benzalkonium,NA,NA,NA,NA | |
| D09AA12,chlorhexidine,NA,NA,NA,NA | |
| D09AA13,iodoform,NA,NA,NA,NA | |
| D09AB,Zinc bandages,NA,NA,NA,NA | |
| D09AB01,zinc bandage without supplements,NA,NA,NA,NA | |
| D09AB02,zinc bandage with supplements,NA,NA,NA,NA | |
| D09AX,Soft paraffin dressings,NA,NA,NA,NA | |
| D10,ANTI-ACNE PREPARATIONS,NA,NA,NA,NA | |
| D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,NA,NA,NA,NA | |
| D10AA,"Corticosteroids, combinations for treatment of acne",NA,NA,NA,NA | |
| D10AA01,fluorometholone,NA,NA,NA,NA | |
| D10AA02,methylprednisolone,NA,NA,NA,NA | |
| D10AA03,dexamethasone,NA,NA,NA,NA | |
| D10AB,Preparations containing sulfur,NA,NA,NA,NA | |
| D10AB01,bithionol,NA,NA,NA,NA | |
| D10AB02,sulfur,NA,NA,NA,NA | |
| D10AB03,tioxolone,NA,NA,NA,NA | |
| D10AB05,mesulfen,NA,NA,NA,NA | |
| D10AD,Retinoids for topical use in acne,NA,NA,NA,NA | |
| D10AD01,tretinoin,NA,NA,NA,NA | |
| D10AD02,retinol,NA,NA,NA,NA | |
| D10AD03,adapalene,NA,NA,NA,NA | |
| D10AD04,isotretinoin,NA,NA,NA,NA | |
| D10AD05,motretinide,NA,NA,NA,NA | |
| D10AD06,trifarotene,NA,NA,NA,NA | |
| D10AD51,"tretinoin, combinations",NA,NA,NA,NA | |
| D10AD53,"adapalene, combinations",NA,NA,NA,NA | |
| D10AD54,"isotretinoin, combinations",NA,NA,NA,NA | |
| D10AE,Peroxides,NA,NA,NA,NA | |
| D10AE01,benzoyl peroxide,NA,NA,NA,NA | |
| D10AE51,"benzoyl peroxide, combinations",NA,NA,NA,NA | |
| D10AF,Antiinfectives for treatment of acne,NA,NA,NA,NA | |
| D10AF01,clindamycin,NA,NA,NA,NA | |
| D10AF02,erythromycin,NA,NA,NA,NA | |
| D10AF03,chloramphenicol,NA,NA,NA,NA | |
| D10AF04,meclocycline,NA,NA,NA,NA | |
| D10AF05,nadifloxacin,NA,NA,NA,NA | |
| D10AF06,sulfacetamide,NA,NA,NA,NA | |
| D10AF07,minocycline,NA,NA,NA,NA | |
| D10AF51,"clindamycin, combinations",NA,NA,NA,NA | |
| D10AF52,"erythromycin, combinations",NA,NA,NA,NA | |
| D10AX,Other anti-acne preparations for topical use,NA,NA,NA,NA | |
| D10AX01,aluminium chloride,NA,NA,NA,NA | |
| D10AX02,resorcinol,NA,NA,NA,NA | |
| D10AX03,azelaic acid,NA,NA,NA,NA | |
| D10AX04,aluminium oxide,NA,NA,NA,NA | |
| D10AX05,dapsone,NA,NA,NA,NA | |
| D10AX30,various combinations,NA,NA,NA,NA | |
| D10B,ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,NA,NA,NA,NA | |
| D10BA,Retinoids for treatment of acne,NA,NA,NA,NA | |
| D10BA01,isotretinoin,30,mg,O,NA | |
| D10BX,Other anti-acne preparations for systemic use,NA,NA,NA,NA | |
| D10BX01,ichtasol,NA,NA,NA,NA | |
| D11,OTHER DERMATOLOGICAL PREPARATIONS,NA,NA,NA,NA | |
| D11A,OTHER DERMATOLOGICAL PREPARATIONS,NA,NA,NA,NA | |
| D11AA,Antihidrotics,NA,NA,NA,NA | |
| D11AA01,glycopyrronium,NA,NA,NA,NA | |
| D11AC,Medicated shampoos,NA,NA,NA,NA | |
| D11AC01,cetrimide,NA,NA,NA,NA | |
| D11AC02,cadmium compounds,NA,NA,NA,NA | |
| D11AC03,selenium compounds,NA,NA,NA,NA | |
| D11AC06,povidone-iodine,NA,NA,NA,NA | |
| D11AC08,sulfur compounds,NA,NA,NA,NA | |
| D11AC09,xenysalate,NA,NA,NA,NA | |
| D11AC30,others,NA,NA,NA,NA | |
| D11AE,Androgens for topical use,NA,NA,NA,NA | |
| D11AE01,metandienone,NA,NA,NA,NA | |
| D11AF,Wart and anti-corn preparations,NA,NA,NA,NA | |
| D11AH,"Agents for dermatitis, excluding corticosteroids",NA,NA,NA,NA | |
| D11AH01,tacrolimus,NA,NA,NA,NA | |
| D11AH02,pimecrolimus,NA,NA,NA,NA | |
| D11AH03,cromoglicic acid,NA,NA,NA,NA | |
| D11AH04,alitretinoin,20,mg,O,NA | |
| D11AH05,dupilumab,21.4,mg,P,NA | |
| D11AH06,crisaborole,NA,NA,NA,NA | |
| D11AH07,tralokinumab,NA,NA,NA,NA | |
| D11AX,Other dermatologicals,NA,NA,NA,NA | |
| D11AX01,minoxidil,NA,NA,NA,NA | |
| D11AX02,gamolenic acid,0.4,g,O,NA | |
| D11AX03,calcium gluconate,NA,NA,NA,NA | |
| D11AX04,lithium succinate,NA,NA,NA,NA | |
| D11AX05,magnesium sulfate,NA,NA,NA,NA | |
| D11AX06,mequinol,NA,NA,NA,NA | |
| D11AX08,tiratricol,NA,NA,NA,NA | |
| D11AX09,oxaceprol,NA,NA,NA,NA | |
| D11AX10,finasteride,1,mg,O,NA | |
| D11AX11,hydroquinone,NA,NA,NA,NA | |
| D11AX12,pyrithione zinc,NA,NA,NA,NA | |
| D11AX13,monobenzone,NA,NA,NA,NA | |
| D11AX16,eflornithine,NA,NA,NA,NA | |
| D11AX18,diclofenac,NA,NA,NA,NA | |
| D11AX21,brimonidine,NA,NA,NA,NA | |
| D11AX22,ivermectin,NA,NA,NA,NA | |
| D11AX23,aminobenzoate potassium,NA,NA,NA,NA | |
| D11AX24,deoxycholic acid,NA,NA,NA,NA | |
| D11AX25,hydrogen peroxide,NA,NA,NA,NA | |
| D11AX26,caffeine,NA,NA,NA,NA | |
| D11AX52,"gamolenic acid, combinations",NA,NA,NA,NA | |
| D11AX57,"collagen, combinations",NA,NA,NA,NA | |
| G,GENITO URINARY SYSTEM AND SEX HORMONES,NA,NA,NA,NA | |
| G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,NA,NA,NA,NA | |
| G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",NA,NA,NA,NA | |
| G01AA,Antibiotics,NA,NA,NA,NA | |
| G01AA01,nystatin,0.1,MU,V,NA | |
| G01AA02,natamycin,25,mg,V,NA | |
| G01AA03,amphotericin B,0.2,g,V,NA | |
| G01AA04,candicidin,6,mg,V,NA | |
| G01AA05,chloramphenicol,NA,NA,NA,NA | |
| G01AA06,hachimycin,NA,NA,NA,NA | |
| G01AA07,oxytetracycline,NA,NA,NA,NA | |
| G01AA08,carfecillin,NA,NA,NA,NA | |
| G01AA09,mepartricin,NA,NA,NA,NA | |
| G01AA10,clindamycin,0.1,g,V,NA | |
| G01AA11,pentamycin,NA,NA,NA,NA | |
| G01AA51,"nystatin, combinations",NA,NA,NA,NA | |
| G01AB,Arsenic compounds,NA,NA,NA,NA | |
| G01AB01,acetarsol,0.5,g,V,NA | |
| G01AC,Quinoline derivatives,NA,NA,NA,NA | |
| G01AC01,diiodohydroxyquinoline,0.2,g,V,NA | |
| G01AC02,clioquinol,NA,NA,NA,NA | |
| G01AC03,chlorquinaldol,0.2,g,V,NA | |
| G01AC05,dequalinium,20,mg,V,NA | |
| G01AC06,broxyquinoline,0.1,g,V,NA | |
| G01AC30,oxyquinoline,NA,NA,NA,NA | |
| G01AD,Organic acids,NA,NA,NA,NA | |
| G01AD01,lactic acid,NA,NA,NA,NA | |
| G01AD02,acetic acid,NA,NA,NA,NA | |
| G01AD03,ascorbic acid,0.25,g,V,NA | |
| G01AE,Sulfonamides,NA,NA,NA,NA | |
| G01AE01,sulfatolamide,NA,NA,NA,NA | |
| G01AE10,combinations of sulfonamides,NA,NA,NA,NA | |
| G01AF,Imidazole derivatives,NA,NA,NA,NA | |
| G01AF01,metronidazole,0.5,g,V,NA | |
| G01AF02,clotrimazole,0.1,g,V,NA | |
| G01AF04,miconazole,0.1,g,V,NA | |
| G01AF05,econazole,0.1,g,V,NA | |
| G01AF06,ornidazole,NA,NA,NA,NA | |
| G01AF07,isoconazole,0.6,g,V,NA | |
| G01AF08,tioconazole,0.3,g,V,Single dose treatment | |
| G01AF11,ketoconazole,0.4,g,V,NA | |
| G01AF12,fenticonazole,0.1,g,V,NA | |
| G01AF13,azanidazole,NA,NA,NA,NA | |
| G01AF14,propenidazole,NA,NA,NA,NA | |
| G01AF15,butoconazole,0.1,g,V,NA | |
| G01AF16,omoconazole,NA,NA,NA,NA | |
| G01AF17,oxiconazole,NA,NA,NA,NA | |
| G01AF18,flutrimazole,NA,NA,NA,NA | |
| G01AF19,sertaconazole,NA,NA,NA,NA | |
| G01AF20,combinations of imidazole derivatives,NA,NA,NA,NA | |
| G01AF55,"econazole, combinations",NA,NA,NA,NA | |
| G01AG,Triazole derivatives,NA,NA,NA,NA | |
| G01AG02,terconazole,80,mg,V,NA | |
| G01AX,Other antiinfectives and antiseptics,NA,NA,NA,NA | |
| G01AX01,clodantoin,0.1,g,V,NA | |
| G01AX02,inosine,NA,NA,NA,NA | |
| G01AX03,policresulen,90,mg,V,NA | |
| G01AX05,nifuratel,0.6,g,O,NA | |
| G01AX05,nifuratel,0.6,g,V,NA | |
| G01AX06,furazolidone,NA,NA,NA,NA | |
| G01AX09,methylrosaniline,NA,NA,NA,NA | |
| G01AX11,povidone-iodine,0.2,g,V,NA | |
| G01AX12,ciclopirox,NA,NA,NA,NA | |
| G01AX13,protiofate,NA,NA,NA,NA | |
| G01AX14,lactobacillus,NA,NA,NA,NA | |
| G01AX15,copper usnate,NA,NA,NA,NA | |
| G01AX16,hexetidine,NA,NA,NA,NA | |
| G01AX17,dapivirine,NA,NA,NA,NA | |
| G01AX66,"octenidine, combinations",NA,NA,NA,NA | |
| G01B,ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS,NA,NA,NA,NA | |
| G01BA,Antibiotics and corticosteroids,NA,NA,NA,NA | |
| G01BC,Quinoline derivatives and corticosteroids,NA,NA,NA,NA | |
| G01BD,Antiseptics and corticosteroids,NA,NA,NA,NA | |
| G01BE,Sulfonamides and corticosteroids,NA,NA,NA,NA | |
| G01BF,Imidazole derivatives and corticosteroids,NA,NA,NA,NA | |
| G02,OTHER GYNECOLOGICALS,NA,NA,NA,NA | |
| G02A,UTEROTONICS,NA,NA,NA,NA | |
| G02AB,Ergot alkaloids,NA,NA,NA,NA | |
| G02AB01,methylergometrine,0.2,mg,O,NA | |
| G02AB01,methylergometrine,0.2,mg,P,NA | |
| G02AB02,ergot alkaloids,NA,NA,NA,NA | |
| G02AB03,ergometrine,0.2,mg,O,NA | |
| G02AB03,ergometrine,0.2,mg,P,NA | |
| G02AC,"Ergot alkaloids and oxytocin incl. analogues, in combination",NA,NA,NA,NA | |
| G02AC01,methylergometrine and oxytocin,NA,NA,NA,NA | |
| G02AD,Prostaglandins,NA,NA,NA,NA | |
| G02AD01,dinoprost,25,mg,P,NA | |
| G02AD02,dinoprostone,0.5,mg,O,NA | |
| G02AD02,dinoprostone,0.5,mg,V,NA | |
| G02AD03,gemeprost,1,mg,V,Single dose treatment | |
| G02AD04,carboprost,2.5,mg,P,Single dose treatment | |
| G02AD05,sulprostone,0.5,mg,P,NA | |
| G02AD06,misoprostol,0.2,mg,O,NA | |
| G02AD06,misoprostol,0.2,mg,V,"""vaginal insert, refers to the content of one vaginal insert""" | |
| G02AX,Other uterotonics,NA,NA,NA,NA | |
| G02B,CONTRACEPTIVES FOR TOPICAL USE,NA,NA,NA,NA | |
| G02BA,Intrauterine contraceptives,NA,NA,NA,NA | |
| G02BA01,plastic IUD,NA,NA,NA,NA | |
| G02BA02,plastic IUD with copper,NA,NA,NA,NA | |
| G02BA03,plastic IUD with progestogen,NA,NA,NA,NA | |
| G02BB,Intravaginal contraceptives,NA,NA,NA,NA | |
| G02BB01,vaginal ring with progestogen and estrogen,NA,NA,NA,NA | |
| G02BB02,vaginal ring with progestogen,NA,NA,NA,NA | |
| G02C,OTHER GYNECOLOGICALS,NA,NA,NA,NA | |
| G02CA,"Sympathomimetics, labour repressants",NA,NA,NA,NA | |
| G02CA01,ritodrine,40,mg,O,NA | |
| G02CA01,ritodrine,40,mg,P,NA | |
| G02CA02,buphenine,30,mg,P,NA | |
| G02CA03,fenoterol,NA,NA,NA,NA | |
| G02CB,Prolactine inhibitors,NA,NA,NA,NA | |
| G02CB01,bromocriptine,5,mg,O,NA | |
| G02CB01,bromocriptine,5,mg,P,NA | |
| G02CB02,lisuride,0.6,mg,O,NA | |
| G02CB03,cabergoline,0.5,mg,O,NA | |
| G02CB04,quinagolide,75,mcg,O,NA | |
| G02CB05,metergoline,NA,NA,NA,NA | |
| G02CB06,terguride,NA,NA,NA,NA | |
| G02CC,Antiinflammatory products for vaginal administration,NA,NA,NA,NA | |
| G02CC01,ibuprofen,NA,NA,NA,NA | |
| G02CC02,naproxen,NA,NA,NA,NA | |
| G02CC03,benzydamine,NA,NA,NA,NA | |
| G02CC04,flunoxaprofen,NA,NA,NA,NA | |
| G02CX,Other gynecologicals,NA,NA,NA,NA | |
| G02CX01,atosiban,165,mg,P,NA | |
| G02CX02,flibanserin,NA,NA,NA,NA | |
| G02CX03,Agni casti fructus,NA,NA,NA,NA | |
| G02CX04,Cimicifugae rhizoma,NA,NA,NA,NA | |
| G02CX05,bremelanotide,NA,NA,NA,NA | |
| G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,NA,NA,NA,NA | |
| G03A,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,NA,NA,NA,NA | |
| G03AA,"Progestogens and estrogens, fixed combinations",NA,NA,NA,NA | |
| G03AA01,etynodiol and ethinylestradiol,NA,NA,NA,NA | |
| G03AA02,quingestanol and ethinylestradiol,NA,NA,NA,NA | |
| G03AA03,lynestrenol and ethinylestradiol,NA,NA,NA,NA | |
| G03AA04,megestrol and ethinylestradiol,NA,NA,NA,NA | |
| G03AA05,norethisterone and ethinylestradiol,NA,NA,NA,NA | |
| G03AA06,norgestrel and ethinylestradiol,NA,NA,NA,NA | |
| G03AA07,levonorgestrel and ethinylestradiol,NA,NA,NA,NA | |
| G03AA08,medroxyprogesterone and ethinylestradiol,NA,NA,NA,NA | |
| G03AA09,desogestrel and ethinylestradiol,NA,NA,NA,NA | |
| G03AA10,gestodene and ethinylestradiol,NA,NA,NA,NA | |
| G03AA11,norgestimate and ethinylestradiol,NA,NA,NA,NA | |
| G03AA12,drospirenone and ethinylestradiol,NA,NA,NA,NA | |
| G03AA13,norelgestromin and ethinylestradiol,NA,NA,NA,NA | |
| G03AA14,nomegestrol and estradiol,NA,NA,NA,NA | |
| G03AA15,chlormadinone and ethinylestradiol,NA,NA,NA,NA | |
| G03AA16,dienogest and ethinylestradiol,NA,NA,NA,NA | |
| G03AA17,medroxyprogesterone and estradiol,NA,NA,NA,NA | |
| G03AA18,drospirenone and estetrol,NA,NA,NA,NA | |
| G03AB,"Progestogens and estrogens, sequential preparations",NA,NA,NA,NA | |
| G03AB01,megestrol and ethinylestradiol,NA,NA,NA,NA | |
| G03AB02,lynestrenol and ethinylestradiol,NA,NA,NA,NA | |
| G03AB03,levonorgestrel and ethinylestradiol,NA,NA,NA,NA | |
| G03AB04,norethisterone and ethinylestradiol,NA,NA,NA,NA | |
| G03AB05,desogestrel and ethinylestradiol,NA,NA,NA,NA | |
| G03AB06,gestodene and ethinylestradiol,NA,NA,NA,NA | |
| G03AB07,chlormadinone and ethinylestradiol,NA,NA,NA,NA | |
| G03AB08,dienogest and estradiol,NA,NA,NA,NA | |
| G03AB09,norgestimate and ethinylestradiol,NA,NA,NA,NA | |
| G03AC,Progestogens,NA,NA,NA,NA | |
| G03AC01,norethisterone,2.5,mg,P,NA | |
| G03AC02,lynestrenol,NA,NA,NA,NA | |
| G03AC03,levonorgestrel,NA,NA,NA,NA | |
| G03AC04,quingestanol,NA,NA,NA,NA | |
| G03AC05,megestrol,NA,NA,NA,NA | |
| G03AC06,medroxyprogesterone,1.67,mg,P,NA | |
| G03AC07,norgestrienone,NA,NA,NA,NA | |
| G03AC08,etonogestrel,68,mcg,s.c. implant,NA | |
| G03AC09,desogestrel,NA,NA,NA,NA | |
| G03AC10,drospirenone,NA,NA,NA,NA | |
| G03AD,Emergency contraceptives,NA,NA,NA,NA | |
| G03AD01,levonorgestrel,1.5,mg,O,NA | |
| G03AD02,ulipristal,30,mg,O,NA | |
| G03B,ANDROGENS,NA,NA,NA,NA | |
| G03BA,3-oxoandrosten (4) derivatives,NA,NA,NA,NA | |
| G03BA01,fluoxymesterone,5,mg,O,NA | |
| G03BA02,methyltestosterone,25,mg,O,NA | |
| G03BA03,testosterone,0.12,g,O,NA | |
| G03BA03,testosterone,18,mg,P,NA | |
| G03BA03,testosterone,0.12,g,R,NA | |
| G03BA03,testosterone,60,mg,SL,NA | |
| G03BA03,testosterone,50,mg,TD,gel | |
| G03BA03,testosterone,3,mg,TD,NA | |
| G03BB,5-androstanon (3) derivatives,NA,NA,NA,NA | |
| G03BB01,mesterolone,50,mg,O,NA | |
| G03BB02,androstanolone,NA,NA,NA,NA | |
| G03C,ESTROGENS,NA,NA,NA,NA | |
| G03CA,"Natural and semisynthetic estrogens, plain",NA,NA,NA,NA | |
| G03CA01,ethinylestradiol,25,mcg,O,NA | |
| G03CA03,estradiol,0.3,mg,N,NA | |
| G03CA03,estradiol,2,mg,O,NA | |
| G03CA03,estradiol,1,mg,P,depot short duration | |
| G03CA03,estradiol,0.3,mg,P,depot long duration | |
| G03CA03,estradiol,5,mg,R,NA | |
| G03CA03,estradiol,50,mcg,TD,"""patch, refer to amount delivered per 24 hours""" | |
| G03CA03,estradiol,1,mg,TD,gel | |
| G03CA03,estradiol,1.53,mg,TD,spray | |
| G03CA03,estradiol,25,mcg,V,NA | |
| G03CA03,estradiol,7.5,mcg,V,"""vaginal ring, refers to amount delivered per 24 hours""" | |
| G03CA04,estriol,2,mg,O,NA | |
| G03CA04,estriol,2,mg,P,NA | |
| G03CA04,estriol,0.2,mg,V,NA | |
| G03CA06,chlorotrianisene,24,mg,O,NA | |
| G03CA07,estrone,1,mg,O,NA | |
| G03CA09,promestriene,NA,NA,NA,NA | |
| G03CA53,"estradiol, combinations",NA,NA,NA,NA | |
| G03CA57,conjugated estrogens,0.625,mg,O,NA | |
| G03CA57,conjugated estrogens,0.625,mg,V,NA | |
| G03CB,"Synthetic estrogens, plain",NA,NA,NA,NA | |
| G03CB01,dienestrol,2.5,mg,O,NA | |
| G03CB01,dienestrol,0.2,mg,V,NA | |
| G03CB02,diethylstilbestrol,0.2,mg,O,NA | |
| G03CB02,diethylstilbestrol,1,mg,V,NA | |
| G03CB03,methallenestril,9,mg,O,NA | |
| G03CB04,moxestrol,NA,NA,NA,NA | |
| G03CC,"Estrogens, combinations with other drugs",NA,NA,NA,NA | |
| G03CC02,dienestrol,NA,NA,NA,NA | |
| G03CC03,methallenestril,NA,NA,NA,NA | |
| G03CC04,estrone,NA,NA,NA,NA | |
| G03CC05,diethylstilbestrol,NA,NA,NA,NA | |
| G03CC06,estriol,NA,NA,NA,NA | |
| G03CC07,conjugated estrogens and bazedoxifene,NA,NA,NA,NA | |
| G03CX,Other estrogens,NA,NA,NA,NA | |
| G03CX01,tibolone,2.5,mg,O,NA | |
| G03D,PROGESTOGENS,NA,NA,NA,NA | |
| G03DA,Pregnen (4) derivatives,NA,NA,NA,NA | |
| G03DA01,gestonorone,30,mg,P,NA | |
| G03DA02,medroxyprogesterone,5,mg,O,NA | |
| G03DA02,medroxyprogesterone,7,mg,P,NA | |
| G03DA03,hydroxyprogesterone,10,mg,P,NA | |
| G03DA04,progesterone,0.3,g,O,NA | |
| G03DA04,progesterone,5,mg,P,NA | |
| G03DA04,progesterone,0.2,g,R,NA | |
| G03DA04,progesterone,90,mg,V,NA | |
| G03DB,Pregnadien derivatives,NA,NA,NA,NA | |
| G03DB01,dydrogesterone,10,mg,O,NA | |
| G03DB02,megestrol,5,mg,O,NA | |
| G03DB03,medrogestone,NA,NA,NA,NA | |
| G03DB04,nomegestrol,NA,NA,NA,NA | |
| G03DB05,demegestone,NA,NA,NA,NA | |
| G03DB06,chlormadinone,NA,NA,NA,NA | |
| G03DB07,promegestone,NA,NA,NA,NA | |
| G03DB08,dienogest,2,mg,O,NA | |
| G03DC,Estren derivatives,NA,NA,NA,NA | |
| G03DC01,allylestrenol,10,mg,O,NA | |
| G03DC02,norethisterone,5,mg,O,NA | |
| G03DC03,lynestrenol,5,mg,O,NA | |
| G03DC04,ethisterone,5,mg,O,NA | |
| G03DC06,etynodiol,NA,NA,NA,NA | |
| G03DC31,methylestrenolone,5,mg,O,NA | |
| G03E,ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION,NA,NA,NA,NA | |
| G03EA,Androgens and estrogens,NA,NA,NA,NA | |
| G03EA01,methyltestosterone and estrogen,NA,NA,NA,NA | |
| G03EA02,testosterone and estrogen,NA,NA,NA,NA | |
| G03EA03,prasterone and estrogen,NA,NA,NA,NA | |
| G03EB,"Androgen, progestogen and estrogen in combination",NA,NA,NA,NA | |
| G03EK,Androgens and female sex hormones in combination with other drugs,NA,NA,NA,NA | |
| G03EK01,methyltestosterone,NA,NA,NA,NA | |
| G03F,PROGESTOGENS AND ESTROGENS IN COMBINATION,NA,NA,NA,NA | |
| G03FA,"Progestogens and estrogens, fixed combinations",NA,NA,NA,NA | |
| G03FA01,norethisterone and estrogen,NA,NA,NA,NA | |
| G03FA02,hydroxyprogesterone and estrogen,NA,NA,NA,NA | |
| G03FA03,ethisterone and estrogen,NA,NA,NA,NA | |
| G03FA04,progesterone and estrogen,NA,NA,NA,NA | |
| G03FA05,methylnortestosterone and estrogen,NA,NA,NA,NA | |
| G03FA06,etynodiol and estrogen,NA,NA,NA,NA | |
| G03FA07,lynestrenol and estrogen,NA,NA,NA,NA | |
| G03FA08,megestrol and estrogen,NA,NA,NA,NA | |
| G03FA09,noretynodrel and estrogen,NA,NA,NA,NA | |
| G03FA10,norgestrel and estrogen,NA,NA,NA,NA | |
| G03FA11,levonorgestrel and estrogen,NA,NA,NA,NA | |
| G03FA12,medroxyprogesterone and estrogen,NA,NA,NA,NA | |
| G03FA13,norgestimate and estrogen,NA,NA,NA,NA | |
| G03FA14,dydrogesterone and estrogen,NA,NA,NA,NA | |
| G03FA15,dienogest and estrogen,NA,NA,NA,NA | |
| G03FA16,trimegestone and estrogen,NA,NA,NA,NA | |
| G03FA17,drospirenone and estrogen,NA,NA,NA,NA | |
| G03FB,"Progestogens and estrogens, sequential preparations",NA,NA,NA,NA | |
| G03FB01,norgestrel and estrogen,NA,NA,NA,NA | |
| G03FB02,lynestrenol and estrogen,NA,NA,NA,NA | |
| G03FB03,chlormadinone and estrogen,NA,NA,NA,NA | |
| G03FB04,megestrol and estrogen,NA,NA,NA,NA | |
| G03FB05,norethisterone and estrogen,NA,NA,NA,NA | |
| G03FB06,medroxyprogesterone and estrogen,NA,NA,NA,NA | |
| G03FB07,medrogestone and estrogen,NA,NA,NA,NA | |
| G03FB08,dydrogesterone and estrogen,NA,NA,NA,NA | |
| G03FB09,levonorgestrel and estrogen,NA,NA,NA,NA | |
| G03FB10,desogestrel and estrogen,NA,NA,NA,NA | |
| G03FB11,trimegestone and estrogen,NA,NA,NA,NA | |
| G03FB12,nomegestrol and estrogen,NA,NA,NA,NA | |
| G03G,GONADOTROPINS AND OTHER OVULATION STIMULANTS,NA,NA,NA,NA | |
| G03GA,Gonadotropins,NA,NA,NA,NA | |
| G03GA01,chorionic gonadotrophin,250,U,P,NA | |
| G03GA02,human menopausal gonadotrophin,75,U,P,NA | |
| G03GA03,serum gonadotrophin,750,U,P,NA | |
| G03GA04,urofollitropin,75,U,P,NA | |
| G03GA05,follitropin alfa,75,U,P,NA | |
| G03GA06,follitropin beta,75,U,P,NA | |
| G03GA07,lutropin alfa,75,U,P,NA | |
| G03GA08,choriogonadotropin alfa,0.25,mg,P,NA | |
| G03GA09,corifollitropin alfa,0.15,mg,P,NA | |
| G03GA10,follitropin delta,12,mcg,P,NA | |
| G03GA30,combinations,NA,NA,NA,NA | |
| G03GB,"Ovulation stimulants, synthetic",NA,NA,NA,NA | |
| G03GB01,cyclofenil,0.14,g,O,NA | |
| G03GB02,clomifene,9,mg,O,NA | |
| G03GB03,epimestrol,10,mg,O,NA | |
| G03H,ANTIANDROGENS,NA,NA,NA,NA | |
| G03HA,"Antiandrogens, plain",NA,NA,NA,NA | |
| G03HA01,cyproterone,0.1,g,O,NA | |
| G03HA01,cyproterone,0.1,g,P,NA | |
| G03HB,Antiandrogens and estrogens,NA,NA,NA,NA | |
| G03HB01,cyproterone and estrogen,NA,NA,NA,NA | |
| G03X,OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,NA,NA,NA,NA | |
| G03XA,Antigonadotropins and similar agents,NA,NA,NA,NA | |
| G03XA01,danazol,0.6,g,O,NA | |
| G03XA02,gestrinone,0.7,mg,O,NA | |
| G03XB,Progesterone receptor modulators,NA,NA,NA,NA | |
| G03XB01,mifepristone,0.2,g,O,NA | |
| G03XB02,ulipristal,5,mg,O,NA | |
| G03XB51,"mifepristone, combinations",0.2,g,O,Refers to mifepristone | |
| G03XC,Selective estrogen receptor modulators,NA,NA,NA,NA | |
| G03XC01,raloxifene,60,mg,O,NA | |
| G03XC02,bazedoxifene,20,mg,O,NA | |
| G03XC03,lasofoxifene,0.5,mg,O,NA | |
| G03XC04,ormeloxifene,NA,NA,NA,NA | |
| G03XC05,ospemifene,NA,NA,NA,NA | |
| G03XX,Other sex hormones and modulators of the genital system,NA,NA,NA,NA | |
| G03XX01,prasterone,6.5,mg,V,NA | |
| G04,UROLOGICALS,NA,NA,NA,NA | |
| G04B,UROLOGICALS,NA,NA,NA,NA | |
| G04BA,Acidifiers,NA,NA,NA,NA | |
| G04BA01,ammonium chloride,8.5,g,O,NA | |
| G04BA03,calcium chloride,NA,NA,NA,NA | |
| G04BC,Urinary concrement solvents,NA,NA,NA,NA | |
| G04BD,Drugs for urinary frequency and incontinence,NA,NA,NA,NA | |
| G04BD01,emepronium,0.5,g,O,NA | |
| G04BD01,emepronium,75,mg,P,NA | |
| G04BD02,flavoxate,0.8,g,O,NA | |
| G04BD03,meladrazine,0.45,g,O,NA | |
| G04BD04,oxybutynin,15,mg,O,NA | |
| G04BD04,oxybutynin,3.9,mg,TD,NA | |
| G04BD05,terodiline,50,mg,O,NA | |
| G04BD06,propiverine,30,mg,O,NA | |
| G04BD07,tolterodine,4,mg,O,NA | |
| G04BD08,solifenacin,5,mg,O,NA | |
| G04BD09,trospium,40,mg,O,NA | |
| G04BD10,darifenacin,7.5,mg,O,NA | |
| G04BD11,fesoterodine,4,mg,O,NA | |
| G04BD12,mirabegron,50,mg,O,NA | |
| G04BD13,desfesoterodine,3.5,mg,O,NA | |
| G04BE,Drugs used in erectile dysfunction,NA,NA,NA,NA | |
| G04BE01,alprostadil,20,mcg,P,NA | |
| G04BE01,alprostadil,0.25,mg,urethral,NA | |
| G04BE02,papaverine,NA,NA,NA,NA | |
| G04BE03,sildenafil,50,mg,O,NA | |
| G04BE04,yohimbine,15,mg,O,NA | |
| G04BE06,moxisylyte,NA,NA,NA,NA | |
| G04BE07,apomorphine,2,mg,SL,NA | |
| G04BE08,tadalafil,10,mg,O,NA | |
| G04BE09,vardenafil,10,mg,O,NA | |
| G04BE10,avanafil,0.1,g,O,NA | |
| G04BE11,udenafil,NA,NA,NA,NA | |
| G04BE30,combinations,NA,NA,NA,NA | |
| G04BE52,"papaverine, combinations",NA,NA,NA,NA | |
| G04BX,Other urologicals,NA,NA,NA,NA | |
| G04BX01,magnesium hydroxide,0.5,g,O,NA | |
| G04BX03,acetohydroxamic acid,0.75,g,O,NA | |
| G04BX06,phenazopyridine,0.6,g,O,NA | |
| G04BX10,succinimide,NA,NA,NA,NA | |
| G04BX11,collagen,NA,NA,NA,NA | |
| G04BX12,phenyl salicylate,2,g,O,NA | |
| G04BX13,dimethyl sulfoxide,NA,NA,NA,NA | |
| G04BX14,dapoxetine,30,mg,O,NA | |
| G04BX15,pentosan polysulfate sodium,0.3,g,O,NA | |
| G04BX16,tiopronin,0.8,g,O,NA | |
| G04C,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,NA,NA,NA,NA | |
| G04CA,Alpha-adrenoreceptor antagonists,NA,NA,NA,NA | |
| G04CA01,alfuzosin,7.5,mg,O,NA | |
| G04CA02,tamsulosin,0.4,mg,O,NA | |
| G04CA03,terazosin,5,mg,O,NA | |
| G04CA04,silodosin,8,mg,O,NA | |
| G04CA51,alfuzosin and finasteride,NA,NA,NA,NA | |
| G04CA52,tamsulosin and dutasteride,NA,NA,NA,NA | |
| G04CA53,tamsulosin and solifenacin,NA,NA,NA,NA | |
| G04CA54,tamsulosin and tadalafil,NA,NA,NA,NA | |
| G04CB,Testosterone-5-alpha reductase inhibitors,NA,NA,NA,NA | |
| G04CB01,finasteride,5,mg,O,NA | |
| G04CB02,dutasteride,0.5,mg,O,NA | |
| G04CX,Other drugs used in benign prostatic hypertrophy,NA,NA,NA,NA | |
| G04CX01,Prunus africanae cortex,NA,NA,NA,NA | |
| G04CX02,Sabalis serrulatae fructus,NA,NA,NA,NA | |
| G04CX03,mepartricin,NA,NA,NA,NA | |
| G04CX04,fexapotide,NA,NA,NA,NA | |
| H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",NA,NA,NA,NA | |
| H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,NA,NA,NA,NA | |
| H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,NA,NA,NA,NA | |
| H01AA,ACTH,NA,NA,NA,NA | |
| H01AA01,corticotropin,25,U,P,NA | |
| H01AA02,tetracosactide,0.25,mg,P,NA | |
| H01AB,Thyrotropin,NA,NA,NA,NA | |
| H01AB01,thyrotropin alfa,0.9,mg,P,NA | |
| H01AC,Somatropin and somatropin agonists,NA,NA,NA,NA | |
| H01AC01,somatropin,2,U,P,NA | |
| H01AC02,somatrem,NA,NA,NA,NA | |
| H01AC03,mecasermin,2,mg,P,NA | |
| H01AC04,sermorelin,NA,NA,NA,NA | |
| H01AC05,mecasermin rinfabate,NA,NA,NA,NA | |
| H01AC06,tesamorelin,NA,NA,NA,NA | |
| H01AC07,somapacitan,NA,NA,NA,NA | |
| H01AX,Other anterior pituitary lobe hormones and analogues,NA,NA,NA,NA | |
| H01AX01,pegvisomant,10,mg,P,NA | |
| H01B,POSTERIOR PITUITARY LOBE HORMONES,NA,NA,NA,NA | |
| H01BA,Vasopressin and analogues,NA,NA,NA,NA | |
| H01BA01,vasopressin (argipressin),40,U,P,NA | |
| H01BA02,desmopressin,25,mcg,N,NA | |
| H01BA02,desmopressin,0.4,mg,O,NA | |
| H01BA02,desmopressin,4,mcg,P,NA | |
| H01BA02,desmopressin,0.24,mg,SL,base | |
| H01BA03,lypressin,20,U,N,NA | |
| H01BA03,lypressin,20,U,P,NA | |
| H01BA04,terlipressin,12,mg,P,NA | |
| H01BA05,ornipressin,5,U,P,NA | |
| H01BB,Oxytocin and analogues,NA,NA,NA,NA | |
| H01BB01,demoxytocin,100,U,O,NA | |
| H01BB02,oxytocin,15,U,N,NA | |
| H01BB02,oxytocin,200,U,O,NA | |
| H01BB02,oxytocin,15,U,P,NA | |
| H01BB03,carbetocin,0.1,mg,P,NA | |
| H01C,HYPOTHALAMIC HORMONES,NA,NA,NA,NA | |
| H01CA,Gonadotropin-releasing hormones,NA,NA,NA,NA | |
| H01CA01,gonadorelin,NA,NA,NA,NA | |
| H01CA02,nafarelin,0.4,mg,N,NA | |
| H01CB,Somatostatin and analogues,NA,NA,NA,NA | |
| H01CB01,somatostatin,6,mg,P,NA | |
| H01CB02,octreotide,0.7,mg,P,NA | |
| H01CB03,lanreotide,3,mg,P,NA | |
| H01CB04,vapreotide,NA,NA,NA,NA | |
| H01CB05,pasireotide,1.2,mg,P,NA | |
| H01CC,Anti-gonadotropin-releasing hormones,NA,NA,NA,NA | |
| H01CC01,ganirelix,0.25,mg,P,NA | |
| H01CC02,cetrorelix,0.25,mg,P,NA | |
| H01CC03,elagolix,NA,NA,NA,NA | |
| H01CC54,"relugolix, estradiol and norethisterone",NA,NA,NA,NA | |
| H02,CORTICOSTEROIDS FOR SYSTEMIC USE,NA,NA,NA,NA | |
| H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",NA,NA,NA,NA | |
| H02AA,Mineralocorticoids,NA,NA,NA,NA | |
| H02AA01,aldosterone,NA,NA,NA,NA | |
| H02AA02,fludrocortisone,0.1,mg,O,NA | |
| H02AA03,desoxycortone,5,mg,O,NA | |
| H02AA03,desoxycortone,5,mg,P,NA | |
| H02AB,Glucocorticoids,NA,NA,NA,NA | |
| H02AB01,betamethasone,1.5,mg,O,NA | |
| H02AB01,betamethasone,1.5,mg,P,NA | |
| H02AB01,betamethasone,0.4,mg,P,depot | |
| H02AB02,dexamethasone,1.5,mg,O,NA | |
| H02AB02,dexamethasone,1.5,mg,P,NA | |
| H02AB03,fluocortolone,10,mg,O,NA | |
| H02AB04,methylprednisolone,7.5,mg,O,NA | |
| H02AB04,methylprednisolone,20,mg,P,NA | |
| H02AB05,paramethasone,4,mg,O,NA | |
| H02AB05,paramethasone,4,mg,P,NA | |
| H02AB06,prednisolone,10,mg,O,NA | |
| H02AB06,prednisolone,10,mg,P,NA | |
| H02AB07,prednisone,10,mg,O,NA | |
| H02AB08,triamcinolone,7.5,mg,O,NA | |
| H02AB08,triamcinolone,7.5,mg,P,NA | |
| H02AB09,hydrocortisone,30,mg,O,NA | |
| H02AB09,hydrocortisone,30,mg,P,NA | |
| H02AB10,cortisone,37.5,mg,O,NA | |
| H02AB10,cortisone,37.5,mg,P,NA | |
| H02AB11,prednylidene,12,mg,O,NA | |
| H02AB12,rimexolone,20,mg,P,intraarticular | |
| H02AB13,deflazacort,15,mg,O,NA | |
| H02AB14,cloprednol,NA,NA,NA,NA | |
| H02AB15,meprednisone,NA,NA,NA,NA | |
| H02AB17,cortivazol,NA,NA,NA,NA | |
| H02B,"CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS",NA,NA,NA,NA | |
| H02BX,"Corticosteroids for systemic use, combinations",NA,NA,NA,NA | |
| H02BX01,"methylprednisolone, combinations",NA,NA,NA,NA | |
| H02C,ANTIADRENAL PREPARATIONS,NA,NA,NA,NA | |
| H02CA,Anticorticosteroids,NA,NA,NA,NA | |
| H02CA01,trilostane,0.36,g,O,NA | |
| H02CA02,osilodrostat,NA,NA,NA,NA | |
| H02CA03,ketoconazole,NA,NA,NA,NA | |
| H03,THYROID THERAPY,NA,NA,NA,NA | |
| H03A,THYROID PREPARATIONS,NA,NA,NA,NA | |
| H03AA,Thyroid hormones,NA,NA,NA,NA | |
| H03AA01,levothyroxine sodium,0.15,mg,O,NA | |
| H03AA01,levothyroxine sodium,0.15,mg,P,NA | |
| H03AA02,liothyronine sodium,60,mcg,O,NA | |
| H03AA02,liothyronine sodium,60,mcg,P,NA | |
| H03AA03,combinations of levothyroxine and liothyronine,NA,NA,NA,NA | |
| H03AA04,tiratricol,NA,NA,NA,NA | |
| H03AA05,thyroid gland preparations,0.1,g,O,NA | |
| H03B,ANTITHYROID PREPARATIONS,NA,NA,NA,NA | |
| H03BA,Thiouracils,NA,NA,NA,NA | |
| H03BA01,methylthiouracil,0.1,g,O,NA | |
| H03BA02,propylthiouracil,0.1,g,O,NA | |
| H03BA03,benzylthiouracil,NA,NA,NA,NA | |
| H03BB,Sulfur-containing imidazole derivatives,NA,NA,NA,NA | |
| H03BB01,carbimazole,15,mg,O,NA | |
| H03BB02,thiamazole,10,mg,O,NA | |
| H03BB52,"thiamazole, combinations",NA,NA,NA,NA | |
| H03BC,Perchlorates,NA,NA,NA,NA | |
| H03BC01,potassium perchlorate,NA,NA,NA,NA | |
| H03BX,Other antithyroid preparations,NA,NA,NA,NA | |
| H03BX01,diiodotyrosine,NA,NA,NA,NA | |
| H03BX02,dibromotyrosine,NA,NA,NA,NA | |
| H03C,IODINE THERAPY,NA,NA,NA,NA | |
| H03CA,Iodine therapy,0.33,g,O,NA | |
| H03CA,Iodine therapy,0.33,g,P,NA | |
| H04,PANCREATIC HORMONES,NA,NA,NA,NA | |
| H04A,GLYCOGENOLYTIC HORMONES,NA,NA,NA,NA | |
| H04AA,Glycogenolytic hormones,NA,NA,NA,NA | |
| H04AA01,glucagon,3,mg,N,NA | |
| H04AA01,glucagon,1,mg,P,NA | |
| H05,CALCIUM HOMEOSTASIS,NA,NA,NA,NA | |
| H05A,PARATHYROID HORMONES AND ANALOGUES,NA,NA,NA,NA | |
| H05AA,Parathyroid hormones and analogues,NA,NA,NA,NA | |
| H05AA01,parathyroid gland extract,NA,NA,NA,NA | |
| H05AA02,teriparatide,20,mcg,P,NA | |
| H05AA03,parathyroid hormone,0.1,mg,P,NA | |
| H05AA04,abaloparatide,NA,NA,NA,NA | |
| H05B,ANTI-PARATHYROID AGENTS,NA,NA,NA,NA | |
| H05BA,Calcitonin preparations,NA,NA,NA,NA | |
| H05BA01,calcitonin (salmon synthetic),200,U,N,NA | |
| H05BA01,calcitonin (salmon synthetic),100,U,P,NA | |
| H05BA02,calcitonin (pork natural),100,U,P,NA | |
| H05BA03,calcitonin (human synthetic),100,U,P,NA | |
| H05BA04,elcatonin,NA,NA,NA,NA | |
| H05BX,Other anti-parathyroid agents,NA,NA,NA,NA | |
| H05BX01,cinacalcet,60,mg,O,NA | |
| H05BX02,paricalcitol,2,mcg,O,NA | |
| H05BX02,paricalcitol,2,mcg,P,NA | |
| H05BX03,doxercalciferol,NA,NA,NA,NA | |
| H05BX04,etelcalcetide,2.1,mg,P,NA | |
| H05BX05,calcifediol,30,mcg,O,NA | |
| J,ANTIINFECTIVES FOR SYSTEMIC USE,NA,NA,NA,NA | |
| J01,ANTIBACTERIALS FOR SYSTEMIC USE,NA,NA,NA,NA | |
| J01A,TETRACYCLINES,NA,NA,NA,NA | |
| J01AA,Tetracyclines,NA,NA,NA,NA | |
| J01AA01,demeclocycline,0.6,g,O,NA | |
| J01AA02,doxycycline,0.1,g,O,NA | |
| J01AA02,doxycycline,0.1,g,P,NA | |
| J01AA03,chlortetracycline,1,g,O,NA | |
| J01AA04,lymecycline,0.6,g,O,NA | |
| J01AA04,lymecycline,0.6,g,P,NA | |
| J01AA05,metacycline,0.6,g,O,NA | |
| J01AA06,oxytetracycline,1,g,O,NA | |
| J01AA06,oxytetracycline,1,g,P,NA | |
| J01AA07,tetracycline,1,g,O,NA | |
| J01AA07,tetracycline,1,g,P,NA | |
| J01AA08,minocycline,0.2,g,O,NA | |
| J01AA08,minocycline,0.2,g,P,NA | |
| J01AA09,rolitetracycline,0.35,g,P,NA | |
| J01AA10,penimepicycline,NA,NA,NA,NA | |
| J01AA11,clomocycline,1,g,O,NA | |
| J01AA12,tigecycline,0.1,g,P,NA | |
| J01AA13,eravacycline,NA,NA,NA,NA | |
| J01AA14,sarecycline,0.1,g,O,NA | |
| J01AA15,omadacycline,0.3,g,O,NA | |
| J01AA15,omadacycline,0.1,g,P,NA | |
| J01AA20,combinations of tetracyclines,NA,NA,NA,NA | |
| J01AA56,"oxytetracycline, combinations",NA,NA,NA,NA | |
| J01B,AMPHENICOLS,NA,NA,NA,NA | |
| J01BA,Amphenicols,NA,NA,NA,NA | |
| J01BA01,chloramphenicol,3,g,O,NA | |
| J01BA01,chloramphenicol,3,g,P,NA | |
| J01BA02,thiamphenicol,1.5,g,O,NA | |
| J01BA02,thiamphenicol,1.5,g,P,NA | |
| J01BA52,"thiamphenicol, combinations",NA,NA,NA,NA | |
| J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",NA,NA,NA,NA | |
| J01CA,Penicillins with extended spectrum,NA,NA,NA,NA | |
| J01CA01,ampicillin,2,g,O,NA | |
| J01CA01,ampicillin,6,g,P,NA | |
| J01CA01,ampicillin,2,g,R,NA | |
| J01CA02,pivampicillin,1.05,g,O,NA | |
| J01CA03,carbenicillin,12,g,P,NA | |
| J01CA04,amoxicillin,1.5,g,O,NA | |
| J01CA04,amoxicillin,3,g,P,NA | |
| J01CA05,carindacillin,4,g,O,NA | |
| J01CA06,bacampicillin,1.2,g,O,NA | |
| J01CA07,epicillin,2,g,O,NA | |
| J01CA07,epicillin,2,g,P,NA | |
| J01CA08,pivmecillinam,0.6,g,O,NA | |
| J01CA09,azlocillin,12,g,P,NA | |
| J01CA10,mezlocillin,6,g,P,NA | |
| J01CA11,mecillinam,1.2,g,P,NA | |
| J01CA12,piperacillin,14,g,P,NA | |
| J01CA13,ticarcillin,15,g,P,NA | |
| J01CA14,metampicillin,1.5,g,O,NA | |
| J01CA14,metampicillin,1.5,g,P,NA | |
| J01CA15,talampicillin,2,g,O,NA | |
| J01CA16,sulbenicillin,15,g,P,NA | |
| J01CA17,temocillin,4,g,P,NA | |
| J01CA18,hetacillin,2,g,O,NA | |
| J01CA19,aspoxicillin,4,g,P,NA | |
| J01CA20,combinations,NA,NA,NA,NA | |
| J01CA51,"ampicillin, combinations",NA,NA,NA,NA | |
| J01CE,Beta-lactamase sensitive penicillins,NA,NA,NA,NA | |
| J01CE01,benzylpenicillin,3.6,g,P,NA | |
| J01CE02,phenoxymethylpenicillin,2,g,O,NA | |
| J01CE03,propicillin,0.9,g,O,NA | |
| J01CE04,azidocillin,1.5,g,O,NA | |
| J01CE05,pheneticillin,1,g,O,NA | |
| J01CE06,penamecillin,1.05,g,O,NA | |
| J01CE07,clometocillin,1,g,O,NA | |
| J01CE08,benzathine benzylpenicillin,3.6,g,P,Expressed as benzylpenicillin | |
| J01CE09,procaine benzylpenicillin,0.6,g,P,NA | |
| J01CE10,benzathine phenoxymethylpenicillin,2,g,O,NA | |
| J01CE30,combinations,NA,NA,NA,NA | |
| J01CF,Beta-lactamase resistant penicillins,NA,NA,NA,NA | |
| J01CF01,dicloxacillin,2,g,O,NA | |
| J01CF01,dicloxacillin,2,g,P,NA | |
| J01CF02,cloxacillin,2,g,O,NA | |
| J01CF02,cloxacillin,2,g,P,NA | |
| J01CF03,meticillin,4,g,P,NA | |
| J01CF04,oxacillin,2,g,O,NA | |
| J01CF04,oxacillin,2,g,P,NA | |
| J01CF05,flucloxacillin,2,g,O,NA | |
| J01CF05,flucloxacillin,2,g,P,NA | |
| J01CF06,nafcillin,3,g,P,NA | |
| J01CG,Beta-lactamase inhibitors,NA,NA,NA,NA | |
| J01CG01,sulbactam,1,g,P,NA | |
| J01CG02,tazobactam,NA,NA,NA,NA | |
| J01CR,"Combinations of penicillins, incl. beta-lactamase inhibitors",NA,NA,NA,NA | |
| J01CR01,ampicillin and beta-lactamase inhibitor,6,g,P,Refers to ampicillin | |
| J01CR02,amoxicillin and beta-lactamase inhibitor,1.5,g,O,Refers to amoxicillin | |
| J01CR02,amoxicillin and beta-lactamase inhibitor,3,g,P,Refers to amoxicillin | |
| J01CR03,ticarcillin and beta-lactamase inhibitor,15,g,P,Refers to ticarcillin | |
| J01CR04,sultamicillin,1.5,g,O,NA | |
| J01CR05,piperacillin and beta-lactamase inhibitor,14,g,P,Refers to piperacillin | |
| J01CR50,combinations of penicillins,NA,NA,NA,NA | |
| J01D,OTHER BETA-LACTAM ANTIBACTERIALS,NA,NA,NA,NA | |
| J01DB,First-generation cephalosporins,NA,NA,NA,NA | |
| J01DB01,cefalexin,2,g,O,NA | |
| J01DB02,cefaloridine,3,g,P,NA | |
| J01DB03,cefalotin,4,g,P,NA | |
| J01DB04,cefazolin,3,g,P,NA | |
| J01DB05,cefadroxil,2,g,O,NA | |
| J01DB06,cefazedone,3,g,P,NA | |
| J01DB07,cefatrizine,1,g,O,NA | |
| J01DB08,cefapirin,4,g,P,NA | |
| J01DB09,cefradine,2,g,O,NA | |
| J01DB09,cefradine,2,g,P,NA | |
| J01DB10,cefacetrile,NA,NA,NA,NA | |
| J01DB11,cefroxadine,2.1,g,O,NA | |
| J01DB12,ceftezole,3,g,P,NA | |
| J01DC,Second-generation cephalosporins,NA,NA,NA,NA | |
| J01DC01,cefoxitin,6,g,P,NA | |
| J01DC02,cefuroxime,0.5,g,O,NA | |
| J01DC02,cefuroxime,3,g,P,NA | |
| J01DC03,cefamandole,6,g,P,NA | |
| J01DC04,cefaclor,1,g,O,NA | |
| J01DC05,cefotetan,4,g,P,NA | |
| J01DC06,cefonicid,1,g,P,NA | |
| J01DC07,cefotiam,1.2,g,O,NA | |
| J01DC07,cefotiam,4,g,P,NA | |
| J01DC08,loracarbef,0.6,g,O,NA | |
| J01DC09,cefmetazole,4,g,P,NA | |
| J01DC10,cefprozil,1,g,O,NA | |
| J01DC11,ceforanide,4,g,P,NA | |
| J01DC12,cefminox,4,g,P,NA | |
| J01DC13,cefbuperazone,2,g,P,NA | |
| J01DC14,flomoxef,2,g,P,NA | |
| J01DD,Third-generation cephalosporins,NA,NA,NA,NA | |
| J01DD01,cefotaxime,4,g,P,NA | |
| J01DD02,ceftazidime,4,g,P,NA | |
| J01DD03,cefsulodin,4,g,P,NA | |
| J01DD04,ceftriaxone,2,g,P,NA | |
| J01DD05,cefmenoxime,2,g,P,NA | |
| J01DD06,latamoxef,4,g,P,NA | |
| J01DD07,ceftizoxime,4,g,P,NA | |
| J01DD08,cefixime,0.4,g,O,NA | |
| J01DD09,cefodizime,2,g,P,NA | |
| J01DD10,cefetamet,1,g,O,NA | |
| J01DD11,cefpiramide,2,g,P,NA | |
| J01DD12,cefoperazone,4,g,P,NA | |
| J01DD13,cefpodoxime,0.4,g,O,NA | |
| J01DD14,ceftibuten,0.4,g,O,NA | |
| J01DD15,cefdinir,0.6,g,O,NA | |
| J01DD16,cefditoren,0.4,g,O,NA | |
| J01DD17,cefcapene,0.45,g,O,NA | |
| J01DD18,cefteram,0.4,g,O,NA | |
| J01DD51,cefotaxime and beta-lactamase inhibitor,NA,NA,NA,NA | |
| J01DD52,ceftazidime and beta-lactamase inhibitor,6,g,P,Refers to ceftazidime | |
| J01DD54,"ceftriaxone, combinations",NA,NA,NA,NA | |
| J01DD62,cefoperazone and beta-lactamase inhibitor,4,g,P,Refers to cefoperazone | |
| J01DD63,ceftriaxone and beta-lactamase inhibitor,2,g,P,Refers to ceftriaxone | |
| J01DD64,cefpodoxime and beta-lactamase inhibitor,0.4,g,O,Refers to cefpodoxime | |
| J01DE,Fourth-generation cephalosporins,NA,NA,NA,NA | |
| J01DE01,cefepime,4,g,P,NA | |
| J01DE02,cefpirome,4,g,P,NA | |
| J01DE03,cefozopran,4,g,P,NA | |
| J01DF,Monobactams,NA,NA,NA,NA | |
| J01DF01,aztreonam,0.225,g,Inhal.solution,NA | |
| J01DF01,aztreonam,4,g,P,NA | |
| J01DF02,carumonam,2,g,P,NA | |
| J01DH,Carbapenems,NA,NA,NA,NA | |
| J01DH02,meropenem,3,g,P,NA | |
| J01DH03,ertapenem,1,g,P,NA | |
| J01DH04,doripenem,1.5,g,P,NA | |
| J01DH05,biapenem,1.2,g,P,NA | |
| J01DH06,tebipenem pivoxil,0.56,g,O,NA | |
| J01DH51,imipenem and cilastatin,2,g,P,Refers to imipenem | |
| J01DH52,meropenem and vaborbactam,3,g,P,Refers to meropenem | |
| J01DH55,panipenem and betamipron,2,g,P,Refers to panipenem | |
| J01DH56,"imipenem, cilastatin and relebactam",2,g,P,Refers to imipenem | |
| J01DI,Other cephalosporins and penems,NA,NA,NA,NA | |
| J01DI01,ceftobiprole medocaril,1.5,g,P,NA | |
| J01DI02,ceftaroline fosamil,1.2,g,P,NA | |
| J01DI03,faropenem,0.75,g,O,NA | |
| J01DI04,cefiderocol,NA,NA,NA,NA | |
| J01DI54,ceftolozane and beta-lactamase inhibitor,3,g,P,Refers to ceftolozane | |
| J01E,SULFONAMIDES AND TRIMETHOPRIM,NA,NA,NA,NA | |
| J01EA,Trimethoprim and derivatives,NA,NA,NA,NA | |
| J01EA01,trimethoprim,0.4,g,O,NA | |
| J01EA01,trimethoprim,0.4,g,P,NA | |
| J01EA02,brodimoprim,0.2,g,O,NA | |
| J01EA03,iclaprim,NA,NA,NA,NA | |
| J01EB,Short-acting sulfonamides,NA,NA,NA,NA | |
| J01EB01,sulfaisodimidine,4,g,O,NA | |
| J01EB01,sulfaisodimidine,4,g,P,NA | |
| J01EB02,sulfamethizole,4,g,O,NA | |
| J01EB03,sulfadimidine,4,g,O,NA | |
| J01EB04,sulfapyridine,1,g,O,NA | |
| J01EB05,sulfafurazole,4,g,O,NA | |
| J01EB05,sulfafurazole,4,g,P,NA | |
| J01EB06,sulfanilamide,NA,NA,NA,NA | |
| J01EB07,sulfathiazole,NA,NA,NA,NA | |
| J01EB08,sulfathiourea,6,g,O,NA | |
| J01EB20,combinations,NA,NA,NA,NA | |
| J01EC,Intermediate-acting sulfonamides,NA,NA,NA,NA | |
| J01EC01,sulfamethoxazole,2,g,O,NA | |
| J01EC02,sulfadiazine,0.6,g,O,NA | |
| J01EC03,sulfamoxole,1,g,O,NA | |
| J01EC03,sulfamoxole,1,g,P,NA | |
| J01EC20,combinations,NA,NA,NA,NA | |
| J01ED,Long-acting sulfonamides,NA,NA,NA,NA | |
| J01ED01,sulfadimethoxine,0.5,g,O,NA | |
| J01ED02,sulfalene,0.1,g,O,NA | |
| J01ED03,sulfametomidine,NA,NA,NA,NA | |
| J01ED04,sulfametoxydiazine,0.5,g,O,NA | |
| J01ED05,sulfamethoxypyridazine,0.5,g,O,NA | |
| J01ED06,sulfaperin,0.5,g,O,NA | |
| J01ED07,sulfamerazine,3,g,O,NA | |
| J01ED08,sulfaphenazole,1,g,O,NA | |
| J01ED09,sulfamazone,1.5,g,O,NA | |
| J01ED09,sulfamazone,1.5,g,R,NA | |
| J01ED20,combinations,NA,NA,NA,NA | |
| J01EE,"Combinations of sulfonamides and trimethoprim, incl. derivatives",NA,NA,NA,NA | |
| J01EE01,sulfamethoxazole and trimethoprim,NA,NA,NA,NA | |
| J01EE02,sulfadiazine and trimethoprim,NA,NA,NA,NA | |
| J01EE03,sulfametrole and trimethoprim,NA,NA,NA,NA | |
| J01EE04,sulfamoxole and trimethoprim,NA,NA,NA,NA | |
| J01EE05,sulfadimidine and trimethoprim,NA,NA,NA,NA | |
| J01EE06,sulfadiazine and tetroxoprim,NA,NA,NA,NA | |
| J01EE07,sulfamerazine and trimethoprim,NA,NA,NA,NA | |
| J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",NA,NA,NA,NA | |
| J01FA,Macrolides,NA,NA,NA,NA | |
| J01FA01,erythromycin,1,g,O,NA | |
| J01FA01,erythromycin,2,g,O,erythromycin ethylsuccinate tablets | |
| J01FA01,erythromycin,1,g,P,NA | |
| J01FA02,spiramycin,3,g,O,NA | |
| J01FA03,midecamycin,1.2,g,O,NA | |
| J01FA03,midecamycin,1,g,P,NA | |
| J01FA05,oleandomycin,1,g,O,NA | |
| J01FA06,roxithromycin,0.3,g,O,NA | |
| J01FA07,josamycin,2,g,O,NA | |
| J01FA08,troleandomycin,1,g,O,NA | |
| J01FA09,clarithromycin,0.5,g,O,NA | |
| J01FA09,clarithromycin,1,g,P,NA | |
| J01FA10,azithromycin,0.3,g,O,NA | |
| J01FA10,azithromycin,0.5,g,P,NA | |
| J01FA11,miocamycin,1.2,g,O,NA | |
| J01FA12,rokitamycin,0.8,g,O,NA | |
| J01FA13,dirithromycin,0.5,g,O,NA | |
| J01FA14,flurithromycin,0.75,g,O,NA | |
| J01FA15,telithromycin,0.8,g,O,NA | |
| J01FA16,solithromycin,NA,NA,NA,NA | |
| J01FF,Lincosamides,NA,NA,NA,NA | |
| J01FF01,clindamycin,1.2,g,O,NA | |
| J01FF01,clindamycin,1.8,g,P,NA | |
| J01FF02,lincomycin,1.8,g,O,NA | |
| J01FF02,lincomycin,1.8,g,P,NA | |
| J01FG,Streptogramins,NA,NA,NA,NA | |
| J01FG01,pristinamycin,2,g,O,NA | |
| J01FG02,quinupristin/dalfopristin,1.5,g,P,NA | |
| J01G,AMINOGLYCOSIDE ANTIBACTERIALS,NA,NA,NA,NA | |
| J01GA,Streptomycins,NA,NA,NA,NA | |
| J01GA01,streptomycin,1,g,P,NA | |
| J01GA02,streptoduocin,1,g,P,NA | |
| J01GB,Other aminoglycosides,NA,NA,NA,NA | |
| J01GB01,tobramycin,0.112,g,Inhal.powder,NA | |
| J01GB01,tobramycin,0.3,g,Inhal.solution,NA | |
| J01GB01,tobramycin,0.24,g,P,NA | |
| J01GB03,gentamicin,0.24,g,P,NA | |
| J01GB04,kanamycin,1,g,P,NA | |
| J01GB05,neomycin,1,g,O,NA | |
| J01GB06,amikacin,1,g,P,NA | |
| J01GB07,netilmicin,0.35,g,O,NA | |
| J01GB07,netilmicin,0.35,g,P,NA | |
| J01GB08,sisomicin,0.24,g,P,NA | |
| J01GB09,dibekacin,0.14,g,P,NA | |
| J01GB10,ribostamycin,1,g,P,NA | |
| J01GB11,isepamicin,0.4,g,P,NA | |
| J01GB12,arbekacin,0.2,g,P,NA | |
| J01GB13,bekanamycin,0.6,g,P,NA | |
| J01GB14,plazomicin,NA,NA,NA,NA | |
| J01M,QUINOLONE ANTIBACTERIALS,NA,NA,NA,NA | |
| J01MA,Fluoroquinolones,NA,NA,NA,NA | |
| J01MA01,ofloxacin,0.4,g,O,NA | |
| J01MA01,ofloxacin,0.4,g,P,NA | |
| J01MA02,ciprofloxacin,1,g,O,NA | |
| J01MA02,ciprofloxacin,0.8,g,P,NA | |
| J01MA03,pefloxacin,0.8,g,O,NA | |
| J01MA03,pefloxacin,0.8,g,P,NA | |
| J01MA04,enoxacin,0.8,g,O,NA | |
| J01MA05,temafloxacin,0.8,g,O,NA | |
| J01MA06,norfloxacin,0.8,g,O,NA | |
| J01MA07,lomefloxacin,0.4,g,O,NA | |
| J01MA08,fleroxacin,0.4,g,O,NA | |
| J01MA08,fleroxacin,0.4,g,P,NA | |
| J01MA09,sparfloxacin,0.2,g,O,NA | |
| J01MA10,rufloxacin,0.2,g,O,NA | |
| J01MA11,grepafloxacin,0.4,g,O,NA | |
| J01MA12,levofloxacin,0.24,g,Inhal.solution,NA | |
| J01MA12,levofloxacin,0.5,g,O,NA | |
| J01MA12,levofloxacin,0.5,g,P,NA | |
| J01MA13,trovafloxacin,0.2,g,O,NA | |
| J01MA13,trovafloxacin,0.2,g,P,NA | |
| J01MA14,moxifloxacin,0.4,g,O,NA | |
| J01MA14,moxifloxacin,0.4,g,P,NA | |
| J01MA15,gemifloxacin,0.32,g,O,NA | |
| J01MA16,gatifloxacin,0.4,g,O,NA | |
| J01MA16,gatifloxacin,0.4,g,P,NA | |
| J01MA17,prulifloxacin,0.6,g,O,NA | |
| J01MA18,pazufloxacin,1,g,P,NA | |
| J01MA19,garenoxacin,0.4,g,O,NA | |
| J01MA21,sitafloxacin,0.1,g,O,NA | |
| J01MA22,tosufloxacin,0.45,g,O,NA | |
| J01MA23,delafloxacin,0.9,g,O,NA | |
| J01MA23,delafloxacin,0.6,g,P,NA | |
| J01MA24,levonadifloxacin,NA,NA,NA,NA | |
| J01MA25,lascufloxacin,75,mg,O,NA | |
| J01MB,Other quinolones,NA,NA,NA,NA | |
| J01MB01,rosoxacin,0.3,g,O,NA | |
| J01MB02,nalidixic acid,4,g,O,NA | |
| J01MB03,piromidic acid,2,g,O,NA | |
| J01MB04,pipemidic acid,0.8,g,O,NA | |
| J01MB05,oxolinic acid,1,g,O,NA | |
| J01MB06,cinoxacin,1,g,O,NA | |
| J01MB07,flumequine,1.2,g,O,NA | |
| J01MB08,nemonoxacin,NA,NA,NA,NA | |
| J01R,COMBINATIONS OF ANTIBACTERIALS,NA,NA,NA,NA | |
| J01RA,Combinations of antibacterials,NA,NA,NA,NA | |
| J01RA01,"penicillins, combinations with other antibacterials",NA,NA,NA,NA | |
| J01RA02,"sulfonamides, combinations with other antibacterials (excl. trimethoprim)",NA,NA,NA,NA | |
| J01RA03,cefuroxime and metronidazole,NA,NA,NA,NA | |
| J01RA04,spiramycin and metronidazole,NA,NA,NA,NA | |
| J01RA05,levofloxacin and ornidazole,NA,NA,NA,NA | |
| J01RA06,cefepime and amikacin,NA,NA,NA,NA | |
| J01RA07,"azithromycin, fluconazole and secnidazole",NA,NA,NA,NA | |
| J01RA08,tetracycline and oleandomycin,NA,NA,NA,NA | |
| J01RA09,ofloxacin and ornidazole,NA,NA,NA,NA | |
| J01RA10,ciprofloxacin and metronidazole,NA,NA,NA,NA | |
| J01RA11,ciprofloxacin and tinidazole,NA,NA,NA,NA | |
| J01RA12,ciprofloxacin and ornidazole,NA,NA,NA,NA | |
| J01RA13,norfloxacin and tinidazole,NA,NA,NA,NA | |
| J01X,OTHER ANTIBACTERIALS,NA,NA,NA,NA | |
| J01XA,Glycopeptide antibacterials,NA,NA,NA,NA | |
| J01XA01,vancomycin,2,g,P,NA | |
| J01XA02,teicoplanin,0.4,g,P,NA | |
| J01XA03,telavancin,NA,NA,NA,NA | |
| J01XA04,dalbavancin,1.5,g,P,course dose | |
| J01XA05,oritavancin,NA,NA,NA,NA | |
| J01XB,Polymyxins,NA,NA,NA,NA | |
| J01XB01,colistin,3,MU,Inhal.powder,NA | |
| J01XB01,colistin,3,MU,Inhal.solution,NA | |
| J01XB01,colistin,9,MU,P,NA | |
| J01XB02,polymyxin B,0.15,g,P,NA | |
| J01XC,Steroid antibacterials,NA,NA,NA,NA | |
| J01XC01,fusidic acid,1.5,g,O,NA | |
| J01XC01,fusidic acid,1.5,g,P,NA | |
| J01XD,Imidazole derivatives,NA,NA,NA,NA | |
| J01XD01,metronidazole,1.5,g,P,NA | |
| J01XD02,tinidazole,1.5,g,P,NA | |
| J01XD03,ornidazole,1,g,P,NA | |
| J01XE,Nitrofuran derivatives,NA,NA,NA,NA | |
| J01XE01,nitrofurantoin,0.2,g,O,NA | |
| J01XE02,nifurtoinol,0.16,g,O,NA | |
| J01XE03,furazidin,0.3,g,O,NA | |
| J01XE51,"nitrofurantoin, combinations",NA,NA,NA,NA | |
| J01XX,Other antibacterials,NA,NA,NA,NA | |
| J01XX01,fosfomycin,3,g,O,NA | |
| J01XX01,fosfomycin,8,g,P,NA | |
| J01XX02,xibornol,NA,NA,NA,NA | |
| J01XX03,clofoctol,1.5,g,R,NA | |
| J01XX04,spectinomycin,3,g,P,NA | |
| J01XX05,methenamine,2,g,O,hippurate | |
| J01XX05,methenamine,3,g,O,mandelate | |
| J01XX06,mandelic acid,12,g,O,NA | |
| J01XX07,nitroxoline,1,g,O,NA | |
| J01XX08,linezolid,1.2,g,O,NA | |
| J01XX08,linezolid,1.2,g,P,NA | |
| J01XX09,daptomycin,0.28,g,P,NA | |
| J01XX10,bacitracin,NA,NA,NA,NA | |
| J01XX11,tedizolid,0.2,g,O,NA | |
| J01XX11,tedizolid,0.2,g,P,NA | |
| J01XX12,lefamulin,NA,NA,NA,NA | |
| J02,ANTIMYCOTICS FOR SYSTEMIC USE,NA,NA,NA,NA | |
| J02A,ANTIMYCOTICS FOR SYSTEMIC USE,NA,NA,NA,NA | |
| J02AA,Antibiotics,NA,NA,NA,NA | |
| J02AA01,amphotericin B,35,mg,P,NA | |
| J02AA02,hachimycin,NA,NA,NA,NA | |
| J02AB,Imidazole derivatives,NA,NA,NA,NA | |
| J02AB01,miconazole,1,g,P,NA | |
| J02AB02,ketoconazole,0.2,g,O,NA | |
| J02AC,Triazole derivatives,NA,NA,NA,NA | |
| J02AC01,fluconazole,0.2,g,O,NA | |
| J02AC01,fluconazole,0.2,g,P,NA | |
| J02AC02,itraconazole,0.2,g,O,NA | |
| J02AC02,itraconazole,0.2,g,P,NA | |
| J02AC03,voriconazole,0.4,g,O,NA | |
| J02AC03,voriconazole,0.4,g,P,NA | |
| J02AC04,posaconazole,0.3,g,O,NA | |
| J02AC04,posaconazole,0.3,g,P,NA | |
| J02AC05,isavuconazole,0.2,g,O,NA | |
| J02AC05,isavuconazole,0.2,g,P,NA | |
| J02AX,Other antimycotics for systemic use,NA,NA,NA,NA | |
| J02AX01,flucytosine,10,g,O,NA | |
| J02AX01,flucytosine,10,g,P,NA | |
| J02AX04,caspofungin,50,mg,P,NA | |
| J02AX05,micafungin,0.1,g,P,NA | |
| J02AX06,anidulafungin,0.1,g,P,NA | |
| J04,ANTIMYCOBACTERIALS,NA,NA,NA,NA | |
| J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,NA,NA,NA,NA | |
| J04AA,Aminosalicylic acid and derivatives,NA,NA,NA,NA | |
| J04AA01,4-aminosalicylic acid,12,g,O,NA | |
| J04AA02,sodium aminosalicylate,14,g,O,NA | |
| J04AA02,sodium aminosalicylate,14,g,P,NA | |
| J04AA03,calcium aminosalicylate,15,g,O,NA | |
| J04AB,Antibiotics,NA,NA,NA,NA | |
| J04AB01,cycloserine,0.75,g,O,NA | |
| J04AB02,rifampicin,0.6,g,O,NA | |
| J04AB02,rifampicin,0.6,g,P,NA | |
| J04AB03,rifamycin,0.6,g,P,NA | |
| J04AB04,rifabutin,0.15,g,O,NA | |
| J04AB05,rifapentine,0.11,g,O,NA | |
| J04AB06,enviomycin,1,g,P,NA | |
| J04AB30,capreomycin,1,g,P,NA | |
| J04AC,Hydrazides,NA,NA,NA,NA | |
| J04AC01,isoniazid,0.3,g,O,NA | |
| J04AC01,isoniazid,0.3,g,P,NA | |
| J04AC51,"isoniazid, combinations",NA,NA,NA,NA | |
| J04AD,Thiocarbamide derivatives,NA,NA,NA,NA | |
| J04AD01,protionamide,0.75,g,O,NA | |
| J04AD02,tiocarlide,7,g,O,NA | |
| J04AD03,ethionamide,0.75,g,O,NA | |
| J04AK,Other drugs for treatment of tuberculosis,NA,NA,NA,NA | |
| J04AK01,pyrazinamide,1.5,g,O,NA | |
| J04AK02,ethambutol,1.2,g,O,NA | |
| J04AK02,ethambutol,1.2,g,P,NA | |
| J04AK03,terizidone,NA,NA,NA,NA | |
| J04AK04,morinamide,NA,NA,NA,NA | |
| J04AK05,bedaquiline,86,mg,O,NA | |
| J04AK06,delamanid,0.2,g,O,NA | |
| J04AK07,thioacetazone,NA,NA,NA,NA | |
| J04AK08,pretomanid,NA,NA,NA,NA | |
| J04AM,Combinations of drugs for treatment of tuberculosis,NA,NA,NA,NA | |
| J04AM01,streptomycin and isoniazid,NA,NA,NA,NA | |
| J04AM02,rifampicin and isoniazid,NA,NA,NA,NA | |
| J04AM03,ethambutol and isoniazid,NA,NA,NA,NA | |
| J04AM04,thioacetazone and isoniazid,NA,NA,NA,NA | |
| J04AM05,"rifampicin, pyrazinamide and isoniazid",NA,NA,NA,NA | |
| J04AM06,"rifampicin, pyrazinamide, ethambutol and isoniazid",NA,NA,NA,NA | |
| J04AM07,"rifampicin, ethambutol and isoniazid",NA,NA,NA,NA | |
| J04AM08,"isoniazid, sulfamethoxazole, trimethoprim and pyridoxine",NA,NA,NA,NA | |
| J04B,DRUGS FOR TREATMENT OF LEPRA,NA,NA,NA,NA | |
| J04BA,Drugs for treatment of lepra,NA,NA,NA,NA | |
| J04BA01,clofazimine,0.1,g,O,NA | |
| J04BA02,dapsone,50,mg,O,NA | |
| J04BA03,aldesulfone sodium,0.33,g,O,NA | |
| J05,ANTIVIRALS FOR SYSTEMIC USE,NA,NA,NA,NA | |
| J05A,DIRECT ACTING ANTIVIRALS,NA,NA,NA,NA | |
| J05AA,Thiosemicarbazones,NA,NA,NA,NA | |
| J05AA01,metisazone,NA,NA,NA,NA | |
| J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,NA,NA,NA,NA | |
| J05AB01,aciclovir,4,g,O,NA | |
| J05AB01,aciclovir,4,g,P,NA | |
| J05AB02,idoxuridine,NA,NA,NA,NA | |
| J05AB03,vidarabine,0.7,g,P,NA | |
| J05AB06,ganciclovir,3,g,O,NA | |
| J05AB06,ganciclovir,0.5,g,P,NA | |
| J05AB09,famciclovir,0.75,g,O,NA | |
| J05AB11,valaciclovir,3,g,O,NA | |
| J05AB12,cidofovir,25,mg,P,NA | |
| J05AB13,penciclovir,NA,NA,NA,NA | |
| J05AB14,valganciclovir,0.9,g,O,NA | |
| J05AB15,brivudine,0.125,g,O,NA | |
| J05AC,Cyclic amines,NA,NA,NA,NA | |
| J05AC02,rimantadine,0.2,g,O,NA | |
| J05AC03,tromantadine,NA,NA,NA,NA | |
| J05AD,Phosphonic acid derivatives,NA,NA,NA,NA | |
| J05AD01,foscarnet,6.5,g,P,NA | |
| J05AD02,fosfonet,NA,NA,NA,NA | |
| J05AE,Protease inhibitors,NA,NA,NA,NA | |
| J05AE01,saquinavir,1.8,g,O,NA | |
| J05AE02,indinavir,2.4,g,O,NA | |
| J05AE03,ritonavir,1.2,g,O,NA | |
| J05AE04,nelfinavir,2.25,g,O,NA | |
| J05AE05,amprenavir,1.2,g,O,NA | |
| J05AE07,fosamprenavir,1.4,g,O,NA | |
| J05AE08,atazanavir,0.3,g,O,NA | |
| J05AE09,tipranavir,1,g,O,NA | |
| J05AE10,darunavir,1.2,g,O,NA | |
| J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,NA,NA,NA,NA | |
| J05AF01,zidovudine,0.6,g,O,NA | |
| J05AF01,zidovudine,0.6,g,P,NA | |
| J05AF02,didanosine,0.4,g,O,NA | |
| J05AF03,zalcitabine,2.25,mg,O,NA | |
| J05AF04,stavudine,80,mg,O,NA | |
| J05AF05,lamivudine,0.3,g,O,NA | |
| J05AF06,abacavir,0.6,g,O,NA | |
| J05AF07,tenofovir disoproxil,0.245,g,O,NA | |
| J05AF08,adefovir dipivoxil,10,mg,O,NA | |
| J05AF09,emtricitabine,0.2,g,O,NA | |
| J05AF10,entecavir,0.5,mg,O,NA | |
| J05AF11,telbivudine,0.6,g,O,NA | |
| J05AF12,clevudine,30,mg,O,NA | |
| J05AF13,tenofovir alafenamide,25,mg,O,NA | |
| J05AG,Non-nucleoside reverse transcriptase inhibitors,NA,NA,NA,NA | |
| J05AG01,nevirapine,0.4,g,O,NA | |
| J05AG02,delavirdine,1.2,g,O,NA | |
| J05AG03,efavirenz,0.6,g,O,NA | |
| J05AG04,etravirine,0.4,g,O,NA | |
| J05AG05,rilpivirine,25,mg,O,NA | |
| J05AG06,doravirine,0.1,g,O,NA | |
| J05AH,Neuraminidase inhibitors,NA,NA,NA,NA | |
| J05AH01,zanamivir,20,mg,Inhal.powder,NA | |
| J05AH02,oseltamivir,0.15,g,O,NA | |
| J05AH03,peramivir,0.6,g,P,NA | |
| J05AH04,laninamivir,40,mg,Inhal.powder,NA | |
| J05AJ,Integrase inhibitors,NA,NA,NA,NA | |
| J05AJ01,raltegravir,0.8,g,O,NA | |
| J05AJ02,elvitegravir,NA,NA,NA,NA | |
| J05AJ03,dolutegravir,50,mg,O,NA | |
| J05AJ04,cabotegravir,NA,NA,NA,NA | |
| J05AP,Antivirals for treatment of HCV infections,NA,NA,NA,NA | |
| J05AP01,ribavirin,6,g,Inhal.solution,NA | |
| J05AP01,ribavirin,1,g,O,NA | |
| J05AP02,telaprevir,2.25,g,O,NA | |
| J05AP03,boceprevir,2.4,g,O,NA | |
| J05AP04,faldaprevir,NA,NA,NA,NA | |
| J05AP05,simeprevir,0.15,g,O,NA | |
| J05AP06,asunaprevir,0.2,g,O,NA | |
| J05AP07,daclatasvir,60,mg,O,NA | |
| J05AP08,sofosbuvir,0.4,g,O,NA | |
| J05AP09,dasabuvir,0.5,g,O,NA | |
| J05AP10,elbasvir,50,mg,O,NA | |
| J05AP11,grazoprevir,0.1,g,O,NA | |
| J05AP51,sofosbuvir and ledipasvir,NA,NA,NA,NA | |
| J05AP52,"dasabuvir, ombitasvir, paritaprevir and ritonavir",NA,NA,NA,NA | |
| J05AP53,"ombitasvir, paritaprevir and ritonavir",NA,NA,NA,NA | |
| J05AP54,elbasvir and grazoprevir,NA,NA,NA,NA | |
| J05AP55,sofosbuvir and velpatasvir,NA,NA,NA,NA | |
| J05AP56,"sofosbuvir, velpatasvir and voxilaprevir",NA,NA,NA,NA | |
| J05AP57,glecaprevir and pibrentasvir,NA,NA,NA,NA | |
| J05AP58,"daclatasvir, asunaprevir and beclabuvir",NA,NA,NA,NA | |
| J05AR,"Antivirals for treatment of HIV infections, combinations",NA,NA,NA,NA | |
| J05AR01,zidovudine and lamivudine,NA,NA,NA,NA | |
| J05AR02,lamivudine and abacavir,NA,NA,NA,NA | |
| J05AR03,tenofovir disoproxil and emtricitabine,NA,NA,NA,NA | |
| J05AR04,"zidovudine, lamivudine and abacavir",NA,NA,NA,NA | |
| J05AR05,"zidovudine, lamivudine and nevirapine",NA,NA,NA,NA | |
| J05AR06,"emtricitabine, tenofovir disoproxil and efavirenz",NA,NA,NA,NA | |
| J05AR07,"stavudine, lamivudine and nevirapine",NA,NA,NA,NA | |
| J05AR08,"emtricitabine, tenofovir disoproxil and rilpivirine",NA,NA,NA,NA | |
| J05AR09,"emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat",NA,NA,NA,NA | |
| J05AR10,lopinavir and ritonavir,0.8,g,O,Refers to lopinavir | |
| J05AR11,"lamivudine, tenofovir disoproxil and efavirenz",NA,NA,NA,NA | |
| J05AR12,lamivudine and tenofovir disoproxil,NA,NA,NA,NA | |
| J05AR13,"lamivudine, abacavir and dolutegravir",NA,NA,NA,NA | |
| J05AR14,darunavir and cobicistat,NA,NA,NA,NA | |
| J05AR15,atazanavir and cobicistat,NA,NA,NA,NA | |
| J05AR16,lamivudine and raltegravir,NA,NA,NA,NA | |
| J05AR17,emtricitabine and tenofovir alafenamide,NA,NA,NA,NA | |
| J05AR18,"emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat",NA,NA,NA,NA | |
| J05AR19,"emtricitabine, tenofovir alafenamide and rilpivirine",NA,NA,NA,NA | |
| J05AR20,"emtricitabine, tenofovir alafenamide and bictegravir",NA,NA,NA,NA | |
| J05AR21,dolutegravir and rilpivirine,NA,NA,NA,NA | |
| J05AR22,"emtricitabine, tenofovir alafenamide, darunavir and cobicistat",NA,NA,NA,NA | |
| J05AR23,atazanavir and ritonavir,0.3,g,O,Refers to atazanavir | |
| J05AR24,"lamivudine, tenofovir disoproxil and doravirine",NA,NA,NA,NA | |
| J05AR25,lamivudine and dolutegravir,NA,NA,NA,NA | |
| J05AR26,darunavir and ritonavir,NA,NA,NA,NA | |
| J05AR27,"lamivudine, tenofovir disoproxil and dolutegravir",NA,NA,NA,NA | |
| J05AX,Other antivirals,NA,NA,NA,NA | |
| J05AX01,moroxydine,0.3,g,O,NA | |
| J05AX02,lysozyme,NA,NA,NA,NA | |
| J05AX05,inosine pranobex,3,g,O,NA | |
| J05AX06,pleconaril,NA,NA,NA,NA | |
| J05AX07,enfuvirtide,0.18,g,P,NA | |
| J05AX09,maraviroc,0.6,g,O,NA | |
| J05AX10,maribavir,NA,NA,NA,NA | |
| J05AX13,umifenovir,0.8,g,O,NA | |
| J05AX17,enisamium iodide,1.5,g,O,NA | |
| J05AX18,letermovir,0.48,g,O,NA | |
| J05AX18,letermovir,0.48,g,P,NA | |
| J05AX19,tilorone,0.125,g,O,NA | |
| J05AX21,pentanedioic acid imidazolyl ethanamide,90,mg,O,NA | |
| J05AX23,ibalizumab,NA,NA,NA,NA | |
| J05AX24,tecovirimat,NA,NA,NA,NA | |
| J05AX25,baloxavir marboxil,40,mg,O,NA | |
| J05AX26,amenamevir,0.4,g,O,NA | |
| J05AX27,favipiravir,1.6,g,O,NA | |
| J05AX28,bulevirtide,NA,NA,NA,NA | |
| J05AX29,fostemsavir,NA,NA,NA,NA | |
| J06,IMMUNE SERA AND IMMUNOGLOBULINS,NA,NA,NA,NA | |
| J06A,IMMUNE SERA,NA,NA,NA,NA | |
| J06AA,Immune sera,NA,NA,NA,NA | |
| J06AA01,diphtheria antitoxin,NA,NA,NA,NA | |
| J06AA02,tetanus antitoxin,NA,NA,NA,NA | |
| J06AA03,snake venom antiserum,NA,NA,NA,NA | |
| J06AA04,botulinum antitoxin,NA,NA,NA,NA | |
| J06AA05,gas-gangrene sera,NA,NA,NA,NA | |
| J06AA06,rabies serum,NA,NA,NA,NA | |
| J06B,IMMUNOGLOBULINS,NA,NA,NA,NA | |
| J06BA,"Immunoglobulins, normal human",NA,NA,NA,NA | |
| J06BA01,"immunoglobulins, normal human, for extravascular adm.",NA,NA,NA,NA | |
| J06BA02,"immunoglobulins, normal human, for intravascular adm.",NA,NA,NA,NA | |
| J06BB,Specific immunoglobulins,NA,NA,NA,NA | |
| J06BB01,anti-D (rh) immunoglobulin,NA,NA,NA,NA | |
| J06BB02,tetanus immunoglobulin,NA,NA,NA,NA | |
| J06BB03,varicella/zoster immunoglobulin,NA,NA,NA,NA | |
| J06BB04,hepatitis B immunoglobulin,NA,NA,NA,NA | |
| J06BB05,rabies immunoglobulin,NA,NA,NA,NA | |
| J06BB06,rubella immunoglobulin,NA,NA,NA,NA | |
| J06BB07,vaccinia immunoglobulin,NA,NA,NA,NA | |
| J06BB08,staphylococcus immunoglobulin,NA,NA,NA,NA | |
| J06BB09,cytomegalovirus immunoglobulin,NA,NA,NA,NA | |
| J06BB10,diphtheria immunoglobulin,NA,NA,NA,NA | |
| J06BB11,hepatitis A immunoglobulin,NA,NA,NA,NA | |
| J06BB12,"encephalitis, tick borne immunoglobulin",NA,NA,NA,NA | |
| J06BB13,pertussis immunoglobulin,NA,NA,NA,NA | |
| J06BB14,measles immunoglobulin,NA,NA,NA,NA | |
| J06BB15,mumps immunoglobulin,NA,NA,NA,NA | |
| J06BB16,palivizumab,NA,NA,NA,NA | |
| J06BB17,motavizumab,NA,NA,NA,NA | |
| J06BB18,raxibacumab,NA,NA,NA,NA | |
| J06BB19,anthrax immunoglobulin,NA,NA,NA,NA | |
| J06BB21,bezlotoxumab,NA,NA,NA,NA | |
| J06BB22,obiltoxaximab,NA,NA,NA,NA | |
| J06BB30,combinations,NA,NA,NA,NA | |
| J06BC,Other immunoglobulins,NA,NA,NA,NA | |
| J06BC01,nebacumab,0.1,g,P,NA | |
| J07,VACCINES,NA,NA,NA,NA | |
| J07A,BACTERIAL VACCINES,NA,NA,NA,NA | |
| J07AC,Anthrax vaccines,NA,NA,NA,NA | |
| J07AC01,anthrax antigen,NA,NA,NA,NA | |
| J07AD,Brucellosis vaccines,NA,NA,NA,NA | |
| J07AD01,brucella antigen,NA,NA,NA,NA | |
| J07AE,Cholera vaccines,NA,NA,NA,NA | |
| J07AE01,"cholera, inactivated, whole cell",NA,NA,NA,NA | |
| J07AE02,"cholera, live attenuated",NA,NA,NA,NA | |
| J07AE51,"cholera, combinations with typhoid vaccine, inactivated, whole cell",NA,NA,NA,NA | |
| J07AF,Diphtheria vaccines,NA,NA,NA,NA | |
| J07AF01,diphtheria toxoid,NA,NA,NA,NA | |
| J07AG,Haemophilus influenzae B vaccines,NA,NA,NA,NA | |
| J07AG01,"haemophilus influenzae B, purified antigen conjugated",NA,NA,NA,NA | |
| J07AG51,"haemophilus influenzae B, combinations with toxoids",NA,NA,NA,NA | |
| J07AG52,"haemophilus influenzae B, combinations with pertussis and toxoids",NA,NA,NA,NA | |
| J07AG53,"haemophilus influenzae B, combinations with meningococcus C, conjugated",NA,NA,NA,NA | |
| J07AH,Meningococcal vaccines,NA,NA,NA,NA | |
| J07AH01,"meningococcus A, purified polysaccharides antigen",NA,NA,NA,NA | |
| J07AH02,other meningococcal monovalent purified polysaccharides antigen,NA,NA,NA,NA | |
| J07AH03,"meningococcus A,C, bivalent purified polysaccharides antigen",NA,NA,NA,NA | |
| J07AH04,"meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen",NA,NA,NA,NA | |
| J07AH05,other meningococcal polyvalent purified polysaccharides antigen,NA,NA,NA,NA | |
| J07AH06,"meningococcus B, outer membrane vesicle vaccine",NA,NA,NA,NA | |
| J07AH07,"meningococcus C, purified polysaccharides antigen conjugated",NA,NA,NA,NA | |
| J07AH08,"meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated",NA,NA,NA,NA | |
| J07AH09,"meningococcus B, multicomponent vaccine",NA,NA,NA,NA | |
| J07AH10,"meningococcus A, purified polysaccharides antigen conjugated",NA,NA,NA,NA | |
| J07AJ,Pertussis vaccines,NA,NA,NA,NA | |
| J07AJ01,"pertussis, inactivated, whole cell",NA,NA,NA,NA | |
| J07AJ02,"pertussis, purified antigen",NA,NA,NA,NA | |
| J07AJ51,"pertussis, inactivated, whole cell, combinations with toxoids",NA,NA,NA,NA | |
| J07AJ52,"pertussis, purified antigen, combinations with toxoids",NA,NA,NA,NA | |
| J07AK,Plague vaccines,NA,NA,NA,NA | |
| J07AK01,"plague, inactivated, whole cell",NA,NA,NA,NA | |
| J07AL,Pneumococcal vaccines,NA,NA,NA,NA | |
| J07AL01,"pneumococcus, purified polysaccharides antigen",NA,NA,NA,NA | |
| J07AL02,"pneumococcus, purified polysaccharides antigen conjugated",NA,NA,NA,NA | |
| J07AL52,"pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated",NA,NA,NA,NA | |
| J07AM,Tetanus vaccines,NA,NA,NA,NA | |
| J07AM01,tetanus toxoid,NA,NA,NA,NA | |
| J07AM51,"tetanus toxoid, combinations with diphtheria toxoid",NA,NA,NA,NA | |
| J07AM52,"tetanus toxoid, combinations with tetanus immunoglobulin",NA,NA,NA,NA | |
| J07AN,Tuberculosis vaccines,NA,NA,NA,NA | |
| J07AN01,"tuberculosis, live attenuated",NA,NA,NA,NA | |
| J07AP,Typhoid vaccines,NA,NA,NA,NA | |
| J07AP01,"typhoid, oral, live attenuated",NA,NA,NA,NA | |
| J07AP02,"typhoid, inactivated, whole cell",NA,NA,NA,NA | |
| J07AP03,"typhoid, purified polysaccharide antigen",NA,NA,NA,NA | |
| J07AP10,"typhoid, combinations with paratyphi types",NA,NA,NA,NA | |
| J07AR,Typhus (exanthematicus) vaccines,NA,NA,NA,NA | |
| J07AR01,"typhus exanthematicus, inactivated, whole cell",NA,NA,NA,NA | |
| J07AX,Other bacterial vaccines,NA,NA,NA,NA | |
| J07B,VIRAL VACCINES,NA,NA,NA,NA | |
| J07BA,Encephalitis vaccines,NA,NA,NA,NA | |
| J07BA01,"encephalitis, tick borne, inactivated, whole virus",NA,NA,NA,NA | |
| J07BA02,"encephalitis, Japanese, inactivated, whole virus",NA,NA,NA,NA | |
| J07BA03,"encephalitis, Japanese, live attenuated",NA,NA,NA,NA | |
| J07BB,Influenza vaccines,NA,NA,NA,NA | |
| J07BB01,"influenza, inactivated, whole virus",NA,NA,NA,NA | |
| J07BB02,"influenza, inactivated, split virus or surface antigen",NA,NA,NA,NA | |
| J07BB03,"influenza, live attenuated",NA,NA,NA,NA | |
| J07BB04,"influenza, virus like particles",NA,NA,NA,NA | |
| J07BC,Hepatitis vaccines,NA,NA,NA,NA | |
| J07BC01,"hepatitis B, purified antigen",NA,NA,NA,NA | |
| J07BC02,"hepatitis A, inactivated, whole virus",NA,NA,NA,NA | |
| J07BC20,combinations,NA,NA,NA,NA | |
| J07BD,Measles vaccines,NA,NA,NA,NA | |
| J07BD01,"measles, live attenuated",NA,NA,NA,NA | |
| J07BD51,"measles, combinations with mumps, live attenuated",NA,NA,NA,NA | |
| J07BD52,"measles, combinations with mumps and rubella, live attenuated",NA,NA,NA,NA | |
| J07BD53,"measles, combinations with rubella, live attenuated",NA,NA,NA,NA | |
| J07BD54,"measles, combinations with mumps, rubella and varicella, live attenuated",NA,NA,NA,NA | |
| J07BE,Mumps vaccines,NA,NA,NA,NA | |
| J07BE01,"mumps, live attenuated",NA,NA,NA,NA | |
| J07BF,Poliomyelitis vaccines,NA,NA,NA,NA | |
| J07BF01,"poliomyelitis oral, monovalent, live attenuated",NA,NA,NA,NA | |
| J07BF02,"poliomyelitis oral, trivalent, live attenuated",NA,NA,NA,NA | |
| J07BF03,"poliomyelitis, trivalent, inactivated, whole virus",NA,NA,NA,NA | |
| J07BF04,"poliomyelitis oral, bivalent, live attenuated",NA,NA,NA,NA | |
| J07BG,Rabies vaccines,NA,NA,NA,NA | |
| J07BG01,"rabies, inactivated, whole virus",NA,NA,NA,NA | |
| J07BH,Rota virus diarrhea vaccines,NA,NA,NA,NA | |
| J07BH01,"rota virus, live attenuated",NA,NA,NA,NA | |
| J07BH02,"rota virus, pentavalent, live, reassorted",NA,NA,NA,NA | |
| J07BJ,Rubella vaccines,NA,NA,NA,NA | |
| J07BJ01,"rubella, live attenuated",NA,NA,NA,NA | |
| J07BJ51,"rubella, combinations with mumps, live attenuated",NA,NA,NA,NA | |
| J07BK,Varicella zoster vaccines,NA,NA,NA,NA | |
| J07BK01,"varicella, live attenuated",NA,NA,NA,NA | |
| J07BK02,"zoster, live attenuated",NA,NA,NA,NA | |
| J07BK03,"zoster, purified antigen",NA,NA,NA,NA | |
| J07BL,Yellow fever vaccines,NA,NA,NA,NA | |
| J07BL01,"yellow fever, live attenuated",NA,NA,NA,NA | |
| J07BM,Papillomavirus vaccines,NA,NA,NA,NA | |
| J07BM01,"papillomavirus (human types 6, 11, 16, 18)",NA,NA,NA,NA | |
| J07BM02,"papillomavirus (human types 16, 18)",NA,NA,NA,NA | |
| J07BM03,"papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)",NA,NA,NA,NA | |
| J07BX,Other viral vaccines,NA,NA,NA,NA | |
| J07BX01,smallpox vaccines,NA,NA,NA,NA | |
| J07BX02,ebola vaccines,NA,NA,NA,NA | |
| J07C,"BACTERIAL AND VIRAL VACCINES, COMBINED",NA,NA,NA,NA | |
| J07CA,"Bacterial and viral vaccines, combined",NA,NA,NA,NA | |
| J07CA01,diphtheria-poliomyelitis-tetanus,NA,NA,NA,NA | |
| J07CA02,diphtheria-pertussis-poliomyelitis-tetanus,NA,NA,NA,NA | |
| J07CA03,diphtheria-rubella-tetanus,NA,NA,NA,NA | |
| J07CA04,haemophilus influenzae B and poliomyelitis,NA,NA,NA,NA | |
| J07CA05,diphtheria-hepatitis B-pertussis-tetanus,NA,NA,NA,NA | |
| J07CA06,diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus,NA,NA,NA,NA | |
| J07CA07,diphtheria-hepatitis B-tetanus,NA,NA,NA,NA | |
| J07CA08,haemophilus influenzae B and hepatitis B,NA,NA,NA,NA | |
| J07CA09,diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B,NA,NA,NA,NA | |
| J07CA10,typhoid-hepatitis A,NA,NA,NA,NA | |
| J07CA11,diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B,NA,NA,NA,NA | |
| J07CA12,diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B,NA,NA,NA,NA | |
| J07CA13,diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C,NA,NA,NA,NA | |
| J07X,OTHER VACCINES,NA,NA,NA,NA | |
| L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,NA,NA,NA,NA | |
| L01,ANTINEOPLASTIC AGENTS,NA,NA,NA,NA | |
| L01A,ALKYLATING AGENTS,NA,NA,NA,NA | |
| L01AA,Nitrogen mustard analogues,NA,NA,NA,NA | |
| L01AA01,cyclophosphamide,NA,NA,NA,NA | |
| L01AA02,chlorambucil,NA,NA,NA,NA | |
| L01AA03,melphalan,NA,NA,NA,NA | |
| L01AA05,chlormethine,NA,NA,NA,NA | |
| L01AA06,ifosfamide,NA,NA,NA,NA | |
| L01AA07,trofosfamide,NA,NA,NA,NA | |
| L01AA08,prednimustine,NA,NA,NA,NA | |
| L01AA09,bendamustine,NA,NA,NA,NA | |
| L01AB,Alkyl sulfonates,NA,NA,NA,NA | |
| L01AB01,busulfan,NA,NA,NA,NA | |
| L01AB02,treosulfan,NA,NA,NA,NA | |
| L01AB03,mannosulfan,NA,NA,NA,NA | |
| L01AC,Ethylene imines,NA,NA,NA,NA | |
| L01AC01,thiotepa,NA,NA,NA,NA | |
| L01AC02,triaziquone,NA,NA,NA,NA | |
| L01AC03,carboquone,NA,NA,NA,NA | |
| L01AD,Nitrosoureas,NA,NA,NA,NA | |
| L01AD01,carmustine,NA,NA,NA,NA | |
| L01AD02,lomustine,NA,NA,NA,NA | |
| L01AD03,semustine,NA,NA,NA,NA | |
| L01AD04,streptozocin,NA,NA,NA,NA | |
| L01AD05,fotemustine,NA,NA,NA,NA | |
| L01AD06,nimustine,NA,NA,NA,NA | |
| L01AD07,ranimustine,NA,NA,NA,NA | |
| L01AD08,uramustine,NA,NA,NA,NA | |
| L01AG,Epoxides,NA,NA,NA,NA | |
| L01AG01,etoglucid,NA,NA,NA,NA | |
| L01AX,Other alkylating agents,NA,NA,NA,NA | |
| L01AX01,mitobronitol,NA,NA,NA,NA | |
| L01AX02,pipobroman,NA,NA,NA,NA | |
| L01AX03,temozolomide,NA,NA,NA,NA | |
| L01AX04,dacarbazine,NA,NA,NA,NA | |
| L01B,ANTIMETABOLITES,NA,NA,NA,NA | |
| L01BA,Folic acid analogues,NA,NA,NA,NA | |
| L01BA01,methotrexate,NA,NA,NA,NA | |
| L01BA03,raltitrexed,NA,NA,NA,NA | |
| L01BA04,pemetrexed,NA,NA,NA,NA | |
| L01BA05,pralatrexate,NA,NA,NA,NA | |
| L01BB,Purine analogues,NA,NA,NA,NA | |
| L01BB02,mercaptopurine,NA,NA,NA,NA | |
| L01BB03,tioguanine,NA,NA,NA,NA | |
| L01BB04,cladribine,NA,NA,NA,NA | |
| L01BB05,fludarabine,NA,NA,NA,NA | |
| L01BB06,clofarabine,NA,NA,NA,NA | |
| L01BB07,nelarabine,NA,NA,NA,NA | |
| L01BC,Pyrimidine analogues,NA,NA,NA,NA | |
| L01BC01,cytarabine,NA,NA,NA,NA | |
| L01BC02,fluorouracil,NA,NA,NA,NA | |
| L01BC03,tegafur,NA,NA,NA,NA | |
| L01BC04,carmofur,NA,NA,NA,NA | |
| L01BC05,gemcitabine,NA,NA,NA,NA | |
| L01BC06,capecitabine,NA,NA,NA,NA | |
| L01BC07,azacitidine,NA,NA,NA,NA | |
| L01BC08,decitabine,NA,NA,NA,NA | |
| L01BC09,floxuridine,NA,NA,NA,NA | |
| L01BC52,"fluorouracil, combinations",NA,NA,NA,NA | |
| L01BC53,"tegafur, combinations",NA,NA,NA,NA | |
| L01BC59,"trifluridine, combinations",NA,NA,NA,NA | |
| L01C,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,NA,NA,NA,NA | |
| L01CA,Vinca alkaloids and analogues,NA,NA,NA,NA | |
| L01CA01,vinblastine,NA,NA,NA,NA | |
| L01CA02,vincristine,NA,NA,NA,NA | |
| L01CA03,vindesine,NA,NA,NA,NA | |
| L01CA04,vinorelbine,NA,NA,NA,NA | |
| L01CA05,vinflunine,NA,NA,NA,NA | |
| L01CA06,vintafolide,NA,NA,NA,NA | |
| L01CB,Podophyllotoxin derivatives,NA,NA,NA,NA | |
| L01CB01,etoposide,NA,NA,NA,NA | |
| L01CB02,teniposide,NA,NA,NA,NA | |
| L01CC,Colchicine derivatives,NA,NA,NA,NA | |
| L01CC01,demecolcine,NA,NA,NA,NA | |
| L01CD,Taxanes,NA,NA,NA,NA | |
| L01CD01,paclitaxel,NA,NA,NA,NA | |
| L01CD02,docetaxel,NA,NA,NA,NA | |
| L01CD03,paclitaxel poliglumex,NA,NA,NA,NA | |
| L01CD04,cabazitaxel,NA,NA,NA,NA | |
| L01CE,Topoisomerase 1 (TOP1) inhibitors,NA,NA,NA,NA | |
| L01CE01,topotecan,NA,NA,NA,NA | |
| L01CE02,irinotecan,NA,NA,NA,NA | |
| L01CE03,etirinotecan pegol,NA,NA,NA,NA | |
| L01CE04,belotecan,NA,NA,NA,NA | |
| L01CX,Other plant alkaloids and natural products,NA,NA,NA,NA | |
| L01CX01,trabectedin,NA,NA,NA,NA | |
| L01D,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,NA,NA,NA,NA | |
| L01DA,Actinomycines,NA,NA,NA,NA | |
| L01DA01,dactinomycin,NA,NA,NA,NA | |
| L01DB,Anthracyclines and related substances,NA,NA,NA,NA | |
| L01DB01,doxorubicin,NA,NA,NA,NA | |
| L01DB02,daunorubicin,NA,NA,NA,NA | |
| L01DB03,epirubicin,NA,NA,NA,NA | |
| L01DB04,aclarubicin,NA,NA,NA,NA | |
| L01DB05,zorubicin,NA,NA,NA,NA | |
| L01DB06,idarubicin,NA,NA,NA,NA | |
| L01DB07,mitoxantrone,NA,NA,NA,NA | |
| L01DB08,pirarubicin,NA,NA,NA,NA | |
| L01DB09,valrubicin,NA,NA,NA,NA | |
| L01DB10,amrubicin,NA,NA,NA,NA | |
| L01DB11,pixantrone,NA,NA,NA,NA | |
| L01DC,Other cytotoxic antibiotics,NA,NA,NA,NA | |
| L01DC01,bleomycin,NA,NA,NA,NA | |
| L01DC02,plicamycin,NA,NA,NA,NA | |
| L01DC03,mitomycin,NA,NA,NA,NA | |
| L01DC04,ixabepilone,NA,NA,NA,NA | |
| L01E,PROTEIN KINASE INHIBITORS,NA,NA,NA,NA | |
| L01EA,BCR-ABL tyrosine kinase inhibitors,NA,NA,NA,NA | |
| L01EA01,imatinib,NA,NA,NA,NA | |
| L01EA02,dasatinib,NA,NA,NA,NA | |
| L01EA03,nilotinib,NA,NA,NA,NA | |
| L01EA04,bosutinib,NA,NA,NA,NA | |
| L01EA05,ponatinib,NA,NA,NA,NA | |
| L01EB,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,NA,NA,NA,NA | |
| L01EB01,gefitinib,NA,NA,NA,NA | |
| L01EB02,erlotinib,NA,NA,NA,NA | |
| L01EB03,afatinib,NA,NA,NA,NA | |
| L01EB04,osimertinib,NA,NA,NA,NA | |
| L01EB05,rociletinib,NA,NA,NA,NA | |
| L01EB06,olmutinib,NA,NA,NA,NA | |
| L01EB07,dacomitinib,NA,NA,NA,NA | |
| L01EB08,icotinib,NA,NA,NA,NA | |
| L01EC,B-Raf serine-threonine kinase (BRAF) inhibitors,NA,NA,NA,NA | |
| L01EC01,vemurafenib,NA,NA,NA,NA | |
| L01EC02,dabrafenib,NA,NA,NA,NA | |
| L01EC03,encorafenib,NA,NA,NA,NA | |
| L01ED,Anaplastic lymphoma kinase (ALK) inhibitors,NA,NA,NA,NA | |
| L01ED01,crizotinib,NA,NA,NA,NA | |
| L01ED02,ceritinib,NA,NA,NA,NA | |
| L01ED03,alectinib,NA,NA,NA,NA | |
| L01ED04,brigatinib,NA,NA,NA,NA | |
| L01ED05,lorlatinib,NA,NA,NA,NA | |
| L01EE,Mitogen-activated protein kinase (MEK) inhibitors,NA,NA,NA,NA | |
| L01EE01,trametinib,NA,NA,NA,NA | |
| L01EE02,cobimetinib,NA,NA,NA,NA | |
| L01EE03,binimetinib,NA,NA,NA,NA | |
| L01EE04,selumetinib,NA,NA,NA,NA | |
| L01EF,Cyclin-dependent kinase (CDK) inhibitors,NA,NA,NA,NA | |
| L01EF01,palbociclib,NA,NA,NA,NA | |
| L01EF02,ribociclib,NA,NA,NA,NA | |
| L01EF03,abemaciclib,NA,NA,NA,NA | |
| L01EG,Mammalian target of rapamycin (mTOR) kinase inhibitors,NA,NA,NA,NA | |
| L01EG01,temsirolimus,NA,NA,NA,NA | |
| L01EG02,everolimus,NA,NA,NA,NA | |
| L01EG03,ridaforolimus,NA,NA,NA,NA | |
| L01EH,Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors,NA,NA,NA,NA | |
| L01EH01,lapatinib,NA,NA,NA,NA | |
| L01EH02,neratinib,NA,NA,NA,NA | |
| L01EH03,tucatinib,NA,NA,NA,NA | |
| L01EJ,Janus-associated kinase (JAK) inhibitors,NA,NA,NA,NA | |
| L01EJ01,ruxolitinib,NA,NA,NA,NA | |
| L01EJ02,fedratinib,NA,NA,NA,NA | |
| L01EK,Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors,NA,NA,NA,NA | |
| L01EK01,axitinib,NA,NA,NA,NA | |
| L01EK02,cediranib,NA,NA,NA,NA | |
| L01EK03,tivozanib,NA,NA,NA,NA | |
| L01EL,Bruton's tyrosine kinase (BTK) inhibitors,NA,NA,NA,NA | |
| L01EL01,ibrutinib,NA,NA,NA,NA | |
| L01EL02,acalabrutinib,NA,NA,NA,NA | |
| L01EL03,zanubrutinib,NA,NA,NA,NA | |
| L01EM,Phosphatidylinositol-3-kinase (Pi3K) inhibitors,NA,NA,NA,NA | |
| L01EM01,idelalisib,NA,NA,NA,NA | |
| L01EM02,copanlisib,NA,NA,NA,NA | |
| L01EM03,alpelisib,NA,NA,NA,NA | |
| L01EM04,duvelisib,NA,NA,NA,NA | |
| L01EX,Other protein kinase inhibitors,NA,NA,NA,NA | |
| L01EX01,sunitinib,NA,NA,NA,NA | |
| L01EX02,sorafenib,NA,NA,NA,NA | |
| L01EX03,pazopanib,NA,NA,NA,NA | |
| L01EX04,vandetanib,NA,NA,NA,NA | |
| L01EX05,regorafenib,NA,NA,NA,NA | |
| L01EX06,masitinib,NA,NA,NA,NA | |
| L01EX07,cabozantinib,NA,NA,NA,NA | |
| L01EX08,lenvatinib,NA,NA,NA,NA | |
| L01EX09,nintedanib,NA,NA,NA,NA | |
| L01EX10,midostaurin,NA,NA,NA,NA | |
| L01EX11,quizartinib,NA,NA,NA,NA | |
| L01EX12,larotrectinib,NA,NA,NA,NA | |
| L01EX13,gilteritinib,NA,NA,NA,NA | |
| L01EX14,entrectinib,NA,NA,NA,NA | |
| L01EX15,pexidartinib,NA,NA,NA,NA | |
| L01EX16,erdafitinib,NA,NA,NA,NA | |
| L01EX17,capmatinib,NA,NA,NA,NA | |
| L01EX18,avapritinib,NA,NA,NA,NA | |
| L01EX19,ripretinib,NA,NA,NA,NA | |
| L01EX20,pemigatinib,NA,NA,NA,NA | |
| L01EX21,tepotinib,NA,NA,NA,NA | |
| L01X,OTHER ANTINEOPLASTIC AGENTS,NA,NA,NA,NA | |
| L01XA,Platinum compounds,NA,NA,NA,NA | |
| L01XA01,cisplatin,NA,NA,NA,NA | |
| L01XA02,carboplatin,NA,NA,NA,NA | |
| L01XA03,oxaliplatin,NA,NA,NA,NA | |
| L01XA04,satraplatin,NA,NA,NA,NA | |
| L01XA05,polyplatillen,NA,NA,NA,NA | |
| L01XB,Methylhydrazines,NA,NA,NA,NA | |
| L01XB01,procarbazine,NA,NA,NA,NA | |
| L01XC,Monoclonal antibodies,NA,NA,NA,NA | |
| L01XC01,edrecolomab,NA,NA,NA,NA | |
| L01XC02,rituximab,NA,NA,NA,NA | |
| L01XC03,trastuzumab,NA,NA,NA,NA | |
| L01XC05,gemtuzumab ozogamicin,NA,NA,NA,NA | |
| L01XC06,cetuximab,NA,NA,NA,NA | |
| L01XC07,bevacizumab,NA,NA,NA,NA | |
| L01XC08,panitumumab,NA,NA,NA,NA | |
| L01XC09,catumaxomab,NA,NA,NA,NA | |
| L01XC10,ofatumumab,NA,NA,NA,NA | |
| L01XC11,ipilimumab,NA,NA,NA,NA | |
| L01XC12,brentuximab vedotin,NA,NA,NA,NA | |
| L01XC13,pertuzumab,NA,NA,NA,NA | |
| L01XC14,trastuzumab emtansine,NA,NA,NA,NA | |
| L01XC15,obinutuzumab,NA,NA,NA,NA | |
| L01XC16,dinutuximab beta,NA,NA,NA,NA | |
| L01XC17,nivolumab,NA,NA,NA,NA | |
| L01XC18,pembrolizumab,NA,NA,NA,NA | |
| L01XC19,blinatumomab,NA,NA,NA,NA | |
| L01XC21,ramucirumab,NA,NA,NA,NA | |
| L01XC22,necitumumab,NA,NA,NA,NA | |
| L01XC23,elotuzumab,NA,NA,NA,NA | |
| L01XC24,daratumumab,NA,NA,NA,NA | |
| L01XC25,mogamulizumab,NA,NA,NA,NA | |
| L01XC26,inotuzumab ozogamicin,NA,NA,NA,NA | |
| L01XC27,olaratumab,NA,NA,NA,NA | |
| L01XC28,durvalumab,NA,NA,NA,NA | |
| L01XC29,bermekimab,NA,NA,NA,NA | |
| L01XC31,avelumab,NA,NA,NA,NA | |
| L01XC32,atezolizumab,NA,NA,NA,NA | |
| L01XC33,cemiplimab,NA,NA,NA,NA | |
| L01XC34,moxetumomab pasudotox,NA,NA,NA,NA | |
| L01XC35,tafasitamab,NA,NA,NA,NA | |
| L01XC36,enfortumab vedotin,NA,NA,NA,NA | |
| L01XC37,polatuzumab vedotin,NA,NA,NA,NA | |
| L01XC38,isatuximab,NA,NA,NA,NA | |
| L01XC39,belantamab mafodotin,NA,NA,NA,NA | |
| L01XC40,dostarlimab,NA,NA,NA,NA | |
| L01XC41,trastuzumab deruxtecan,NA,NA,NA,NA | |
| L01XD,Sensitizers used in photodynamic/radiation therapy,NA,NA,NA,NA | |
| L01XD01,porfimer sodium,NA,NA,NA,NA | |
| L01XD03,methyl aminolevulinate,NA,NA,NA,NA | |
| L01XD04,aminolevulinic acid,NA,NA,NA,NA | |
| L01XD05,temoporfin,NA,NA,NA,NA | |
| L01XD06,efaproxiral,NA,NA,NA,NA | |
| L01XD07,padeliporfin,NA,NA,NA,NA | |
| L01XF,Retinoids for cancer treatment,NA,NA,NA,NA | |
| L01XF01,tretinoin,NA,NA,NA,NA | |
| L01XF02,alitretinoin,NA,NA,NA,NA | |
| L01XF03,bexarotene,NA,NA,NA,NA | |
| L01XG,Proteasome inhibitors,NA,NA,NA,NA | |
| L01XG01,bortezomib,NA,NA,NA,NA | |
| L01XG02,carfilzomib,NA,NA,NA,NA | |
| L01XG03,ixazomib,NA,NA,NA,NA | |
| L01XH,Histone deacetylase (HDAC) inhibitors,NA,NA,NA,NA | |
| L01XH01,vorinostat,NA,NA,NA,NA | |
| L01XH02,romidepsin,NA,NA,NA,NA | |
| L01XH03,panobinostat,NA,NA,NA,NA | |
| L01XH04,belinostat,NA,NA,NA,NA | |
| L01XH05,entinostat,NA,NA,NA,NA | |
| L01XJ,Hedgehog pathway inhibitors,NA,NA,NA,NA | |
| L01XJ01,vismodegib,NA,NA,NA,NA | |
| L01XJ02,sonidegib,NA,NA,NA,NA | |
| L01XJ03,glasdegib,NA,NA,NA,NA | |
| L01XK,Poly (ADP-ribose) polymerase (PARP) inhibitors,NA,NA,NA,NA | |
| L01XK01,olaparib,NA,NA,NA,NA | |
| L01XK02,niraparib,NA,NA,NA,NA | |
| L01XK03,rucaparib,NA,NA,NA,NA | |
| L01XK04,talazoparib,NA,NA,NA,NA | |
| L01XK05,veliparib,NA,NA,NA,NA | |
| L01XX,Other antineoplastic agents,NA,NA,NA,NA | |
| L01XX01,amsacrine,NA,NA,NA,NA | |
| L01XX02,asparaginase,NA,NA,NA,NA | |
| L01XX03,altretamine,NA,NA,NA,NA | |
| L01XX05,hydroxycarbamide,NA,NA,NA,NA | |
| L01XX07,lonidamine,NA,NA,NA,NA | |
| L01XX08,pentostatin,NA,NA,NA,NA | |
| L01XX10,masoprocol,NA,NA,NA,NA | |
| L01XX11,estramustine,NA,NA,NA,NA | |
| L01XX16,mitoguazone,NA,NA,NA,NA | |
| L01XX18,tiazofurine,NA,NA,NA,NA | |
| L01XX23,mitotane,NA,NA,NA,NA | |
| L01XX24,pegaspargase,NA,NA,NA,NA | |
| L01XX27,arsenic trioxide,NA,NA,NA,NA | |
| L01XX29,denileukin diftitox,NA,NA,NA,NA | |
| L01XX33,celecoxib,NA,NA,NA,NA | |
| L01XX35,anagrelide,NA,NA,NA,NA | |
| L01XX36,oblimersen,NA,NA,NA,NA | |
| L01XX37,sitimagene ceradenovec,NA,NA,NA,NA | |
| L01XX40,omacetaxine mepesuccinate,NA,NA,NA,NA | |
| L01XX41,eribulin,NA,NA,NA,NA | |
| L01XX44,aflibercept,NA,NA,NA,NA | |
| L01XX51,talimogene laherparepvec,NA,NA,NA,NA | |
| L01XX52,venetoclax,NA,NA,NA,NA | |
| L01XX53,vosaroxin,NA,NA,NA,NA | |
| L01XX57,plitidepsin,NA,NA,NA,NA | |
| L01XX58,epacadostat,NA,NA,NA,NA | |
| L01XX59,enasidenib,NA,NA,NA,NA | |
| L01XX62,ivosidenib,NA,NA,NA,NA | |
| L01XX66,selinexor,NA,NA,NA,NA | |
| L01XX67,tagraxofusp,NA,NA,NA,NA | |
| L01XX69,lurbinectedin,NA,NA,NA,NA | |
| L01XX70,axicabtagene ciloleucel,NA,NA,NA,NA | |
| L01XX71,tisagenlecleucel,NA,NA,NA,NA | |
| L01XY,Combinations of antineoplastic agents,NA,NA,NA,NA | |
| L01XY01,cytarabine and daunorubicin,NA,NA,NA,NA | |
| L01XY02,pertuzumab and trastuzumab,NA,NA,NA,NA | |
| L02,ENDOCRINE THERAPY,NA,NA,NA,NA | |
| L02A,HORMONES AND RELATED AGENTS,NA,NA,NA,NA | |
| L02AA,Estrogens,NA,NA,NA,NA | |
| L02AA01,diethylstilbestrol,3,mg,O,NA | |
| L02AA02,polyestradiol phosphate,6,mg,P,NA | |
| L02AA03,ethinylestradiol,1.5,mg,O,NA | |
| L02AA04,fosfestrol,0.25,g,O,NA | |
| L02AA04,fosfestrol,0.25,g,P,NA | |
| L02AB,Progestogens,NA,NA,NA,NA | |
| L02AB01,megestrol,0.16,g,O,NA | |
| L02AB02,medroxyprogesterone,1,g,O,NA | |
| L02AB02,medroxyprogesterone,1,g,P,NA | |
| L02AB03,gestonorone,40,mg,P,NA | |
| L02AE,Gonadotropin releasing hormone analogues,NA,NA,NA,NA | |
| L02AE01,buserelin,0.11,mg,implant,NA | |
| L02AE01,buserelin,1.2,mg,N,NA | |
| L02AE01,buserelin,1.5,mg,P,NA | |
| L02AE02,leuprorelin,60,mcg,implant,NA | |
| L02AE02,leuprorelin,1,mg,P,NA | |
| L02AE02,leuprorelin,0.134,mg,P,depot inj | |
| L02AE03,goserelin,0.129,mg,implant,NA | |
| L02AE04,triptorelin,0.134,mg,P,depot inj | |
| L02AE04,triptorelin,0.1,mg,P,NA | |
| L02AE05,histrelin,0.137,mg,implant,NA | |
| L02AE51,leuprorelin and bicalutamide,NA,NA,NA,NA | |
| L02AX,Other hormones,NA,NA,NA,NA | |
| L02B,HORMONE ANTAGONISTS AND RELATED AGENTS,NA,NA,NA,NA | |
| L02BA,Anti-estrogens,NA,NA,NA,NA | |
| L02BA01,tamoxifen,20,mg,O,NA | |
| L02BA02,toremifene,60,mg,O,NA | |
| L02BA03,fulvestrant,8.3,mg,P,NA | |
| L02BB,Anti-androgens,NA,NA,NA,NA | |
| L02BB01,flutamide,0.75,g,O,NA | |
| L02BB02,nilutamide,0.3,g,O,NA | |
| L02BB03,bicalutamide,50,mg,O,NA | |
| L02BB04,enzalutamide,0.16,g,O,NA | |
| L02BB05,apalutamide,0.24,g,O,NA | |
| L02BB06,darolutamide,NA,NA,NA,NA | |
| L02BG,Aromatase inhibitors,NA,NA,NA,NA | |
| L02BG01,aminoglutethimide,1,g,O,NA | |
| L02BG02,formestane,18,mg,P,NA | |
| L02BG03,anastrozole,1,mg,O,NA | |
| L02BG04,letrozole,2.5,mg,O,NA | |
| L02BG05,vorozole,NA,NA,NA,NA | |
| L02BG06,exemestane,25,mg,O,NA | |
| L02BX,Other hormone antagonists and related agents,NA,NA,NA,NA | |
| L02BX01,abarelix,3.6,mg,P,NA | |
| L02BX02,degarelix,2.7,mg,P,NA | |
| L02BX03,abiraterone,1,g,O,NA | |
| L03,IMMUNOSTIMULANTS,NA,NA,NA,NA | |
| L03A,IMMUNOSTIMULANTS,NA,NA,NA,NA | |
| L03AA,Colony stimulating factors,NA,NA,NA,NA | |
| L03AA02,filgrastim,0.35,mg,P,NA | |
| L03AA03,molgramostim,0.35,mg,P,NA | |
| L03AA09,sargramostim,0.45,mg,P,NA | |
| L03AA10,lenograstim,0.35,mg,P,NA | |
| L03AA12,ancestim,1.4,mg,P,NA | |
| L03AA13,pegfilgrastim,0.3,mg,P,NA | |
| L03AA14,lipegfilgrastim,0.3,mg,P,NA | |
| L03AA15,balugrastim,NA,NA,NA,NA | |
| L03AA16,empegfilgrastim,NA,NA,NA,NA | |
| L03AA17,pegteograstim,0.3,mg,P,NA | |
| L03AB,Interferons,NA,NA,NA,NA | |
| L03AB01,interferon alfa natural,2,MU,P,NA | |
| L03AB02,interferon beta natural,33.33,TU,P,NA | |
| L03AB03,interferon gamma,40,mcg,P,NA | |
| L03AB04,interferon alfa-2a,2,MU,P,NA | |
| L03AB05,interferon alfa-2b,2,MU,P,NA | |
| L03AB06,interferon alfa-n1,5,MU,P,NA | |
| L03AB07,interferon beta-1a,4.3,mcg,P,NA | |
| L03AB08,interferon beta-1b,4,MU,P,NA | |
| L03AB09,interferon alfacon-1,4,mcg,P,NA | |
| L03AB10,peginterferon alfa-2b,7.5,mcg,P,NA | |
| L03AB11,peginterferon alfa-2a,26,mcg,P,NA | |
| L03AB12,albinterferon alfa-2b,NA,NA,NA,NA | |
| L03AB13,peginterferon beta-1a,8.9,mcg,P,NA | |
| L03AB14,cepeginterferon alfa-2b,17,mcg,P,NA | |
| L03AB15,ropeginterferon alfa-2b,NA,NA,NA,NA | |
| L03AB60,"peginterferon alfa-2b, combinations",NA,NA,NA,NA | |
| L03AB61,"peginterferon alfa-2a, combinations",NA,NA,NA,NA | |
| L03AC,Interleukins,NA,NA,NA,NA | |
| L03AC01,aldesleukin,0.2,mg,P,NA | |
| L03AC02,oprelvekin,3.5,mg,P,NA | |
| L03AX,Other immunostimulants,NA,NA,NA,NA | |
| L03AX01,lentinan,0.3,mg,O,NA | |
| L03AX01,lentinan,0.3,mg,P,NA | |
| L03AX02,roquinimex,NA,NA,NA,NA | |
| L03AX03,BCG vaccine,1.8,mg,intravesical,NA | |
| L03AX04,pegademase,NA,NA,NA,NA | |
| L03AX05,pidotimod,1.6,g,O,NA | |
| L03AX07,poly I:C,NA,NA,NA,NA | |
| L03AX08,poly ICLC,NA,NA,NA,NA | |
| L03AX09,thymopentin,NA,NA,NA,NA | |
| L03AX10,immunocyanin,3,mg,intravesical,NA | |
| L03AX11,tasonermin,3.5,mg,P,NA | |
| L03AX12,melanoma vaccine,NA,NA,NA,NA | |
| L03AX13,glatiramer acetate,20,mg,P,NA | |
| L03AX14,histamine dihydrochloride,0.5,mg,P,NA | |
| L03AX15,mifamurtide,0.7,mg,P,NA | |
| L03AX16,plerixafor,16.8,mg,P,NA | |
| L03AX17,sipuleucel-T,NA,NA,NA,NA | |
| L03AX18,cridanimod,NA,NA,NA,NA | |
| L03AX19,dasiprotimut-T,NA,NA,NA,NA | |
| L03AX21,elapegademase,NA,NA,NA,NA | |
| L04,IMMUNOSUPPRESSANTS,NA,NA,NA,NA | |
| L04A,IMMUNOSUPPRESSANTS,NA,NA,NA,NA | |
| L04AA,Selective immunosuppressants,NA,NA,NA,NA | |
| L04AA02,muromonab-CD3,5,mg,P,NA | |
| L04AA03,antilymphocyte immunoglobulin (horse),NA,NA,NA,NA | |
| L04AA04,antithymocyte immunoglobulin (rabbit),0.1,g,P,NA | |
| L04AA06,mycophenolic acid,2,g,O,as mycophenolate mofetil | |
| L04AA06,mycophenolic acid,2,g,P,as mycophenolate mofetil | |
| L04AA10,sirolimus,3,mg,O,NA | |
| L04AA13,leflunomide,20,mg,O,NA | |
| L04AA15,alefacept,NA,NA,NA,NA | |
| L04AA18,everolimus,1.5,mg,O,NA | |
| L04AA19,gusperimus,NA,NA,NA,NA | |
| L04AA21,efalizumab,10,mg,P,NA | |
| L04AA22,abetimus,NA,NA,NA,NA | |
| L04AA23,natalizumab,10,mg,P,NA | |
| L04AA24,abatacept,27,mg,P,NA | |
| L04AA25,eculizumab,64,mg,P,NA | |
| L04AA26,belimumab,25,mg,P,NA | |
| L04AA27,fingolimod,0.5,mg,O,NA | |
| L04AA28,belatacept,12.5,mg,P,NA | |
| L04AA29,tofacitinib,10,mg,O,NA | |
| L04AA31,teriflunomide,14,mg,O,NA | |
| L04AA32,apremilast,60,mg,O,NA | |
| L04AA33,vedolizumab,5.4,mg,P,NA | |
| L04AA34,alemtuzumab,0.13,mg,P,NA | |
| L04AA35,begelomab,NA,NA,NA,NA | |
| L04AA36,ocrelizumab,3.29,mg,P,NA | |
| L04AA37,baricitinib,4,mg,O,NA | |
| L04AA38,ozanimod,NA,NA,NA,NA | |
| L04AA39,emapalumab,NA,NA,NA,NA | |
| L04AA40,cladribine,0.34,mg,O,NA | |
| L04AA41,imlifidase,NA,NA,NA,NA | |
| L04AA42,siponimod,NA,NA,NA,NA | |
| L04AA43,ravulizumab,NA,NA,NA,NA | |
| L04AA44,upadacitinib,NA,NA,NA,NA | |
| L04AA45,filgotinib,NA,NA,NA,NA | |
| L04AA46,itacitinib,NA,NA,NA,NA | |
| L04AA47,inebilizumab,NA,NA,NA,NA | |
| L04AB,Tumor necrosis factor alpha (TNF-alpha) inhibitors,NA,NA,NA,NA | |
| L04AB01,etanercept,7,mg,P,NA | |
| L04AB02,infliximab,3.75,mg,P,NA | |
| L04AB03,afelimomab,NA,NA,NA,NA | |
| L04AB04,adalimumab,2.9,mg,P,NA | |
| L04AB05,certolizumab pegol,14,mg,P,NA | |
| L04AB06,golimumab,1.66,mg,P,NA | |
| L04AB07,opinercept,7,mg,P,NA | |
| L04AC,Interleukin inhibitors,NA,NA,NA,NA | |
| L04AC01,daclizumab,5,mg,P,NA | |
| L04AC02,basiliximab,40,mg,P,course dose | |
| L04AC03,anakinra,0.1,g,P,NA | |
| L04AC04,rilonacept,23,mg,P,NA | |
| L04AC05,ustekinumab,0.54,mg,P,NA | |
| L04AC07,tocilizumab,20,mg,P,NA | |
| L04AC08,canakinumab,2.7,mg,P,NA | |
| L04AC09,briakinumab,NA,NA,NA,NA | |
| L04AC10,secukinumab,10,mg,P,NA | |
| L04AC11,siltuximab,37,mg,P,NA | |
| L04AC12,brodalumab,15,mg,P,NA | |
| L04AC13,ixekizumab,2.9,mg,P,NA | |
| L04AC14,sarilumab,14.3,mg,P,NA | |
| L04AC15,sirukumab,NA,NA,NA,NA | |
| L04AC16,guselkumab,1.79,mg,P,NA | |
| L04AC17,tildrakizumab,1.11,mg,P,NA | |
| L04AC18,risankizumab,1.67,mg,P,NA | |
| L04AC19,satralizumab,NA,NA,NA,NA | |
| L04AD,Calcineurin inhibitors,NA,NA,NA,NA | |
| L04AD01,ciclosporin,0.25,g,O,NA | |
| L04AD01,ciclosporin,0.25,g,P,NA | |
| L04AD02,tacrolimus,5,mg,O,NA | |
| L04AD02,tacrolimus,5,mg,P,NA | |
| L04AD03,voclosporin,NA,NA,NA,NA | |
| L04AX,Other immunosuppressants,NA,NA,NA,NA | |
| L04AX01,azathioprine,0.15,g,O,NA | |
| L04AX01,azathioprine,0.15,g,P,NA | |
| L04AX02,thalidomide,0.1,g,O,NA | |
| L04AX03,methotrexate,2.5,mg,O,NA | |
| L04AX03,methotrexate,2.5,mg,P,NA | |
| L04AX04,lenalidomide,10,mg,O,NA | |
| L04AX05,pirfenidone,2.4,g,O,NA | |
| L04AX06,pomalidomide,3,mg,O,NA | |
| L04AX07,dimethyl fumarate,0.48,g,O,NA | |
| L04AX08,darvadstrocel,NA,NA,NA,NA | |
| M,MUSCULO-SKELETAL SYSTEM,NA,NA,NA,NA | |
| M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,NA,NA,NA,NA | |
| M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",NA,NA,NA,NA | |
| M01AA,Butylpyrazolidines,NA,NA,NA,NA | |
| M01AA01,phenylbutazone,0.3,g,O,NA | |
| M01AA01,phenylbutazone,0.3,g,P,NA | |
| M01AA01,phenylbutazone,0.3,g,R,NA | |
| M01AA02,mofebutazone,0.75,g,O,NA | |
| M01AA02,mofebutazone,0.75,g,P,NA | |
| M01AA03,oxyphenbutazone,0.3,g,O,NA | |
| M01AA03,oxyphenbutazone,0.3,g,R,NA | |
| M01AA05,clofezone,0.6,g,O,NA | |
| M01AA05,clofezone,0.6,g,R,NA | |
| M01AA06,kebuzone,NA,NA,NA,NA | |
| M01AB,Acetic acid derivatives and related substances,NA,NA,NA,NA | |
| M01AB01,indometacin,0.1,g,O,NA | |
| M01AB01,indometacin,0.1,g,P,NA | |
| M01AB01,indometacin,0.1,g,R,NA | |
| M01AB02,sulindac,0.4,g,O,NA | |
| M01AB02,sulindac,0.4,g,P,NA | |
| M01AB02,sulindac,0.4,g,R,NA | |
| M01AB03,tolmetin,0.7,g,O,NA | |
| M01AB03,tolmetin,0.7,g,R,NA | |
| M01AB04,zomepirac,0.3,g,O,NA | |
| M01AB05,diclofenac,0.1,g,O,NA | |
| M01AB05,diclofenac,0.1,g,P,NA | |
| M01AB05,diclofenac,0.1,g,R,NA | |
| M01AB06,alclofenac,1.25,g,O,NA | |
| M01AB06,alclofenac,1.25,g,R,NA | |
| M01AB07,bumadizone,0.4,g,O,NA | |
| M01AB08,etodolac,0.4,g,O,NA | |
| M01AB09,lonazolac,0.6,g,O,NA | |
| M01AB10,fentiazac,NA,NA,NA,NA | |
| M01AB11,acemetacin,0.12,g,O,NA | |
| M01AB12,difenpiramide,NA,NA,NA,NA | |
| M01AB13,oxametacin,NA,NA,NA,NA | |
| M01AB14,proglumetacin,NA,NA,NA,NA | |
| M01AB15,ketorolac,30,mg,O,NA | |
| M01AB15,ketorolac,30,mg,P,NA | |
| M01AB16,aceclofenac,0.2,g,O,NA | |
| M01AB17,bufexamac,NA,NA,NA,NA | |
| M01AB51,"indometacin, combinations",0.1,g,O,Refers to indometacin | |
| M01AB51,"indometacin, combinations",0.1,g,R,Refers to indometacin | |
| M01AB55,"diclofenac, combinations",0.1,g,O,Refers to diclofenac | |
| M01AC,Oxicams,NA,NA,NA,NA | |
| M01AC01,piroxicam,20,mg,O,NA | |
| M01AC01,piroxicam,20,mg,P,NA | |
| M01AC01,piroxicam,20,mg,R,NA | |
| M01AC02,tenoxicam,20,mg,O,NA | |
| M01AC02,tenoxicam,20,mg,P,NA | |
| M01AC02,tenoxicam,20,mg,R,NA | |
| M01AC04,droxicam,NA,NA,NA,NA | |
| M01AC05,lornoxicam,12,mg,O,NA | |
| M01AC05,lornoxicam,12,mg,P,NA | |
| M01AC05,lornoxicam,12,mg,R,NA | |
| M01AC06,meloxicam,15,mg,O,NA | |
| M01AC06,meloxicam,15,mg,P,NA | |
| M01AC06,meloxicam,15,mg,R,NA | |
| M01AC56,"meloxicam, combinations",NA,NA,NA,NA | |
| M01AE,Propionic acid derivatives,NA,NA,NA,NA | |
| M01AE01,ibuprofen,1.2,g,O,NA | |
| M01AE01,ibuprofen,1.2,g,P,NA | |
| M01AE01,ibuprofen,1.2,g,R,NA | |
| M01AE02,naproxen,0.5,g,O,NA | |
| M01AE02,naproxen,0.5,g,R,NA | |
| M01AE03,ketoprofen,0.15,g,O,NA | |
| M01AE03,ketoprofen,0.15,g,P,NA | |
| M01AE03,ketoprofen,0.15,g,R,NA | |
| M01AE04,fenoprofen,1.2,g,O,NA | |
| M01AE05,fenbufen,0.6,g,O,NA | |
| M01AE06,benoxaprofen,NA,NA,NA,NA | |
| M01AE07,suprofen,0.4,g,O,NA | |
| M01AE08,pirprofen,0.8,g,O,NA | |
| M01AE09,flurbiprofen,0.2,g,O,NA | |
| M01AE09,flurbiprofen,0.2,g,R,NA | |
| M01AE10,indoprofen,NA,NA,NA,NA | |
| M01AE11,tiaprofenic acid,0.6,g,O,NA | |
| M01AE11,tiaprofenic acid,0.6,g,R,NA | |
| M01AE12,oxaprozin,0.9,g,O,NA | |
| M01AE13,ibuproxam,NA,NA,NA,NA | |
| M01AE14,dexibuprofen,0.8,g,O,NA | |
| M01AE15,flunoxaprofen,NA,NA,NA,NA | |
| M01AE16,alminoprofen,NA,NA,NA,NA | |
| M01AE17,dexketoprofen,75,mg,O,NA | |
| M01AE17,dexketoprofen,75,mg,P,NA | |
| M01AE18,naproxcinod,NA,NA,NA,NA | |
| M01AE51,"ibuprofen, combinations",NA,NA,NA,NA | |
| M01AE52,naproxen and esomeprazole,0.5,g,O,Refers to naproxen | |
| M01AE53,"ketoprofen, combinations",NA,NA,NA,NA | |
| M01AE56,naproxen and misoprostol,NA,NA,NA,NA | |
| M01AG,Fenamates,NA,NA,NA,NA | |
| M01AG01,mefenamic acid,1,g,O,NA | |
| M01AG02,tolfenamic acid,0.3,g,O,NA | |
| M01AG02,tolfenamic acid,0.3,g,R,NA | |
| M01AG03,flufenamic acid,0.5,g,O,NA | |
| M01AG04,meclofenamic acid,NA,NA,NA,NA | |
| M01AH,Coxibs,NA,NA,NA,NA | |
| M01AH01,celecoxib,0.2,g,O,NA | |
| M01AH02,rofecoxib,25,mg,O,NA | |
| M01AH03,valdecoxib,10,mg,O,NA | |
| M01AH04,parecoxib,40,mg,P,NA | |
| M01AH05,etoricoxib,60,mg,O,NA | |
| M01AH06,lumiracoxib,0.1,g,O,NA | |
| M01AH07,polmacoxib,NA,NA,NA,NA | |
| M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids",NA,NA,NA,NA | |
| M01AX01,nabumetone,1,g,O,NA | |
| M01AX02,niflumic acid,0.75,g,O,NA | |
| M01AX04,azapropazone,0.75,g,O,NA | |
| M01AX05,glucosamine,1.5,g,O,Refers to glucosamine sulfate | |
| M01AX07,benzydamine,0.15,g,O,NA | |
| M01AX07,benzydamine,0.15,g,R,NA | |
| M01AX12,glucosaminoglycan polysulfate,50,mg,P,NA | |
| M01AX13,proquazone,0.9,g,O,NA | |
| M01AX13,proquazone,0.9,g,R,NA | |
| M01AX14,orgotein,NA,NA,NA,NA | |
| M01AX17,nimesulide,0.2,g,O,NA | |
| M01AX18,feprazone,NA,NA,NA,NA | |
| M01AX21,diacerein,NA,NA,NA,NA | |
| M01AX22,morniflumate,NA,NA,NA,NA | |
| M01AX23,tenidap,NA,NA,NA,NA | |
| M01AX24,oxaceprol,NA,NA,NA,NA | |
| M01AX25,chondroitin sulfate,NA,NA,NA,NA | |
| M01AX26,"avocado and soyabean oil, unsaponifiables",NA,NA,NA,NA | |
| M01AX68,"feprazone, combinations",NA,NA,NA,NA | |
| M01B,ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION,NA,NA,NA,NA | |
| M01BA,Antiinflammatory/antirheumatic agents in combination with corticosteroids,NA,NA,NA,NA | |
| M01BA01,phenylbutazone and corticosteroids,NA,NA,NA,NA | |
| M01BA02,dipyrocetyl and corticosteroids,NA,NA,NA,NA | |
| M01BA03,acetylsalicylic acid and corticosteroids,NA,NA,NA,NA | |
| M01BX,Other antiinflammatory/antirheumatic agents in combination with other drugs,NA,NA,NA,NA | |
| M01C,SPECIFIC ANTIRHEUMATIC AGENTS,NA,NA,NA,NA | |
| M01CA,Quinolines,NA,NA,NA,NA | |
| M01CA03,oxycinchophen,1.5,g,O,NA | |
| M01CB,Gold preparations,NA,NA,NA,NA | |
| M01CB01,sodium aurothiomalate,2.4,mg,P,NA | |
| M01CB02,sodium aurotiosulfate,14,mg,P,NA | |
| M01CB03,auranofin,6,mg,O,NA | |
| M01CB04,aurothioglucose,2.4,mg,P,NA | |
| M01CB05,aurotioprol,NA,NA,NA,NA | |
| M01CC,Penicillamine and similar agents,NA,NA,NA,NA | |
| M01CC01,penicillamine,0.5,g,O,NA | |
| M01CC02,bucillamine,NA,NA,NA,NA | |
| M01CX,Other specific antirheumatic agents,NA,NA,NA,NA | |
| M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,NA,NA,NA,NA | |
| M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,NA,NA,NA,NA | |
| M02AA,"Antiinflammatory preparations, non-steroids for topical use",NA,NA,NA,NA | |
| M02AA01,phenylbutazone,NA,NA,NA,NA | |
| M02AA02,mofebutazone,NA,NA,NA,NA | |
| M02AA03,clofezone,NA,NA,NA,NA | |
| M02AA04,oxyphenbutazone,NA,NA,NA,NA | |
| M02AA05,benzydamine,NA,NA,NA,NA | |
| M02AA06,etofenamate,NA,NA,NA,NA | |
| M02AA07,piroxicam,NA,NA,NA,NA | |
| M02AA08,felbinac,NA,NA,NA,NA | |
| M02AA09,bufexamac,NA,NA,NA,NA | |
| M02AA10,ketoprofen,NA,NA,NA,NA | |
| M02AA11,bendazac,NA,NA,NA,NA | |
| M02AA12,naproxen,NA,NA,NA,NA | |
| M02AA13,ibuprofen,NA,NA,NA,NA | |
| M02AA14,fentiazac,NA,NA,NA,NA | |
| M02AA15,diclofenac,NA,NA,NA,NA | |
| M02AA16,feprazone,NA,NA,NA,NA | |
| M02AA17,niflumic acid,NA,NA,NA,NA | |
| M02AA18,meclofenamic acid,NA,NA,NA,NA | |
| M02AA19,flurbiprofen,NA,NA,NA,NA | |
| M02AA21,tolmetin,NA,NA,NA,NA | |
| M02AA22,suxibuzone,NA,NA,NA,NA | |
| M02AA23,indometacin,NA,NA,NA,NA | |
| M02AA24,nifenazone,NA,NA,NA,NA | |
| M02AA25,aceclofenac,NA,NA,NA,NA | |
| M02AA26,nimesulide,NA,NA,NA,NA | |
| M02AA27,dexketoprofen,NA,NA,NA,NA | |
| M02AA28,piketoprofen,NA,NA,NA,NA | |
| M02AA29,esflurbiprofen,NA,NA,NA,NA | |
| M02AB,Capsaicin and similar agents,NA,NA,NA,NA | |
| M02AB01,capsaicin,NA,NA,NA,NA | |
| M02AB02,zucapsaicin,NA,NA,NA,NA | |
| M02AC,Preparations with salicylic acid derivatives,NA,NA,NA,NA | |
| M02AX,Other topical products for joint and muscular pain,NA,NA,NA,NA | |
| M02AX02,tolazoline,NA,NA,NA,NA | |
| M02AX03,dimethyl sulfoxide,NA,NA,NA,NA | |
| M02AX05,idrocilamide,NA,NA,NA,NA | |
| M02AX06,tolperisone,NA,NA,NA,NA | |
| M02AX10,various,NA,NA,NA,NA | |
| M03,MUSCLE RELAXANTS,NA,NA,NA,NA | |
| M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",NA,NA,NA,NA | |
| M03AA,Curare alkaloids,NA,NA,NA,NA | |
| M03AA01,alcuronium,NA,NA,NA,NA | |
| M03AA02,tubocurarine,NA,NA,NA,NA | |
| M03AA04,dimethyltubocurarine,NA,NA,NA,NA | |
| M03AB,Choline derivatives,NA,NA,NA,NA | |
| M03AB01,suxamethonium,NA,NA,NA,NA | |
| M03AC,Other quaternary ammonium compounds,NA,NA,NA,NA | |
| M03AC01,pancuronium,NA,NA,NA,NA | |
| M03AC02,gallamine,NA,NA,NA,NA | |
| M03AC03,vecuronium,NA,NA,NA,NA | |
| M03AC04,atracurium,NA,NA,NA,NA | |
| M03AC05,hexafluronium,NA,NA,NA,NA | |
| M03AC06,pipecuronium bromide,NA,NA,NA,NA | |
| M03AC07,doxacurium chloride,NA,NA,NA,NA | |
| M03AC08,fazadinium bromide,NA,NA,NA,NA | |
| M03AC09,rocuronium bromide,NA,NA,NA,NA | |
| M03AC10,mivacurium chloride,NA,NA,NA,NA | |
| M03AC11,cisatracurium,NA,NA,NA,NA | |
| M03AX,"Other muscle relaxants, peripherally acting agents",NA,NA,NA,NA | |
| M03AX01,botulinum toxin,NA,NA,NA,NA | |
| M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",NA,NA,NA,NA | |
| M03BA,Carbamic acid esters,NA,NA,NA,NA | |
| M03BA01,phenprobamate,1.6,g,O,NA | |
| M03BA02,carisoprodol,1.4,g,O,NA | |
| M03BA03,methocarbamol,3,g,O,NA | |
| M03BA03,methocarbamol,3,g,P,NA | |
| M03BA04,styramate,0.5,g,O,NA | |
| M03BA05,febarbamate,0.3,g,O,NA | |
| M03BA51,"phenprobamate, combinations excl. psycholeptics",NA,NA,NA,NA | |
| M03BA52,"carisoprodol, combinations excl. psycholeptics",NA,NA,NA,NA | |
| M03BA53,"methocarbamol, combinations excl. psycholeptics",NA,NA,NA,NA | |
| M03BA71,"phenprobamate, combinations with psycholeptics",NA,NA,NA,NA | |
| M03BA72,"carisoprodol, combinations with psycholeptics",NA,NA,NA,NA | |
| M03BA73,"methocarbamol, combinations with psycholeptics",NA,NA,NA,NA | |
| M03BB,"Oxazol, thiazine, and triazine derivatives",NA,NA,NA,NA | |
| M03BB02,chlormezanone,0.6,g,O,NA | |
| M03BB03,chlorzoxazone,1.5,g,O,NA | |
| M03BB52,"chlormezanone, combinations excl. psycholeptics",NA,NA,NA,NA | |
| M03BB53,"chlorzoxazone, combinations excl. psycholeptics",NA,NA,NA,NA | |
| M03BB72,"chlormezanone, combinations with psycholeptics",NA,NA,NA,NA | |
| M03BB73,"chlorzoxazone, combinations with psycholeptics",NA,NA,NA,NA | |
| M03BC,"Ethers, chemically close to antihistamines",NA,NA,NA,NA | |
| M03BC01,orphenadrine (citrate),0.12,g,O,NA | |
| M03BC01,orphenadrine (citrate),0.12,g,P,NA | |
| M03BC51,"orphenadrine, combinations",NA,NA,NA,NA | |
| M03BX,Other centrally acting agents,NA,NA,NA,NA | |
| M03BX01,baclofen,50,mg,O,NA | |
| M03BX01,baclofen,0.55,mg,P,NA | |
| M03BX02,tizanidine,12,mg,O,NA | |
| M03BX03,pridinol,6,mg,O,NA | |
| M03BX04,tolperisone,0.2,g,O,NA | |
| M03BX05,thiocolchicoside,NA,NA,NA,NA | |
| M03BX06,mephenesin,NA,NA,NA,NA | |
| M03BX07,tetrazepam,NA,NA,NA,NA | |
| M03BX08,cyclobenzaprine,NA,NA,NA,NA | |
| M03BX09,eperisone,0.15,g,O,NA | |
| M03BX30,fenyramidol,2,g,O,NA | |
| M03BX55,"thiocolchicoside, combinations",NA,NA,NA,NA | |
| M03C,"MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS",NA,NA,NA,NA | |
| M03CA,Dantrolene and derivatives,NA,NA,NA,NA | |
| M03CA01,dantrolene,0.1,g,O,NA | |
| M04,ANTIGOUT PREPARATIONS,NA,NA,NA,NA | |
| M04A,ANTIGOUT PREPARATIONS,NA,NA,NA,NA | |
| M04AA,Preparations inhibiting uric acid production,NA,NA,NA,NA | |
| M04AA01,allopurinol,0.4,g,O,NA | |
| M04AA01,allopurinol,0.4,g,P,NA | |
| M04AA02,tisopurine,NA,NA,NA,NA | |
| M04AA03,febuxostat,80,mg,O,NA | |
| M04AA51,"allopurinol, combinations",NA,NA,NA,NA | |
| M04AB,Preparations increasing uric acid excretion,NA,NA,NA,NA | |
| M04AB01,probenecid,1,g,O,NA | |
| M04AB02,sulfinpyrazone,0.3,g,O,NA | |
| M04AB03,benzbromarone,0.1,g,O,NA | |
| M04AB04,isobromindione,NA,NA,NA,NA | |
| M04AB05,lesinurad,0.2,g,O,NA | |
| M04AC,Preparations with no effect on uric acid metabolism,NA,NA,NA,NA | |
| M04AC01,colchicine,1,mg,O,NA | |
| M04AC01,colchicine,1,mg,P,NA | |
| M04AC02,cinchophen,1,g,O,NA | |
| M04AX,Other antigout preparations,NA,NA,NA,NA | |
| M04AX01,urate oxidase,NA,NA,NA,NA | |
| M04AX02,pegloticase,0.57,mg,P,NA | |
| M05,DRUGS FOR TREATMENT OF BONE DISEASES,NA,NA,NA,NA | |
| M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,NA,NA,NA,NA | |
| M05BA,Bisphosphonates,NA,NA,NA,NA | |
| M05BA01,etidronic acid,0.4,g,O,NA | |
| M05BA01,etidronic acid,1.5,g,P,course dose | |
| M05BA02,clodronic acid,1.6,g,O,NA | |
| M05BA02,clodronic acid,1.5,g,P,course dose | |
| M05BA03,pamidronic acid,60,mg,P,course dose | |
| M05BA04,alendronic acid,10,mg,O,NA | |
| M05BA05,tiludronic acid,0.4,g,O,NA | |
| M05BA06,ibandronic acid,5,mg,O,NA | |
| M05BA06,ibandronic acid,6,mg,P,course dose | |
| M05BA07,risedronic acid,5,mg,O,NA | |
| M05BA08,zoledronic acid,4,mg,P,NA | |
| M05BB,"Bisphosphonates, combinations",NA,NA,NA,NA | |
| M05BB01,"etidronic acid and calcium, sequential",0.4,g,O,Refers to etidronic acid | |
| M05BB02,"risedronic acid and calcium, sequential",NA,NA,NA,NA | |
| M05BB03,alendronic acid and colecalciferol,10,mg,O,Refers to alendronic acid | |
| M05BB04,"risedronic acid, calcium and colecalciferol, sequential",5,mg,O,Refers to risedronic acid | |
| M05BB05,"alendronic acid, calcium and colecalciferol, sequential",10,mg,O,Refers to alendronic acid | |
| M05BB06,"alendronic acid and alfacalcidol, sequential",10,mg,O,Refers to alendronic acid | |
| M05BB07,risedronic acid and colecalciferol,NA,NA,NA,NA | |
| M05BB08,"zoledronic acid, calcium and colecalciferol, sequential",NA,NA,NA,NA | |
| M05BB09,ibandronic acid and colecalciferol,NA,NA,NA,NA | |
| M05BC,Bone morphogenetic proteins,NA,NA,NA,NA | |
| M05BC01,dibotermin alfa,NA,NA,NA,NA | |
| M05BC02,eptotermin alfa,NA,NA,NA,NA | |
| M05BX,Other drugs affecting bone structure and mineralization,NA,NA,NA,NA | |
| M05BX01,ipriflavone,NA,NA,NA,NA | |
| M05BX02,aluminium chlorohydrate,NA,NA,NA,NA | |
| M05BX03,strontium ranelate,2,g,O,NA | |
| M05BX04,denosumab,0.33,mg,P,NA | |
| M05BX05,burosumab,NA,NA,NA,NA | |
| M05BX06,romosozumab,NA,NA,NA,NA | |
| M05BX53,strontium ranelate and colecalciferol,NA,NA,NA,NA | |
| M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,NA,NA,NA,NA | |
| M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,NA,NA,NA,NA | |
| M09AA,Quinine and derivatives,NA,NA,NA,NA | |
| M09AA01,hydroquinine,0.2,g,O,NA | |
| M09AA72,"quinine, combinations with psycholeptics",NA,NA,NA,NA | |
| M09AB,Enzymes,NA,NA,NA,NA | |
| M09AB01,chymopapain,NA,NA,NA,NA | |
| M09AB02,collagenase clostridium histolyticum,0.9,mg,P,NA | |
| M09AB03,bromelains,NA,NA,NA,NA | |
| M09AB52,"trypsin, combinations",NA,NA,NA,NA | |
| M09AX,Other drugs for disorders of the musculo-skeletal system,NA,NA,NA,NA | |
| M09AX01,hyaluronic acid,3.6,mg,P,intraarticular | |
| M09AX02,"chondrocytes, autologous",NA,NA,NA,NA | |
| M09AX03,ataluren,2.8,g,O,NA | |
| M09AX04,drisapersen,NA,NA,NA,NA | |
| M09AX05,aceneuramic acid,NA,NA,NA,NA | |
| M09AX06,eteplirsen,NA,NA,NA,NA | |
| M09AX07,nusinersen,0.1,mg,P,NA | |
| M09AX08,golodirsen,NA,NA,NA,NA | |
| M09AX09,onasemnogene abeparvovec,NA,NA,NA,NA | |
| M09AX10,risdiplam,NA,NA,NA,NA | |
| M09AX11,palovarotene,NA,NA,NA,NA | |
| N,NERVOUS SYSTEM,NA,NA,NA,NA | |
| N01,ANESTHETICS,NA,NA,NA,NA | |
| N01A,"ANESTHETICS, GENERAL",NA,NA,NA,NA | |
| N01AA,Ethers,NA,NA,NA,NA | |
| N01AA01,diethyl ether,NA,NA,NA,NA | |
| N01AA02,vinyl ether,NA,NA,NA,NA | |
| N01AB,Halogenated hydrocarbons,NA,NA,NA,NA | |
| N01AB01,halothane,NA,NA,NA,NA | |
| N01AB02,chloroform,NA,NA,NA,NA | |
| N01AB04,enflurane,NA,NA,NA,NA | |
| N01AB05,trichloroethylene,NA,NA,NA,NA | |
| N01AB06,isoflurane,NA,NA,NA,NA | |
| N01AB07,desflurane,NA,NA,NA,NA | |
| N01AB08,sevoflurane,NA,NA,NA,NA | |
| N01AF,"Barbiturates, plain",NA,NA,NA,NA | |
| N01AF01,methohexital,NA,NA,NA,NA | |
| N01AF02,hexobarbital,NA,NA,NA,NA | |
| N01AF03,thiopental,NA,NA,NA,NA | |
| N01AG,Barbiturates in combination with other drugs,NA,NA,NA,NA | |
| N01AG01,narcobarbital,NA,NA,NA,NA | |
| N01AH,Opioid anesthetics,NA,NA,NA,NA | |
| N01AH01,fentanyl,NA,NA,NA,NA | |
| N01AH02,alfentanil,NA,NA,NA,NA | |
| N01AH03,sufentanil,NA,NA,NA,NA | |
| N01AH04,phenoperidine,NA,NA,NA,NA | |
| N01AH05,anileridine,NA,NA,NA,NA | |
| N01AH06,remifentanil,NA,NA,NA,NA | |
| N01AH51,"fentanyl, combinations",NA,NA,NA,NA | |
| N01AX,Other general anesthetics,NA,NA,NA,NA | |
| N01AX03,ketamine,NA,NA,NA,NA | |
| N01AX04,propanidid,NA,NA,NA,NA | |
| N01AX05,alfaxalone,NA,NA,NA,NA | |
| N01AX07,etomidate,NA,NA,NA,NA | |
| N01AX10,propofol,NA,NA,NA,NA | |
| N01AX11,sodium oxybate,NA,NA,NA,NA | |
| N01AX13,nitrous oxide,NA,NA,NA,NA | |
| N01AX14,esketamine,NA,NA,NA,NA | |
| N01AX15,xenon,NA,NA,NA,NA | |
| N01AX63,"nitrous oxide, combinations",NA,NA,NA,NA | |
| N01B,"ANESTHETICS, LOCAL",NA,NA,NA,NA | |
| N01BA,Esters of aminobenzoic acid,NA,NA,NA,NA | |
| N01BA01,metabutethamine,NA,NA,NA,NA | |
| N01BA02,procaine,NA,NA,NA,NA | |
| N01BA03,tetracaine,NA,NA,NA,NA | |
| N01BA04,chloroprocaine,NA,NA,NA,NA | |
| N01BA05,benzocaine,NA,NA,NA,NA | |
| N01BA52,"procaine, combinations",NA,NA,NA,NA | |
| N01BA53,"tetracaine, combinations",NA,NA,NA,NA | |
| N01BB,Amides,NA,NA,NA,NA | |
| N01BB01,bupivacaine,NA,NA,NA,NA | |
| N01BB02,lidocaine,NA,NA,NA,NA | |
| N01BB03,mepivacaine,NA,NA,NA,NA | |
| N01BB04,prilocaine,NA,NA,NA,NA | |
| N01BB05,butanilicaine,NA,NA,NA,NA | |
| N01BB06,cinchocaine,NA,NA,NA,NA | |
| N01BB07,etidocaine,NA,NA,NA,NA | |
| N01BB08,articaine,NA,NA,NA,NA | |
| N01BB09,ropivacaine,NA,NA,NA,NA | |
| N01BB10,levobupivacaine,NA,NA,NA,NA | |
| N01BB20,combinations,NA,NA,NA,NA | |
| N01BB51,"bupivacaine, combinations",NA,NA,NA,NA | |
| N01BB52,"lidocaine, combinations",NA,NA,NA,NA | |
| N01BB53,"mepivacaine, combinations",NA,NA,NA,NA | |
| N01BB54,"prilocaine, combinations",NA,NA,NA,NA | |
| N01BB57,"etidocaine, combinations",NA,NA,NA,NA | |
| N01BB58,"articaine, combinations",NA,NA,NA,NA | |
| N01BB59,bupivacaine and meloxicam,NA,NA,NA,NA | |
| N01BC,Esters of benzoic acid,NA,NA,NA,NA | |
| N01BC01,cocaine,NA,NA,NA,NA | |
| N01BX,Other local anesthetics,NA,NA,NA,NA | |
| N01BX01,ethyl chloride,NA,NA,NA,NA | |
| N01BX02,dyclonine,NA,NA,NA,NA | |
| N01BX03,phenol,NA,NA,NA,NA | |
| N01BX04,capsaicin,NA,NA,NA,NA | |
| N02,ANALGESICS,NA,NA,NA,NA | |
| N02A,OPIOIDS,NA,NA,NA,NA | |
| N02AA,Natural opium alkaloids,NA,NA,NA,NA | |
| N02AA01,morphine,0.1,g,O,NA | |
| N02AA01,morphine,30,mg,P,NA | |
| N02AA01,morphine,30,mg,R,NA | |
| N02AA02,opium,NA,NA,NA,NA | |
| N02AA03,hydromorphone,20,mg,O,NA | |
| N02AA03,hydromorphone,4,mg,P,NA | |
| N02AA03,hydromorphone,4,mg,R,NA | |
| N02AA04,nicomorphine,30,mg,O,NA | |
| N02AA04,nicomorphine,30,mg,P,NA | |
| N02AA04,nicomorphine,30,mg,R,NA | |
| N02AA05,oxycodone,75,mg,O,NA | |
| N02AA05,oxycodone,30,mg,P,NA | |
| N02AA08,dihydrocodeine,0.15,g,O,NA | |
| N02AA10,papaveretum,NA,NA,NA,NA | |
| N02AA11,oxymorphone,NA,NA,NA,NA | |
| N02AA51,"morphine, combinations",NA,NA,NA,NA | |
| N02AA53,hydromorphone and naloxone,NA,NA,NA,NA | |
| N02AA55,oxycodone and naloxone,75,mg,O,Refers to oxycodone | |
| N02AA56,oxycodone and naltrexone,NA,NA,NA,NA | |
| N02AA58,"dihydrocodeine, combinations",NA,NA,NA,NA | |
| N02AA59,"codeine, combinations excl. psycholeptics",NA,NA,NA,NA | |
| N02AA79,"codeine, combinations with psycholeptics",NA,NA,NA,NA | |
| N02AB,Phenylpiperidine derivatives,NA,NA,NA,NA | |
| N02AB01,ketobemidone,50,mg,O,NA | |
| N02AB01,ketobemidone,50,mg,P,NA | |
| N02AB02,pethidine,0.4,g,O,NA | |
| N02AB02,pethidine,0.4,g,P,NA | |
| N02AB02,pethidine,0.4,g,R,NA | |
| N02AB03,fentanyl,0.6,mg,N,NA | |
| N02AB03,fentanyl,0.6,mg,SL,NA | |
| N02AB03,fentanyl,1.2,mg,TD,NA | |
| N02AB52,"pethidine, combinations excl. psycholeptics",NA,NA,NA,NA | |
| N02AB72,"pethidine, combinations with psycholeptics",NA,NA,NA,NA | |
| N02AC,Diphenylpropylamine derivatives,NA,NA,NA,NA | |
| N02AC01,dextromoramide,20,mg,O,NA | |
| N02AC01,dextromoramide,20,mg,P,NA | |
| N02AC01,dextromoramide,40,mg,R,NA | |
| N02AC03,piritramide,45,mg,P,NA | |
| N02AC04,dextropropoxyphene,0.2,g,O,chloride | |
| N02AC04,dextropropoxyphene,0.3,g,O,napsylate | |
| N02AC05,bezitramide,15,mg,O,NA | |
| N02AC52,"methadone, combinations excl. psycholeptics",NA,NA,NA,NA | |
| N02AC54,"dextropropoxyphene, combinations excl. psycholeptics",NA,NA,NA,NA | |
| N02AC74,"dextropropoxyphene, combinations with psycholeptics",NA,NA,NA,NA | |
| N02AD,Benzomorphan derivatives,NA,NA,NA,NA | |
| N02AD01,pentazocine,0.2,g,O,NA | |
| N02AD01,pentazocine,0.2,g,P,NA | |
| N02AD02,phenazocine,3,mg,P,NA | |
| N02AE,Oripavine derivatives,NA,NA,NA,NA | |
| N02AE01,buprenorphine,1.2,mg,P,NA | |
| N02AE01,buprenorphine,1.2,mg,SL,NA | |
| N02AE01,buprenorphine,1.2,mg,TD,NA | |
| N02AF,Morphinan derivatives,NA,NA,NA,NA | |
| N02AF01,butorphanol,12,mg,P,NA | |
| N02AF02,nalbuphine,80,mg,P,NA | |
| N02AG,Opioids in combination with antispasmodics,NA,NA,NA,NA | |
| N02AG01,morphine and antispasmodics,NA,NA,NA,NA | |
| N02AG02,ketobemidone and antispasmodics,NA,NA,NA,NA | |
| N02AG03,pethidine and antispasmodics,NA,NA,NA,NA | |
| N02AG04,hydromorphone and antispasmodics,NA,NA,NA,NA | |
| N02AJ,Opioids in combination with non-opioid analgesics,NA,NA,NA,NA | |
| N02AJ01,dihydrocodeine and paracetamol,NA,NA,NA,NA | |
| N02AJ02,dihydrocodeine and acetylsalicylic acid,NA,NA,NA,NA | |
| N02AJ03,dihydrocodeine and other non-opioid analgesics,NA,NA,NA,NA | |
| N02AJ06,codeine and paracetamol,NA,NA,NA,NA | |
| N02AJ07,codeine and acetylsalicylic acid,NA,NA,NA,NA | |
| N02AJ08,codeine and ibuprofen,NA,NA,NA,NA | |
| N02AJ09,codeine and other non-opioid analgesics,NA,NA,NA,NA | |
| N02AJ13,tramadol and paracetamol,NA,NA,NA,NA | |
| N02AJ14,tramadol and dexketoprofen,NA,NA,NA,NA | |
| N02AJ15,tramadol and other non-opioid analgesics,NA,NA,NA,NA | |
| N02AJ17,oxycodone and paracetamol,NA,NA,NA,NA | |
| N02AJ18,oxycodone and acetylsalicylic acid,NA,NA,NA,NA | |
| N02AJ19,oxycodone and ibuprofen,NA,NA,NA,NA | |
| N02AX,Other opioids,NA,NA,NA,NA | |
| N02AX01,tilidine,0.2,g,O,NA | |
| N02AX01,tilidine,0.2,g,P,NA | |
| N02AX02,tramadol,0.3,g,O,NA | |
| N02AX02,tramadol,0.3,g,P,NA | |
| N02AX02,tramadol,0.3,g,R,NA | |
| N02AX03,dezocine,NA,NA,NA,NA | |
| N02AX05,meptazinol,1.2,g,O,NA | |
| N02AX05,meptazinol,1.2,g,P,NA | |
| N02AX06,tapentadol,0.4,g,O,NA | |
| N02B,OTHER ANALGESICS AND ANTIPYRETICS,NA,NA,NA,NA | |
| N02BA,Salicylic acid and derivatives,NA,NA,NA,NA | |
| N02BA01,acetylsalicylic acid,3,g,O,NA | |
| N02BA01,acetylsalicylic acid,1,g,P,Expressed as lysine acetylsalisylate | |
| N02BA01,acetylsalicylic acid,3,g,R,NA | |
| N02BA02,aloxiprin,3,g,O,NA | |
| N02BA03,choline salicylate,3,g,O,NA | |
| N02BA04,sodium salicylate,3,g,O,NA | |
| N02BA05,salicylamide,3,g,O,NA | |
| N02BA06,salsalate,3,g,O,NA | |
| N02BA07,ethenzamide,3,g,O,NA | |
| N02BA08,morpholine salicylate,NA,NA,NA,NA | |
| N02BA09,dipyrocetyl,3,g,O,NA | |
| N02BA10,benorilate,3,g,O,NA | |
| N02BA11,diflunisal,0.75,g,O,NA | |
| N02BA12,potassium salicylate,7,g,O,NA | |
| N02BA14,guacetisal,NA,NA,NA,NA | |
| N02BA15,carbasalate calcium,3.6,g,O,NA | |
| N02BA16,imidazole salicylate,NA,NA,NA,NA | |
| N02BA51,"acetylsalicylic acid, combinations excl. psycholeptics",NA,NA,NA,NA | |
| N02BA55,"salicylamide, combinations excl. psycholeptics",NA,NA,NA,NA | |
| N02BA57,"ethenzamide, combinations excl. psycholeptics",NA,NA,NA,NA | |
| N02BA59,"dipyrocetyl, combinations excl. psycholeptics",NA,NA,NA,NA | |
| N02BA65,carbasalate calcium combinations excl. psycholeptics,NA,NA,NA,NA | |
| N02BA71,"acetylsalicylic acid, combinations with psycholeptics",NA,NA,NA,NA | |
| N02BA75,"salicylamide, combinations with psycholeptics",NA,NA,NA,NA | |
| N02BA77,"ethenzamide, combinations with psycholeptics",NA,NA,NA,NA | |
| N02BA79,"dipyrocetyl, combinations with psycholeptics",NA,NA,NA,NA | |
| N02BB,Pyrazolones,NA,NA,NA,NA | |
| N02BB01,phenazone,3,g,O,NA | |
| N02BB02,metamizole sodium,3,g,O,NA | |
| N02BB02,metamizole sodium,3,g,P,NA | |
| N02BB02,metamizole sodium,3,g,R,NA | |
| N02BB03,aminophenazone,0.5,g,R,NA | |
| N02BB04,propyphenazone,3,g,R,NA | |
| N02BB05,nifenazone,NA,NA,NA,NA | |
| N02BB51,"phenazone, combinations excl. psycholeptics",3,g,O,Refers to phenazone | |
| N02BB52,"metamizole sodium, combinations excl. psycholeptics",NA,NA,NA,NA | |
| N02BB53,"aminophenazone, combinations excl. psycholeptics",NA,NA,NA,NA | |
| N02BB54,"propyphenazone, combinations excl. psycholeptics",3,g,O,Refers to propyphenazone | |
| N02BB71,"phenazone, combinations with psycholeptics",NA,NA,NA,NA | |
| N02BB72,"metamizole sodium, combinations with psycholeptics",NA,NA,NA,NA | |
| N02BB73,"aminophenazone, combinations with psycholeptics",NA,NA,NA,NA | |
| N02BB74,"propyphenazone, combinations with psycholeptics",NA,NA,NA,NA | |
| N02BE,Anilides,NA,NA,NA,NA | |
| N02BE01,paracetamol,3,g,O,NA | |
| N02BE01,paracetamol,3,g,P,NA | |
| N02BE01,paracetamol,3,g,R,NA | |
| N02BE03,phenacetin,1.8,g,O,NA | |
| N02BE04,bucetin,NA,NA,NA,NA | |
| N02BE05,propacetamol,6,g,P,NA | |
| N02BE51,"paracetamol, combinations excl. psycholeptics",NA,NA,NA,NA | |
| N02BE53,"phenacetin, combinations excl. psycholeptics",NA,NA,NA,NA | |
| N02BE54,"bucetin, combinations excl. psycholeptics",NA,NA,NA,NA | |
| N02BE71,"paracetamol, combinations with psycholeptics",NA,NA,NA,NA | |
| N02BE73,"phenacetin, combinations with psycholeptics",NA,NA,NA,NA | |
| N02BE74,"bucetin, combinations with psycholeptics",NA,NA,NA,NA | |
| N02BG,Other analgesics and antipyretics,NA,NA,NA,NA | |
| N02BG02,rimazolium,0.9,g,O,NA | |
| N02BG03,glafenine,0.8,g,O,NA | |
| N02BG04,floctafenine,1,g,O,NA | |
| N02BG05,viminol,NA,NA,NA,NA | |
| N02BG06,nefopam,NA,NA,NA,NA | |
| N02BG07,flupirtine,0.4,g,O,NA | |
| N02BG08,ziconotide,12,mcg,P,NA | |
| N02BG09,methoxyflurane,NA,NA,NA,NA | |
| N02BG10,cannabinoids,NA,NA,NA,NA | |
| N02BG11,mirogabalin,NA,NA,NA,NA | |
| N02C,ANTIMIGRAINE PREPARATIONS,NA,NA,NA,NA | |
| N02CA,Ergot alkaloids,NA,NA,NA,NA | |
| N02CA01,dihydroergotamine,1,mg,N,NA | |
| N02CA01,dihydroergotamine,4,mg,O,NA | |
| N02CA01,dihydroergotamine,4,mg,P,NA | |
| N02CA02,ergotamine,4,mg,Inhal.aerosol,NA | |
| N02CA02,ergotamine,4,mg,O,NA | |
| N02CA02,ergotamine,4,mg,P,NA | |
| N02CA02,ergotamine,4,mg,R,NA | |
| N02CA02,ergotamine,4,mg,SL,NA | |
| N02CA04,methysergide,4,mg,O,NA | |
| N02CA07,lisuride,NA,NA,NA,NA | |
| N02CA51,"dihydroergotamine, combinations",NA,NA,NA,NA | |
| N02CA52,"ergotamine, combinations excl. psycholeptics",4,mg,O,Refers to ergotamine | |
| N02CA72,"ergotamine, combinations with psycholeptics",4,mg,O,Refers to ergotamine | |
| N02CB,Corticosteroid derivatives,NA,NA,NA,NA | |
| N02CB01,flumedroxone,20,mg,O,NA | |
| N02CC,Selective serotonin (5HT1) agonists,NA,NA,NA,NA | |
| N02CC01,sumatriptan,20,mg,N,NA | |
| N02CC01,sumatriptan,50,mg,O,NA | |
| N02CC01,sumatriptan,6,mg,P,NA | |
| N02CC01,sumatriptan,25,mg,R,NA | |
| N02CC02,naratriptan,2.5,mg,O,NA | |
| N02CC03,zolmitriptan,2.5,mg,N,NA | |
| N02CC03,zolmitriptan,2.5,mg,O,NA | |
| N02CC04,rizatriptan,10,mg,O,NA | |
| N02CC05,almotriptan,12.5,mg,O,NA | |
| N02CC06,eletriptan,40,mg,O,NA | |
| N02CC07,frovatriptan,2.5,mg,O,NA | |
| N02CD,Calcitonin gene-related peptide (CGRP) antagonists,NA,NA,NA,NA | |
| N02CD01,erenumab,2.5,mg,P,NA | |
| N02CD02,galcanezumab,4,mg,P,NA | |
| N02CD03,fremanezumab,7.5,mg,P,NA | |
| N02CX,Other antimigraine preparations,NA,NA,NA,NA | |
| N02CX01,pizotifen,1.5,mg,O,NA | |
| N02CX02,clonidine,0.1,mg,O,NA | |
| N02CX03,iprazochrome,24,mg,O,NA | |
| N02CX05,dimetotiazine,NA,NA,NA,NA | |
| N02CX06,oxetorone,NA,NA,NA,NA | |
| N03,ANTIEPILEPTICS,NA,NA,NA,NA | |
| N03A,ANTIEPILEPTICS,NA,NA,NA,NA | |
| N03AA,Barbiturates and derivatives,NA,NA,NA,NA | |
| N03AA01,methylphenobarbital,0.5,g,O,NA | |
| N03AA02,phenobarbital,0.1,g,O,NA | |
| N03AA02,phenobarbital,0.1,g,P,NA | |
| N03AA03,primidone,1.25,g,O,NA | |
| N03AA04,barbexaclone,NA,NA,NA,NA | |
| N03AA30,metharbital,0.2,g,O,NA | |
| N03AB,Hydantoin derivatives,NA,NA,NA,NA | |
| N03AB01,ethotoin,2.5,g,O,NA | |
| N03AB02,phenytoin,0.3,g,O,NA | |
| N03AB02,phenytoin,0.3,g,P,NA | |
| N03AB03,amino(diphenylhydantoin) valeric acid,0.3,g,O,NA | |
| N03AB04,mephenytoin,0.4,g,O,NA | |
| N03AB05,fosphenytoin,0.45,g,P,NA | |
| N03AB52,"phenytoin, combinations",NA,NA,NA,NA | |
| N03AB54,"mephenytoin, combinations",NA,NA,NA,NA | |
| N03AC,Oxazolidine derivatives,NA,NA,NA,NA | |
| N03AC01,paramethadione,0.9,g,O,NA | |
| N03AC02,trimethadione,1.5,g,O,NA | |
| N03AC03,ethadione,NA,NA,NA,NA | |
| N03AD,Succinimide derivatives,NA,NA,NA,NA | |
| N03AD01,ethosuximide,1.25,g,O,NA | |
| N03AD02,phensuximide,2,g,O,NA | |
| N03AD03,mesuximide,0.9,g,O,NA | |
| N03AD51,"ethosuximide, combinations",NA,NA,NA,NA | |
| N03AE,Benzodiazepine derivatives,NA,NA,NA,NA | |
| N03AE01,clonazepam,8,mg,O,NA | |
| N03AE01,clonazepam,8,mg,P,NA | |
| N03AF,Carboxamide derivatives,NA,NA,NA,NA | |
| N03AF01,carbamazepine,1,g,O,NA | |
| N03AF01,carbamazepine,1,g,R,NA | |
| N03AF02,oxcarbazepine,1,g,O,NA | |
| N03AF03,rufinamide,1.4,g,O,NA | |
| N03AF04,eslicarbazepine,0.8,g,O,NA | |
| N03AG,Fatty acid derivatives,NA,NA,NA,NA | |
| N03AG01,valproic acid,1.5,g,O,NA | |
| N03AG01,valproic acid,1.5,g,P,NA | |
| N03AG01,valproic acid,1.5,g,R,NA | |
| N03AG02,valpromide,1.5,g,O,NA | |
| N03AG03,aminobutyric acid,1,g,O,NA | |
| N03AG03,aminobutyric acid,1,g,P,NA | |
| N03AG04,vigabatrin,2,g,O,NA | |
| N03AG05,progabide,NA,NA,NA,NA | |
| N03AG06,tiagabine,30,mg,O,NA | |
| N03AX,Other antiepileptics,NA,NA,NA,NA | |
| N03AX03,sultiame,0.4,g,O,NA | |
| N03AX07,phenacemide,1.5,g,O,NA | |
| N03AX09,lamotrigine,0.3,g,O,NA | |
| N03AX10,felbamate,2.4,g,O,NA | |
| N03AX11,topiramate,0.3,g,O,NA | |
| N03AX12,gabapentin,1.8,g,O,NA | |
| N03AX13,pheneturide,NA,NA,NA,NA | |
| N03AX14,levetiracetam,1.5,g,O,NA | |
| N03AX14,levetiracetam,1.5,g,P,NA | |
| N03AX15,zonisamide,0.2,g,O,NA | |
| N03AX16,pregabalin,0.3,g,O,NA | |
| N03AX17,stiripentol,1,g,O,NA | |
| N03AX18,lacosamide,0.3,g,O,NA | |
| N03AX18,lacosamide,0.3,g,P,NA | |
| N03AX19,carisbamate,NA,NA,NA,NA | |
| N03AX21,retigabine,0.9,g,O,NA | |
| N03AX22,perampanel,8,mg,O,NA | |
| N03AX23,brivaracetam,0.1,g,O,NA | |
| N03AX23,brivaracetam,0.1,g,P,NA | |
| N03AX24,cannabidiol,NA,NA,NA,NA | |
| N03AX25,cenobamate,0.2,g,O,NA | |
| N03AX26,fenfluramine,NA,NA,NA,NA | |
| N03AX30,beclamide,NA,NA,NA,NA | |
| N04,ANTI-PARKINSON DRUGS,NA,NA,NA,NA | |
| N04A,ANTICHOLINERGIC AGENTS,NA,NA,NA,NA | |
| N04AA,Tertiary amines,NA,NA,NA,NA | |
| N04AA01,trihexyphenidyl,10,mg,O,NA | |
| N04AA02,biperiden,10,mg,O,NA | |
| N04AA02,biperiden,10,mg,P,NA | |
| N04AA03,metixene,40,mg,O,NA | |
| N04AA04,procyclidine,25,mg,O,NA | |
| N04AA04,procyclidine,25,mg,P,NA | |
| N04AA05,profenamine,NA,NA,NA,NA | |
| N04AA08,dexetimide,0.5,mg,O,NA | |
| N04AA08,dexetimide,0.125,mg,P,NA | |
| N04AA09,phenglutarimide,NA,NA,NA,NA | |
| N04AA10,mazaticol,NA,NA,NA,NA | |
| N04AA11,bornaprine,NA,NA,NA,NA | |
| N04AA12,tropatepine,NA,NA,NA,NA | |
| N04AB,Ethers chemically close to antihistamines,NA,NA,NA,NA | |
| N04AB01,etanautine,NA,NA,NA,NA | |
| N04AB02,orphenadrine (chloride),0.2,g,O,NA | |
| N04AB02,orphenadrine (chloride),0.2,g,P,NA | |
| N04AC,Ethers of tropine or tropine derivatives,NA,NA,NA,NA | |
| N04AC01,benzatropine,2,mg,O,NA | |
| N04AC01,benzatropine,2,mg,P,NA | |
| N04AC30,etybenzatropine,9,mg,O,NA | |
| N04B,DOPAMINERGIC AGENTS,NA,NA,NA,NA | |
| N04BA,Dopa and dopa derivatives,NA,NA,NA,NA | |
| N04BA01,levodopa,3.5,g,O,NA | |
| N04BA02,levodopa and decarboxylase inhibitor,0.6,g,O,Refers to levodopa | |
| N04BA03,"levodopa, decarboxylase inhibitor and COMT inhibitor",0.45,g,O,Refers to levodopa | |
| N04BA04,melevodopa,NA,NA,NA,NA | |
| N04BA05,melevodopa and decarboxylase inhibitor,NA,NA,NA,NA | |
| N04BA06,etilevodopa and decarboxylase inhibitor,NA,NA,NA,NA | |
| N04BB,Adamantane derivatives,NA,NA,NA,NA | |
| N04BB01,amantadine,0.2,g,O,NA | |
| N04BC,Dopamine agonists,NA,NA,NA,NA | |
| N04BC01,bromocriptine,40,mg,O,NA | |
| N04BC02,pergolide,3,mg,O,NA | |
| N04BC03,dihydroergocryptine mesylate,NA,NA,NA,NA | |
| N04BC04,ropinirole,6,mg,O,NA | |
| N04BC05,pramipexole,2.5,mg,O,hydrochloride | |
| N04BC06,cabergoline,3,mg,O,NA | |
| N04BC07,apomorphine,20,mg,P,NA | |
| N04BC08,piribedil,0.2,g,O,NA | |
| N04BC09,rotigotine,6,mg,TD,patch | |
| N04BD,Monoamine oxidase B inhibitors,NA,NA,NA,NA | |
| N04BD01,selegiline,5,mg,O,NA | |
| N04BD02,rasagiline,1,mg,O,NA | |
| N04BD03,safinamide,75,mg,O,NA | |
| N04BX,Other dopaminergic agents,NA,NA,NA,NA | |
| N04BX01,tolcapone,0.45,g,O,NA | |
| N04BX02,entacapone,1,g,O,NA | |
| N04BX03,budipine,NA,NA,NA,NA | |
| N04BX04,opicapone,50,mg,O,NA | |
| N04C,OTHER ANTIPARKINSON DRUGS,NA,NA,NA,NA | |
| N04CX,Other antiparkinson drugs,NA,NA,NA,NA | |
| N04CX01,istradefylline,NA,NA,NA,NA | |
| N05,PSYCHOLEPTICS,NA,NA,NA,NA | |
| N05A,ANTIPSYCHOTICS,NA,NA,NA,NA | |
| N05AA,Phenothiazines with aliphatic side-chain,NA,NA,NA,NA | |
| N05AA01,chlorpromazine,0.3,g,O,NA | |
| N05AA01,chlorpromazine,0.1,g,P,NA | |
| N05AA01,chlorpromazine,0.3,g,R,NA | |
| N05AA02,levomepromazine,0.3,g,O,NA | |
| N05AA02,levomepromazine,0.1,g,P,NA | |
| N05AA03,promazine,0.3,g,O,NA | |
| N05AA03,promazine,0.1,g,P,NA | |
| N05AA04,acepromazine,0.1,g,O,NA | |
| N05AA04,acepromazine,50,mg,P,NA | |
| N05AA05,triflupromazine,0.1,g,O,NA | |
| N05AA05,triflupromazine,0.1,g,P,NA | |
| N05AA06,cyamemazine,NA,NA,NA,NA | |
| N05AA07,chlorproethazine,NA,NA,NA,NA | |
| N05AB,Phenothiazines with piperazine structure,NA,NA,NA,NA | |
| N05AB01,dixyrazine,50,mg,O,NA | |
| N05AB01,dixyrazine,30,mg,P,NA | |
| N05AB02,fluphenazine,10,mg,O,NA | |
| N05AB02,fluphenazine,1,mg,P,depot | |
| N05AB03,perphenazine,30,mg,O,NA | |
| N05AB03,perphenazine,7,mg,P,depot | |
| N05AB03,perphenazine,10,mg,P,NA | |
| N05AB03,perphenazine,16,mg,R,NA | |
| N05AB04,prochlorperazine,0.1,g,O,NA | |
| N05AB04,prochlorperazine,50,mg,P,NA | |
| N05AB04,prochlorperazine,0.1,g,R,NA | |
| N05AB05,thiopropazate,60,mg,O,NA | |
| N05AB06,trifluoperazine,20,mg,O,NA | |
| N05AB06,trifluoperazine,8,mg,P,NA | |
| N05AB06,trifluoperazine,20,mg,R,NA | |
| N05AB07,acetophenazine,50,mg,O,NA | |
| N05AB08,thioproperazine,75,mg,O,NA | |
| N05AB08,thioproperazine,20,mg,P,NA | |
| N05AB09,butaperazine,10,mg,O,NA | |
| N05AB10,perazine,0.1,g,O,NA | |
| N05AB10,perazine,0.1,g,P,NA | |
| N05AC,Phenothiazines with piperidine structure,NA,NA,NA,NA | |
| N05AC01,periciazine,50,mg,O,NA | |
| N05AC01,periciazine,20,mg,P,NA | |
| N05AC02,thioridazine,0.3,g,O,NA | |
| N05AC03,mesoridazine,0.2,g,O,NA | |
| N05AC03,mesoridazine,0.2,g,P,NA | |
| N05AC04,pipotiazine,10,mg,O,NA | |
| N05AC04,pipotiazine,5,mg,P,depot | |
| N05AD,Butyrophenone derivatives,NA,NA,NA,NA | |
| N05AD01,haloperidol,8,mg,O,NA | |
| N05AD01,haloperidol,8,mg,P,NA | |
| N05AD01,haloperidol,3.3,mg,P,depot | |
| N05AD02,trifluperidol,2,mg,O,NA | |
| N05AD03,melperone,0.3,g,O,NA | |
| N05AD03,melperone,0.3,g,P,NA | |
| N05AD04,moperone,20,mg,O,NA | |
| N05AD04,moperone,20,mg,P,NA | |
| N05AD05,pipamperone,0.2,g,O,NA | |
| N05AD06,bromperidol,10,mg,O,NA | |
| N05AD06,bromperidol,10,mg,P,NA | |
| N05AD06,bromperidol,3.3,mg,P,depot | |
| N05AD07,benperidol,1.5,mg,O,NA | |
| N05AD08,droperidol,2.5,mg,P,NA | |
| N05AD09,fluanisone,NA,NA,NA,NA | |
| N05AE,Indole derivatives,NA,NA,NA,NA | |
| N05AE01,oxypertine,0.12,g,O,NA | |
| N05AE02,molindone,50,mg,O,NA | |
| N05AE03,sertindole,16,mg,O,NA | |
| N05AE04,ziprasidone,80,mg,O,NA | |
| N05AE04,ziprasidone,40,mg,P,NA | |
| N05AE05,lurasidone,60,mg,O,as hydrochloride | |
| N05AF,Thioxanthene derivatives,NA,NA,NA,NA | |
| N05AF01,flupentixol,6,mg,O,NA | |
| N05AF01,flupentixol,4,mg,P,depot | |
| N05AF02,clopenthixol,0.1,g,O,NA | |
| N05AF02,clopenthixol,0.1,g,P,NA | |
| N05AF03,chlorprothixene,0.3,g,O,NA | |
| N05AF03,chlorprothixene,50,mg,P,NA | |
| N05AF04,tiotixene,30,mg,O,NA | |
| N05AF05,zuclopenthixol,30,mg,O,NA | |
| N05AF05,zuclopenthixol,15,mg,P,depot | |
| N05AF05,zuclopenthixol,30,mg,P,NA | |
| N05AG,Diphenylbutylpiperidine derivatives,NA,NA,NA,NA | |
| N05AG01,fluspirilene,0.7,mg,P,depot | |
| N05AG02,pimozide,4,mg,O,NA | |
| N05AG03,penfluridol,6,mg,O,NA | |
| N05AH,"Diazepines, oxazepines, thiazepines and oxepines",NA,NA,NA,NA | |
| N05AH01,loxapine,9.1,mg,Inhal.powder,delivered dose | |
| N05AH01,loxapine,0.1,g,O,NA | |
| N05AH02,clozapine,0.3,g,O,NA | |
| N05AH02,clozapine,0.3,g,P,NA | |
| N05AH03,olanzapine,10,mg,O,NA | |
| N05AH03,olanzapine,10,mg,P,NA | |
| N05AH03,olanzapine,10,mg,P,depot | |
| N05AH04,quetiapine,0.4,g,O,NA | |
| N05AH05,asenapine,20,mg,O,NA | |
| N05AH06,clotiapine,80,mg,O,NA | |
| N05AH06,clotiapine,80,mg,P,NA | |
| N05AL,Benzamides,NA,NA,NA,NA | |
| N05AL01,sulpiride,0.8,g,O,NA | |
| N05AL01,sulpiride,0.8,g,P,NA | |
| N05AL02,sultopride,1.2,g,O,NA | |
| N05AL03,tiapride,0.4,g,O,NA | |
| N05AL03,tiapride,0.4,g,P,NA | |
| N05AL04,remoxipride,0.3,g,O,NA | |
| N05AL04,remoxipride,0.3,g,P,NA | |
| N05AL05,amisulpride,0.4,g,O,NA | |
| N05AL06,veralipride,NA,NA,NA,NA | |
| N05AL07,levosulpiride,0.4,g,O,NA | |
| N05AN,Lithium,NA,NA,NA,NA | |
| N05AN01,lithium,24,mmol,O,NA | |
| N05AX,Other antipsychotics,NA,NA,NA,NA | |
| N05AX07,prothipendyl,0.24,g,O,NA | |
| N05AX07,prothipendyl,0.24,g,P,NA | |
| N05AX08,risperidone,5,mg,O,NA | |
| N05AX08,risperidone,2.7,mg,P,depot | |
| N05AX10,mosapramine,NA,NA,NA,NA | |
| N05AX11,zotepine,0.2,g,O,NA | |
| N05AX12,aripiprazole,15,mg,O,NA | |
| N05AX12,aripiprazole,15,mg,P,NA | |
| N05AX12,aripiprazole,13.3,mg,P,depot | |
| N05AX13,paliperidone,6,mg,O,NA | |
| N05AX13,paliperidone,2.5,mg,P,depot Expressed as paliperidone | |
| N05AX14,iloperidone,18,mg,O,NA | |
| N05AX15,cariprazine,3,mg,O,NA | |
| N05AX16,brexpiprazole,3,mg,O,NA | |
| N05AX17,pimavanserin,NA,NA,NA,NA | |
| N05B,ANXIOLYTICS,NA,NA,NA,NA | |
| N05BA,Benzodiazepine derivatives,NA,NA,NA,NA | |
| N05BA01,diazepam,10,mg,O,NA | |
| N05BA01,diazepam,10,mg,P,NA | |
| N05BA01,diazepam,10,mg,R,NA | |
| N05BA02,chlordiazepoxide,30,mg,O,NA | |
| N05BA02,chlordiazepoxide,50,mg,P,NA | |
| N05BA03,medazepam,20,mg,O,NA | |
| N05BA04,oxazepam,50,mg,O,NA | |
| N05BA05,potassium clorazepate,20,mg,O,NA | |
| N05BA06,lorazepam,2.5,mg,O,NA | |
| N05BA06,lorazepam,2.5,mg,P,NA | |
| N05BA06,lorazepam,2.5,mg,SL,NA | |
| N05BA07,adinazolam,NA,NA,NA,NA | |
| N05BA08,bromazepam,10,mg,O,NA | |
| N05BA09,clobazam,20,mg,O,NA | |
| N05BA10,ketazolam,NA,NA,NA,NA | |
| N05BA11,prazepam,30,mg,O,NA | |
| N05BA12,alprazolam,1,mg,O,NA | |
| N05BA13,halazepam,0.1,g,O,NA | |
| N05BA14,pinazepam,NA,NA,NA,NA | |
| N05BA15,camazepam,30,mg,O,NA | |
| N05BA16,nordazepam,15,mg,O,NA | |
| N05BA17,fludiazepam,0.75,mg,O,NA | |
| N05BA18,ethyl loflazepate,2,mg,O,NA | |
| N05BA19,etizolam,NA,NA,NA,NA | |
| N05BA21,clotiazepam,NA,NA,NA,NA | |
| N05BA22,cloxazolam,NA,NA,NA,NA | |
| N05BA23,tofisopam,NA,NA,NA,NA | |
| N05BA24,bentazepam,75,mg,O,NA | |
| N05BA56,"lorazepam, combinations",NA,NA,NA,NA | |
| N05BB,Diphenylmethane derivatives,NA,NA,NA,NA | |
| N05BB01,hydroxyzine,75,mg,O,NA | |
| N05BB01,hydroxyzine,75,mg,P,NA | |
| N05BB02,captodiame,0.2,g,O,NA | |
| N05BB51,"hydroxyzine, combinations",NA,NA,NA,NA | |
| N05BC,Carbamates,NA,NA,NA,NA | |
| N05BC01,meprobamate,1.2,g,O,NA | |
| N05BC03,emylcamate,0.9,g,O,NA | |
| N05BC04,mebutamate,NA,NA,NA,NA | |
| N05BC51,"meprobamate, combinations",NA,NA,NA,NA | |
| N05BD,Dibenzo-bicyclo-octadiene derivatives,NA,NA,NA,NA | |
| N05BD01,benzoctamine,30,mg,O,NA | |
| N05BD01,benzoctamine,30,mg,P,NA | |
| N05BE,Azaspirodecanedione derivatives,NA,NA,NA,NA | |
| N05BE01,buspirone,30,mg,O,NA | |
| N05BX,Other anxiolytics,NA,NA,NA,NA | |
| N05BX01,mephenoxalone,1.2,g,O,NA | |
| N05BX02,gedocarnil,NA,NA,NA,NA | |
| N05BX03,etifoxine,NA,NA,NA,NA | |
| N05BX04,fabomotizole,30,mg,O,NA | |
| N05BX05,Lavandulae aetheroleum,NA,NA,NA,NA | |
| N05C,HYPNOTICS AND SEDATIVES,NA,NA,NA,NA | |
| N05CA,"Barbiturates, plain",NA,NA,NA,NA | |
| N05CA01,pentobarbital,0.1,g,O,NA | |
| N05CA01,pentobarbital,0.1,g,P,NA | |
| N05CA01,pentobarbital,0.1,g,R,NA | |
| N05CA02,amobarbital,0.1,g,O,NA | |
| N05CA02,amobarbital,0.1,g,P,NA | |
| N05CA03,butobarbital,0.15,g,O,NA | |
| N05CA04,barbital,0.5,g,O,NA | |
| N05CA05,aprobarbital,0.1,g,O,NA | |
| N05CA05,aprobarbital,0.1,g,P,NA | |
| N05CA06,secobarbital,0.1,g,O,NA | |
| N05CA07,talbutal,0.1,g,O,NA | |
| N05CA08,vinylbital,0.15,g,O,NA | |
| N05CA09,vinbarbital,0.1,g,O,NA | |
| N05CA10,cyclobarbital,0.2,g,O,NA | |
| N05CA11,heptabarbital,0.2,g,O,NA | |
| N05CA12,reposal,0.2,g,O,NA | |
| N05CA15,methohexital,NA,NA,NA,NA | |
| N05CA16,hexobarbital,0.25,g,O,NA | |
| N05CA19,thiopental,NA,NA,NA,NA | |
| N05CA20,etallobarbital,NA,NA,NA,NA | |
| N05CA21,allobarbital,NA,NA,NA,NA | |
| N05CA22,proxibarbal,NA,NA,NA,NA | |
| N05CB,"Barbiturates, combinations",NA,NA,NA,NA | |
| N05CB01,combinations of barbiturates,NA,NA,NA,NA | |
| N05CB02,barbiturates in combination with other drugs,NA,NA,NA,NA | |
| N05CC,Aldehydes and derivatives,NA,NA,NA,NA | |
| N05CC01,chloral hydrate,1,g,O,NA | |
| N05CC01,chloral hydrate,1,g,R,NA | |
| N05CC02,chloralodol,1.6,g,O,NA | |
| N05CC03,acetylglycinamide chloral hydrate,1.7,g,O,NA | |
| N05CC04,dichloralphenazone,1.3,g,O,NA | |
| N05CC05,paraldehyde,5,g,O,NA | |
| N05CC05,paraldehyde,5,g,P,NA | |
| N05CC05,paraldehyde,5,g,R,NA | |
| N05CD,Benzodiazepine derivatives,NA,NA,NA,NA | |
| N05CD01,flurazepam,30,mg,O,NA | |
| N05CD02,nitrazepam,5,mg,O,NA | |
| N05CD03,flunitrazepam,1,mg,O,NA | |
| N05CD03,flunitrazepam,1,mg,P,NA | |
| N05CD04,estazolam,3,mg,O,NA | |
| N05CD05,triazolam,0.25,mg,O,NA | |
| N05CD05,triazolam,0.2,mg,SL,NA | |
| N05CD06,lormetazepam,1,mg,O,NA | |
| N05CD07,temazepam,20,mg,O,NA | |
| N05CD08,midazolam,5,mg,N,NA | |
| N05CD08,midazolam,15,mg,O,NA | |
| N05CD08,midazolam,15,mg,P,NA | |
| N05CD08,midazolam,10,mg,SL,NA | |
| N05CD09,brotizolam,0.25,mg,O,NA | |
| N05CD10,quazepam,15,mg,O,NA | |
| N05CD11,loprazolam,1,mg,O,NA | |
| N05CD12,doxefazepam,NA,NA,NA,NA | |
| N05CD13,cinolazepam,NA,NA,NA,NA | |
| N05CD14,remimazolam,NA,NA,NA,NA | |
| N05CD15,nimetazepam,NA,NA,NA,NA | |
| N05CE,Piperidinedione derivatives,NA,NA,NA,NA | |
| N05CE01,glutethimide,0.25,g,O,NA | |
| N05CE02,methyprylon,0.2,g,O,NA | |
| N05CE03,pyrithyldione,0.2,g,O,NA | |
| N05CF,Benzodiazepine related drugs,NA,NA,NA,NA | |
| N05CF01,zopiclone,7.5,mg,O,NA | |
| N05CF02,zolpidem,10,mg,O,NA | |
| N05CF03,zaleplon,10,mg,O,NA | |
| N05CF04,eszopiclone,NA,NA,NA,NA | |
| N05CH,Melatonin receptor agonists,NA,NA,NA,NA | |
| N05CH01,melatonin,2,mg,O,NA | |
| N05CH02,ramelteon,NA,NA,NA,NA | |
| N05CH03,tasimelteon,NA,NA,NA,NA | |
| N05CM,Other hypnotics and sedatives,NA,NA,NA,NA | |
| N05CM01,methaqualone,0.2,g,O,NA | |
| N05CM02,clomethiazole,1.5,g,O,NA | |
| N05CM02,clomethiazole,1.5,g,P,NA | |
| N05CM03,bromisoval,0.6,g,O,NA | |
| N05CM04,carbromal,1,g,O,NA | |
| N05CM05,scopolamine,0.9,mg,O,NA | |
| N05CM05,scopolamine,0.9,mg,P,NA | |
| N05CM06,propiomazine,25,mg,O,NA | |
| N05CM07,triclofos,1,g,O,NA | |
| N05CM08,ethchlorvynol,0.5,g,O,NA | |
| N05CM09,Valerianae radix,NA,NA,NA,NA | |
| N05CM10,hexapropymate,0.4,g,O,NA | |
| N05CM11,bromides,NA,NA,NA,NA | |
| N05CM12,apronal,0.25,g,O,NA | |
| N05CM13,valnoctamide,0.6,g,O,NA | |
| N05CM15,methylpentynol,NA,NA,NA,NA | |
| N05CM16,niaprazine,NA,NA,NA,NA | |
| N05CM18,dexmedetomidine,1,mg,P,NA | |
| N05CM19,suvorexant,NA,NA,NA,NA | |
| N05CX,"Hypnotics and sedatives in combination, excl. barbiturates",NA,NA,NA,NA | |
| N05CX01,"meprobamate, combinations",NA,NA,NA,NA | |
| N05CX02,"methaqualone, combinations",NA,NA,NA,NA | |
| N05CX03,"methylpentynol, combinations",NA,NA,NA,NA | |
| N05CX04,"clomethiazole, combinations",NA,NA,NA,NA | |
| N05CX05,"emepronium, combinations",NA,NA,NA,NA | |
| N05CX06,"dipiperonylaminoethanol, combinations",NA,NA,NA,NA | |
| N06,PSYCHOANALEPTICS,NA,NA,NA,NA | |
| N06A,ANTIDEPRESSANTS,NA,NA,NA,NA | |
| N06AA,Non-selective monoamine reuptake inhibitors,NA,NA,NA,NA | |
| N06AA01,desipramine,0.1,g,O,NA | |
| N06AA02,imipramine,0.1,g,O,NA | |
| N06AA02,imipramine,0.1,g,P,NA | |
| N06AA03,imipramine oxide,0.1,g,O,NA | |
| N06AA04,clomipramine,0.1,g,O,NA | |
| N06AA04,clomipramine,0.1,g,P,NA | |
| N06AA05,opipramol,0.15,g,O,NA | |
| N06AA06,trimipramine,0.15,g,O,NA | |
| N06AA06,trimipramine,0.15,g,P,NA | |
| N06AA07,lofepramine,0.105,g,O,NA | |
| N06AA08,dibenzepin,0.3,g,O,NA | |
| N06AA09,amitriptyline,75,mg,O,NA | |
| N06AA09,amitriptyline,75,mg,P,NA | |
| N06AA10,nortriptyline,75,mg,O,NA | |
| N06AA10,nortriptyline,30,mg,P,NA | |
| N06AA11,protriptyline,30,mg,O,NA | |
| N06AA12,doxepin,0.1,g,O,NA | |
| N06AA12,doxepin,0.1,g,P,NA | |
| N06AA13,iprindole,90,mg,O,NA | |
| N06AA14,melitracen,75,mg,O,NA | |
| N06AA14,melitracen,75,mg,P,NA | |
| N06AA15,butriptyline,75,mg,O,NA | |
| N06AA16,dosulepin,0.15,g,O,NA | |
| N06AA17,amoxapine,0.15,g,O,NA | |
| N06AA18,dimetacrine,0.15,g,O,NA | |
| N06AA19,amineptine,NA,NA,NA,NA | |
| N06AA21,maprotiline,0.1,g,O,NA | |
| N06AA21,maprotiline,0.1,g,P,NA | |
| N06AA23,quinupramine,NA,NA,NA,NA | |
| N06AB,Selective serotonin reuptake inhibitors,NA,NA,NA,NA | |
| N06AB02,zimeldine,0.2,g,O,NA | |
| N06AB03,fluoxetine,20,mg,O,NA | |
| N06AB04,citalopram,20,mg,O,NA | |
| N06AB04,citalopram,20,mg,P,NA | |
| N06AB05,paroxetine,20,mg,O,NA | |
| N06AB06,sertraline,50,mg,O,NA | |
| N06AB07,alaproclate,NA,NA,NA,NA | |
| N06AB08,fluvoxamine,0.1,g,O,NA | |
| N06AB09,etoperidone,NA,NA,NA,NA | |
| N06AB10,escitalopram,10,mg,O,NA | |
| N06AF,"Monoamine oxidase inhibitors, non-selective",NA,NA,NA,NA | |
| N06AF01,isocarboxazid,15,mg,O,NA | |
| N06AF02,nialamide,0.1,g,O,NA | |
| N06AF03,phenelzine,60,mg,O,NA | |
| N06AF04,tranylcypromine,10,mg,O,NA | |
| N06AF05,iproniazide,NA,NA,NA,NA | |
| N06AF06,iproclozide,NA,NA,NA,NA | |
| N06AG,Monoamine oxidase A inhibitors,NA,NA,NA,NA | |
| N06AG02,moclobemide,0.3,g,O,NA | |
| N06AG03,toloxatone,NA,NA,NA,NA | |
| N06AX,Other antidepressants,NA,NA,NA,NA | |
| N06AX01,oxitriptan,NA,NA,NA,NA | |
| N06AX02,tryptophan,NA,NA,NA,NA | |
| N06AX03,mianserin,60,mg,O,NA | |
| N06AX04,nomifensine,0.15,g,O,NA | |
| N06AX05,trazodone,0.3,g,O,NA | |
| N06AX06,nefazodone,0.4,g,O,NA | |
| N06AX07,minaprine,0.1,g,O,NA | |
| N06AX08,bifemelane,NA,NA,NA,NA | |
| N06AX09,viloxazine,0.2,g,O,NA | |
| N06AX10,oxaflozane,NA,NA,NA,NA | |
| N06AX11,mirtazapine,30,mg,O,NA | |
| N06AX12,bupropion,0.3,g,O,NA | |
| N06AX13,medifoxamine,NA,NA,NA,NA | |
| N06AX14,tianeptine,37.5,mg,O,NA | |
| N06AX15,pivagabine,NA,NA,NA,NA | |
| N06AX16,venlafaxine,0.1,g,O,NA | |
| N06AX17,milnacipran,0.1,g,O,NA | |
| N06AX18,reboxetine,8,mg,O,NA | |
| N06AX19,gepirone,NA,NA,NA,NA | |
| N06AX21,duloxetine,60,mg,O,NA | |
| N06AX22,agomelatine,25,mg,O,NA | |
| N06AX23,desvenlafaxine,50,mg,O,NA | |
| N06AX24,vilazodone,NA,NA,NA,NA | |
| N06AX25,Hyperici herba,NA,NA,NA,NA | |
| N06AX26,vortioxetine,10,mg,O,NA | |
| N06AX27,esketamine,NA,NA,NA,NA | |
| N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",NA,NA,NA,NA | |
| N06BA,Centrally acting sympathomimetics,NA,NA,NA,NA | |
| N06BA01,amfetamine,15,mg,O,NA | |
| N06BA01,amfetamine,15,mg,P,NA | |
| N06BA02,dexamfetamine,15,mg,O,NA | |
| N06BA03,metamfetamine,15,mg,O,NA | |
| N06BA04,methylphenidate,30,mg,O,NA | |
| N06BA05,pemoline,40,mg,O,NA | |
| N06BA06,fencamfamin,NA,NA,NA,NA | |
| N06BA07,modafinil,0.3,g,O,NA | |
| N06BA08,fenozolone,NA,NA,NA,NA | |
| N06BA09,atomoxetine,80,mg,O,NA | |
| N06BA10,fenetylline,NA,NA,NA,NA | |
| N06BA11,dexmethylphenidate,15,mg,O,NA | |
| N06BA12,lisdexamfetamine,30,mg,O,NA | |
| N06BA13,armodafinil,0.15,g,O,NA | |
| N06BA14,solriamfetol,NA,NA,NA,NA | |
| N06BC,Xanthine derivatives,NA,NA,NA,NA | |
| N06BC01,caffeine,0.4,g,O,NA | |
| N06BC01,caffeine,0.4,g,P,NA | |
| N06BC02,propentofylline,NA,NA,NA,NA | |
| N06BX,Other psychostimulants and nootropics,NA,NA,NA,NA | |
| N06BX01,meclofenoxate,NA,NA,NA,NA | |
| N06BX02,pyritinol,0.6,g,O,NA | |
| N06BX03,piracetam,2.4,g,O,NA | |
| N06BX03,piracetam,6,g,P,NA | |
| N06BX04,deanol,NA,NA,NA,NA | |
| N06BX05,fipexide,NA,NA,NA,NA | |
| N06BX06,citicoline,NA,NA,NA,NA | |
| N06BX07,oxiracetam,NA,NA,NA,NA | |
| N06BX08,pirisudanol,NA,NA,NA,NA | |
| N06BX09,linopirdine,NA,NA,NA,NA | |
| N06BX10,nizofenone,NA,NA,NA,NA | |
| N06BX11,aniracetam,NA,NA,NA,NA | |
| N06BX12,acetylcarnitine,NA,NA,NA,NA | |
| N06BX13,idebenone,0.9,g,O,NA | |
| N06BX14,prolintane,NA,NA,NA,NA | |
| N06BX15,pipradrol,30,mg,O,NA | |
| N06BX16,pramiracetam,NA,NA,NA,NA | |
| N06BX17,adrafinil,NA,NA,NA,NA | |
| N06BX18,vinpocetine,15,mg,O,NA | |
| N06BX21,tetramethylglycoluril,NA,NA,NA,NA | |
| N06BX22,phenibut,NA,NA,NA,NA | |
| N06C,PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION,NA,NA,NA,NA | |
| N06CA,Antidepressants in combination with psycholeptics,NA,NA,NA,NA | |
| N06CA01,amitriptyline and psycholeptics,NA,NA,NA,NA | |
| N06CA02,melitracen and psycholeptics,NA,NA,NA,NA | |
| N06CA03,fluoxetine and psycholeptics,NA,NA,NA,NA | |
| N06CB,Psychostimulants in combination with psycholeptics,NA,NA,NA,NA | |
| N06D,ANTI-DEMENTIA DRUGS,NA,NA,NA,NA | |
| N06DA,Anticholinesterases,NA,NA,NA,NA | |
| N06DA01,tacrine,0.12,g,O,NA | |
| N06DA02,donepezil,7.5,mg,O,NA | |
| N06DA03,rivastigmine,9,mg,O,NA | |
| N06DA03,rivastigmine,9.5,mg,TD,delivered dose | |
| N06DA04,galantamine,16,mg,O,NA | |
| N06DA05,ipidacrine,NA,NA,NA,NA | |
| N06DA52,donepezil and memantine,NA,NA,NA,NA | |
| N06DA53,"donepezil, memantine and Ginkgo folium",NA,NA,NA,NA | |
| N06DX,Other anti-dementia drugs,NA,NA,NA,NA | |
| N06DX01,memantine,20,mg,O,NA | |
| N06DX02,Ginkgo folium,0.12,g,O,NA | |
| N06DX30,combinations,NA,NA,NA,NA | |
| N07,OTHER NERVOUS SYSTEM DRUGS,NA,NA,NA,NA | |
| N07A,PARASYMPATHOMIMETICS,NA,NA,NA,NA | |
| N07AA,Anticholinesterases,NA,NA,NA,NA | |
| N07AA01,neostigmine,60,mg,O,NA | |
| N07AA01,neostigmine,2,mg,P,NA | |
| N07AA02,pyridostigmine,0.18,g,O,NA | |
| N07AA02,pyridostigmine,10,mg,P,NA | |
| N07AA03,distigmine,5,mg,O,NA | |
| N07AA03,distigmine,0.25,mg,P,NA | |
| N07AA30,ambenonium,60,mg,O,NA | |
| N07AA51,"neostigmine, combinations",NA,NA,NA,NA | |
| N07AB,Choline esters,NA,NA,NA,NA | |
| N07AB01,carbachol,6,mg,O,NA | |
| N07AB01,carbachol,0.5,mg,P,NA | |
| N07AB02,bethanechol,45,mg,O,NA | |
| N07AX,Other parasympathomimetics,NA,NA,NA,NA | |
| N07AX01,pilocarpine,15,mg,O,NA | |
| N07AX01,pilocarpine,10,mg,P,NA | |
| N07AX02,choline alfoscerate,NA,NA,NA,NA | |
| N07AX03,cevimeline,90,mg,O,NA | |
| N07B,DRUGS USED IN ADDICTIVE DISORDERS,NA,NA,NA,NA | |
| N07BA,Drugs used in nicotine dependence,NA,NA,NA,NA | |
| N07BA01,nicotine,30,mg,Chewing gum,NA | |
| N07BA01,nicotine,60,mg,Inhal,NA | |
| N07BA01,nicotine,30,mg,N,NA | |
| N07BA01,nicotine,30,mg,SL,NA | |
| N07BA01,nicotine,14,mg,TD,NA | |
| N07BA03,varenicline,2,mg,O,NA | |
| N07BA04,cytisine,NA,NA,NA,NA | |
| N07BB,Drugs used in alcohol dependence,NA,NA,NA,NA | |
| N07BB01,disulfiram,0.2,g,O,NA | |
| N07BB02,calcium carbimide,NA,NA,NA,NA | |
| N07BB03,acamprosate,2,g,O,NA | |
| N07BB04,naltrexone,50,mg,O,NA | |
| N07BB05,nalmefene,18,mg,O,NA | |
| N07BC,Drugs used in opioid dependence,NA,NA,NA,NA | |
| N07BC01,buprenorphine,2.1,mg,P,NA | |
| N07BC01,buprenorphine,8,mg,SL,NA | |
| N07BC02,methadone,25,mg,O,NA | |
| N07BC02,methadone,25,mg,P,NA | |
| N07BC03,levacetylmethadol,NA,NA,NA,NA | |
| N07BC04,lofexidine,1.4,mg,O,NA | |
| N07BC05,levomethadone,15,mg,O,NA | |
| N07BC06,diamorphine,NA,NA,NA,NA | |
| N07BC51,"buprenorphine, combinations",8,mg,SL,Refers to buprenorphine | |
| N07C,ANTIVERTIGO PREPARATIONS,NA,NA,NA,NA | |
| N07CA,Antivertigo preparations,NA,NA,NA,NA | |
| N07CA01,betahistine,24,mg,O,NA | |
| N07CA02,cinnarizine,90,mg,O,NA | |
| N07CA03,flunarizine,10,mg,O,NA | |
| N07CA04,acetylleucine,NA,NA,NA,NA | |
| N07CA52,"cinnarizine, combinations",90,mg,O,Refers to cinnarizine | |
| N07X,OTHER NERVOUS SYSTEM DRUGS,NA,NA,NA,NA | |
| N07XA,Gangliosides and ganglioside derivatives,NA,NA,NA,NA | |
| N07XX,Other nervous system drugs,NA,NA,NA,NA | |
| N07XX01,tirilazad,0.42,g,P,NA | |
| N07XX02,riluzole,0.1,g,O,NA | |
| N07XX03,xaliproden,NA,NA,NA,NA | |
| N07XX04,sodium oxybate,7.5,g,O,NA | |
| N07XX05,amifampridine,40,mg,O,NA | |
| N07XX06,tetrabenazine,0.1,g,O,NA | |
| N07XX07,fampridine,20,mg,O,NA | |
| N07XX08,tafamidis,20,mg,O,NA | |
| N07XX10,laquinimod,NA,NA,NA,NA | |
| N07XX11,pitolisant,18,mg,O,NA | |
| N07XX12,patisiran,NA,NA,NA,NA | |
| N07XX13,valbenazine,NA,NA,NA,NA | |
| N07XX14,edaravone,NA,NA,NA,NA | |
| N07XX15,inotersen,NA,NA,NA,NA | |
| N07XX59,"dextromethorphan, combinations",40,mg,O,Refers to dextromethorphan | |
| P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",NA,NA,NA,NA | |
| P01,ANTIPROTOZOALS,NA,NA,NA,NA | |
| P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,NA,NA,NA,NA | |
| P01AA,Hydroxyquinoline derivatives,NA,NA,NA,NA | |
| P01AA01,broxyquinoline,NA,NA,NA,NA | |
| P01AA02,clioquinol,NA,NA,NA,NA | |
| P01AA04,chlorquinaldol,NA,NA,NA,NA | |
| P01AA05,tilbroquinol,NA,NA,NA,NA | |
| P01AA52,"clioquinol, combinations",NA,NA,NA,NA | |
| P01AB,Nitroimidazole derivatives,NA,NA,NA,NA | |
| P01AB01,metronidazole,2,g,O,NA | |
| P01AB01,metronidazole,2,g,R,NA | |
| P01AB02,tinidazole,2,g,O,NA | |
| P01AB02,tinidazole,2,g,R,NA | |
| P01AB03,ornidazole,1.5,g,O,NA | |
| P01AB04,azanidazole,NA,NA,NA,NA | |
| P01AB05,propenidazole,NA,NA,NA,NA | |
| P01AB06,nimorazole,2,g,O,NA | |
| P01AB07,secnidazole,2,g,O,NA | |
| P01AB51,"metronidazole, combinations",NA,NA,NA,NA | |
| P01AC,Dichloroacetamide derivatives,NA,NA,NA,NA | |
| P01AC01,diloxanide,1.5,g,O,NA | |
| P01AC02,clefamide,NA,NA,NA,NA | |
| P01AC03,etofamide,NA,NA,NA,NA | |
| P01AC04,teclozan,NA,NA,NA,NA | |
| P01AR,Arsenic compounds,NA,NA,NA,NA | |
| P01AR01,arsthinol,NA,NA,NA,NA | |
| P01AR02,difetarsone,NA,NA,NA,NA | |
| P01AR03,glycobiarsol,NA,NA,NA,NA | |
| P01AR53,"glycobiarsol, combinations",NA,NA,NA,NA | |
| P01AX,Other agents against amoebiasis and other protozoal diseases,NA,NA,NA,NA | |
| P01AX01,chiniofon,NA,NA,NA,NA | |
| P01AX02,emetine,60,mg,P,NA | |
| P01AX04,phanquinone,NA,NA,NA,NA | |
| P01AX05,mepacrine,0.3,g,O,NA | |
| P01AX06,atovaquone,2.25,g,O,NA | |
| P01AX07,trimetrexate,85,mg,P,NA | |
| P01AX08,tenonitrozole,NA,NA,NA,NA | |
| P01AX09,dehydroemetine,60,mg,P,NA | |
| P01AX10,fumagillin,NA,NA,NA,NA | |
| P01AX11,nitazoxanide,1,g,O,NA | |
| P01AX52,"emetine, combinations",NA,NA,NA,NA | |
| P01B,ANTIMALARIALS,NA,NA,NA,NA | |
| P01BA,Aminoquinolines,NA,NA,NA,NA | |
| P01BA01,chloroquine,0.5,g,O,base | |
| P01BA01,chloroquine,0.5,g,P,base | |
| P01BA02,hydroxychloroquine,0.516,g,O,base | |
| P01BA03,primaquine,15,mg,O,base | |
| P01BA06,amodiaquine,0.5,g,O,NA | |
| P01BA07,tafenoquine,NA,NA,NA,NA | |
| P01BB,Biguanides,NA,NA,NA,NA | |
| P01BB01,proguanil,0.2,g,O,"""hydrochloride, (prophylactic daily dose)""" | |
| P01BB02,cycloguanil embonate,NA,NA,NA,NA | |
| P01BB51,"proguanil, combinations",NA,NA,NA,NA | |
| P01BC,Methanolquinolines,NA,NA,NA,NA | |
| P01BC01,quinine,1.5,g,O,base | |
| P01BC01,quinine,1.5,g,P,base | |
| P01BC02,mefloquine,1,g,O,base | |
| P01BD,Diaminopyrimidines,NA,NA,NA,NA | |
| P01BD01,pyrimethamine,75,mg,O,NA | |
| P01BD51,"pyrimethamine, combinations",75,mg,O,Refers to pyrimethamine | |
| P01BD51,"pyrimethamine, combinations",75,mg,P,Refers to pyrimethamine | |
| P01BE,"Artemisinin and derivatives, plain",NA,NA,NA,NA | |
| P01BE01,artemisinin,1,g,O,NA | |
| P01BE02,artemether,0.28,g,O,NA | |
| P01BE02,artemether,0.12,g,P,NA | |
| P01BE02,artemether,0.28,g,R,NA | |
| P01BE03,artesunate,0.28,g,O,NA | |
| P01BE03,artesunate,0.28,g,P,NA | |
| P01BE03,artesunate,0.28,g,R,NA | |
| P01BE04,artemotil,NA,NA,NA,NA | |
| P01BE05,artenimol,0.28,g,O,NA | |
| P01BF,"Artemisinin and derivatives, combinations",NA,NA,NA,NA | |
| P01BF01,artemether and lumefantrine,0.28,g,O,Refers to arthemether | |
| P01BF02,artesunate and mefloquine,NA,NA,NA,NA | |
| P01BF03,artesunate and amodiaquine,NA,NA,NA,NA | |
| P01BF04,"artesunate, sulfalene and pyrimethamine",NA,NA,NA,NA | |
| P01BF05,artenimol and piperaquine,NA,NA,NA,NA | |
| P01BF06,artesunate and pyronaridine,NA,NA,NA,NA | |
| P01BX,Other antimalarials,NA,NA,NA,NA | |
| P01BX01,halofantrine,1.5,g,O,NA | |
| P01BX02,arterolane and piperaquine,NA,NA,NA,NA | |
| P01C,AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS,NA,NA,NA,NA | |
| P01CA,Nitroimidazole derivatives,NA,NA,NA,NA | |
| P01CA02,benznidazole,0.4,g,O,NA | |
| P01CA03,fexinidazole,1.44,g,O,NA | |
| P01CB,Antimony compounds,NA,NA,NA,NA | |
| P01CB01,meglumine antimonate,0.85,g,P,Sb5+ | |
| P01CB02,sodium stibogluconate,0.85,g,P,Sb5+ | |
| P01CC,Nitrofuran derivatives,NA,NA,NA,NA | |
| P01CC01,nifurtimox,0.7,g,O,NA | |
| P01CC02,nitrofural,NA,NA,NA,NA | |
| P01CD,Arsenic compounds,NA,NA,NA,NA | |
| P01CD01,melarsoprol,60,mg,P,NA | |
| P01CD02,acetarsol,NA,NA,NA,NA | |
| P01CX,Other agents against leishmaniasis and trypanosomiasis,NA,NA,NA,NA | |
| P01CX01,pentamidine isethionate,0.28,g,P,per injection | |
| P01CX02,suramin sodium,0.27,g,P,NA | |
| P01CX03,eflornithine,NA,NA,NA,NA | |
| P01CX04,miltefosine,NA,NA,NA,NA | |
| P02,ANTHELMINTICS,NA,NA,NA,NA | |
| P02B,ANTITREMATODALS,NA,NA,NA,NA | |
| P02BA,Quinoline derivatives and related substances,NA,NA,NA,NA | |
| P02BA01,praziquantel,3,g,O,NA | |
| P02BA02,oxamniquine,1,g,O,NA | |
| P02BB,Organophosphorous compounds,NA,NA,NA,NA | |
| P02BB01,metrifonate,40,mg,O,NA | |
| P02BX,Other antitrematodal agents,NA,NA,NA,NA | |
| P02BX01,bithionol,NA,NA,NA,NA | |
| P02BX02,niridazole,NA,NA,NA,NA | |
| P02BX03,stibophen,NA,NA,NA,NA | |
| P02BX04,triclabendazole,NA,NA,NA,NA | |
| P02C,ANTINEMATODAL AGENTS,NA,NA,NA,NA | |
| P02CA,Benzimidazole derivatives,NA,NA,NA,NA | |
| P02CA01,mebendazole,0.2,g,O,NA | |
| P02CA02,tiabendazole,3,g,O,NA | |
| P02CA03,albendazole,0.4,g,O,NA | |
| P02CA04,ciclobendazole,NA,NA,NA,NA | |
| P02CA05,flubendazole,0.2,g,O,NA | |
| P02CA06,fenbendazole,NA,NA,NA,NA | |
| P02CA51,"mebendazole, combinations",NA,NA,NA,NA | |
| P02CB,Piperazine and derivatives,NA,NA,NA,NA | |
| P02CB01,piperazine,3.5,g,O,as hydrate | |
| P02CB02,diethylcarbamazine,0.4,g,O,NA | |
| P02CC,Tetrahydropyrimidine derivatives,NA,NA,NA,NA | |
| P02CC01,pyrantel,0.75,g,O,NA | |
| P02CC02,oxantel,NA,NA,NA,NA | |
| P02CE,Imidazothiazole derivatives,NA,NA,NA,NA | |
| P02CE01,levamisole,0.15,g,O,NA | |
| P02CF,Avermectines,NA,NA,NA,NA | |
| P02CF01,ivermectin,12,mg,O,NA | |
| P02CX,Other antinematodals,NA,NA,NA,NA | |
| P02CX01,pyrvinium,0.35,g,O,NA | |
| P02CX02,bephenium,NA,NA,NA,NA | |
| P02CX03,moxidectin,NA,NA,NA,NA | |
| P02D,ANTICESTODALS,NA,NA,NA,NA | |
| P02DA,Salicylic acid derivatives,NA,NA,NA,NA | |
| P02DA01,niclosamide,2,g,O,NA | |
| P02DX,Other anticestodals,NA,NA,NA,NA | |
| P02DX01,desaspidin,NA,NA,NA,NA | |
| P02DX02,dichlorophen,NA,NA,NA,NA | |
| P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",NA,NA,NA,NA | |
| P03A,"ECTOPARASITICIDES, INCL. SCABICIDES",NA,NA,NA,NA | |
| P03AA,Sulfur containing products,NA,NA,NA,NA | |
| P03AA01,dixanthogen,NA,NA,NA,NA | |
| P03AA02,potassium polysulfide,NA,NA,NA,NA | |
| P03AA03,mesulfen,NA,NA,NA,NA | |
| P03AA04,disulfiram,NA,NA,NA,NA | |
| P03AA05,thiram,NA,NA,NA,NA | |
| P03AA54,"disulfiram, combinations",NA,NA,NA,NA | |
| P03AB,Chlorine containing products,NA,NA,NA,NA | |
| P03AB01,clofenotane,NA,NA,NA,NA | |
| P03AB02,lindane,NA,NA,NA,NA | |
| P03AB51,"clofenotane, combinations",NA,NA,NA,NA | |
| P03AC,"Pyrethrines, incl. synthetic compounds",NA,NA,NA,NA | |
| P03AC01,pyrethrum,NA,NA,NA,NA | |
| P03AC02,bioallethrin,NA,NA,NA,NA | |
| P03AC03,phenothrin,NA,NA,NA,NA | |
| P03AC04,permethrin,NA,NA,NA,NA | |
| P03AC51,"pyrethrum, combinations",NA,NA,NA,NA | |
| P03AC52,"bioallethrin, combinations",NA,NA,NA,NA | |
| P03AC53,"phenothrin, combinations",NA,NA,NA,NA | |
| P03AC54,"permethrin, combinations",NA,NA,NA,NA | |
| P03AX,"Other ectoparasiticides, incl. scabicides",NA,NA,NA,NA | |
| P03AX01,benzyl benzoate,NA,NA,NA,NA | |
| P03AX02,copper oleinate,NA,NA,NA,NA | |
| P03AX03,malathion,NA,NA,NA,NA | |
| P03AX04,quassia,NA,NA,NA,NA | |
| P03AX05,dimeticone,NA,NA,NA,NA | |
| P03AX06,benzyl alcohol,NA,NA,NA,NA | |
| P03B,INSECTICIDES AND REPELLENTS,NA,NA,NA,NA | |
| P03BA,Pyrethrines,NA,NA,NA,NA | |
| P03BA01,cyfluthrin,NA,NA,NA,NA | |
| P03BA02,cypermethrin,NA,NA,NA,NA | |
| P03BA03,decamethrin,NA,NA,NA,NA | |
| P03BA04,tetramethrin,NA,NA,NA,NA | |
| P03BX,Other insecticides and repellents,NA,NA,NA,NA | |
| P03BX01,diethyltoluamide,NA,NA,NA,NA | |
| P03BX02,dimethylphthalate,NA,NA,NA,NA | |
| P03BX03,dibutylphthalate,NA,NA,NA,NA | |
| P03BX04,dibutylsuccinate,NA,NA,NA,NA | |
| P03BX05,dimethylcarbate,NA,NA,NA,NA | |
| P03BX06,etohexadiol,NA,NA,NA,NA | |
| R,RESPIRATORY SYSTEM,NA,NA,NA,NA | |
| R01,"NASAL PREPARATIONS",NA,NA,NA,NA | |
| R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,NA,NA,NA,NA | |
| R01AA,"Sympathomimetics, plain",NA,NA,NA,NA | |
| R01AA02,cyclopentamine,NA,NA,NA,NA | |
| R01AA03,ephedrine,8,mg,N,NA | |
| R01AA04,phenylephrine,4,mg,N,NA | |
| R01AA05,oxymetazoline,0.4,mg,N,NA | |
| R01AA06,tetryzoline,0.8,mg,N,NA | |
| R01AA07,xylometazoline,0.8,mg,N,NA | |
| R01AA08,naphazoline,0.4,mg,N,NA | |
| R01AA09,tramazoline,NA,NA,NA,NA | |
| R01AA10,metizoline,NA,NA,NA,NA | |
| R01AA11,tuaminoheptane,NA,NA,NA,NA | |
| R01AA12,fenoxazoline,NA,NA,NA,NA | |
| R01AA13,tymazoline,NA,NA,NA,NA | |
| R01AA14,epinephrine,NA,NA,NA,NA | |
| R01AA15,indanazoline,NA,NA,NA,NA | |
| R01AB,"Sympathomimetics, combinations excl. corticosteroids",NA,NA,NA,NA | |
| R01AB01,phenylephrine,NA,NA,NA,NA | |
| R01AB02,naphazoline,NA,NA,NA,NA | |
| R01AB03,tetryzoline,NA,NA,NA,NA | |
| R01AB05,ephedrine,NA,NA,NA,NA | |
| R01AB06,xylometazoline,NA,NA,NA,NA | |
| R01AB07,oxymetazoline,NA,NA,NA,NA | |
| R01AB08,tuaminoheptane,NA,NA,NA,NA | |
| R01AC,"Antiallergic agents, excl. corticosteroids",NA,NA,NA,NA | |
| R01AC01,cromoglicic acid,40,mg,N,NA | |
| R01AC02,levocabastine,0.6,mg,N,NA | |
| R01AC03,azelastine,0.56,mg,N,NA | |
| R01AC04,antazoline,NA,NA,NA,NA | |
| R01AC05,spaglumic acid,NA,NA,NA,NA | |
| R01AC06,thonzylamine,NA,NA,NA,NA | |
| R01AC07,nedocromil,10.4,mg,N,NA | |
| R01AC08,olopatadine,NA,NA,NA,NA | |
| R01AC51,"cromoglicic acid, combinations",NA,NA,NA,NA | |
| R01AD,Corticosteroids,NA,NA,NA,NA | |
| R01AD01,beclometasone,0.4,mg,N,NA | |
| R01AD02,prednisolone,NA,NA,NA,NA | |
| R01AD03,dexamethasone,NA,NA,NA,NA | |
| R01AD04,flunisolide,0.15,mg,N,NA | |
| R01AD05,budesonide,0.2,mg,N,NA | |
| R01AD06,betamethasone,0.4,mg,N,NA | |
| R01AD07,tixocortol,8,mg,N,NA | |
| R01AD08,fluticasone,0.2,mg,N,NA | |
| R01AD09,mometasone,0.2,mg,N,NA | |
| R01AD11,triamcinolone,0.22,mg,N,NA | |
| R01AD12,fluticasone furoate,0.11,mg,N,NA | |
| R01AD13,ciclesonide,0.2,mg,N,NA | |
| R01AD52,"prednisolone, combinations",NA,NA,NA,NA | |
| R01AD53,"dexamethasone, combinations",NA,NA,NA,NA | |
| R01AD57,"tixocortol, combinations",NA,NA,NA,NA | |
| R01AD58,"fluticasone, combinations",NA,NA,NA,NA | |
| R01AD59,"mometasone, combinations",NA,NA,NA,NA | |
| R01AD60,"hydrocortisone, combinations",NA,NA,NA,NA | |
| R01AX,Other nasal preparations,NA,NA,NA,NA | |
| R01AX01,calcium hexamine thiocyanate,NA,NA,NA,NA | |
| R01AX02,retinol,800,U,N,NA | |
| R01AX03,ipratropium bromide,0.24,mg,N,NA | |
| R01AX05,ritiometan,NA,NA,NA,NA | |
| R01AX06,mupirocin,NA,NA,NA,NA | |
| R01AX07,hexamidine,NA,NA,NA,NA | |
| R01AX08,framycetin,NA,NA,NA,NA | |
| R01AX09,hyaluronic acid,NA,NA,NA,NA | |
| R01AX10,various,NA,NA,NA,NA | |
| R01AX30,combinations,NA,NA,NA,NA | |
| R01B,"NASAL DECONGESTANTS FOR SYSTEMIC USE",NA,NA,NA,NA | |
| R01BA,Sympathomimetics,NA,NA,NA,NA | |
| R01BA01,phenylpropanolamine,0.1,g,O,NA | |
| R01BA02,pseudoephedrine,0.24,g,O,NA | |
| R01BA03,phenylephrine,40,mg,O,NA | |
| R01BA51,"phenylpropanolamine, combinations",0.1,g,O,Refers to phenylpropanolamine | |
| R01BA52,"pseudoephedrine, combinations",0.24,g,O,Refers to pseudoephedrine | |
| R01BA53,"phenylephrine, combinations",NA,NA,NA,NA | |
| R02,THROAT PREPARATIONS,NA,NA,NA,NA | |
| R02A,THROAT PREPARATIONS,NA,NA,NA,NA | |
| R02AA,Antiseptics,NA,NA,NA,NA | |
| R02AA01,ambazone,40,mg,O,NA | |
| R02AA02,dequalinium,1.5,mg,O,NA | |
| R02AA03,dichlorobenzyl alcohol,NA,NA,NA,NA | |
| R02AA05,chlorhexidine,30,mg,O,NA | |
| R02AA06,cetylpyridinium,NA,NA,NA,NA | |
| R02AA09,benzethonium,NA,NA,NA,NA | |
| R02AA10,myristyl-benzalkonium,NA,NA,NA,NA | |
| R02AA11,chlorquinaldol,NA,NA,NA,NA | |
| R02AA12,hexylresorcinol,NA,NA,NA,NA | |
| R02AA13,acriflavinium chloride,NA,NA,NA,NA | |
| R02AA14,oxyquinoline,NA,NA,NA,NA | |
| R02AA15,povidone-iodine,NA,NA,NA,NA | |
| R02AA16,benzalkonium,NA,NA,NA,NA | |
| R02AA17,cetrimonium,NA,NA,NA,NA | |
| R02AA18,hexamidine,NA,NA,NA,NA | |
| R02AA19,phenol,NA,NA,NA,NA | |
| R02AA20,various,NA,NA,NA,NA | |
| R02AA21,octenidine,NA,NA,NA,NA | |
| R02AB,Antibiotics,NA,NA,NA,NA | |
| R02AB01,neomycin,NA,NA,NA,NA | |
| R02AB02,tyrothricin,NA,NA,NA,NA | |
| R02AB03,fusafungine,NA,NA,NA,NA | |
| R02AB04,bacitracin,NA,NA,NA,NA | |
| R02AB30,gramicidin,NA,NA,NA,NA | |
| R02AD,"Anesthetics, local",NA,NA,NA,NA | |
| R02AD01,benzocaine,NA,NA,NA,NA | |
| R02AD02,lidocaine,NA,NA,NA,NA | |
| R02AD03,cocaine,NA,NA,NA,NA | |
| R02AD04,dyclonine,NA,NA,NA,NA | |
| R02AX,Other throat preparations,NA,NA,NA,NA | |
| R02AX01,flurbiprofen,44,mg,O,NA | |
| R02AX02,ibuprofen,NA,NA,NA,NA | |
| R02AX03,benzydamine,9,mg,O,NA | |
| R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,NA,NA,NA,NA | |
| R03A,"ADRENERGICS, INHALANTS",NA,NA,NA,NA | |
| R03AA,Alpha- and beta-adrenoreceptor agonists,NA,NA,NA,NA | |
| R03AA01,epinephrine,2.24,mg,Inhal.aerosol,NA | |
| R03AA01,epinephrine,20,mg,Inhal.solution,NA | |
| R03AB,Non-selective beta-adrenoreceptor agonists,NA,NA,NA,NA | |
| R03AB02,isoprenaline,0.64,mg,Inhal.aerosol,NA | |
| R03AB02,isoprenaline,10,mg,Inhal.solution,NA | |
| R03AB03,orciprenaline,6,mg,Inhal.aerosol,NA | |
| R03AC,Selective beta-2-adrenoreceptor agonists,NA,NA,NA,NA | |
| R03AC02,salbutamol,0.8,mg,Inhal.aerosol,NA | |
| R03AC02,salbutamol,0.8,mg,Inhal.powder,NA | |
| R03AC02,salbutamol,10,mg,Inhal.solution,NA | |
| R03AC03,terbutaline,2,mg,Inhal.aerosol,NA | |
| R03AC03,terbutaline,2,mg,Inhal.powder,NA | |
| R03AC03,terbutaline,20,mg,Inhal.solution,NA | |
| R03AC04,fenoterol,0.6,mg,Inhal.aerosol,NA | |
| R03AC04,fenoterol,0.6,mg,Inhal.powder,NA | |
| R03AC04,fenoterol,4,mg,Inhal.solution,NA | |
| R03AC05,rimiterol,1.6,mg,Inhal.aerosol,NA | |
| R03AC06,hexoprenaline,1.5,mg,Inhal.aerosol,NA | |
| R03AC07,isoetarine,NA,NA,NA,NA | |
| R03AC08,pirbuterol,1.2,mg,Inhal.aerosol,NA | |
| R03AC09,tretoquinol,NA,NA,NA,NA | |
| R03AC10,carbuterol,NA,NA,NA,NA | |
| R03AC11,tulobuterol,1.6,mg,Inhal.aerosol,NA | |
| R03AC12,salmeterol,0.1,mg,Inhal.aerosol,NA | |
| R03AC12,salmeterol,0.1,mg,Inhal.powder,NA | |
| R03AC13,formoterol,24,mcg,Inhal.aerosol,NA | |
| R03AC13,formoterol,24,mcg,Inhal.powder,NA | |
| R03AC14,clenbuterol,NA,NA,NA,NA | |
| R03AC15,reproterol,NA,NA,NA,NA | |
| R03AC16,procaterol,60,mcg,Inhal.aerosol,NA | |
| R03AC17,bitolterol,NA,NA,NA,NA | |
| R03AC18,indacaterol,0.15,mg,Inhal.powder,NA | |
| R03AC19,olodaterol,5,mcg,Inhal.solution,NA | |
| R03AH,Combinations of adrenergics,NA,NA,NA,NA | |
| R03AK,"Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",NA,NA,NA,NA | |
| R03AK01,epinephrine and other drugs for obstructive airway diseases,NA,NA,NA,NA | |
| R03AK02,isoprenaline and other drugs for obstructive airway diseases,NA,NA,NA,NA | |
| R03AK04,salbutamol and sodium cromoglicate,NA,NA,NA,NA | |
| R03AK05,reproterol and sodium cromoglicate,NA,NA,NA,NA | |
| R03AK06,salmeterol and fluticasone,NA,NA,NA,NA | |
| R03AK07,formoterol and budesonide,NA,NA,NA,NA | |
| R03AK08,formoterol and beclometasone,NA,NA,NA,NA | |
| R03AK09,formoterol and mometasone,NA,NA,NA,NA | |
| R03AK10,vilanterol and fluticasone furoate,NA,NA,NA,NA | |
| R03AK11,formoterol and fluticasone,NA,NA,NA,NA | |
| R03AK12,salmeterol and budesonide,NA,NA,NA,NA | |
| R03AK13,salbutamol and beclometasone,NA,NA,NA,NA | |
| R03AK14,indacaterol and mometasone,NA,NA,NA,NA | |
| R03AL,Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids,NA,NA,NA,NA | |
| R03AL01,fenoterol and ipratropium bromide,NA,NA,NA,NA | |
| R03AL02,salbutamol and ipratropium bromide,NA,NA,NA,NA | |
| R03AL03,vilanterol and umeclidinium bromide,NA,NA,NA,NA | |
| R03AL04,indacaterol and glycopyrronium bromide,NA,NA,NA,NA | |
| R03AL05,formoterol and aclidinium bromide,NA,NA,NA,NA | |
| R03AL06,olodaterol and tiotropium bromide,NA,NA,NA,NA | |
| R03AL07,formoterol and glycopyrronium bromide,NA,NA,NA,NA | |
| R03AL08,"vilanterol, umeclidinium bromide and fluticasone furoate",NA,NA,NA,NA | |
| R03AL09,"formoterol, glycopyrronium bromide and beclometasone",NA,NA,NA,NA | |
| R03AL10,formoterol and tiotropium bromide,NA,NA,NA,NA | |
| R03AL11,"formoterol, glycopyrronium bromide and budesonide",NA,NA,NA,NA | |
| R03AL12,"indacaterol, glycopyrronium bromide and mometasone",NA,NA,NA,NA | |
| R03B,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",NA,NA,NA,NA | |
| R03BA,Glucocorticoids,NA,NA,NA,NA | |
| R03BA01,beclometasone,0.8,mg,Inhal.aerosol,NA | |
| R03BA01,beclometasone,0.8,mg,Inhal.powder,NA | |
| R03BA01,beclometasone,1.5,mg,Inhal.solution,NA | |
| R03BA02,budesonide,0.8,mg,Inhal.aerosol,NA | |
| R03BA02,budesonide,0.8,mg,Inhal.powder,NA | |
| R03BA02,budesonide,1.5,mg,Inhal.solution,NA | |
| R03BA03,flunisolide,1,mg,Inhal.aerosol,NA | |
| R03BA04,betamethasone,NA,NA,NA,NA | |
| R03BA05,fluticasone,0.6,mg,Inhal.aerosol,NA | |
| R03BA05,fluticasone,0.6,mg,Inhal.powder,NA | |
| R03BA05,fluticasone,1.5,mg,Inhal.solution,NA | |
| R03BA06,triamcinolone,NA,NA,NA,NA | |
| R03BA07,mometasone,0.4,mg,Inhal.powder,NA | |
| R03BA08,ciclesonide,0.16,mg,Inhal.aerosol,NA | |
| R03BA09,fluticasone furoate,NA,NA,NA,NA | |
| R03BB,Anticholinergics,NA,NA,NA,NA | |
| R03BB01,ipratropium bromide,0.12,mg,Inhal.aerosol,NA | |
| R03BB01,ipratropium bromide,0.12,mg,Inhal.powder,NA | |
| R03BB01,ipratropium bromide,0.3,mg,Inhal.solution,NA | |
| R03BB02,oxitropium bromide,0.6,mg,Inhal.aerosol,NA | |
| R03BB02,oxitropium bromide,4,mg,Inhal.solution,NA | |
| R03BB03,stramoni preparations,NA,NA,NA,NA | |
| R03BB04,tiotropium bromide,10,mcg,Inhal.powder,"""Expressed as tiotropium, delivered dose""" | |
| R03BB04,tiotropium bromide,5,mcg,Inhal.solution,NA | |
| R03BB05,aclidinium bromide,0.644,mg,Inhal.powder,"""Expressed as aclidinium, delivered dose""" | |
| R03BB06,glycopyrronium bromide,44,mcg,Inhal.powder,"""Expressed as glycopyrronium, delivered dose""" | |
| R03BB07,umeclidinium bromide,55,mcg,Inhal.powder,"""Expressed as umeclidinium, delivered dose""" | |
| R03BB08,revefenacin,NA,NA,NA,NA | |
| R03BB54,"tiotropium bromide, combinations",NA,NA,NA,NA | |
| R03BC,"Antiallergic agents, excl. corticosteroids",NA,NA,NA,NA | |
| R03BC01,cromoglicic acid,40,mg,Inhal.aerosol,NA | |
| R03BC01,cromoglicic acid,80,mg,Inhal.powder,NA | |
| R03BC01,cromoglicic acid,80,mg,Inhal.solution,NA | |
| R03BC03,nedocromil,8,mg,Inhal.aerosol,NA | |
| R03BX,"Other drugs for obstructive airway diseases, inhalants",NA,NA,NA,NA | |
| R03BX01,fenspiride,NA,NA,NA,NA | |
| R03C,ADRENERGICS FOR SYSTEMIC USE,NA,NA,NA,NA | |
| R03CA,Alpha- and beta-adrenoreceptor agonists,NA,NA,NA,NA | |
| R03CA02,ephedrine,50,mg,O,NA | |
| R03CB,Non-selective beta-adrenoreceptor agonists,NA,NA,NA,NA | |
| R03CB01,isoprenaline,40,mg,O,NA | |
| R03CB02,methoxyphenamine,0.4,g,O,NA | |
| R03CB03,orciprenaline,60,mg,O,NA | |
| R03CB03,orciprenaline,60,mg,P,NA | |
| R03CB51,"isoprenaline, combinations",NA,NA,NA,NA | |
| R03CB53,"orciprenaline, combinations",NA,NA,NA,NA | |
| R03CC,Selective beta-2-adrenoreceptor agonists,NA,NA,NA,NA | |
| R03CC02,salbutamol,12,mg,O,NA | |
| R03CC02,salbutamol,12,mg,P,NA | |
| R03CC03,terbutaline,15,mg,O,NA | |
| R03CC03,terbutaline,15,mg,P,NA | |
| R03CC04,fenoterol,10,mg,O,NA | |
| R03CC04,fenoterol,10,mg,R,NA | |
| R03CC05,hexoprenaline,1.5,mg,O,NA | |
| R03CC05,hexoprenaline,1.5,mg,P,NA | |
| R03CC06,isoetarine,40,mg,O,NA | |
| R03CC07,pirbuterol,30,mg,O,NA | |
| R03CC08,procaterol,0.1,mg,O,NA | |
| R03CC09,tretoquinol,9,mg,O,NA | |
| R03CC09,tretoquinol,0.2,mg,P,NA | |
| R03CC10,carbuterol,6,mg,O,NA | |
| R03CC11,tulobuterol,4,mg,O,NA | |
| R03CC12,bambuterol,20,mg,O,NA | |
| R03CC13,clenbuterol,40,mcg,O,NA | |
| R03CC14,reproterol,NA,NA,NA,NA | |
| R03CC53,"terbutaline, combinations",NA,NA,NA,NA | |
| R03CC63,clenbuterol and ambroxol,NA,NA,NA,NA | |
| R03CK,Adrenergics and other drugs for obstructive airway diseases,NA,NA,NA,NA | |
| R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,NA,NA,NA,NA | |
| R03DA,Xanthines,NA,NA,NA,NA | |
| R03DA01,diprophylline,1,g,O,NA | |
| R03DA01,diprophylline,1,g,P,NA | |
| R03DA01,diprophylline,1,g,R,NA | |
| R03DA02,choline theophyllinate,0.6,g,O,NA | |
| R03DA02,choline theophyllinate,0.6,g,R,NA | |
| R03DA03,proxyphylline,1.2,g,O,NA | |
| R03DA03,proxyphylline,1.2,g,P,NA | |
| R03DA03,proxyphylline,1.2,g,R,NA | |
| R03DA04,theophylline,0.4,g,O,NA | |
| R03DA04,theophylline,0.4,g,P,NA | |
| R03DA04,theophylline,0.4,g,R,NA | |
| R03DA05,aminophylline,0.6,g,O,NA | |
| R03DA05,aminophylline,0.6,g,P,NA | |
| R03DA05,aminophylline,0.6,g,R,NA | |
| R03DA06,etamiphylline,NA,NA,NA,NA | |
| R03DA07,theobromine,NA,NA,NA,NA | |
| R03DA08,bamifylline,NA,NA,NA,NA | |
| R03DA09,acefylline piperazine,NA,NA,NA,NA | |
| R03DA10,bufylline,NA,NA,NA,NA | |
| R03DA11,doxofylline,0.8,g,O,NA | |
| R03DA11,doxofylline,0.8,g,P,NA | |
| R03DA12,mepyramine theophyllinacetate,0.6,g,O,NA | |
| R03DA20,combinations of xanthines,NA,NA,NA,NA | |
| R03DA51,"diprophylline, combinations",NA,NA,NA,NA | |
| R03DA54,"theophylline, combinations excl. psycholeptics",NA,NA,NA,NA | |
| R03DA55,"aminophylline, combinations",NA,NA,NA,NA | |
| R03DA57,"theobromine, combinations",NA,NA,NA,NA | |
| R03DA74,"theophylline, combinations with psycholeptics",NA,NA,NA,NA | |
| R03DB,Xanthines and adrenergics,NA,NA,NA,NA | |
| R03DB01,diprophylline and adrenergics,NA,NA,NA,NA | |
| R03DB02,choline theophyllinate and adrenergics,NA,NA,NA,NA | |
| R03DB03,proxyphylline and adrenergics,NA,NA,NA,NA | |
| R03DB04,theophylline and adrenergics,NA,NA,NA,NA | |
| R03DB05,aminophylline and adrenergics,NA,NA,NA,NA | |
| R03DB06,etamiphylline and adrenergics,NA,NA,NA,NA | |
| R03DC,Leukotriene receptor antagonists,NA,NA,NA,NA | |
| R03DC01,zafirlukast,40,mg,O,NA | |
| R03DC02,pranlukast,NA,NA,NA,NA | |
| R03DC03,montelukast,10,mg,O,NA | |
| R03DC04,ibudilast,NA,NA,NA,NA | |
| R03DC53,"montelukast, combinations",NA,NA,NA,NA | |
| R03DX,Other systemic drugs for obstructive airway diseases,NA,NA,NA,NA | |
| R03DX01,amlexanox,NA,NA,NA,NA | |
| R03DX02,eprozinol,NA,NA,NA,NA | |
| R03DX03,fenspiride,NA,NA,NA,NA | |
| R03DX05,omalizumab,16,mg,P,NA | |
| R03DX06,seratrodast,NA,NA,NA,NA | |
| R03DX07,roflumilast,0.5,mg,O,NA | |
| R03DX08,reslizumab,7.1,mg,P,NA | |
| R03DX09,mepolizumab,3.6,mg,P,NA | |
| R03DX10,benralizumab,0.54,mg,P,NA | |
| R05,COUGH AND COLD PREPARATIONS,NA,NA,NA,NA | |
| R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",NA,NA,NA,NA | |
| R05CA,Expectorants,NA,NA,NA,NA | |
| R05CA01,tyloxapol,5,mg,Inhal.solution,NA | |
| R05CA02,potassium iodide,1.2,g,O,NA | |
| R05CA03,guaifenesin,0.9,g,O,NA | |
| R05CA03,guaifenesin,0.9,g,P,NA | |
| R05CA04,ipecacuanha,4,mg,O,emetine | |
| R05CA05,althea root,1.6,g,O,root | |
| R05CA06,senega,3,g,O,root | |
| R05CA07,antimony pentasulfide,0.2,g,O,NA | |
| R05CA08,creosote,NA,NA,NA,NA | |
| R05CA09,guaiacolsulfonate,NA,NA,NA,NA | |
| R05CA10,combinations,NA,NA,NA,NA | |
| R05CA11,levoverbenone,NA,NA,NA,NA | |
| R05CA12,Hederae helicis folium,NA,NA,NA,NA | |
| R05CA13,cineole,NA,NA,NA,NA | |
| R05CB,Mucolytics,NA,NA,NA,NA | |
| R05CB01,acetylcysteine,1.6,g,Inhal.solution,NA | |
| R05CB01,acetylcysteine,0.5,g,O,NA | |
| R05CB02,bromhexine,24,mg,O,NA | |
| R05CB02,bromhexine,24,mg,P,NA | |
| R05CB03,carbocisteine,1.5,g,O,NA | |
| R05CB04,eprazinone,0.2,g,O,NA | |
| R05CB05,mesna,1.2,g,Inhal.solution,NA | |
| R05CB06,ambroxol,0.12,g,O,NA | |
| R05CB07,sobrerol,NA,NA,NA,NA | |
| R05CB08,domiodol,NA,NA,NA,NA | |
| R05CB09,letosteine,NA,NA,NA,NA | |
| R05CB10,combinations,NA,NA,NA,NA | |
| R05CB11,stepronin,NA,NA,NA,NA | |
| R05CB13,dornase alfa (desoxyribonuclease),2.5,mg,Inhal.solution,NA | |
| R05CB14,neltenexine,NA,NA,NA,NA | |
| R05CB15,erdosteine,0.6,g,O,NA | |
| R05CB16,mannitol,0.8,g,Inhal.powder,NA | |
| R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",NA,NA,NA,NA | |
| R05DA,Opium alkaloids and derivatives,NA,NA,NA,NA | |
| R05DA01,ethylmorphine,50,mg,O,NA | |
| R05DA03,hydrocodone,15,mg,O,NA | |
| R05DA04,codeine,0.1,g,O,NA | |
| R05DA05,opium alkaloids with morphine,NA,NA,NA,NA | |
| R05DA06,normethadone,NA,NA,NA,NA | |
| R05DA07,noscapine,0.125,g,O,NA | |
| R05DA08,pholcodine,50,mg,O,NA | |
| R05DA09,dextromethorphan,90,mg,O,NA | |
| R05DA10,thebacon,15,mg,O,NA | |
| R05DA11,dimemorfan,NA,NA,NA,NA | |
| R05DA12,acetyldihydrocodeine,30,mg,O,NA | |
| R05DA20,combinations,NA,NA,NA,NA | |
| R05DB,Other cough suppressants,NA,NA,NA,NA | |
| R05DB01,benzonatate,0.6,g,O,NA | |
| R05DB02,benproperine,75,mg,O,NA | |
| R05DB03,clobutinol,0.12,g,O,NA | |
| R05DB03,clobutinol,0.12,g,P,NA | |
| R05DB04,isoaminile,0.11,g,O,NA | |
| R05DB05,pentoxyverine,0.1,g,O,NA | |
| R05DB05,pentoxyverine,0.1,g,R,NA | |
| R05DB07,oxolamine,0.6,g,O,NA | |
| R05DB09,oxeladin,80,mg,O,NA | |
| R05DB10,clofedanol,60,mg,O,NA | |
| R05DB11,pipazetate,80,mg,O,NA | |
| R05DB12,bibenzonium bromide,90,mg,O,NA | |
| R05DB13,butamirate,25,mg,O,NA | |
| R05DB14,fedrilate,0.2,g,O,NA | |
| R05DB15,zipeprol,NA,NA,NA,NA | |
| R05DB16,dibunate,NA,NA,NA,NA | |
| R05DB17,droxypropine,NA,NA,NA,NA | |
| R05DB18,prenoxdiazine,NA,NA,NA,NA | |
| R05DB19,dropropizine,NA,NA,NA,NA | |
| R05DB20,combinations,NA,NA,NA,NA | |
| R05DB21,cloperastine,60,mg,O,Expressed as cloperastine hydrochloride | |
| R05DB22,meprotixol,NA,NA,NA,NA | |
| R05DB23,piperidione,NA,NA,NA,NA | |
| R05DB24,tipepidine,NA,NA,NA,NA | |
| R05DB25,morclofone,NA,NA,NA,NA | |
| R05DB26,nepinalone,NA,NA,NA,NA | |
| R05DB27,levodropropizine,0.12,g,O,NA | |
| R05DB28,dimethoxanate,NA,NA,NA,NA | |
| R05F,"COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS",NA,NA,NA,NA | |
| R05FA,Opium derivatives and expectorants,NA,NA,NA,NA | |
| R05FA01,opium derivatives and mucolytics,NA,NA,NA,NA | |
| R05FA02,opium derivatives and expectorants,NA,NA,NA,NA | |
| R05FB,Other cough suppressants and expectorants,NA,NA,NA,NA | |
| R05FB01,cough suppressants and mucolytics,NA,NA,NA,NA | |
| R05FB02,cough suppressants and expectorants,NA,NA,NA,NA | |
| R05X,OTHER COLD PREPARATIONS,NA,NA,NA,NA | |
| R06,ANTIHISTAMINES FOR SYSTEMIC USE,NA,NA,NA,NA | |
| R06A,ANTIHISTAMINES FOR SYSTEMIC USE,NA,NA,NA,NA | |
| R06AA,Aminoalkyl ethers,NA,NA,NA,NA | |
| R06AA01,bromazine,NA,NA,NA,NA | |
| R06AA02,diphenhydramine,0.2,g,O,chloride | |
| R06AA02,diphenhydramine,0.3,g,O,teoclate | |
| R06AA02,diphenhydramine,0.2,g,R,chloride | |
| R06AA02,diphenhydramine,0.3,g,R,teoclate | |
| R06AA04,clemastine,2,mg,O,NA | |
| R06AA04,clemastine,2,mg,P,NA | |
| R06AA06,chlorphenoxamine,80,mg,O,NA | |
| R06AA06,chlorphenoxamine,80,mg,P,NA | |
| R06AA07,diphenylpyraline,10,mg,O,NA | |
| R06AA08,carbinoxamine,16,mg,O,NA | |
| R06AA09,doxylamine,25,mg,O,NA | |
| R06AA10,trimethobenzamide,NA,NA,NA,NA | |
| R06AA52,"diphenhydramine, combinations",NA,NA,NA,NA | |
| R06AA54,"clemastine, combinations",NA,NA,NA,NA | |
| R06AA56,"chlorphenoxamine, combinations",NA,NA,NA,NA | |
| R06AA57,"diphenylpyraline, combinations",NA,NA,NA,NA | |
| R06AA59,"doxylamine, combinations",NA,NA,NA,NA | |
| R06AB,Substituted alkylamines,NA,NA,NA,NA | |
| R06AB01,brompheniramine,24,mg,O,NA | |
| R06AB02,dexchlorpheniramine,6,mg,O,NA | |
| R06AB02,dexchlorpheniramine,6,mg,P,NA | |
| R06AB03,dimetindene,4,mg,O,NA | |
| R06AB04,chlorphenamine,12,mg,O,NA | |
| R06AB04,chlorphenamine,12,mg,P,NA | |
| R06AB05,pheniramine,75,mg,O,NA | |
| R06AB06,dexbrompheniramine,NA,NA,NA,NA | |
| R06AB07,talastine,NA,NA,NA,NA | |
| R06AB51,"brompheniramine, combinations",NA,NA,NA,NA | |
| R06AB52,"dexchlorpheniramine, combinations",NA,NA,NA,NA | |
| R06AB54,"chlorphenamine, combinations",NA,NA,NA,NA | |
| R06AB56,"dexbrompheniramine, combinations",NA,NA,NA,NA | |
| R06AC,Substituted ethylene diamines,NA,NA,NA,NA | |
| R06AC01,mepyramine,0.2,g,O,NA | |
| R06AC01,mepyramine,0.2,g,P,NA | |
| R06AC02,histapyrrodine,80,mg,O,NA | |
| R06AC03,chloropyramine,0.15,g,O,NA | |
| R06AC03,chloropyramine,20,mg,P,NA | |
| R06AC04,tripelennamine,0.15,g,O,NA | |
| R06AC05,methapyrilene,NA,NA,NA,NA | |
| R06AC06,thonzylamine,NA,NA,NA,NA | |
| R06AC52,"histapyrrodine, combinations",NA,NA,NA,NA | |
| R06AC53,"chloropyramine, combinations",NA,NA,NA,NA | |
| R06AD,Phenothiazine derivatives,NA,NA,NA,NA | |
| R06AD01,alimemazine,30,mg,O,NA | |
| R06AD01,alimemazine,30,mg,P,NA | |
| R06AD02,promethazine,25,mg,O,NA | |
| R06AD02,promethazine,25,mg,P,NA | |
| R06AD02,promethazine,25,mg,R,NA | |
| R06AD03,thiethylperazine,13,mg,O,NA | |
| R06AD03,thiethylperazine,13,mg,P,NA | |
| R06AD03,thiethylperazine,13,mg,R,NA | |
| R06AD04,methdilazine,16,mg,O,NA | |
| R06AD05,hydroxyethylpromethazine,75,mg,O,NA | |
| R06AD06,thiazinam,0.9,g,O,NA | |
| R06AD06,thiazinam,0.3,g,R,NA | |
| R06AD07,mequitazine,10,mg,O,NA | |
| R06AD08,oxomemazine,30,mg,O,NA | |
| R06AD09,isothipendyl,NA,NA,NA,NA | |
| R06AD52,"promethazine, combinations",NA,NA,NA,NA | |
| R06AD55,"hydroxyethylpromethazine, combinations",NA,NA,NA,NA | |
| R06AE,Piperazine derivatives,NA,NA,NA,NA | |
| R06AE01,buclizine,50,mg,O,NA | |
| R06AE03,cyclizine,0.1,g,O,NA | |
| R06AE03,cyclizine,0.1,g,P,NA | |
| R06AE03,cyclizine,0.3,g,R,NA | |
| R06AE04,chlorcyclizine,0.1,g,O,NA | |
| R06AE05,meclozine,50,mg,O,NA | |
| R06AE05,meclozine,50,mg,R,NA | |
| R06AE06,oxatomide,60,mg,O,NA | |
| R06AE07,cetirizine,10,mg,O,NA | |
| R06AE09,levocetirizine,5,mg,O,NA | |
| R06AE51,"buclizine, combinations",NA,NA,NA,NA | |
| R06AE53,"cyclizine, combinations",NA,NA,NA,NA | |
| R06AE55,"meclozine, combinations",NA,NA,NA,NA | |
| R06AK,Combinations of antihistamines,NA,NA,NA,NA | |
| R06AX,Other antihistamines for systemic use,NA,NA,NA,NA | |
| R06AX01,bamipine,0.1,g,O,NA | |
| R06AX02,cyproheptadine,12,mg,O,NA | |
| R06AX03,thenalidine,NA,NA,NA,NA | |
| R06AX04,phenindamine,NA,NA,NA,NA | |
| R06AX05,antazoline,0.3,g,O,NA | |
| R06AX05,antazoline,0.3,g,P,NA | |
| R06AX07,triprolidine,7.5,mg,O,NA | |
| R06AX08,pyrrobutamine,NA,NA,NA,NA | |
| R06AX09,azatadine,2,mg,O,NA | |
| R06AX11,astemizole,10,mg,O,NA | |
| R06AX12,terfenadine,0.12,g,O,NA | |
| R06AX13,loratadine,10,mg,O,NA | |
| R06AX15,mebhydrolin,0.2,g,O,NA | |
| R06AX16,deptropine,2,mg,O,NA | |
| R06AX17,ketotifen,2,mg,O,NA | |
| R06AX18,acrivastine,24,mg,O,NA | |
| R06AX19,azelastine,4,mg,O,NA | |
| R06AX21,tritoqualine,NA,NA,NA,NA | |
| R06AX22,ebastine,10,mg,O,NA | |
| R06AX23,pimethixene,NA,NA,NA,NA | |
| R06AX24,epinastine,NA,NA,NA,NA | |
| R06AX25,mizolastine,10,mg,O,NA | |
| R06AX26,fexofenadine,0.12,g,O,NA | |
| R06AX27,desloratadine,5,mg,O,NA | |
| R06AX28,rupatadine,10,mg,O,NA | |
| R06AX29,bilastine,20,mg,O,NA | |
| R06AX31,quifenadine,NA,NA,NA,NA | |
| R06AX32,sequifenadine,NA,NA,NA,NA | |
| R06AX53,"thenalidine, combinations",NA,NA,NA,NA | |
| R06AX58,"pyrrobutamine, combinations",NA,NA,NA,NA | |
| R07,OTHER RESPIRATORY SYSTEM PRODUCTS,NA,NA,NA,NA | |
| R07A,OTHER RESPIRATORY SYSTEM PRODUCTS,NA,NA,NA,NA | |
| R07AA,Lung surfactants,NA,NA,NA,NA | |
| R07AA01,colfosceril palmitate,0.108,g,Inhal.powder,NA | |
| R07AA02,natural phospholipids,0.16,g,Instill.solution,NA | |
| R07AA30,combinations,NA,NA,NA,NA | |
| R07AB,Respiratory stimulants,NA,NA,NA,NA | |
| R07AB01,doxapram,0.4,g,P,NA | |
| R07AB02,nikethamide,0.5,g,O,NA | |
| R07AB02,nikethamide,0.5,g,P,NA | |
| R07AB03,pentetrazol,0.1,g,O,NA | |
| R07AB04,etamivan,NA,NA,NA,NA | |
| R07AB05,bemegride,NA,NA,NA,NA | |
| R07AB06,prethcamide,0.4,g,O,NA | |
| R07AB06,prethcamide,0.4,g,P,NA | |
| R07AB07,almitrine,0.1,g,O,NA | |
| R07AB08,dimefline,NA,NA,NA,NA | |
| R07AB09,mepixanox,NA,NA,NA,NA | |
| R07AB52,"nikethamide, combinations",NA,NA,NA,NA | |
| R07AB53,"pentetrazol, combinations",NA,NA,NA,NA | |
| R07AX,Other respiratory system products,NA,NA,NA,NA | |
| R07AX01,nitric oxide,NA,NA,NA,NA | |
| R07AX02,ivacaftor,0.3,g,O,NA | |
| R07AX30,ivacaftor and lumacaftor,NA,NA,NA,NA | |
| R07AX31,ivacaftor and tezacaftor,NA,NA,NA,NA | |
| R07AX32,"ivacaftor, tezacaftor and elexacaftor",NA,NA,NA,NA | |
| S,SENSORY ORGANS,NA,NA,NA,NA | |
| S01,OPHTHALMOLOGICALS,NA,NA,NA,NA | |
| S01A,ANTIINFECTIVES,NA,NA,NA,NA | |
| S01AA,Antibiotics,NA,NA,NA,NA | |
| S01AA01,chloramphenicol,NA,NA,NA,NA | |
| S01AA02,chlortetracycline,NA,NA,NA,NA | |
| S01AA03,neomycin,NA,NA,NA,NA | |
| S01AA04,oxytetracycline,NA,NA,NA,NA | |
| S01AA05,tyrothricin,NA,NA,NA,NA | |
| S01AA07,framycetin,NA,NA,NA,NA | |
| S01AA09,tetracycline,NA,NA,NA,NA | |
| S01AA10,natamycin,NA,NA,NA,NA | |
| S01AA11,gentamicin,NA,NA,NA,NA | |
| S01AA12,tobramycin,NA,NA,NA,NA | |
| S01AA13,fusidic acid,NA,NA,NA,NA | |
| S01AA14,benzylpenicillin,NA,NA,NA,NA | |
| S01AA15,dihydrostreptomycin,NA,NA,NA,NA | |
| S01AA16,rifamycin,NA,NA,NA,NA | |
| S01AA17,erythromycin,NA,NA,NA,NA | |
| S01AA18,polymyxin B,NA,NA,NA,NA | |
| S01AA19,ampicillin,NA,NA,NA,NA | |
| S01AA20,antibiotics in combination with other drugs,NA,NA,NA,NA | |
| S01AA21,amikacin,NA,NA,NA,NA | |
| S01AA22,micronomicin,NA,NA,NA,NA | |
| S01AA23,netilmicin,NA,NA,NA,NA | |
| S01AA24,kanamycin,NA,NA,NA,NA | |
| S01AA25,azidamfenicol,NA,NA,NA,NA | |
| S01AA26,azithromycin,NA,NA,NA,NA | |
| S01AA27,cefuroxime,NA,NA,NA,NA | |
| S01AA28,vancomycin,NA,NA,NA,NA | |
| S01AA30,combinations of different antibiotics,NA,NA,NA,NA | |
| S01AB,Sulfonamides,NA,NA,NA,NA | |
| S01AB01,sulfamethizole,NA,NA,NA,NA | |
| S01AB02,sulfafurazole,NA,NA,NA,NA | |
| S01AB03,sulfadicramide,NA,NA,NA,NA | |
| S01AB04,sulfacetamide,NA,NA,NA,NA | |
| S01AB05,sulfafenazol,NA,NA,NA,NA | |
| S01AD,Antivirals,NA,NA,NA,NA | |
| S01AD01,idoxuridine,NA,NA,NA,NA | |
| S01AD02,trifluridine,NA,NA,NA,NA | |
| S01AD03,aciclovir,NA,NA,NA,NA | |
| S01AD05,interferon,NA,NA,NA,NA | |
| S01AD06,vidarabine,NA,NA,NA,NA | |
| S01AD07,famciclovir,NA,NA,NA,NA | |
| S01AD08,fomivirsen,NA,NA,NA,NA | |
| S01AD09,ganciclovir,NA,NA,NA,NA | |
| S01AE,Fluoroquinolones,NA,NA,NA,NA | |
| S01AE01,ofloxacin,NA,NA,NA,NA | |
| S01AE02,norfloxacin,NA,NA,NA,NA | |
| S01AE03,ciprofloxacin,NA,NA,NA,NA | |
| S01AE04,lomefloxacin,NA,NA,NA,NA | |
| S01AE05,levofloxacin,NA,NA,NA,NA | |
| S01AE06,gatifloxacin,NA,NA,NA,NA | |
| S01AE07,moxifloxacin,NA,NA,NA,NA | |
| S01AE08,besifloxacin,NA,NA,NA,NA | |
| S01AX,Other antiinfectives,NA,NA,NA,NA | |
| S01AX01,mercury compounds,NA,NA,NA,NA | |
| S01AX02,silver compounds,NA,NA,NA,NA | |
| S01AX03,zinc compounds,NA,NA,NA,NA | |
| S01AX04,nitrofural,NA,NA,NA,NA | |
| S01AX05,bibrocathol,NA,NA,NA,NA | |
| S01AX06,resorcinol,NA,NA,NA,NA | |
| S01AX07,sodium borate,NA,NA,NA,NA | |
| S01AX08,hexamidine,NA,NA,NA,NA | |
| S01AX09,chlorhexidine,NA,NA,NA,NA | |
| S01AX10,sodium propionate,NA,NA,NA,NA | |
| S01AX14,dibrompropamidine,NA,NA,NA,NA | |
| S01AX15,propamidine,NA,NA,NA,NA | |
| S01AX16,picloxydine,NA,NA,NA,NA | |
| S01AX18,povidone-iodine,NA,NA,NA,NA | |
| S01B,ANTIINFLAMMATORY AGENTS,NA,NA,NA,NA | |
| S01BA,"Corticosteroids, plain",NA,NA,NA,NA | |
| S01BA01,dexamethasone,NA,NA,NA,NA | |
| S01BA02,hydrocortisone,NA,NA,NA,NA | |
| S01BA03,cortisone,NA,NA,NA,NA | |
| S01BA04,prednisolone,NA,NA,NA,NA | |
| S01BA05,triamcinolone,NA,NA,NA,NA | |
| S01BA06,betamethasone,NA,NA,NA,NA | |
| S01BA07,fluorometholone,NA,NA,NA,NA | |
| S01BA08,medrysone,NA,NA,NA,NA | |
| S01BA09,clobetasone,NA,NA,NA,NA | |
| S01BA10,alclometasone,NA,NA,NA,NA | |
| S01BA11,desonide,NA,NA,NA,NA | |
| S01BA12,formocortal,NA,NA,NA,NA | |
| S01BA13,rimexolone,NA,NA,NA,NA | |
| S01BA14,loteprednol,NA,NA,NA,NA | |
| S01BA15,fluocinolone acetonide,NA,NA,NA,NA | |
| S01BB,Corticosteroids and mydriatics in combination,NA,NA,NA,NA | |
| S01BB01,hydrocortisone and mydriatics,NA,NA,NA,NA | |
| S01BB02,prednisolone and mydriatics,NA,NA,NA,NA | |
| S01BB03,fluorometholone and mydriatics,NA,NA,NA,NA | |
| S01BB04,betamethasone and mydriatics,NA,NA,NA,NA | |
| S01BC,"Antiinflammatory agents, non-steroids",NA,NA,NA,NA | |
| S01BC01,indometacin,NA,NA,NA,NA | |
| S01BC02,oxyphenbutazone,NA,NA,NA,NA | |
| S01BC03,diclofenac,NA,NA,NA,NA | |
| S01BC04,flurbiprofen,NA,NA,NA,NA | |
| S01BC05,ketorolac,NA,NA,NA,NA | |
| S01BC06,piroxicam,NA,NA,NA,NA | |
| S01BC07,bendazac,NA,NA,NA,NA | |
| S01BC08,salicylic acid,NA,NA,NA,NA | |
| S01BC09,pranoprofen,NA,NA,NA,NA | |
| S01BC10,nepafenac,NA,NA,NA,NA | |
| S01BC11,bromfenac,NA,NA,NA,NA | |
| S01C,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION,NA,NA,NA,NA | |
| S01CA,Corticosteroids and antiinfectives in combination,NA,NA,NA,NA | |
| S01CA01,dexamethasone and antiinfectives,NA,NA,NA,NA | |
| S01CA02,prednisolone and antiinfectives,NA,NA,NA,NA | |
| S01CA03,hydrocortisone and antiinfectives,NA,NA,NA,NA | |
| S01CA04,fluocortolone and antiinfectives,NA,NA,NA,NA | |
| S01CA05,betamethasone and antiinfectives,NA,NA,NA,NA | |
| S01CA06,fludrocortisone and antiinfectives,NA,NA,NA,NA | |
| S01CA07,fluorometholone and antiinfectives,NA,NA,NA,NA | |
| S01CA08,methylprednisolone and antiinfectives,NA,NA,NA,NA | |
| S01CA09,chloroprednisone and antiinfectives,NA,NA,NA,NA | |
| S01CA10,fluocinolone acetonide and antiinfectives,NA,NA,NA,NA | |
| S01CA11,clobetasone and antiinfectives,NA,NA,NA,NA | |
| S01CB,Corticosteroids/antiinfectives/mydriatics in combination,NA,NA,NA,NA | |
| S01CB01,dexamethasone,NA,NA,NA,NA | |
| S01CB02,prednisolone,NA,NA,NA,NA | |
| S01CB03,hydrocortisone,NA,NA,NA,NA | |
| S01CB04,betamethasone,NA,NA,NA,NA | |
| S01CB05,fluorometholone,NA,NA,NA,NA | |
| S01CC,"Antiinflammatory agents, non-steroids and antiinfectives in combination",NA,NA,NA,NA | |
| S01CC01,diclofenac and antiinfectives,NA,NA,NA,NA | |
| S01CC02,indometacin and antiinfectives,NA,NA,NA,NA | |
| S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,NA,NA,NA,NA | |
| S01EA,Sympathomimetics in glaucoma therapy,NA,NA,NA,NA | |
| S01EA01,epinephrine,NA,NA,NA,NA | |
| S01EA02,dipivefrine,NA,NA,NA,NA | |
| S01EA03,apraclonidine,NA,NA,NA,NA | |
| S01EA04,clonidine,NA,NA,NA,NA | |
| S01EA05,brimonidine,NA,NA,NA,NA | |
| S01EA51,"epinephrine, combinations",NA,NA,NA,NA | |
| S01EB,Parasympathomimetics,NA,NA,NA,NA | |
| S01EB01,pilocarpine,0.4,ml,NA,NA | |
| S01EB01,pilocarpine,0.285,NA,lamella,NA | |
| S01EB01,pilocarpine,40,mg,ointment,NA | |
| S01EB02,carbachol,0.4,ml,NA,NA | |
| S01EB03,ecothiopate,0.2,ml,NA,NA | |
| S01EB04,demecarium,0.1,ml,NA,NA | |
| S01EB05,physostigmine,0.4,ml,NA,NA | |
| S01EB06,neostigmine,0.4,ml,NA,NA | |
| S01EB06,neostigmine,40,mg,ointment,NA | |
| S01EB07,fluostigmine,NA,NA,NA,NA | |
| S01EB08,aceclidine,NA,NA,NA,NA | |
| S01EB09,acetylcholine,NA,NA,NA,NA | |
| S01EB10,paraoxon,NA,NA,NA,NA | |
| S01EB51,"pilocarpine, combinations",NA,NA,NA,NA | |
| S01EB58,"aceclidine, combinations",NA,NA,NA,NA | |
| S01EC,Carbonic anhydrase inhibitors,NA,NA,NA,NA | |
| S01EC01,acetazolamide,0.75,g,O,NA | |
| S01EC01,acetazolamide,0.75,g,P,NA | |
| S01EC02,diclofenamide,0.1,g,O,NA | |
| S01EC03,dorzolamide,0.3,ml,NA,NA | |
| S01EC04,brinzolamide,0.2,ml,NA,NA | |
| S01EC05,methazolamide,0.2,g,O,NA | |
| S01EC54,"brinzolamide, combinations",NA,NA,NA,NA | |
| S01ED,Beta blocking agents,NA,NA,NA,NA | |
| S01ED01,timolol,NA,NA,NA,NA | |
| S01ED02,betaxolol,NA,NA,NA,NA | |
| S01ED03,levobunolol,NA,NA,NA,NA | |
| S01ED04,metipranolol,NA,NA,NA,NA | |
| S01ED05,carteolol,NA,NA,NA,NA | |
| S01ED06,befunolol,NA,NA,NA,NA | |
| S01ED51,"timolol, combinations",NA,NA,NA,NA | |
| S01ED52,"betaxolol, combinations",NA,NA,NA,NA | |
| S01ED54,"metipranolol, combinations",NA,NA,NA,NA | |
| S01ED55,"carteolol, combinations",NA,NA,NA,NA | |
| S01EE,Prostaglandin analogues,NA,NA,NA,NA | |
| S01EE01,latanoprost,NA,NA,NA,NA | |
| S01EE02,unoprostone,NA,NA,NA,NA | |
| S01EE03,bimatoprost,NA,NA,NA,NA | |
| S01EE04,travoprost,NA,NA,NA,NA | |
| S01EE05,tafluprost,NA,NA,NA,NA | |
| S01EE06,latanoprostene bunod,NA,NA,NA,NA | |
| S01EE51,latanoprost and netarsudil,NA,NA,NA,NA | |
| S01EX,Other antiglaucoma preparations,NA,NA,NA,NA | |
| S01EX01,guanethidine,NA,NA,NA,NA | |
| S01EX02,dapiprazole,NA,NA,NA,NA | |
| S01EX05,netarsudil,NA,NA,NA,NA | |
| S01EX06,omidenepag,NA,NA,NA,NA | |
| S01F,MYDRIATICS AND CYCLOPLEGICS,NA,NA,NA,NA | |
| S01FA,Anticholinergics,NA,NA,NA,NA | |
| S01FA01,atropine,NA,NA,NA,NA | |
| S01FA02,scopolamine,NA,NA,NA,NA | |
| S01FA03,methylscopolamine,NA,NA,NA,NA | |
| S01FA04,cyclopentolate,NA,NA,NA,NA | |
| S01FA05,homatropine,NA,NA,NA,NA | |
| S01FA06,tropicamide,NA,NA,NA,NA | |
| S01FA54,"cyclopentolate, combinations",NA,NA,NA,NA | |
| S01FA56,"tropicamide, combinations",NA,NA,NA,NA | |
| S01FB,Sympathomimetics excl. antiglaucoma preparations,NA,NA,NA,NA | |
| S01FB01,phenylephrine,NA,NA,NA,NA | |
| S01FB02,ephedrine,NA,NA,NA,NA | |
| S01FB03,ibopamine,NA,NA,NA,NA | |
| S01FB51,phenylephrine and ketorolac,NA,NA,NA,NA | |
| S01G,DECONGESTANTS AND ANTIALLERGICS,NA,NA,NA,NA | |
| S01GA,Sympathomimetics used as decongestants,NA,NA,NA,NA | |
| S01GA01,naphazoline,NA,NA,NA,NA | |
| S01GA02,tetryzoline,NA,NA,NA,NA | |
| S01GA03,xylometazoline,NA,NA,NA,NA | |
| S01GA04,oxymetazoline,NA,NA,NA,NA | |
| S01GA05,phenylephrine,NA,NA,NA,NA | |
| S01GA06,oxedrine,NA,NA,NA,NA | |
| S01GA07,brimonidine,NA,NA,NA,NA | |
| S01GA51,"naphazoline, combinations",NA,NA,NA,NA | |
| S01GA52,"tetryzoline, combinations",NA,NA,NA,NA | |
| S01GA53,"xylometazoline, combinations",NA,NA,NA,NA | |
| S01GA55,"phenylephrine, combinations",NA,NA,NA,NA | |
| S01GA56,"oxedrine, combinations",NA,NA,NA,NA | |
| S01GX,Other antiallergics,NA,NA,NA,NA | |
| S01GX01,cromoglicic acid,NA,NA,NA,NA | |
| S01GX02,levocabastine,NA,NA,NA,NA | |
| S01GX03,spaglumic acid,NA,NA,NA,NA | |
| S01GX04,nedocromil,NA,NA,NA,NA | |
| S01GX05,lodoxamide,NA,NA,NA,NA | |
| S01GX06,emedastine,NA,NA,NA,NA | |
| S01GX07,azelastine,NA,NA,NA,NA | |
| S01GX08,ketotifen,NA,NA,NA,NA | |
| S01GX09,olopatadine,NA,NA,NA,NA | |
| S01GX10,epinastine,NA,NA,NA,NA | |
| S01GX11,alcaftadine,NA,NA,NA,NA | |
| S01GX51,"cromoglicic acid, combinations",NA,NA,NA,NA | |
| S01H,LOCAL ANESTHETICS,NA,NA,NA,NA | |
| S01HA,Local anesthetics,NA,NA,NA,NA | |
| S01HA01,cocaine,NA,NA,NA,NA | |
| S01HA02,oxybuprocaine,NA,NA,NA,NA | |
| S01HA03,tetracaine,NA,NA,NA,NA | |
| S01HA04,proxymetacaine,NA,NA,NA,NA | |
| S01HA05,procaine,NA,NA,NA,NA | |
| S01HA06,cinchocaine,NA,NA,NA,NA | |
| S01HA07,lidocaine,NA,NA,NA,NA | |
| S01HA30,combinations,NA,NA,NA,NA | |
| S01J,DIAGNOSTIC AGENTS,NA,NA,NA,NA | |
| S01JA,Colouring agents,NA,NA,NA,NA | |
| S01JA01,fluorescein,NA,NA,NA,NA | |
| S01JA02,rose bengal sodium,NA,NA,NA,NA | |
| S01JA51,"fluorescein, combinations",NA,NA,NA,NA | |
| S01JX,Other ophthalmological diagnostic agents,NA,NA,NA,NA | |
| S01K,SURGICAL AIDS,NA,NA,NA,NA | |
| S01KA,Viscoelastic substances,NA,NA,NA,NA | |
| S01KA01,hyaluronic acid,NA,NA,NA,NA | |
| S01KA02,hypromellose,NA,NA,NA,NA | |
| S01KA51,"hyaluronic acid, combinations",NA,NA,NA,NA | |
| S01KX,Other surgical aids,NA,NA,NA,NA | |
| S01KX01,chymotrypsin,NA,NA,NA,NA | |
| S01L,OCULAR VASCULAR DISORDER AGENTS,NA,NA,NA,NA | |
| S01LA,Antineovascularisation agents,NA,NA,NA,NA | |
| S01LA01,verteporfin,NA,NA,NA,NA | |
| S01LA02,anecortave,NA,NA,NA,NA | |
| S01LA03,pegaptanib,NA,NA,NA,NA | |
| S01LA04,ranibizumab,NA,NA,NA,NA | |
| S01LA05,aflibercept,NA,NA,NA,NA | |
| S01LA06,brolucizumab,NA,NA,NA,NA | |
| S01LA07,abicipar pegol,NA,NA,NA,NA | |
| S01X,OTHER OPHTHALMOLOGICALS,NA,NA,NA,NA | |
| S01XA,Other ophthalmologicals,NA,NA,NA,NA | |
| S01XA01,guaiazulen,NA,NA,NA,NA | |
| S01XA02,retinol,NA,NA,NA,NA | |
| S01XA03,"sodium chloride, hypertonic",NA,NA,NA,NA | |
| S01XA04,potassium iodide,NA,NA,NA,NA | |
| S01XA05,sodium edetate,NA,NA,NA,NA | |
| S01XA06,ethylmorphine,NA,NA,NA,NA | |
| S01XA07,alum,NA,NA,NA,NA | |
| S01XA08,acetylcysteine,NA,NA,NA,NA | |
| S01XA09,iodoheparinate,NA,NA,NA,NA | |
| S01XA10,inosine,NA,NA,NA,NA | |
| S01XA11,nandrolone,NA,NA,NA,NA | |
| S01XA12,dexpanthenol,NA,NA,NA,NA | |
| S01XA13,alteplase,NA,NA,NA,NA | |
| S01XA14,heparin,NA,NA,NA,NA | |
| S01XA15,ascorbic acid,NA,NA,NA,NA | |
| S01XA18,ciclosporin,NA,NA,NA,NA | |
| S01XA19,"limbal stem cells, autologous",NA,NA,NA,NA | |
| S01XA20,artificial tears and other indifferent preparations,NA,NA,NA,NA | |
| S01XA21,mercaptamine,NA,NA,NA,NA | |
| S01XA22,ocriplasmin,NA,NA,NA,NA | |
| S01XA23,sirolimus,NA,NA,NA,NA | |
| S01XA24,cenegermin,NA,NA,NA,NA | |
| S01XA25,lifitegrast,NA,NA,NA,NA | |
| S01XA26,riboflavin,NA,NA,NA,NA | |
| S01XA27,voretigene neparvovec,NA,NA,NA,NA | |
| S02,OTOLOGICALS,NA,NA,NA,NA | |
| S02A,ANTIINFECTIVES,NA,NA,NA,NA | |
| S02AA,Antiinfectives,NA,NA,NA,NA | |
| S02AA01,chloramphenicol,NA,NA,NA,NA | |
| S02AA02,nitrofural,NA,NA,NA,NA | |
| S02AA03,boric acid,NA,NA,NA,NA | |
| S02AA04,aluminium acetotartrate,NA,NA,NA,NA | |
| S02AA05,clioquinol,NA,NA,NA,NA | |
| S02AA06,hydrogen peroxide,NA,NA,NA,NA | |
| S02AA07,neomycin,NA,NA,NA,NA | |
| S02AA08,tetracycline,NA,NA,NA,NA | |
| S02AA09,chlorhexidine,NA,NA,NA,NA | |
| S02AA10,acetic acid,NA,NA,NA,NA | |
| S02AA11,polymyxin B,NA,NA,NA,NA | |
| S02AA12,rifamycin,NA,NA,NA,NA | |
| S02AA13,miconazole,NA,NA,NA,NA | |
| S02AA14,gentamicin,NA,NA,NA,NA | |
| S02AA15,ciprofloxacin,NA,NA,NA,NA | |
| S02AA16,ofloxacin,NA,NA,NA,NA | |
| S02AA30,"antiinfectives, combinations",NA,NA,NA,NA | |
| S02B,CORTICOSTEROIDS,NA,NA,NA,NA | |
| S02BA,Corticosteroids,NA,NA,NA,NA | |
| S02BA01,hydrocortisone,NA,NA,NA,NA | |
| S02BA03,prednisolone,NA,NA,NA,NA | |
| S02BA06,dexamethasone,NA,NA,NA,NA | |
| S02BA07,betamethasone,NA,NA,NA,NA | |
| S02BA08,fluocinolone acetonide,NA,NA,NA,NA | |
| S02C,CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION,NA,NA,NA,NA | |
| S02CA,Corticosteroids and antiinfectives in combination,NA,NA,NA,NA | |
| S02CA01,prednisolone and antiinfectives,NA,NA,NA,NA | |
| S02CA02,flumetasone and antiinfectives,NA,NA,NA,NA | |
| S02CA03,hydrocortisone and antiinfectives,NA,NA,NA,NA | |
| S02CA04,triamcinolone and antiinfectives,NA,NA,NA,NA | |
| S02CA05,fluocinolone acetonide and antiinfectives,NA,NA,NA,NA | |
| S02CA06,dexamethasone and antiinfectives,NA,NA,NA,NA | |
| S02CA07,fludrocortisone and antiinfectives,NA,NA,NA,NA | |
| S02D,OTHER OTOLOGICALS,NA,NA,NA,NA | |
| S02DA,Analgesics and anesthetics,NA,NA,NA,NA | |
| S02DA01,lidocaine,NA,NA,NA,NA | |
| S02DA02,cocaine,NA,NA,NA,NA | |
| S02DA03,phenazone,NA,NA,NA,NA | |
| S02DA04,cinchocaine,NA,NA,NA,NA | |
| S02DA30,combinations,NA,NA,NA,NA | |
| S02DC,Indifferent preparations,NA,NA,NA,NA | |
| S03,OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,NA,NA,NA,NA | |
| S03A,ANTIINFECTIVES,NA,NA,NA,NA | |
| S03AA,Antiinfectives,NA,NA,NA,NA | |
| S03AA01,neomycin,NA,NA,NA,NA | |
| S03AA02,tetracycline,NA,NA,NA,NA | |
| S03AA03,polymyxin B,NA,NA,NA,NA | |
| S03AA04,chlorhexidine,NA,NA,NA,NA | |
| S03AA05,hexamidine,NA,NA,NA,NA | |
| S03AA06,gentamicin,NA,NA,NA,NA | |
| S03AA07,ciprofloxacin,NA,NA,NA,NA | |
| S03AA08,chloramphenicol,NA,NA,NA,NA | |
| S03AA30,"antiinfectives, combinations",NA,NA,NA,NA | |
| S03B,CORTICOSTEROIDS,NA,NA,NA,NA | |
| S03BA,Corticosteroids,NA,NA,NA,NA | |
| S03BA01,dexamethasone,NA,NA,NA,NA | |
| S03BA02,prednisolone,NA,NA,NA,NA | |
| S03BA03,betamethasone,NA,NA,NA,NA | |
| S03C,CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION,NA,NA,NA,NA | |
| S03CA,Corticosteroids and antiinfectives in combination,NA,NA,NA,NA | |
| S03CA01,dexamethasone and antiinfectives,NA,NA,NA,NA | |
| S03CA02,prednisolone and antiinfectives,NA,NA,NA,NA | |
| S03CA04,hydrocortisone and antiinfectives,NA,NA,NA,NA | |
| S03CA05,fludrocortisone and antiinfectives,NA,NA,NA,NA | |
| S03CA06,betamethasone and antiinfectives,NA,NA,NA,NA | |
| S03D,OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,NA,NA,NA,NA | |
| V,VARIOUS,NA,NA,NA,NA | |
| V01,ALLERGENS,NA,NA,NA,NA | |
| V01A,ALLERGENS,NA,NA,NA,NA | |
| V01AA,Allergen extracts,NA,NA,NA,NA | |
| V01AA01,feather,NA,NA,NA,NA | |
| V01AA02,grass pollen,NA,NA,NA,NA | |
| V01AA03,house dust mites,NA,NA,NA,NA | |
| V01AA04,mould fungus and yeast fungus,NA,NA,NA,NA | |
| V01AA05,tree pollen,NA,NA,NA,NA | |
| V01AA07,insects,NA,NA,NA,NA | |
| V01AA08,food,NA,NA,NA,NA | |
| V01AA09,textiles,NA,NA,NA,NA | |
| V01AA10,flowers,NA,NA,NA,NA | |
| V01AA11,animals,NA,NA,NA,NA | |
| V01AA20,various,NA,NA,NA,NA | |
| V03,ALL OTHER THERAPEUTIC PRODUCTS,NA,NA,NA,NA | |
| V03A,ALL OTHER THERAPEUTIC PRODUCTS,NA,NA,NA,NA | |
| V03AB,Antidotes,NA,NA,NA,NA | |
| V03AB01,ipecacuanha,NA,NA,NA,NA | |
| V03AB02,nalorphine,NA,NA,NA,NA | |
| V03AB03,edetates,NA,NA,NA,NA | |
| V03AB04,pralidoxime,NA,NA,NA,NA | |
| V03AB05,prednisolone and promethazine,NA,NA,NA,NA | |
| V03AB06,thiosulfate,NA,NA,NA,NA | |
| V03AB08,sodium nitrite,NA,NA,NA,NA | |
| V03AB09,dimercaprol,NA,NA,NA,NA | |
| V03AB13,obidoxime,NA,NA,NA,NA | |
| V03AB14,protamine,NA,NA,NA,NA | |
| V03AB15,naloxone,NA,NA,NA,NA | |
| V03AB16,ethanol,NA,NA,NA,NA | |
| V03AB17,methylthioninium chloride,NA,NA,NA,NA | |
| V03AB18,potassium permanganate,NA,NA,NA,NA | |
| V03AB19,physostigmine,NA,NA,NA,NA | |
| V03AB20,copper sulfate,NA,NA,NA,NA | |
| V03AB21,potassium iodide,NA,NA,NA,NA | |
| V03AB22,amyl nitrite,NA,NA,NA,NA | |
| V03AB23,acetylcysteine,NA,NA,NA,NA | |
| V03AB24,digitalis antitoxin,NA,NA,NA,NA | |
| V03AB25,flumazenil,NA,NA,NA,NA | |
| V03AB26,methionine,NA,NA,NA,NA | |
| V03AB27,4-dimethylaminophenol,NA,NA,NA,NA | |
| V03AB29,cholinesterase,NA,NA,NA,NA | |
| V03AB31,prussian blue,NA,NA,NA,NA | |
| V03AB32,glutathione,NA,NA,NA,NA | |
| V03AB33,hydroxocobalamin,NA,NA,NA,NA | |
| V03AB34,fomepizole,NA,NA,NA,NA | |
| V03AB35,sugammadex,NA,NA,NA,NA | |
| V03AB36,phentolamine,NA,NA,NA,NA | |
| V03AB37,idarucizumab,NA,NA,NA,NA | |
| V03AB38,andexanet alfa,NA,NA,NA,NA | |
| V03AC,Iron chelating agents,NA,NA,NA,NA | |
| V03AC01,deferoxamine,NA,NA,NA,NA | |
| V03AC02,deferiprone,NA,NA,NA,NA | |
| V03AC03,deferasirox,NA,NA,NA,NA | |
| V03AE,Drugs for treatment of hyperkalemia and hyperphosphatemia,NA,NA,NA,NA | |
| V03AE01,polystyrene sulfonate,45,g,O,NA | |
| V03AE02,sevelamer,6.4,g,O,NA | |
| V03AE03,lanthanum carbonate,2.25,g,O,Expressed as lanthanum | |
| V03AE04,calcium acetate and magnesium carbonate,NA,NA,NA,NA | |
| V03AE05,sucroferric oxyhydroxide,1.5,g,O,NA | |
| V03AE06,colestilan,NA,NA,NA,NA | |
| V03AE07,calcium acetate,6,g,O,NA | |
| V03AE08,ferric citrate,6,g,O,NA | |
| V03AE09,patiromer calcium,8.4,g,O,NA | |
| V03AE10,sodium zirconium cyclosilicate,7.5,g,O,NA | |
| V03AF,Detoxifying agents for antineoplastic treatment,NA,NA,NA,NA | |
| V03AF01,mesna,NA,NA,NA,NA | |
| V03AF02,dexrazoxane,1.5,g,P,NA | |
| V03AF03,calcium folinate,60,mg,O,Expressed as folinic acid | |
| V03AF03,calcium folinate,60,mg,P,Expressed as folinic acid | |
| V03AF04,calcium levofolinate,30,mg,O,"""Expressed as levofolinic acid""" | |
| V03AF04,calcium levofolinate,30,mg,P,"""Expressed as levofolinic acid""" | |
| V03AF05,amifostine,1.7,g,P,NA | |
| V03AF06,sodium folinate,60,mg,P,Expressed as folinic acid | |
| V03AF07,rasburicase,14,mg,P,NA | |
| V03AF08,palifermin,4.2,mg,P,NA | |
| V03AF09,glucarpidase,NA,NA,NA,NA | |
| V03AF10,sodium levofolinate,30,mg,P,Expressed as levofolinic acid | |
| V03AF11,arginine and lysine,NA,NA,NA,NA | |
| V03AG,Drugs for treatment of hypercalcemia,NA,NA,NA,NA | |
| V03AG01,sodium cellulose phosphate,NA,NA,NA,NA | |
| V03AH,Drugs for treatment of hypoglycemia,NA,NA,NA,NA | |
| V03AH01,diazoxide,NA,NA,NA,NA | |
| V03AK,Tissue adhesives,NA,NA,NA,NA | |
| V03AM,Drugs for embolisation,NA,NA,NA,NA | |
| V03AN,Medical gases,NA,NA,NA,NA | |
| V03AN01,oxygen,NA,NA,NA,NA | |
| V03AN02,carbon dioxide,NA,NA,NA,NA | |
| V03AN03,helium,NA,NA,NA,NA | |
| V03AN04,nitrogen,NA,NA,NA,NA | |
| V03AN05,medical air,NA,NA,NA,NA | |
| V03AX,Other therapeutic products,NA,NA,NA,NA | |
| V03AX02,nalfurafine,NA,NA,NA,NA | |
| V03AX03,cobicistat,0.15,g,O,NA | |
| V03AZ,Nerve depressants,NA,NA,NA,NA | |
| V03AZ01,ethanol,NA,NA,NA,NA | |
| V04,DIAGNOSTIC AGENTS,NA,NA,NA,NA | |
| V04B,URINE TESTS,NA,NA,NA,NA | |
| V04C,OTHER DIAGNOSTIC AGENTS,NA,NA,NA,NA | |
| V04CA,Tests for diabetes,NA,NA,NA,NA | |
| V04CA01,tolbutamide,NA,NA,NA,NA | |
| V04CA02,glucose,NA,NA,NA,NA | |
| V04CB,Tests for fat absorption,NA,NA,NA,NA | |
| V04CB01,vitamin A concentrates,NA,NA,NA,NA | |
| V04CC,Tests for bile duct patency,NA,NA,NA,NA | |
| V04CC01,sorbitol,NA,NA,NA,NA | |
| V04CC02,magnesium sulfate,NA,NA,NA,NA | |
| V04CC03,sincalide,NA,NA,NA,NA | |
| V04CC04,ceruletide,NA,NA,NA,NA | |
| V04CD,Tests for pituitary function,NA,NA,NA,NA | |
| V04CD01,metyrapone,NA,NA,NA,NA | |
| V04CD03,sermorelin,NA,NA,NA,NA | |
| V04CD04,corticorelin,NA,NA,NA,NA | |
| V04CD05,somatorelin,NA,NA,NA,NA | |
| V04CD06,macimorelin,NA,NA,NA,NA | |
| V04CE,Tests for liver functional capacity,NA,NA,NA,NA | |
| V04CE01,galactose,NA,NA,NA,NA | |
| V04CE02,sulfobromophthalein,NA,NA,NA,NA | |
| V04CE03,methacetin (13C),NA,NA,NA,NA | |
| V04CF,Tuberculosis diagnostics,NA,NA,NA,NA | |
| V04CF01,tuberculin,NA,NA,NA,NA | |
| V04CG,Tests for gastric secretion,NA,NA,NA,NA | |
| V04CG01,cation exchange resins,NA,NA,NA,NA | |
| V04CG02,betazole,NA,NA,NA,NA | |
| V04CG03,histamine phosphate,NA,NA,NA,NA | |
| V04CG04,pentagastrin,NA,NA,NA,NA | |
| V04CG05,methylthioninium chloride,NA,NA,NA,NA | |
| V04CG30,caffeine and sodium benzoate,NA,NA,NA,NA | |
| V04CH,Tests for renal function and ureteral injuries,NA,NA,NA,NA | |
| V04CH01,inulin and other polyfructosans,NA,NA,NA,NA | |
| V04CH02,indigo carmine,NA,NA,NA,NA | |
| V04CH03,phenolsulfonphthalein,NA,NA,NA,NA | |
| V04CH04,alsactide,NA,NA,NA,NA | |
| V04CH30,aminohippuric acid,NA,NA,NA,NA | |
| V04CJ,Tests for thyreoidea function,NA,NA,NA,NA | |
| V04CJ01,thyrotropin,NA,NA,NA,NA | |
| V04CJ02,protirelin,NA,NA,NA,NA | |
| V04CK,Tests for pancreatic function,NA,NA,NA,NA | |
| V04CK01,secretin,NA,NA,NA,NA | |
| V04CK02,pancreozymin (cholecystokinin),NA,NA,NA,NA | |
| V04CK03,bentiromide,NA,NA,NA,NA | |
| V04CL,Tests for allergic diseases,NA,NA,NA,NA | |
| V04CM,Tests for fertility disturbances,NA,NA,NA,NA | |
| V04CM01,gonadorelin,NA,NA,NA,NA | |
| V04CX,Other diagnostic agents,NA,NA,NA,NA | |
| V04CX01,indocyanine green,NA,NA,NA,NA | |
| V04CX02,folic acid,NA,NA,NA,NA | |
| V04CX03,methacholine,NA,NA,NA,NA | |
| V04CX04,mannitol,NA,NA,NA,NA | |
| V04CX05,13C-urea,NA,NA,NA,NA | |
| V04CX06,hexaminolevulinate,NA,NA,NA,NA | |
| V04CX07,edrophonium,NA,NA,NA,NA | |
| V04CX08,carbon monoxide,NA,NA,NA,NA | |
| V04CX09,patent blue,NA,NA,NA,NA | |
| V06,GENERAL NUTRIENTS,NA,NA,NA,NA | |
| V06A,DIET FORMULATIONS FOR TREATMENT OF OBESITY,NA,NA,NA,NA | |
| V06AA,Low-energy diets,NA,NA,NA,NA | |
| V06B,PROTEIN SUPPLEMENTS,NA,NA,NA,NA | |
| V06C,INFANT FORMULAS,NA,NA,NA,NA | |
| V06CA,Nutrients without phenylalanine,NA,NA,NA,NA | |
| V06D,OTHER NUTRIENTS,NA,NA,NA,NA | |
| V06DA,"Carbohydrates/proteins/minerals/vitamins, combinations",NA,NA,NA,NA | |
| V06DB,"Fat/carbohydrates/proteins/minerals/vitamins, combinations",NA,NA,NA,NA | |
| V06DC,Carbohydrates,NA,NA,NA,NA | |
| V06DC01,glucose,NA,NA,NA,NA | |
| V06DC02,fructose,NA,NA,NA,NA | |
| V06DD,"Amino acids, incl. combinations with polypeptides",NA,NA,NA,NA | |
| V06DE,"Amino acids/carbohydrates/minerals/vitamins, combinations",NA,NA,NA,NA | |
| V06DF,Milk substitutes,NA,NA,NA,NA | |
| V06DX,Other combinations of nutrients,NA,NA,NA,NA | |
| V07,ALL OTHER NON-THERAPEUTIC PRODUCTS,NA,NA,NA,NA | |
| V07A,ALL OTHER NON-THERAPEUTIC PRODUCTS,NA,NA,NA,NA | |
| V07AA,Plasters,NA,NA,NA,NA | |
| V07AB,"Solvents and diluting agents, incl. irrigating solutions",NA,NA,NA,NA | |
| V07AC,"Blood transfusion, auxiliary products",NA,NA,NA,NA | |
| V07AD,"Blood tests, auxiliary products",NA,NA,NA,NA | |
| V07AN,Incontinence equipment,NA,NA,NA,NA | |
| V07AR,"Sensitivity tests, discs and tablets",NA,NA,NA,NA | |
| V07AS,Stomi equipment,NA,NA,NA,NA | |
| V07AT,Cosmetics,NA,NA,NA,NA | |
| V07AV,Technical disinfectants,NA,NA,NA,NA | |
| V07AX,Washing agents etc.,NA,NA,NA,NA | |
| V07AY,Other non-therapeutic auxiliary products,NA,NA,NA,NA | |
| V07AZ,Chemicals and reagents for analysis,NA,NA,NA,NA | |
| V08,CONTRAST MEDIA,NA,NA,NA,NA | |
| V08A,"X-RAY CONTRAST MEDIA, IODINATED",NA,NA,NA,NA | |
| V08AA,"Watersoluble, nephrotropic, high osmolar X-ray contrast media",NA,NA,NA,NA | |
| V08AA01,diatrizoic acid,NA,NA,NA,NA | |
| V08AA02,metrizoic acid,NA,NA,NA,NA | |
| V08AA03,iodamide,NA,NA,NA,NA | |
| V08AA04,iotalamic acid,NA,NA,NA,NA | |
| V08AA05,ioxitalamic acid,NA,NA,NA,NA | |
| V08AA06,ioglicic acid,NA,NA,NA,NA | |
| V08AA07,acetrizoic acid,NA,NA,NA,NA | |
| V08AA08,iocarmic acid,NA,NA,NA,NA | |
| V08AA09,methiodal,NA,NA,NA,NA | |
| V08AA10,diodone,NA,NA,NA,NA | |
| V08AB,"Watersoluble, nephrotropic, low osmolar X-ray contrast media",NA,NA,NA,NA | |
| V08AB01,metrizamide,NA,NA,NA,NA | |
| V08AB02,iohexol,NA,NA,NA,NA | |
| V08AB03,ioxaglic acid,NA,NA,NA,NA | |
| V08AB04,iopamidol,NA,NA,NA,NA | |
| V08AB05,iopromide,NA,NA,NA,NA | |
| V08AB06,iotrolan,NA,NA,NA,NA | |
| V08AB07,ioversol,NA,NA,NA,NA | |
| V08AB08,iopentol,NA,NA,NA,NA | |
| V08AB09,iodixanol,NA,NA,NA,NA | |
| V08AB10,iomeprol,NA,NA,NA,NA | |
| V08AB11,iobitridol,NA,NA,NA,NA | |
| V08AB12,ioxilan,NA,NA,NA,NA | |
| V08AC,"Watersoluble, hepatotropic X-ray contrast media",NA,NA,NA,NA | |
| V08AC01,iodoxamic acid,NA,NA,NA,NA | |
| V08AC02,iotroxic acid,NA,NA,NA,NA | |
| V08AC03,ioglycamic acid,NA,NA,NA,NA | |
| V08AC04,adipiodone,NA,NA,NA,NA | |
| V08AC05,iobenzamic acid,NA,NA,NA,NA | |
| V08AC06,iopanoic acid,NA,NA,NA,NA | |
| V08AC07,iocetamic acid,NA,NA,NA,NA | |
| V08AC08,sodium iopodate,NA,NA,NA,NA | |
| V08AC09,tyropanoic acid,NA,NA,NA,NA | |
| V08AC10,calcium iopodate,NA,NA,NA,NA | |
| V08AD,Non-watersoluble X-ray contrast media,NA,NA,NA,NA | |
| V08AD01,ethyl esters of iodised fatty acids,NA,NA,NA,NA | |
| V08AD02,iopydol,NA,NA,NA,NA | |
| V08AD03,propyliodone,NA,NA,NA,NA | |
| V08AD04,iofendylate,NA,NA,NA,NA | |
| V08B,"X-RAY CONTRAST MEDIA, NON-IODINATED",NA,NA,NA,NA | |
| V08BA,Barium sulfate containing X-ray contrast media,NA,NA,NA,NA | |
| V08BA01,barium sulfate with suspending agents,NA,NA,NA,NA | |
| V08BA02,barium sulfate without suspending agents,NA,NA,NA,NA | |
| V08C,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,NA,NA,NA,NA | |
| V08CA,Paramagnetic contrast media,NA,NA,NA,NA | |
| V08CA01,gadopentetic acid,NA,NA,NA,NA | |
| V08CA02,gadoteric acid,NA,NA,NA,NA | |
| V08CA03,gadodiamide,NA,NA,NA,NA | |
| V08CA04,gadoteridol,NA,NA,NA,NA | |
| V08CA05,mangafodipir,NA,NA,NA,NA | |
| V08CA06,gadoversetamide,NA,NA,NA,NA | |
| V08CA07,ferric ammonium citrate,NA,NA,NA,NA | |
| V08CA08,gadobenic acid,NA,NA,NA,NA | |
| V08CA09,gadobutrol,NA,NA,NA,NA | |
| V08CA10,gadoxetic acid,NA,NA,NA,NA | |
| V08CA11,gadofosveset,NA,NA,NA,NA | |
| V08CB,Superparamagnetic contrast media,NA,NA,NA,NA | |
| V08CB01,ferumoxsil,NA,NA,NA,NA | |
| V08CB02,ferristene,NA,NA,NA,NA | |
| V08CB03,"iron oxide, nanoparticles",NA,NA,NA,NA | |
| V08CX,Other magnetic resonance imaging contrast media,NA,NA,NA,NA | |
| V08CX01,perflubron,NA,NA,NA,NA | |
| V08D,ULTRASOUND CONTRAST MEDIA,NA,NA,NA,NA | |
| V08DA,Ultrasound contrast media,NA,NA,NA,NA | |
| V08DA01,"perflutren, human albumin microspheres",NA,NA,NA,NA | |
| V08DA02,microparticles of galactose,NA,NA,NA,NA | |
| V08DA03,perflenapent,NA,NA,NA,NA | |
| V08DA04,"perflutren, phospholipid microspheres",NA,NA,NA,NA | |
| V08DA05,"sulfur hexafluoride, phospholipid microspheres",NA,NA,NA,NA | |
| V08DA06,"perflubutane, phospholipid microspheres",NA,NA,NA,NA | |
| V09,DIAGNOSTIC RADIOPHARMACEUTICALS,NA,NA,NA,NA | |
| V09A,CENTRAL NERVOUS SYSTEM,NA,NA,NA,NA | |
| V09AA,Technetium (99mTc) compounds,NA,NA,NA,NA | |
| V09AA01,technetium (99mTc) exametazime,NA,NA,NA,NA | |
| V09AA02,technetium (99mTc) bicisate,NA,NA,NA,NA | |
| V09AB,Iodine (123I) compounds,NA,NA,NA,NA | |
| V09AB01,iodine iofetamine (123I),NA,NA,NA,NA | |
| V09AB02,iodine iolopride (123I),NA,NA,NA,NA | |
| V09AB03,iodine ioflupane (123I),NA,NA,NA,NA | |
| V09AX,Other central nervous system diagnostic radiopharmaceuticals,NA,NA,NA,NA | |
| V09AX01,indium (111In) pentetic acid,NA,NA,NA,NA | |
| V09AX03,iodine (124I) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropane,NA,NA,NA,NA | |
| V09AX04,flutemetamol (18F),NA,NA,NA,NA | |
| V09AX05,florbetapir (18F),NA,NA,NA,NA | |
| V09AX06,florbetaben (18F),NA,NA,NA,NA | |
| V09B,SKELETON,NA,NA,NA,NA | |
| V09BA,Technetium (99mTc) compounds,NA,NA,NA,NA | |
| V09BA01,technetium (99mTc) oxidronic acid,NA,NA,NA,NA | |
| V09BA02,technetium (99mTc) medronic acid,NA,NA,NA,NA | |
| V09BA03,technetium (99mTc) pyrophosphate,NA,NA,NA,NA | |
| V09BA04,technetium (99mTc) butedronic acid,NA,NA,NA,NA | |
| V09C,RENAL SYSTEM,NA,NA,NA,NA | |
| V09CA,Technetium (99mTc) compounds,NA,NA,NA,NA | |
| V09CA01,technetium (99mTc) pentetic acid,NA,NA,NA,NA | |
| V09CA02,technetium (99mTc) succimer,NA,NA,NA,NA | |
| V09CA03,technetium (99mTc) mertiatide,NA,NA,NA,NA | |
| V09CA04,technetium (99mTc) gluceptate,NA,NA,NA,NA | |
| V09CA05,technetium (99mTc) gluconate,NA,NA,NA,NA | |
| V09CA06,technetium (99mTc) ethylenedicysteine,NA,NA,NA,NA | |
| V09CX,Other renal system diagnostic radiopharmaceuticals,NA,NA,NA,NA | |
| V09CX01,sodium iodohippurate (123I),NA,NA,NA,NA | |
| V09CX02,sodium iodohippurate (131I),NA,NA,NA,NA | |
| V09CX03,sodium iothalamate (125I),NA,NA,NA,NA | |
| V09CX04,chromium (51Cr) edetate,NA,NA,NA,NA | |
| V09D,HEPATIC AND RETICULO ENDOTHELIAL SYSTEM,NA,NA,NA,NA | |
| V09DA,Technetium (99mTc) compounds,NA,NA,NA,NA | |
| V09DA01,technetium (99mTc) disofenin,NA,NA,NA,NA | |
| V09DA02,technetium (99mTc) etifenin,NA,NA,NA,NA | |
| V09DA03,technetium (99mTc) lidofenin,NA,NA,NA,NA | |
| V09DA04,technetium (99mTc) mebrofenin,NA,NA,NA,NA | |
| V09DA05,technetium (99mTc) galtifenin,NA,NA,NA,NA | |
| V09DB,"Technetium (99mTc), particles and colloids",NA,NA,NA,NA | |
| V09DB01,technetium (99mTc) nanocolloid,NA,NA,NA,NA | |
| V09DB02,technetium (99mTc) microcolloid,NA,NA,NA,NA | |
| V09DB03,technetium (99mTc) millimicrospheres,NA,NA,NA,NA | |
| V09DB04,technetium (99mTc) tin colloid,NA,NA,NA,NA | |
| V09DB05,technetium (99mTc) sulfur colloid,NA,NA,NA,NA | |
| V09DB06,technetium (99mTc) rheniumsulfide colloid,NA,NA,NA,NA | |
| V09DB07,technetium (99mTc) phytate,NA,NA,NA,NA | |
| V09DX,Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals,NA,NA,NA,NA | |
| V09DX01,selenium (75Se) tauroselcholic acid,NA,NA,NA,NA | |
| V09E,RESPIRATORY SYSTEM,NA,NA,NA,NA | |
| V09EA,"Technetium (99mTc), inhalants",NA,NA,NA,NA | |
| V09EA01,technetium (99mTc) pentetic acid,NA,NA,NA,NA | |
| V09EA02,technetium (99mTc) technegas,NA,NA,NA,NA | |
| V09EA03,technetium (99mTc) nanocolloid,NA,NA,NA,NA | |
| V09EB,"Technetium (99mTc), particles for injection",NA,NA,NA,NA | |
| V09EB01,technetium (99mTc) macrosalb,NA,NA,NA,NA | |
| V09EB02,technetium (99mTc) microspheres,NA,NA,NA,NA | |
| V09EX,Other respiratory system diagnostic radiopharmaceuticals,NA,NA,NA,NA | |
| V09EX01,krypton (81mKr) gas,NA,NA,NA,NA | |
| V09EX02,xenon (127Xe) gas,NA,NA,NA,NA | |
| V09EX03,xenon (133Xe) gas,NA,NA,NA,NA | |
| V09F,THYROID,NA,NA,NA,NA | |
| V09FX,Various thyroid diagnostic radiopharmaceuticals,NA,NA,NA,NA | |
| V09FX01,technetium (99mTc) pertechnetate,NA,NA,NA,NA | |
| V09FX02,sodium iodide (123I),NA,NA,NA,NA | |
| V09FX03,sodium iodide (131I),NA,NA,NA,NA | |
| V09FX04,sodium iodide (124I),NA,NA,NA,NA | |
| V09G,CARDIOVASCULAR SYSTEM,NA,NA,NA,NA | |
| V09GA,Technetium (99mTc) compounds,NA,NA,NA,NA | |
| V09GA01,technetium (99mTc) sestamibi,NA,NA,NA,NA | |
| V09GA02,technetium (99mTc) tetrofosmin,NA,NA,NA,NA | |
| V09GA03,technetium (99mTc) teboroxime,NA,NA,NA,NA | |
| V09GA04,technetium (99mTc) human albumin,NA,NA,NA,NA | |
| V09GA05,technetium (99mTc) furifosmin,NA,NA,NA,NA | |
| V09GA06,technetium (99mTc) stannous agent labelled cells,NA,NA,NA,NA | |
| V09GA07,technetium (99mTc) apcitide,NA,NA,NA,NA | |
| V09GB,Iodine (125I) compounds,NA,NA,NA,NA | |
| V09GB01,fibrinogen (125I),NA,NA,NA,NA | |
| V09GB02,iodine (125I) human albumin,NA,NA,NA,NA | |
| V09GX,Other cardiovascular system diagnostic radiopharmaceuticals,NA,NA,NA,NA | |
| V09GX01,thallium (201Tl) chloride,NA,NA,NA,NA | |
| V09GX02,indium (111In) imciromab,NA,NA,NA,NA | |
| V09GX03,chromium (51Cr) chromate labelled cells,NA,NA,NA,NA | |
| V09GX04,rubidium (82Rb) chloride,NA,NA,NA,NA | |
| V09H,INFLAMMATION AND INFECTION DETECTION,NA,NA,NA,NA | |
| V09HA,Technetium (99mTc) compounds,NA,NA,NA,NA | |
| V09HA01,technetium (99mTc) human immunoglobulin,NA,NA,NA,NA | |
| V09HA02,technetium (99mTc) exametazime labelled cells,NA,NA,NA,NA | |
| V09HA03,technetium (99mTc) antigranulocyte antibody,NA,NA,NA,NA | |
| V09HA04,technetium (99mTc) sulesomab,NA,NA,NA,NA | |
| V09HB,Indium (111In) compounds,NA,NA,NA,NA | |
| V09HB01,indium (111In) oxinate labelled cells,NA,NA,NA,NA | |
| V09HB02,indium (111In) tropolonate labelled cells,NA,NA,NA,NA | |
| V09HX,Other diagnostic radiopharmaceuticals for inflammation and infection detection,NA,NA,NA,NA | |
| V09HX01,gallium (67Ga) citrate,NA,NA,NA,NA | |
| V09I,TUMOUR DETECTION,NA,NA,NA,NA | |
| V09IA,Technetium (99mTc) compounds,NA,NA,NA,NA | |
| V09IA01,technetium (99mTc) antiCarcinoEmbryonicAntigen antibody,NA,NA,NA,NA | |
| V09IA02,technetium (99mTc) antimelanoma antibody,NA,NA,NA,NA | |
| V09IA03,technetium (99mTc) pentavalent succimer,NA,NA,NA,NA | |
| V09IA04,technetium (99mTc) votumumab,NA,NA,NA,NA | |
| V09IA05,technetium (99mTc) depreotide,NA,NA,NA,NA | |
| V09IA06,technetium (99mTc) arcitumomab,NA,NA,NA,NA | |
| V09IA07,technetium (99mTc) hynic-octreotide,NA,NA,NA,NA | |
| V09IA08,technetium (99mTc) etarfolatide,NA,NA,NA,NA | |
| V09IA09,technetium (99mTc) tilmanocept,NA,NA,NA,NA | |
| V09IB,Indium (111In) compounds,NA,NA,NA,NA | |
| V09IB01,indium (111In) pentetreotide,NA,NA,NA,NA | |
| V09IB02,indium (111In) satumomab pendetide,NA,NA,NA,NA | |
| V09IB03,indium (111In) antiovariumcarcinoma antibody,NA,NA,NA,NA | |
| V09IB04,indium (111In) capromab pendetide,NA,NA,NA,NA | |
| V09IX,Other diagnostic radiopharmaceuticals for tumour detection,NA,NA,NA,NA | |
| V09IX01,iobenguane (123I),NA,NA,NA,NA | |
| V09IX02,iobenguane (131I),NA,NA,NA,NA | |
| V09IX03,iodine (125I) CC49-monoclonal antibody,NA,NA,NA,NA | |
| V09IX04,fludeoxyglucose (18F),NA,NA,NA,NA | |
| V09IX05,fluorodopa (18F),NA,NA,NA,NA | |
| V09IX06,sodium fluoride (18F),NA,NA,NA,NA | |
| V09IX07,fluorocholine(18F),NA,NA,NA,NA | |
| V09IX08,fluoroethylcholine (18F),NA,NA,NA,NA | |
| V09IX09,gallium (68Ga) edotreotide,NA,NA,NA,NA | |
| V09IX10,fluoroethyl-L-tyrosine (18F),NA,NA,NA,NA | |
| V09IX11,fluoroestradiol (18F),NA,NA,NA,NA | |
| V09IX12,fluciclovine (18F),NA,NA,NA,NA | |
| V09IX13,methionine (11C),NA,NA,NA,NA | |
| V09X,OTHER DIAGNOSTIC RADIOPHARMACEUTICALS,NA,NA,NA,NA | |
| V09XA,Iodine (131I) compounds,NA,NA,NA,NA | |
| V09XA01,iodine (131I) norcholesterol,NA,NA,NA,NA | |
| V09XA02,iodocholesterol (131I),NA,NA,NA,NA | |
| V09XA03,iodine (131I) human albumin,NA,NA,NA,NA | |
| V09XX,Various diagnostic radiopharmaceuticals,NA,NA,NA,NA | |
| V09XX01,cobalt (57Co) cyanocobalamine,NA,NA,NA,NA | |
| V09XX02,cobalt (58Co) cyanocobalamine,NA,NA,NA,NA | |
| V09XX03,selenium (75Se) norcholesterol,NA,NA,NA,NA | |
| V09XX04,ferric (59Fe) citrate,NA,NA,NA,NA | |
| V10,THERAPEUTIC RADIOPHARMACEUTICALS,NA,NA,NA,NA | |
| V10A,ANTIINFLAMMATORY AGENTS,NA,NA,NA,NA | |
| V10AA,Yttrium (90Y) compounds,NA,NA,NA,NA | |
| V10AA01,yttrium (90Y) citrate colloid,NA,NA,NA,NA | |
| V10AA02,yttrium (90Y) ferrihydroxide colloid,NA,NA,NA,NA | |
| V10AA03,yttrium (90Y) silicate colloid,NA,NA,NA,NA | |
| V10AX,Other antiinflammatory therapeutic radiopharmaceuticals,NA,NA,NA,NA | |
| V10AX01,phosphorous (32P) chromicphosphate colloid,NA,NA,NA,NA | |
| V10AX02,samarium (153Sm) hydroxyapatite colloid,NA,NA,NA,NA | |
| V10AX03,dysprosium (165Dy) colloid,NA,NA,NA,NA | |
| V10AX04,erbium (169Er) citrate colloid,NA,NA,NA,NA | |
| V10AX05,rhenium (186Re) sulfide colloid,NA,NA,NA,NA | |
| V10AX06,gold (198Au) colloidal,NA,NA,NA,NA | |
| V10B,PAIN PALLIATION (BONE SEEKING AGENTS),NA,NA,NA,NA | |
| V10BX,Various pain palliation radiopharmaceuticals,NA,NA,NA,NA | |
| V10BX01,strontium (89Sr) chloride,NA,NA,NA,NA | |
| V10BX02,samarium (153Sm) lexidronam,NA,NA,NA,NA | |
| V10BX03,rhenium (186Re) etidronic acid,NA,NA,NA,NA | |
| V10X,OTHER THERAPEUTIC RADIOPHARMACEUTICALS,NA,NA,NA,NA | |
| V10XA,Iodine (131I) compounds,NA,NA,NA,NA | |
| V10XA01,sodium iodide (131I),NA,NA,NA,NA | |
| V10XA02,iobenguane (131I),NA,NA,NA,NA | |
| V10XA53,tositumomab/iodine (131I) tositumomab,NA,NA,NA,NA | |
| V10XX,Various therapeutic radiopharmaceuticals,NA,NA,NA,NA | |
| V10XX01,sodium phosphate (32P),NA,NA,NA,NA | |
| V10XX02,ibritumomab tiuxetan (90Y),NA,NA,NA,NA | |
| V10XX03,radium (223Ra) dichloride,NA,NA,NA,NA | |
| V10XX04,lutetium (177Lu) oxodotreotide,NA,NA,NA,NA | |
| V20,SURGICAL DRESSINGS,NA,NA,NA,NA | |
Xet Storage Details
- Size:
- 275 kB
- Xet hash:
- 2c0762b060ac134c878ea4a9265480e523a2ad63900ee311d07b94f6ae47491d
·
Xet efficiently stores files, intelligently splitting them into unique chunks and accelerating uploads and downloads. More info.